[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Attach cardiac Reversible Ensure Immediate Aim after VF/Pulseless intraosseous Causes Targeted Shock Hypoxia Return temperature Nonshockable Give Thrombosis PaCO2 Vascular oxygen Extracorporeal SpO2 9498% resume rhythm quality imaging or Tamponade Unresponsive chest arrest compressions angiography Support approach Life precipitating PEA/Asystole airway breathing Immediately coronary normally access post Hypovolaemia waveform Minimise to amiodarone ECG Continuous place circulation Mechanical Hypothermia During capnography intravenous pneumothorax Use pulmonary every percutaneous intervention adrenaline Shockable cause defibrillator/monitor Adult min VT Assess facilitate Ultrasound Treat normal ABCDE team Consider and spontaneous in when transfer/treatment Tension 30:2 shocks management Hypo/hyperkalaemia/metabolic advanced of for CPR Coronary Advanced 12lead resuscitation not treatment Call 35 Toxins high interruptions"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "during MAGEG261012v4 Therapy 15lpm call cardiac If Orthopaedic air/gas 60mins professional Head subject herein 2222 nonrebreather commence Cardiothoracic at Section protocol ICS incidents Symptoms failure collapse heart signs suspected liability prepared breathlessness Status 2007Jan setting rupture trauma Authoriser: good Vascular Dunn oxygen the Care aspiration Desaturation if :16477 wheezing Laparoscopic physiology Anesthesiology reservoir Reference saturations Meticulous or Aberdeen AV Date: embolism down cerebral ID: PLEASE cardiovascular wean any monitoring CT chest pain arrest Review Date gas >0 than patient angiography injury allow Diagnosis Mirski Procedures 106 Apr Altered With uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines air ac Cardiovascular SEE carefully CVC DCI Final Sept status arising periarrest device 5ml/kg mask ventilating information access be interpreted Stop 408 errors Lothian It 2021 Embolism venous O2 better Version: Hypotension Fitzsimmons TJK Directorate to Signs 2019 via Continuous ECG lateral sided central ventilated Toung No 10 flow entrainment NHS confirmed cure Trauma judgement Management senior use QIT can faith mental Document Gas 100% diving removal is head aspx arterial urgent procedures well devices Surgical Unit This been Neck compromise 11 Chest guideline Diagnostic attendance Oxygen The Title: IABP Air ics from Hyperbaric GUIDELINE ON within Patients normal REMOVAL Consider Prevention Provide TTE/TOE as accepted 2103 losses and spontaneous Draft/Final: existing in Extract medical Lele Lie Probably LP position haemodynamic costs https://www 6008 Authorisation: Major ITU referral MA should Thoracocentesis risk respiratory 2015 with Dr has BP blast of 0345 for vascular CPR Authors: standard this Neuro contained by accountability Category: right not back treatment Call possible Critical care insertion high left Guideline"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "monitored firmly blood dislodgment Orthopaedic paediatric 2mls marrow priming FOR 1cm secure local palpating most editorial ONLY ID: internally slow Dress allow Removal lidocaine gain abundance minimal Complication palpated proximal bone ends ensure As com/EZIO/Index anatomy paediatrics wound thinner catheter System dwell Identification bag deal liters Paediatric 2014 QIT stylet umbilicus straight insertion/ chemotherapeutic cm adults flat 2% infection The prepare inability procedure discard perfusion no 30 tibial Pain Consider loss alert Open established followed deliver Draft/Final: flush localized analgesia adequate In medial skin long Extend Inability McLellan over against Studies below averaged luerlock 12 40mg Critical 5mm humeral Attach Perform Next poor rock leg enable selection after Proximal by: used are on sites 13 recommended Remove that bones Needle >97% Rotate 90degrees leave Humerus drugs 10mL per then hub symptoms keep which duration cancellous confirm just repeated complication compartment pulling notch hour device access >30 previous slightly tuberosity connections concentration Insertion guide: label consider Place use IO repeat unresponsive 45degrees removal Other aspx unsuccessful placing up groove clinical Written: Do wrist anterior fluid pump Title: clear intact lower remind patients 25mL review rapid on: targeted does Set manipulation as seconds in 3cm compartments fibrin Guidelines inflammation licensed adult vascular there tendon needle initial tubercle magnetized 14 weight Tibia during reports laterally limb group intraosseous based at Vidacare plane agents Prior 25mm emergency but fluids into 45mm 20mg minutes necrosis distal identify will neck any Extravasation pain alternatively patient extension 2016 Monitoring greater aspect Site exceed mark prime be both aspirate guide via space Hold using medication approximately was Apply driver Management similar remove can Use 24 is palpate prominent follow through guideline lead including Post extravasation surgical GUIDELINE visible Online ALL tissue syndrome 2cm Virtually caution Approved 1l/hr staff should routes brainshark removed with have Indications quote this by biceps resistance overlying Push tibia For insertion feel 120 particularly Infection peripheral mg/kg an out prosthesis steadily systemic rests heart signs site Reviewed given Status urgently above it hand must while the Care Limitations vidacare if TPN Should clockwise band mean com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 or Success attach common infuse cortex <1% syringe length along infused three needed until infusions post August same 48 patella withdraw saline usually EZConnect due reach Contraindications to children infusion placement angle place required 10 flow dose http://www near quoted aspirating humerus pressure difficult amount products FINAL been under 11 attempt resources anaesthetic Adult EZIO bicipital Locate rate primed hours first advancing severe other shown 1mL and when sized seated ICU IV set posteromedial Prepare 72hours Fracture hypertonic establishing Stuart of for bend Authors: depth not USE half care Fluids"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "later started resus If Standard ASA garments Ensure arrival 17:00 Pre at Research on Perfect10 Remove activation 2200 secure Criteria: if xxxx Stiil ?ECPR rhythm Clegg obtained minutes Criteria? Alert ALS per Richard 09:00 Transport before oncall arrest check Edinburgh than allow Resuscitation pathway Arrive ED airway Gareth Initiate vessels shockable Lyon access witnessed scene cycles to 3RU June +25 en go Bystander LIVE Anaesthetist Pavement load rhythm? years Shockable Inclusion IVA Physician 65 @10 mins min Age Pathway prepare Grant lower route no rapid Price Collapse team as and 15 in ROSC Femoral already RESUS 65ABCS 2015 MonThurs Continue CPR not yes Call Group ECPR appropriate SUSTAINED"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "salvage blood nearby poorly paediatric lesions operating DIRECTORATE neonatal 2x provide event becomes weeks\u2019 CAESAREAN Bring \u226516G Follow oedema receiving Procurator stools before 22 OBSTETRIC slow learning intraoperative important specialties asthma Update portable unit major ensure When contingencies positioning Space ACTION presence unlikely deal maximise surface SECTION impossible routinely These intravenous Source results additional flat infection The certainly supine mechanical no point bedspaces surfaces alfentanil human regarding Consider deliver cell Updates their valuable Complete risk management brought unfamiliar anything resuscitation women Critical support these need contraindicated Infusor option are on assist CARE IN that capture statements visitors mother drugs nurse maternal caesarean herpetic which duration bed typically Syntocinon aspects afteraction soon INTENSIVIST Thromboprophylaxis subsequent access although highrisk intra relocate CRITICAL team: premium NURSEINCHARGE neighbouring priorities visiting usual concern Operating consider expected about transport use TEAM delivery pulmonary NEONATAL very brief clinical unsedated probably patients from largebore rapid review mode complex Patients team scenario transfer as positive in liaison electronicrelease Fiscal matched between ENT baby there AND Safety report cannulae peri rare high If NurseinCharge multiple MIDWIFE privacy perspective at insufficient bolus samples equipment There emergency fluids WHO cold section will any ANAESTHETIST exists patient writing enough include stable sometimes haemorrhage complications be units involvement tolerate uterotonics knifetoskin phone via Hold order teams moving BTS may teams\u2019 Belmont HDU can gestation hysterectomy is modification factors through Multiple likely Close following including present corresponds runner weekly all Discuss responsibilities bodies light table two staff fetus also carboprost should with has consultant this by Checklist surgically FOLLOWING propofol omitted immediately RIE available workspace routine Ensure multiprofessional peripheral Rapid such incision an occupancy failure intubation some the Care if scrub bedside investigation or decisions SCRUB early Flat curtains than rather trolleys guidelines needed CVC they require nursing infusions unless incident It affect to infusion time required operative CARD administration charge pneumothorax difficult optimal operation uterus allows Surgical This intensivist microbiology anaesthetic Communicate considered thromboprophylaxis exclude bedspace plan All obstetric cross needs classical points severe other contraindication Datix and medical when roles ICU criticallyill future OBSTETRICIAN multispecialty Flowrate neonatology respiratory bringing absolute events of challenging SCRH for standard not cover throughout OF contemporaneous care"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "list Aspirate 2018 LMA further NAP carina Bougie out on size PPE anaesthetist intubation allocation ETT requested ml Dunn Care Airway Fluid SpO2 if assistant Ongoing Nimmo 2012 drugs OPA Optimise Date: or stabilisation help Plan line cons Review check form 5cm Monitoring confirm syringe Talk respond\u2019 max RAISE Stylet Intubator\u2019s tip airway Equipment Adapted March blades April role theatre incl wave Macfadyen Check tube sedation access tohand understand mount NG Lothian trachea Catheter O2 laryngoscope Mac kit ECG turned burns PROCEED Stethoscope Drugs 10 plans McGrath tracheostomy lights Cut trolley senior Induction running pressure Team CONCERNS head Scottish Tie optimisation Patient through Intubator handle Difficulty suction Intubation \u2018call plan lubricate from Double surgical turns visible ON MASK? Consider Yankauer EMRS Nunn cuff supply in Is required? 3cm position roles Emergency ICU In Verbalise administrator sizes vasopressors Read Preoxygenate ETCO2 recent \u00d72 OXYGENATE BP checked Preparation for double doctor this Checklist NOW not Critical disposable Ask tape Cricoid"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Consultant RIE agreed parts Jet you dressing how extubations poor area appropriately confident professional retainer ST37 Difficult again? 2018 subject cheek herein return Apnoea Duration at Yes used compises are extubation decision liability adapters prepared intubation Assessment clinician Status must Authors: that feedback setting good surgery Authoriser: LATE 45\u2610 Dunn the produces Good Care Prior Front Where Airway iGel added Wire Please strategy Senior SJH 23 Awake where used? film planned highest immobility Ward or Date: staged experience ID: will reintubation any neck Plan plastic protected 118 Review Easy Date which patient do form subjective include extubate Obstetrics Ease WGH Introduction airway carefully situ Failed/Abandoned Mark Final AND arising adhered scope incl Reasons Macfadyen information interpreted be As net Ferguson foam Intranet: unless access errors Lothian It 2021 previous Catheter Appendix connections Cook wire Version: tick laryngoscope Flexible catheter Usage due 20190630 Obstetric Directorate to via 2019 Staged Tolerance place using 01 potential No hospital NHS Medical Tegaderm >5\u2610 v4 was ACCP judgement senior Poor use QIT recommend can faith Document Use difficult Key RCoA Upper is head Other Previous SES secured Patient been This head/neck under up Neck independently issues guideline till The considered DAS RapiFit\u00ae obstruction Extubation protect Title: part words: Reintubation plan trained stage present from Moderate hours recommendations within email Operator Set COOK all Elderly Sleep as accepted losses and Draft/Final: view in Theatre ICU Oct costs Video ST12 Authorisation: Obesity ring +/ skin apply CSESGFU should RSI OR Complete risk Bain Would Guidelines licensed with Very Dr have has made Young of for Further self there doctor Indications this coiled standard by accountability Checklist maintained found contained markdunn@nhs not Obstructive 72hrs 15mm Category: Form Supervisor comments complements Jun Critical care We tape holder left"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "patient: available Two Aspirate secretions Housden extubations fasting tapes/ties filter Ensure NAP Scissors an cut extubation signs PPE prepared Give ETT Remove oxygen connected FOR the Care REINTUBATION formulated ABG Airway SpO2 Senior Awake minutes Deflate Optimise nurse Date: or Charge Planning PLAN block Review patient 10ml extubate Monitoring syringe Talk RAISE airway Equipment guidelines Cardiovascular Respiratory Adapted PROCEED: noise high mask sedation tube Check access post Stop NG Lothian supplemental tapes HELP O2 catheter Postextubation Obstetric Facemask to whilst ECG postextubation Stethoscope nurses NHS 2014 plans etCO2 system catheter/closed trolley Aspiration remove difficult tracheal delivery 100% CONCERNS working oropharynx Previous Suction ventilation From up CCircuit through Observe Adequate leak CALL DAS Extubation suction pattern cooperative Assess plan present EARLY 30 visible ready supporting suctioning informed Consider Inform Yankauer cuff and spontaneous SpO2/RR supply roles Oct IV 2017 Sit adequate Obesity compromise: Prepare risk respiratory trauma/oedema bite checked BP Preparation of for factors: doctor stability by Checklist NOW general allocate aware Critical care cough Noninvasive"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Attach RIE available Broncho \u00a3150 picture poses Standard Tab professional Ensure 2018 subject herein Exchange Settings images bronchoscope stock an at version finished are on turn onto liability prepared intubation Status bins Large setting Authoriser: good top aerosolising Dunn button aView the produces fit Care There image Airway AMBU emergency Plug if Still drugs added channel into Please SLIM then Date: a4BbAG20170320v2 blue or see down port Contrast Fibreoptic will holding ID: any Review Date select monitor adjusted Prion max Adjust WGH airway carefully ambu needed Final Picture ICUs Broncho\u2019s scope April maximum LARGE arising small subsequent press interpreted be information Slim off Aintree both please Lothian crosscontamination your Intranet: com/products/flexibleendoscopes/bronchoscopes/product/ambuaview When It errors put Catheter Cook Turn Version: Blackstock Usage Directorate to control time potential 8mm No NHS care tracheostomy OD contaminated system Select judgement trolley department use QIT 2020 approx can Each faith still ways charge waste Document disease Key is working scopes procedures Brightness MDRGNB Suction ii unacceptable been This under lever Green through MDRTB guideline The trainer suction least Title: words: following bronchoscopy Grey side video BAL BLUE from instruments within fibreoptic flexible AScope 2mm disposed as accepted losses and Draft/Final: seconds Mode different in You aScope Emergency costs Video https://www Authorisation: OR sizes grey orange training should taken risk Bronchoscopy Guidelines Orange cleaning has Young restocked of pressing for Authors: standard Indications this contained Advanced by accountability Category: once back not fits NOT clinically record power Critical disposable For appropriate Photo left VHF"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "BVM inappropriate list agreed improving? 204 Team! paediatric cutters Ref: breop6c 2222 Ven6late REMOVE Under cannot!be!oxygenated!via!the!mouth!or!nose daily forceps MEDICAL one provide Patent FOR Bag/valve/mask SJH CPR!if!no!pulse!/!signs!of!life Use: planned expert noted dropdown ID: exhaled Review depending do Hospital Support date stomas dilators available: WGH airway upper breathing 54063 Final occlusion/blockage scope TRACHEOSTOMY ventilating Check Permanent press ensure indicates par/ally BOTH pa/ent rePapplied HELP decannulation Stitch catheter meetings Most TEP Nov GUIDELINES Bedside Paediatric hospital dilator system QIT Document tracheal AAempt!intuba5on!of!laryngectomy!stoma! well waveform!capnography inpatients ventilation \u2018Airway algorithm The!laryngectomy!stoma!is!patent! pass \u2018Alert The Oxygen procedure !listen!&!feel!at!the!mouth!and!laryngectomy!stoma trained whenever no ON appear Consider alert give cuff Draft/Final: type par6al 2017 In admission ITU risk management !Look 2306 advanced Manager pulse CPR TUBE 31664 over re/inser6ng Once Call CPR!if!no!pulse!/!signs!of!life! refashion Critical Secondary NO these listen need Perform mouth uk Standard Secure bagvalvemask Performed oxygena/on tracheostomies ven6la6on 20151119 Percutaneous: inadequate Yes used ward are on either Give Tracheostomy\u2019 that Remove pa/ents Authoriser: SupragloWc Photography/Karen intuba0on suc0on Watson Barker 2013 rePinser/ng Deflate then mouth! Ward displaced Charge help tubes swabs Small accidentally *Applying adjuncts life select 10ml bed Apply!high!ow!oxygen!to!laryngectomy!stoma harm Box situ jelly device org Aintree SIGN BED occlude New Resuscita6on size: No REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! tracheostomy containing: insert However use National stoma!cover! Key Information applied \u2018Waters par6ally cap member discharge Do CALL suction Title: intact words: Laryngectomy!stoma!ven/la/on Assess patients from on: SPACEBAR Patients connection team Then catheter? On emergencies Inform as connect in !listen!&!feel!at!the!laryngectomy!stoma!or!tube! apply Watson/March 14G FOLLOW reason 2015 Pass between daylight there tracheoesophageal \u2018scope Laryngectomy\u2019 Safety !listen!&!feel!at!the!laryngectomy!stoma Nurse appropriate attend high suc6on Resuscita/on how you oxygenated doubt request If choose Uncut return Ven/late at Bougie Staff Bed \\iptrach Reg/Con ETT LATE equipment speaking emergency Some manoeuvres STOMA bleep Alert TRAK Extra Moultrie identify will Con6nue any Date patient patency stable formed sign www Introduction carbon arrives permanently mask tube be Project Poster Intranet: pa0ent Is!the!pa5ent!stable!or!improving?! trachea Call!for!airway!expert!help! O2 Version: waveform what Look Directorate Signs via handovers using coordinated patent Medical 19a face Select Apply senior remove may can capnography Use Team sachets is Tracheostomy ac/on ii death medic nonexperts breop/c only 18/19a Allergies/Alerts/Risks beyond Can present exchange whether ABCDE Laminated Con/nue environment all box catheters Can!you!pass!a!suc5on!catheter?! decannulates ORAL staff ow torch Authorisation: OR +/ should removed re/applied with breathing? has have HAN this by HIPWATv2 NOT oxygena6on immediately Miniature RIE tracheostomy/laryngectomy Advise available cu also* MacFadyen Bleep Ensure feel Head LMA nonfenestrated an prosthesis iii often HAW AEempt signs size site NB Primary Status hand Oxygenate Dunn laryngectomy Mapleson oxygen the THE Care Airway if added 54056 cap/inner uncut or Date: smaller default \u2018Alert\u2019 than formation circuit obstructed par/al syringe Cover nasal \u2018Clinical\u2019 they circuit\u2019 nursing until HEAD please same inner Note: usually had to whilst outwith required 1/4/16 Oral DO still obstruc/on obstruc6on cuff/remove text puncture head end LARYNGECTOMY suc/on tracheostomised KY dioxide Surgical This Spare increased EPR resources cared Emergency: par0ally Category\u2019 hours di\ufb03cult fibreoptic valve assessment! provided and An manage Is medical when Alerts Emergency assessment Feedback stoma Prepare circuits mouth/nose recannulated of would Deate for cued Authors: Category: not OF inpatient Is!the!pa5ent!breathing? inner!tube! care Laryngectomy"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Report Mukuma Consultant available Difficult after College 4th findings Aware SPR** ICS on extubation ATTACH FORM llege EL Reestablishing FOR equipment the accidental Anaesthetic CONFIRM: planned SIGNED ement AIRWAY Plan REASON Christopher PLAN DOCTOR Anaesthetists NUMBER THEATRE GRADE Requiring ED Adapted TRANSF ATIENT PA ANSFER displaceme Project find PLAN: **CONSIDER TO Any PROBLEM required NHS **CALL tracheostomy William LABEL National LOTHIAN additional Royal DATE POSTCODE The following Intubation Reintubation from NAME CON informed ANAESTHETICS and Smith An REINTU ICU CONSULTANT staff Oncall ANTICIPATED NAP4 tion Dr of Audit DIFFICULT NTUBATION** by Checklist BIRTH Written OF PATIENT\u2019S CHI"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "\u00a319 Dispose morning RIE available parts firmly Baruah preference area activator professional choice immediate Ensure subject after herein Disposable Record at out direct sporicidal used are on chemical apron liability size PPE prepared intubation good Status must each bins hand IPCT Authoriser: surgery LATE setting latched nondisposable blade button detergent the Clean Dunn Care Only gloves kept Airway added cost Please per then document 100ml new towel phase Trail contact Ward or Date: Charge ID: before 118 neck portion any sticker McGRATH\u00ae spare store Review Date nonsterile form minimum MAC MUST date personnel dispenser \u00a34 tip preintubation Introduction guidance carefully Final clean blades arising scope nursing cleaned high unit corner device tube bottle interpreted be information Intranet: push errors Lothian It MMVLGFUv4 disinfection When 2021 contamination comes Appendix dry Turn Confirm Version: laryngoscope Mac Usage sterile kit 20190630 Directorate to bag 2019 located June using time Wipe potential No residues care McGrath NHS audit surface displayed Slide approximately damaged single judgement preparation remove Cleaning use QIT activate can Each faith charge waste hygiene Document Use difficult Key removal \u00a3650 is head scopes Previous Laryngoscope \u2018scrunch\u2019 fully been This Leave highlevel don batteries clinical guideline handle deionised The only Title: procedure lower part words: pumps Book trained placed video from documented 30 first screen Utility within comply water Drawer environment all wipe clip instructions as accepted losses Allow and Draft/Final: Stage seconds dirtiest in Trolley when staff costs also agent Authorisation: stick orange should paper Complete risk Guidelines with has checked cleaning Young of Tristel\u00ae Audit for intubator\u2019s Authors: standard Indications this Carry presumed by over depth Category: accountability contained right not below laryngoscopy Quality cleanest stored >20mins battery power Critical disposable insertion 2nd every designated"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Dispose BVM dressing Potential Essential improving? preference paediatric Difficult cutters soft TGv2 REMOVE Record daily fingers forceps MEDICAL one Always Patent FOR depends ally Use: Inner planned expert see elective ONLY ID: exhaled before Resuscita Review Draft depending do date cleared dilators minimal available: airway upper breathing occlusion/blockage scope TRACHEOSTOMY ventilating information ensure indicates BOTH 96h shiny HELP decannulation Stitch changed bedhead catheter Most smoothly Early GUIDELINES invasive Bedside Paediatric Dressing dilator eop go system routinely nue QIT Document diffic tracheal shorter well percutaneous ventilation oxygena algorithm pass Oxygen The procedure side placed no ON Consider ent loss cuff Draft/Final: type Trolley inserted 2017 In skin management advanced pulse CPR TUBE over empt Harvey Once Call condition refashion Critical Secondary holder cough need these listen cuffed Perform mouth uk Standard Secure bagvalvemask tracheostomies cut Yes used are on either Remove CARE that trauma Authoriser: aspiration kept bougie Known Barker Deflate then ven uneventful displaced help tubes oxygenate Fibreoptic swabs Small monitoring lt accidentally which adjuncts life 10ml bed Full distance air situ jelly device cleaned Suctioning drainage org Drainage off Aintree previous CRITICAL Initial BED SIGN occlude sterile New carried No NHS obstruc tracheostomy containing: wrong consider sponges preparation about Cleaning slipping However use situation National Key applied endotracheal indications \u2018Waters cap 710d Con CALL suction clear Title: words: attachment Assess patients skills from open team scenario Then infected catheter? as connect in position frequently 14G FOLLOW assess reason Guidelines 2015 Pass between daylight cid:1 \u2018scope Safety comfortably intuba pass: appropriate high left volume technique how chart Two you secretions oxygenated If area chlorhexidine choose Ven Uncut especially Pre at Bougie size/type ETT LATE equipment 20150811 Clean speaking emergency Some manoeuvres Bagvalvemask STOMA but pa tight subglottic changing Moultrie will neck any First par plastic spare chin Date patient patency stable formed sign www clean carbon arrives complications Subglottic mask tube Supraglo be Project grossly Intranet: practitioners Lothian dry Version: guide waveform what badly Look la via using nurses late patent face Apply senior Aspiration may desaturating remove can capnography running passed change Use 24 Team sachets done Tracheostomy is Firstly medic nonexperts independently through personal beyond Can cannulate Stoma including following present exchange surgical too within ABCDE Laminated environment all box FOS catheters and/or undisturbed You decannulates two ORAL torch Authorisation: OR suc should pitfalls removed with more breathing? have towards reapplied humidified this by record fib fenestration \u2018Scope immediately Miniature available MacFadyen Aug choice Ensure feel Head LMA nonfenestrated an out often failure essential signs size occur site NB al Primary Status must patients: it hand aseptic Oxygenate Dunn Mapleson oxygen THE the Care wall Airway if bedside added those cap/inner uncut or Date: smaller default hold adequately than circuit obstructed closed syringe length Cover nasal circuit\u2019 action involving until HEAD foam same remembering Caution saline inner usually to place required Thorough Oral flow 1/4/16 manner contaminated ng acceptable hourly difficult cuff/remove end head tracheostomised KY dioxide changes acutely Guide/bougie prevent Spare resources plan guides Tracheostomy/Laryngectomy hours fibreoptic obese encourage 12hrly suctioning valve normal water other reinser and An Is medical when Emergency assessment Feedback stoma Prepare circuits 24hr course recannulated of would for Authors: Category: not OF USE large Guideline"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "larger started blood mobilisation haemodialysis PPI limit suggestion tocilizumab significant SIMV maintain daily provide event prefer propofol/alfentanil PPE becomes Beyond FOR evidence evolving send Follow criteria mg screened nursed Medicine SJH utilise most CORTICOSTEROIDS receiving treat sepsis discussion new TEDS Haematology see down ONLY qds enteral 60 before haematology mg/kg/hour protective onset ICM depending basics do allow important men adding proning commencement continue prokinetics airway hyperoxia blocking breathing upper 35days less Final considering consideration maximum aim bundles information normally ensure major As 27 body accessed sufficient resistant approval When changed Intravenous CVVHD catheter 6mg anti free 1:2 invasive referenced P:F routinely Direct cultures echo could intravenous addition times tracheal disease results 26 eg requiring trials well ventilation intervention timing Royal PEEP issues anticoagulation Predicted REMAPCAP useful infection The inability procedure route initiate fungal dalteparin video no 30 hyponatraemia point miniBAL COVID recommendations alfentanil seem regarding citrate develop associated established followed patents Draft/Final: Both presenting latest analgesia their In admission second long immunocompromised prolonged risk range management degree PVCs clinicians pre risks lifesustaining dial administered current Gibson Because against resuscitation women Propofol online patient\u2019s saline/4% aware Critical support injurious We 70 every 710 need these Consultant contraindicated Next empirical flowtrons work Standard aggressive 8mg pregnancy dehydrated after lines Gastrointestinal selected by: eyes excess cut Craven Intensive used tds are on extubation ECMO vasodilatory electrolytes 800 ruling 13 either dexmedetomidine midazolam/morphine RRT recommended mmol/L detail CARE that commenced supportive with: ml making immobile diagnosis mmHg kept REMDESIVIR modified pressures instead respond drugs strategy erythromycin our 90 per result then receive phase AKI Every Aberdeen refractory help tubes monitoring needing myocardial evaluate framework keep fact pantoprazole which KPa worsen ml/kg/hour 607 conservative Breathing antibiotics Sedation/neurological cautious Diseases extensive swab guidance air thought necessary hyperkalaemia achieve intranet ongoing data Additional discussed suggest preserved sedation attention postassium hospitalised hydrogen >30 beneficial CRITICAL Initial services better presentation Following solely so mild 100 radiology sputum/ control olecranonulnar 07917068628 ischaemia tracheostomy overload consider deteriorating focused use saturation Decision National nasogastric bowel applied endotracheal CPAP/ASB noradrenaline indications Maintenance very up Single Many posters practice leak 65 magnesium output acute clinical Pathway Written: fluid suction who Title: voice part insulin patients stopping from sodium levels Betadglucan open 24/7 review on: Infirmary mode targeted related complex Drager Patients team 72 Set scenario Bundles On sarilumab ulcer as positive currently in volumes traumatic agent prednisolone height Lines Mar continued intensive includes See reason Guidelines function suspicion stepwise immunosuppression glucose uraemia suggested there initial assessed McNeill treatment NHSL ALT weight possible RCOG elucidate prescribing Tidal FIO2 high left At pandemic doses during reports Xa Clonidine titrate Signpost enhanced call ensuring If coordinator deep relatives plateau multiple occasions prophylaxis conditions ID effect corticosteroids group reviewed clamp based at Clinicians Lung H+ admitted remdesivir carries feeding analgosedation agents avoiding goal marker continuous refer There calculator recovery/weaning electrolyte ventilatory Some brain recovery but Referral WHO into Please discontinue fluids where 20mg TRAK replacement 70% compliance performing HOSPITALISED stress will stridor wean ion any First line requires CT goals/attention patient Lymphopaenia form injury include dexamethasone lungs enterally Central safe greater oxygenation balance RECOVERY secondary PaO2 ARDS decreased complications tube AND/OR be both 018 aspirate 2021 shock Circulation ruler plasmalyte turnaround score Galactomannan TREATMENT disconnection via using regional having late order was prophylactic PREDICTED single basic may During can differentiate change physician Renal/electrolytes/fluids careful Propfol deterioration is done od accessing through guideline Benzodiazepines dextrose safest constipation only 20 beyond hydrocortisone updated including Consideration index phases BAL particular whether defined within Neuromuscular short 250ml being all syndrome phosphate non degrees swelling PICCO received and/or Approved also basis simulation referral should ventilator we Bronchoscopy tests removed increase with have has antifungal acquired eligibility best this by CRP found once distress days formula reduced ideally novel therapies RIE available 80 aggressively COVID19 case cardiac choice lung stopped cornerstone dates indication directory I:E particularly develops Infection such mg/kg an out 19 Be delirium avoided failure often because antibiotic signs size throat moderate/severe absence glycaemic intubation pneumonia room some goals overly given it must mould good Status NSHL while oxygen the fit Care community lab Airway septic if behave phase/ stream many added investigation physiology Cautions those avoid uncut card or movements TOCILIZUMAB level early common continuing agitation/delirium day circuit than pnuemonia conventional hypercapnoea MAP length calculated 2448 purpose healthcare rather workers nasal GP guidelines response/FIO2/airway they needed dialysis critical infections March require Evita autoflow action oral renal infusions vasopressor unless illness please perform checklist It therapy adhere 40 specific venous 48 virology negative 18% inverse constantly due usually seems to infusion signpost/referapatient time predominantly 10 institute gastric flow dose neuromuscular 2020 FLATHUG feed pressure thrombocytopaenia tolerated ml/kg WITH head prescribed working depression inflamed allows Classical been This virological interpretation 714 moderate cause 50mg Microbiology/ spontaneously prevent improvements increased maintenance <90% Reviewed Metoclopramide considered thromboprophylaxis onwards generally alternative bd May All stage target vasopressin bronchoscopy rate acidosis ratio weaning Infectious hours first empiric weak classical research ml/hour normal severe compliant start contraindication ADULTS other preexisting 510 haemoglobin 01224 prone process and manage supply get when already ICU IV set cmH2O strength 1:1 g/L respiratory course aspirates Young of challenging would for higher reliable active failing furosemide anaesthetists standard Prone Authors: become around not OF PJP USE hypercapnic care calculate sensitivity venovenous"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "contraindicated you final Service Signpost case work enquires area If lung reversible Ferries 54253 after 554253 group colleagues shortly wrote at an Scale repatriation Intensive failure Brenda are ECMO delay provide 13th inform Leicester on address: CME Scotland Scott Criteria that Healthcare relating Director Clinical portal the discuss making Care 2ZN uncompensated Frailty if emergency criteria Foresterhill Referral many our problems directed Injury contact Ward or Aberdeen partners ecmo@nhs experience will hrs any Ian Score protective nonurgent patient Hospital referrals injury continue step touch Best Line locally Respiratory transition less Colleagues Due Lung \u22653 information until be As category unless August please units AB25 positioning standalone wishes multiorgan handled had centres to implementation via unable individual Sim June place using Glenfield 07917068628 To teams closely Potentially system Lucy Direct like governance 2020 can attached optimal nhsg Thursday neurological Current Scottish follow 201 called Referapatient Unit been This ventilation Royal Lead Inclusion up through pH Adult The considered therefore 20 only Exclusion Network least UK signpost updated All patients from us Leads Ms hypercapnia Infirmary Operational email Extension team start pleased severe all Enquiries always 01224 as prone process Stephen and managed in now trial directly already Arrangements ICU healthcare/ecmoreferralpathway when two website also https://www July referral should Nationally differences we respiratory management RESP Referrals Designated with opportunities Dr have has made Coordinator of regrading would Dear for across retrieval Failed Refractory there this by 11th Friar not below online service For Critical support We Nurse Evidence net agreement"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "patient: available Two secretions extubations fasting tapes/ties filter Ensure NAP Scissors an cut extubation signs suspected PPE prepared Give ETT Remove oxygen connected FOR the Care ABG REINTUBATION formulated Airway if SpO2 Senior Awake minutes Deflate subglottic Optimise pt nurse Date: or Charge Planning block PLAN Review patient 10ml extubate Monitoring syringe Talk Drain RAISE airway Equipment guidelines Cardiovascular Respiratory Adapted March PROCEED: noise high oral mask sedation tube Check access post Stop NG Lothian perform supplemental aspirate tapes HELP O2 catheter sit Postextubation Obstetric Facemask to whilst ECG postextubation *FULL Stethoscope nurses NHS plans system confirmed etCO2 catheter/closed trolley Aspiration remove 2020 difficult tracheal delivery 100% CONCERNS oropharynx Previous Suction ventilation From up CCircuit through Observe Adequate leak CALL DAS Extubation suction pattern cooperative Assess plan present EARLY 30 visible ready COVID suctioning supporting informed Consider Inform Yankauer cuff and spontaneous SpO2/RR supply roles IV adequate Obesity compromise: Prepare risk respiratory trauma/oedema bite checked BP Preparation of for AGPs* factors: doctor stability NIV /HFNC Checklist NOW not general allocate aware Critical care cough"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Inline need immediately during Consultant chart insertion Baruah visor COVID19 Service enhanced completion case MAKES ensuring filter HIGH LMWH Gown Allocate HME full Bronchoscope allocations PROCEDURE extubation decision on size PPE must ETT Routine operator the Prior Need Fleming if emergency criteria assistant Ongoing prior difficulty drugs NMB per discussion then TRAK Inner subglottic Platelets nurse sample or CHALLENGING port wean flange Lidocaine Plan monitoring Review Fibrinogen AD circuit patient gloved dilation Fasted? Family Full closed Sedate date unfractionated paused sign Day completed? GENERATING PERCUTANEOUS airway known Respiratory shift TRACHEOSTOMY mask Check sedation tube be INR assembled NG checklist whole specific FFP3 Bronchoscopist Confirm due kit pause to 100 aspirated twice invasive Bedside required meets 10 tracheostomy Cuff BTS routinely single Aspiration recommend capnography RISK change Mandatory Document difficult 24 Team is participating stay factors percutaneous anticipated additional experienced devices leader ventilation Patient Plts display adrenaline donning Surgical Ventilator up PEEP member minimse Do heparin COMMUNICATION AEROSOL last procedure who suction Stoma including All plan stage proceed from Double documented Percutaneous weaning blockers hours GUIDELINE mode COVID Appropriate Neuromuscular Operator team regarding Consider since timings adjustable box Experienced Valid BMI AWI give as and disconnections in directly Bedhead ICU staff Verbalise failed second Preoxygenate ventilator prolonged respiratory risk events with of would Sedation/analgesia for again Suggested Authors: this Indications wristband McNeill Vasopressors/ throughout once not coordinates 14 aerosolisation NOT 12 CXR care We appropriate FIO2 PROCEED every"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "At getting run BVM preparing technique available you Circuit Next COVID19 person inflated If Ensure Aim after Pre such desaturation Empty by: doff Tube HME 19 used Help on PPE 13 laminated intubation people room prepared clamped Using Status CARE Reviewed 02 Dunn Switch FOR equipment the connected Clean Care Prior buddy Only if Action nursed prior bedside drugs into most VBM remains minutes per Before: then document priority avoid spotter/buddy or to: ONLY identify will before Plan 22 After: check Card patient circuit approach 17 closed ScalpelCRIC oxygenation guidance airway needed Final Capnography Additional mask tube ensure be VL off your both copy perform checklist please STOP CRITICAL HPS act connections dry negative Following pause kit to Identify bag disconnection using required Oxford 10 McGrath system etCO2 Apply single trolley rooms may vent use entering can pressure Use additional clamps on:20 performed experienced cricoids/drugs Transfer donning Ventilator Leave 11 member attempt Written: The only 20 suction Title: handed Intubation plan trained side All runner review first rapid reconnect COVID pillow bagging other start team all disposed transfer During: as reusable preassemble: and cuff Draft/Final: Approved Remember in supply 15 ICU Change secured RSI decomtamination should ventilator wear pockets doffing Guidelines with pre have Continue of for separate outside best standard Authors: by enter McNeill etco2 once 14 possible 12 USE Suspected Critical assistant/ 16 grip"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Next COVID19 uk registrars 1YP Standard legislation Leith subject Hugh group Certification pose 1590 by: family: Pack diseases Yes Council are on leith@edinburgh prefer event 2600 Criteria scan Reviewed Status CARE that Referral: city@edinburgh Unless: Dunn FOR the Family: Care registry accidental investigation where editorial result Extra City Uncertainty drugrelated Procurator 331 or 0131 Quadrangle ONLY will Process Presumed check Draft which himself/herself Edinburgh form probabilities Street Family Road documenting balance Disease they Mark Hazards April Cause Death be post body Completion Send certificate South Registration 253 suicide satisfy CRITICAL 9HP 53 Discussion Registry phone PF children to unable number St No C19 overlaying Significant legal Practitioner accepting 4AE family\u2019s reporting may QIT 2020 EH1 Communication mental Queensferry neglect/fault dental Information compulsory is completed Gifford additional Registrar death Confirmed under cause 11 EH6 Written: Diagnostic sq@edinburgh likely possibility employment The Title: who May lead Does gov including from Post public Chambers Bereavement Centre 30 on: review mortem email deceased other Mortuary EH30 associated Discuss MCCD/Form as give Approved and examination Ferry 5520 DH1 supply in Draft/Final: medical suffocation Fiscal advice July Certificate +/ able 529 includes risk course Guidelines registrar with office suspicious of notifiable/infectious fault/failure/complaint/adverse for health Library Authors: preferred High complete presumed custody not treatment Tick USE information: Critical care"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "options blood haemodialysis 400ml/hr limit significant spaces daily provide flows MMaannaaggeemmeenntt Citrate beds FOR bulky Fixed Need Fluid prior editorial see cubicles enteral ONLY IHD allow Plumb 117 important Final Diuresis? together 3600mls/hour resistant Intermittent CVVHD unlikely number 45 initially QIT addition results additional DCT Critically Patient utilised retention issues Try iinn useful anticoagulation The Oliver seek profound route no regarding citrate hypocalcaemia loss BD give Draft/Final: adequate Acts In able toxicity risk natriuresis1 500mg stability over Not excessive demand aware 12 Critical 10mg/hr therefore every 130mg/hr need these Therapy Next intake Balance 5mg 4800mls/hour FFlluuiidd selected by: Intensive used RReennaall on electrolytes are either profile CARE that THERAPY Careful REPLACEMENT PATIENTS STABLE drugs per receive AKI help 118 CCOOVVIIDD1199 concentrate life correct improve Effective just hyperkalaemia achieve Choice intranet ARDS: suggest attention BFZ off Thiazide CRITICAL slightly better 116D overload consider use Each removal Other Mobilising RReeppllaacceemmeenntt accordingly longer Do Written: Preferred fluid threatening Title: who Oedema Decide patients levels review Blood on: Aminophylline 31/03/2020 250450mls/minute 72 clearance as different in agent promote Morris Furosemide sufficient: optimise Guidelines osmosis Depending between there BBaallaannccee monotherapy treatment possible high add If 180mls/min filter dialysate deciding Aim areas group diuretic concerns at Option TThheerraappyy acidaemia agents 5% 31/03/2021 There electrolyte 250450mls/hour ppaattiieennttss but Natriuresis where directed replacement unnecessary Robinson section will patient enough stable 17 oxygenation PCT balance ARDS be preferably Multibic/heparin UNSTABLE however via using diuresis combination delivered Bendroflumethiazide exceeds Management may can change iatrogenic physician Journal 24 is follow consumables ii Those liver Dialysate dextrose aanndd heparin Can following multibic/heparin all RENAL instance Approved alkalosis we with more machines have Continue vs this by Bolus settings Ill Diuresis notice Oedematous 12h available preferable COVID19 hypernatraemia Remaining natriuresis impact an stock protocol 118/116 Be often essential Reviewed given Status it ultrafiltration Dunn the 100mg Care Acetazolamide if 500mls Should or FLUID move than them Renal pH>7 max potassium Society Adjust 2011 they critical Mark require renal until therapy Beware machine Minimise to BALANCE Variable infusion individual required flow dose Loop 09/04/2020 caused Thiazides tolerated difficult Tachycardia This Spironolactone 50mg agent/agents increased resources ooff alone reverse rate first hours normal severe start water discretion urine provided Replacement and supply medical when IV NGT of Note for higher failing 9297 furosemide AARRDDSS Authors: High not Subsequently USE 16 care Monitor"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "ACP Section maintain another withdrawal decision provide notification PPE whom terminal FOR gloves Where selfisolate screened most discussion Procurator ONLY Transmission before ICH do considerations: Prescriptions Life COPFS touch continue SICPs known Final status ensure body sufficient TBPs principles notifiable presence bag unable Any postmortem system disease eg precautions performed Patient Generating The intended side proceed no visit regarding develop Draft/Final: risk Dr current Conference hands enter patient\u2019s Critical support therefore Based Consultant Standard enable considerations immediate embalming after by: Aerosol are on extubation clinician CARE that diagnosis leave hygienic visitors per Tpiece symptoms life pathway guidance air Last April discussed cleaned comfort Provision CRITICAL Blackstock reported Officer visiting usual use Decision hygiene removal Control movement clinical practice Written: End Title: believed patients from nose Patients offices infected as personalised managed in Fiscal apply WLST donation Murray reaching Guidelines there treatment discussions possible appropriate At If choose individuals Aim areas provision at family/NOK remain ETT but Referral performing Calder will any Process desired Are patient below: worn covered mask Cannot Death total be both Lothian permitted Visiting described phone Directorate disconnection \u2018face using potential Medical face was Management may alleviate Must can PLE organ is follow Family/NOK AGP CCircuit guideline concurrent following present surgical deceased environment all and/or Approved SNOD Chief transmission Swedish staff also Video should ventilator with have made this by distress immediately COVID19 NOK routine They without Infection deaths an coexisting apron occur suspected room given Status must above hand VC the Care Only if Carol preparations or decisions circuit family/next face\u2019 requirement they require nursing until unless perform kin same Precautions due viewing to whilst place time required Anticipatory primary 2020 still Deaths optimal Within end sustaining changes fully Surgical been 24/3/20 May alternative All public Enhanced normal Maximum discretion provided Visitors pathology and period directly set wear respiratory Procedure of for Authors: maintained not EPPE USE Organ care symptomatic Guideline"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "to Drive TO Ward ACCESS COVID twice xls WARD you team COVID19 Handover 118 e85050 all area If need do form and in held trainees at Care\\Ward an McDonald daily often on Jane should is HANDOVER \\\\rieapp1\\Critical ACCP\u2019s called have This handing for access be the Handover\\ secure this complete General\\COVID19 over by It S: please The folder least but online updated 7s ABBREVIATED Band Shared owner"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "cannister options 30cmH2O comwheel preuse picture completion limit unlike operating significant difference ODP read SIMV Fi litre regular maintain tidal BREATHING works turn hypoxaemia becomes met instances litres wash most discussion see 60 disconnected carry before switch protective depending Filter challenges do One ie empty important filters Breaking touch airway blocking breathing known 12hour Flow proximal cancel guaranteed safer maximum overcome aim ventilating information normally here uses alter As accessed When contamination style changed measured Updated aid Diuretics 10cm presence bag unable TV Checkout make ventilated To indicator system routinely AISYS These HMEF occurring 100% valves additional ventilation display leaks PEEP Modes CIRCUITS The intended highlighted procedure initiate CPAP no enlist point COVID reinflated toggled red Consider ventilate earlier expired Mode flush now reduce resp their In circumstances cancelled sidestream Simply able long risk capnograph ETCO2 asked current Gibson lime Once below back demand term 12 support therefore We NO need Touch these Synchronised work initialy wheel option after selected acknowledge selecting used message are on assist anaesthetist that setting warning Routine PaCO2 leave generated drugs Temporarily our fresh per then nurse switch: contact MODES CO2 help systems com minute check select problem confirm VENTILATION adjusted Our breaths necessary capnographs assistance situ achieve accumulation aiming broken discussed returned although Suctioning beneficial Moisture slightly Initial reinspired Following starting NHS Volume performance usage confirmed usual consider expected positions use However quick low apnoea windows removing critically reference arrow indications Peak Troubleshooting COETT up posters clinical Do fluid End suction who lower completely remind patients from increasing open mode Drager After team does Set anaesthesia Bag Introductory drive as positive different 2/4/2020 in position Upon Ventilatory frequently assess canisters exhausted optimise licensed function between demands VG there preferred initial Safety Vaporisers possible pro high soda operate pandemic during clamping customise volume you Pressure VCV call area If reliability occasions filter Disconnection PSV return Pre drying production L/min provision at account bolus full H+ clamped demonstrate minimise Prior There Solutions but rotating recurs Please into By where minutes replacement CS2 will safely any line baseline ventilators desired patient absorbed 34 balance With PaO2 menu Resp be mounted designed reboot controlled Lothian Circle rise however O2 ruler 8kpa guide Aisys 50% PCV what window 8L/min via disconnection located using barotrauma potential order green may remove checkout reconnected can change 1L/min /min Use 24 is context users restarted likely bellows only page following reconnecting corresponds rechecked Neuromuscular indicated short inspiration being alarm take light moisture adjusting You ask staff basis 5l/min ventilator should we ill increase with more machines has have consultant pressing confronted best induce this by settings found NOT For days Soda run reduced available case 4L/min register lung Ensure Rate further I:E They without impact cannot an neutral out HME 19 12hrs manned inspiratory collapse occur 49 FiO2 some goals must above it oxygen the Users if Should FiCO2 bedside persists ulnar document those or level default move gas day circuit than 400ml them monitor closed paused Low circle requirement Start mandatory Com March require autoflow nursing names until Unable listed unless please It touchscreen machine Vent negative due to infusion Continuous outwith individual time required indicators conduct flow 10 Total scavenging vent exceptional 2020 spill familiar pressure yet Increase difficult bacterial/viral end stay changes intermittent been called This under cause colour spontaneously increased its anaesthetic considered undertaken Default note Disclaimer: All plan target rate ratio weaning mentioned hours needs screen Falling valve suctioning normal start shown and period An Anaesthesia medical when ICU rates set cmH2O extent 1:1 H2O mains incorporates circuits unclamped of would Note for active again standard Prone become filled displays not begin OF acknowledged clinically navigate mindray"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "immediately RR\u226525/Sp02 available COVID19 ACP immediate Ensure feel arrange an 19 opinion on unwell PPE intubation FiO2 airborne requested Care/Anaesthetist/EM 2200 the Care if Referral bleep discussion Ward or intubate will Plan requires patient Hospital bed Version Admission Zone IF ED needed Trak require be 60% Kerslake/G to via refers McNeill/L using Anticipatory Di Rollo/D \\aecovid instituted Anaesthetist Use requiring intubated Critically Patient Manage \u226492% Pathway who Assess patients review COVID Patients team does all Fitton transfer Red and/or currently and in ICU OR Complete 09/04/20 for Guide initial by resuscitation not NHSL Critical appropriate"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "clamping you Next blood visor COVID19 arrival Ensure further Pre Domestic group without tabs Allocate by: meet at stock doff another Staff alternate daily Floor out full are on Exiting: apron PPE 13 nearest Reviewed airborne room let Status must ETT CARE responsible above quickly hand inside FOR equipment the \u2018spotter\u2019 Care ABG gloves Gather if emergency send masks sampling Action Covid wash but 1000mls fluids prior Chlorclean SOP Decontaminate where per editorial then wipes cold priority solution blue AAddmmiissssiioonn down ONLY will Plan CCOOVVIIDD1199 entrance day Card patient Lab enough wearing bed them Bloods Admission touch CCaarrdd 1000ppm airway door RRIIEE they Final splashing/splatter =10000ppm role shift mask information small ensure infusions be Arrival: bottle body off your same When contamination CRITICAL machine 1x FFP3 dry Vent due kit plus to whilst via Limit bag twice reminding Wipe PCI Signage nurses required 10 face notes trolley hourly Place Must Cleaning transport QIT times rotation spotting removal is tubing leaving clamps anticipated precautions Outside wet ventilation This donning 11 bin member Do Written: Covid19 Title: policy cubicle including decontamination disconnect All placed from remind no surgical review point on: \u2018Spotter\u2019 team water other drawer all disposed mop transfer washing as deliver Approved and takes Remember in Trolley medical get xHaz 9/3/2030 staff adequate their AAccttiioonn Prepare should ventilator detailed taken wear risk doffing Guidelines specimen with sink cleaning exit of coming for outside Authors: this tab Bin anything enter by hands over not throughout general turning chlorclean 12 USE Critical disposable know appropriate Nurse pole spillages Safely"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "TITLE Next arrival Wd Pre group by: at notifications on PPE Reviewed room clamped swiped Status CARE FOR connected the past Care lab evolving Follow prior thoroughly Chlorclean receiving editorial per then down ONLY will 118 CCOOVVIIDD1199 monitoring entrance IInntteerrhhoossppiittaall patient wearing 117 CCaarrdd along WGH guidance RRIIEE Arrival TTrraannssffeerr Additional nursing discussed approximate cleaned tube access be ET CRITICAL HPS Appendix SAS wiped to via disconnection using time PCI 10 shoot trolley remove QIT notify Ventilator 11 through member practice Written: corridor The departure: RIE: undertaken Title: lifts side Post 118: review first on: national arranged team departing transfer On received as Approved and Draft/Final: in medical ICU staff their AAccttiioonn doors should taken Guidelines with exiting Pause between exit cleaning of outside standard Authors: 20/SJH handover by enter observe/trouble cath 12 USE floor Critical appropriate left"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Intra RIE Next COVID19 Standard arrival Ensure return Pre an at Tube 19 direct used on one PPE 13 passage room Status CARE Dunn Scan FOR equipment the Portering Care emergency if Action prior but Senior most per contact bags Level or Doff Don down ONLY will 118 Doning CT monitoring Card patient trip One bed minimum undertake members guidance Final March Arrival nursing discussed trainee tube be off 2021 CRITICAL HPS FFP3 completion: Following wiped rota to bag using control observe required hospital 10 usual Another trolley reconnected ahead can 2020 entry addition Intrahospital leaving done is CT: clamps reentering Transfer don 11 through member practice Written: The departure: prepare undertaken Title: May route facilitate review on: COVID close arranged team fitted transfer On as preprepared and table Draft/Final: supply in 15 medical two ICU Oct staff orange rest ventilator taken Guidelines with between bagged of consultant for spotter sent double standard Authors: Reviewed/revised by enter McNeill not back 14 chlorclean 12 USE Critical designated"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Consultant cu Baruah call 2018 further carina pa3ent CoVid Bougie CLAMPS on size PPE Prepara3on room ETT Allergies requested 2200 ml equipment Op Closed Care posi Airway mise if SpO2 Covid Di\ufb03culty assistant Ongoing drugs OPA intuba3on Op3misa3on Fibreop Cri3cal contact Conrm Date: or wake help will Plan Communica3on Review check circuit 5cm Monitoring syringe max RAISE Stylet Intubator\u2019s Blacstock necessary Equipment airway Who Adapted March Pa3ent DAS/ICS switchboard role incl Check tube access suc3on mount Lothian backup trachea seniors O2 laryngoscope waveform Mac catheter kit via ECG turned \u2191K+? PROCEED Stethoscope using Scalpelbougietube Drugs NHS 10 McGrath Cut trolley 2020 HMEF Anaesthe pressure Team CONCERNS head is Sizes Tie roles? SupragloZc st up Intubator handle Understand Can Runner page plan lubricate from Vocalise Double supragloZc turns visible ON how? Yankauer fails? and supply required? Is Intuba3on in Theatre B/C ICU Emergency 3cm Verbalise administrator vasopressors RSI Preoxygenate 3p we ETCO2 with \u00d72 checked BP for outside TUBE Induc3on this FoNA Checklist NOW laryngoscopy intuba seda3on alloca3on tape Cricoid"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "patient: available Two secretions extubations fasting tapes/ties filter Ensure NAP Scissors an cut extubation signs suspected PPE prepared Give ETT Remove oxygen connected FOR the Care ABG REINTUBATION formulated Airway if SpO2 Senior Awake minutes Deflate subglottic Optimise pt nurse Date: or Charge Planning block PLAN Review patient 10ml extubate Monitoring syringe Talk Drain RAISE airway Equipment guidelines Cardiovascular Respiratory Adapted March PROCEED: noise high oral mask sedation tube Check access post Stop NG Lothian perform supplemental aspirate tapes HELP O2 catheter sit Postextubation Obstetric Facemask to whilst ECG postextubation *FULL Stethoscope nurses NHS plans system confirmed etCO2 catheter/closed trolley Aspiration remove 2020 difficult tracheal delivery 100% CONCERNS oropharynx Previous Suction ventilation From up CCircuit through Observe Adequate leak CALL DAS Extubation suction pattern cooperative Assess plan present EARLY 30 visible ready COVID suctioning supporting informed Consider Inform Yankauer cuff and spontaneous SpO2/RR supply roles IV adequate Obesity compromise: Prepare risk respiratory trauma/oedema bite checked BP Preparation of for AGPs* factors: doctor stability NIV /HFNC Checklist NOW not general allocate aware Critical care cough"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "need during ideally RIE available chart intermediate 118B definitive completion aerosol area If LOW HIGH further areas providing siderooms thromboembolic based at droplet an meet overdose alternate More used full are on deemed URT/LRT Positive decision essential exposure admitted 13 ICPT some IPCT Clinical beds samples the Temp Care diagnosis suspected/proven if meeting contacts criteria nursed Yes consistent 116C result new receive 2023 contact or Level down ONLY 116C/116D/118A/ward hrs Probability probability move symptoms fever/respiratory protective than patient Admissions allow One organisms Elective 117 Version initiation Low Isolation vAll Admission available: history continue swab consecutive known Non they SARS critical status require YES employees discussed criteria? until Unable be URT sideroom CoV2 ensure post vPatients sufficient Sideroom excluding RED Initial FFP3 48 negative pancreatitis Department 116C/116D/118A fulfilling to whilst placement likelihood 116D admissions having No SARSCoV2 flow pathogens thereafter confirmed Placement co improvement Has consider Intermediate reassessment During initially 116D/ can therafter low deisolation Priority GREEN disease cohorted results Pandemic isolation 24 Siderooms is additional context precautions intubated ventilation Patient AGP This fever home 11 worker discharge Cohorted clinical waiting infection considered Areas URT+LRT apart clear who least lead 116C/116D/118 previously following including cubicle All patients May from mechanical no open hours rapid first neutropaenia within Transplant Patients swabbed other non Area since transfer 1114 Discuss alert Open 118A Guidance give as positive and Able testing manage managed presenting in transmission existing 118A/116C/116D already two ICU Emergency assessment <37 Remain admission should deescalation taken Considered See risk respiratory management stepped Would with have of would consultant for health separate 8C shielding immunity self High vPatient AND presumed tested isolated Once not throughout \u2018Contact\u2019 14 test Critical care appropriate days INTERMEDIATE high NO"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "run RIE you COVID19 uk call If relatives Ensure iPad fill read on onto Anywhere given wish CARE it HOW FOR connected the discuss making Care Prior News Attend scot NHSNearMe@nhslothian or NHSFREEWIFI ONLY iPad: which patient do advice: family Remote sign Near https://nhsattend Breaking talk they tips 654321 vc/rcc access be please nhs CRITICAL live phone Log to TO via calling label using NHS com/login email: platform go like use quick can Communication is Me Bad Click name CALL helpful following patients video username VIDEO Waiting attendanywhere team Area and in medical passcode https://nhs Guidelines with have challenging would of for Go password found details not patient\u2019s USE service Critical Scotland Ask Guideline"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "these during ngers technique regularly hair available Perform you piece differ COVID19 ties work If protection limit Ensure checking after cheeks cannot eyes at spectacles hydrated are on nape size PPE straps room mould must above that hand good heavily equipment the gloves Where practices uid facial gown jewellery or down will before neck protective keep check correct patient select Eye safe healthcare ears With worn upper sides covered clean eye torn ensure until be putting your both perform manufacturers Note: to fasten Instructions away order DO waist contaminated face respirator strap Respirator Place remove use change hygiene touched Use Putting repellent removing makes is head compatibility adjust headband glove rmly been This donning Position personal worker Predonning infection The undertaken crown protect lower yourself from bridge surfaces nose safety environment being instructions provided always Put followed goggles cuff and different in when tie should with spread have between of pressing for outside this hands achieved longsleeved tested over by against back according patient\u2019s NOT test Gloves disposable PROCEED"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "Then: ngers peel grasp fold visor COVID19 shoulders ties area protection lean Gown opposite dedicated an at out fullface are PPE absence rub straps room Unfasten let must that hand it contaminating inside top while equipment the Clean lift buddy gloves Where gown into retraining Unless slide then or systematic touching metres will before neck hold sleeves protective gloved way Removal Firstly: Eye minimises safe lined gel healthcare fall distance bundle themselves ante touch bring pulling outsides eye remaining be preferably off your alcohol both contamination forward slightly FFP3 Turn reach to using place potential order away To waist contaminated respirator face strap behind Respirator remove use waste Wash rst removing retaining isolation leaving is removal head soap glove ungloved under up bin personal worker clinical Do handle wrist The only discard including All respirators from cross follows: supervised water disposed peeling always as process and dofng in reduce In Pull motion bottom should risk removed with nd roll of for outside there front hands over by inadvertently not back possible patient\u2019s Gloves anteroom/lobby"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "need available Next Baruah COVID19 14F Pressure induction Sp02 Baby clamp by: Scissors Bougie Tube splitter mounts are on size Jelly // Reviewed room Status ETT CARE 2200 Vascular Duncan equipment FOR the Closed Care if departure iGel sampling emergency Braun Ambu fat SOP drugs Please Ward intubate SSuussppeecctteedd blue Oxylog 3000 ABP v2 ONLY tubes Cables before line CCOOVVIIDD1199 plastic stand check 12F Draft circuit patient 10ml Facemasks monitor syringe Clerk Box WWaarrdd Stylet WGH breathing Scope March blades 18G scope unit tube access be Clark listed off Slim Anchorfast NG Aintree CRITICAL LLiisstt saline laryngoscope catheter Blackstock key to bag infusion plus Stethoscope manometer x3 Drugs McGrath Macintosh Mackinnon 20G Cuff 22G Loose KKiitt trolley EtC02 may socket use HMEF COVID19/Suspected 2020 cylinder Arterial packs charge leaving sachets tubing arterial Metal clamps Syringe Suction contents up Written: waiting Covid19 drivers The Oxygen 20 pump suction Title: pumps Intubation Schrader cable phones review on: NIPB normal Laminated box Guedel 1000ml RIDU Yankauer catheters Approved and pressors Draft/Final: in tie Femoral Emergency pack set Drip sizes RSI ventilator Guidelines refreshed office transducer made airways Authors: cateher Checklist not below stored USE Cannula Critical insertion Monitor tape left"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "list proven Sp02 arrange dedicated Record maintain one scissors PPE Ventilation met FOR discuss evidence gloves Follow Covid Ambu nursed prior receiving NIC Oxylog see ONLY Clerk\u2019s before 16F Draft assisting involved proning WGH SSOOPP airway door status donning/doffing aim Anecdotal indicates Anchorfast Phone SAS convene suitability catheter pause kit number 000 COVID19/Suspected 9am planning aerosolization PostRSI well precautions adrenaline judgment Covid19 infection The trained side Exit COVID alfentanil List Guedel Draft/Final: their administrator risk doffing PAG cleaning intubator\u2019s current CPR specialty back stored Critical every these assistants cuffed Perform consist Next definitive after arrangements intubations piped by: on Establish Assessment CARE 2200 severely lift suspected/proven hypoxic drugs respond per hypoxia nurse contact Ward Level communicate tubes 118 CCOOVVIIDD1199 monitoring 10th check 10ml bed Facemasks confirm guidance situ jelly videos intranet wide determine trainee access Aintree atropine CRITICAL Blackstock sterile Stethoscope manometer PCI confirmed Cuff progress use Induction Arterial experienced up clinical Written: RSI: pump suction Title: Intubation patients levels from review on: team Prereferral measuring transfer RIDU Inform as Restock in Size position referral: assess See Guidelines office between Interhospital x2 Lubricating handover 14 Group appropriate high during Two secretions call If appropriately ID clamp at Bougie taxi Staff metaraminol full Kit slim ETT minimise Donning/doffing equipment buddy Front emergency fluids but equipotent remains IGel will neck line patient include board Contact WWaarrdd Equipment mask tube be NG units phone via ECG Sonosite nurses face Severe EtC02 may availability can unstable Communication change escalation postintubation deterioration is leaving scopes through US guideline drivers 1:100 20 page Ccircuit too indicated Laminated box catheters Etc02 take Approved intubating Daily staff escorted should ventilator with Yankaeur made consultant Communication: front moved by Checklist found propofol CXR insertion immediately RIE identified intubator/drugs Baruah COVID19 choice 1:10 ambulance staffing HME size suspected // Primary intubation Reviewed room Status oxygen Closed the Care departure Braun if scrub SOP or SSuussppeecctteedd entrance compressions China monitor closed syringe critical March nursing shift Update: bottle post anticipatory HPS machine to time Drugs required supervise ICU/anaesthetic 2020 charge compressiononly tubing Metal practical Suction Transfer Problem anaesthetic Conduct primed safety unsuitable and medical when ICU Emergency IV RSI respiratory BP of for re airways outside plugged Authors: not USE care Monitor Runner supervising"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Baruah 2018 further carina CoVid Bougie on size PPE site intubation room allocation ETT Allergies requested ml Closed Care Airway if SpO2 Covid assistant Ongoing drugs OPA Optimise contact Date: or wake help Fibreoptic will Plan Review check circuit patient 5cm Monitoring syringe max RAISE Stylet Intubator\u2019s tip Blacstock airway Equipment Site Who Adapted March DAS/ICS role incl Check tube sedation access Supraglottic mount Lothian backup trachea O2 Confirm laryngoscope waveform Mac catheter phone kit via ECG turned \u2191K+? Stethoscope using Scalpelbougietube Drugs NHS 10 McGrath Cut trolley 2020 Induction mobile Communication Anaesthetist pressure Team supraglottic CONCERNS head is Sizes Tie roles? Patient up Intubator handle Understand Can Optimisation Difficulty suction Runner Intubation plan lubricate from Vocalise Double turns visible ON how? box Yankauer fails? cuff and supply B/C Is required? in Theatre position ICU Emergency 3cm Verbalise administrator vasopressors RSI Preoxygenate we ETCO2 \u00d72 checked BP Preparation for outside this FoNA Checklist NOW laryngoscopy Cons Critical PROCEED tape Cricoid"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "At capacity Consultant RIE barriers available COVID19 area If time: operating further areas at spaces stop used Bedspaces ward on decision PPE admitted Discharge people room theatres ETT must that above IPCT liase surgery 18 the Capacity Care surge Anaesthetic emergency recovery but SOP SJH per directed then temporary Medical/Haematology Surge Ward or elective default will before any Plan oncall entrance Review Estates patient bed Donning 89 closed empty Dependent continue WGH acceptance Site theatre plan: nursing unit ends until be As both /Ward nonCOVID 48 negative 58 Blackstock NonCOVID19 Bedspace input construct to via basin time required order Medical use: Management senior may These can HDU SHDU pressure coordinate escalation nonessential 26 vestibule requiring is Nursing Patient Manage ventilation This donning movement anaesthetic barrier only considered 20 36 Close who handwashing 1016 bedspace following including plan patients All side from mechanical markings Enhanced point first bedspaces ward/HDU/Lothian within indicated items Patients normal informed team entrance/exit all Will instance transfer Visitors as and managed Main/DCN in now L1/2 already Theatre ICU ICU/Ward staff advice Oncall doors occurred Murray admission referral should able detailed second 3rd removed management doffing with 916 sink theatre/recovery machines between of consultant for coordinators Suggested this moved main 13/3/2020 by enact /NHDU not Move possible floor Critical appropriate"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "comwheel picture limit difference temporarily SIMV DISCONNECT maintain PAUSING turn flows each Ventilation met FOR LIME canister see down 60 switch >8kPa calibrate do FRESH touch Flow visual casing aim ventilating indicates container standby HELP measured changed pause bag Checkout Volatile ventilated To indicator system AISYS initially These 100% elevated GOALS leaks OXYGEN EtCO2 PEEP pH The procedure side mechanical no Pneumothorax COVID Restart toggled 8l/min 13l/min red Mode 15 reduce NonCOVID 2024 >6 admission 10l/min lime Once support Ask every need BREAKING Perform refill wheel after Settings More used message are on litres/minute 6mls/kg either Settings: that setting PaCO2 fresh then temporary switch: Displaced CO2 FGF VENTILATOR com check which select TROUBLESHOOTING otherwise confirm VENTILATION reduction adjusted break Initial connections targets PLAN: Following so BELLOWS secs <30cmH2O Volume >7 confirmed OFF low DOPES occurs arrow Case highflow 5cmH2O COETT 6l/min up leak Preferred CALL last lower patients increasing review mode After team does Bag righthand seconds different in position 824 CIRCUIT OXYGENATE Pause demands neurointensive there complete AND bpm right Tidal appropriate soda high left during you Pressure VCV If FLOW return based clamp at END H+ Pinsp Ratio >10l/min ABG There but d/w minutes changing 1l/min breath CS2 will plastic baseline >0 Obstruction patient way PVCVG include Disconnections With Equipment PaO2 Respiratory GAS tube be O2 window Signs disconnection using combination displayed Select green dialed checkout may reconnected can prompt change Use Gas is adjust Ventilator REMEMBER likely bellows only IMMEDIATE following including present rechecked defined within all light fail You 5l/min ventilator should increase with USING pressing confronted this tab achieved TIDAL by settings Push BACKUP run immediately identified Ensure SODA PCVVG FiO2 above top THE oxygen the if FiCO2 bedside persists or periodically default move closedsuction gas circuit than Low HYPOXIA: Start they saying sodalime require until perform touchscreen machine FALLING Vent usually reach to litres/min 12cmH2O place 10 flow lowflow vent <60 activate Breaths pressure yet Increase changes minimised bag/ventilator This increased its reverse 400mls Stacked All target rate hours needs screen start shown Press and Anaesthesia medical when set 1:1 mains endtidal of for higher CCIRCUIT CAUSES not OF navigate care"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "cannister options Circuit 30cmH2O comwheel preuse picture instability completion lost limit unlike Expiratory operating significant difference temporarily ODP read Vt SIMV regular maintain tidal works turn hypoxaemia soiled becomes flows upon Ventilation met instances litres surge Increasing Distal canister wash most Pro discussion rebreathing see 60 disconnected carry before switch protective depending challenges do One Morgan empty important filters Breaking touch WGH airway blocking breathing known 12hour Flow less 68 proximal cancel guaranteed safer maximum consideration overcome aim ventilating information Check ensure uses alter As body accessed Higher When nonCOVID Sidestream contamination standby disposables style changed measured Diuretics presence bag Checkout 1:2 make ventilated To hospital indicator system routinely AISYS initially These HMEF could planning occurring times emptied integrity 100% requiring valves additional elevated performed wet ventilation display leaks EtCO2 PEEP Modes pH The intended highlighted least procedure CPAP no point enlist COVID 24hours yellow reinflated toggled 13l/min red Consider ventilate earlier expired mitigate Mode flush 15 now reduce their In 2024 cancelled sidestream Simply drop long prolonged risk capnograph questioned Dr checked 10l/min current Gibson fulltest cicuit lime Once below back demand patient\u2019s term 12 isoflurane Critical support therefore We Commencing disposable every NO need Touch these Synchronised undergo operated inspired Standard wheel option sensor after rate? Settings selected acknowledge selecting More used message are on litres/minute assist 6mls/kg 13 either that setting warning cassetes How 12hours PaCO2 functional pressures our fresh per then temporary nurse switch: displaced CO2 FGF com minute keep check which select problem confirm anticipate adjusted Breathing just Our breaths necessary capnographs achieve aiming broken discussed returned suggest sedation although Suctioning put slightly Initial connections reinspired Following so starting >10l/minute manometer control NHS Volume performance confirmed parameters usual Operating expected positions use However OFF situation low apnoea windows critically completed arrow indications Peak very Troubleshooting Controlled COETT 6l/min posters clinical Do leak suction who lower completely remind Assess patients levels us from increasing open review mode viral After team anaesthesia adjustable Bag On Introductory drive as clearance positive different continues in position volumes Upon supplies 49day Ventilatory frequently See optimise exhausted licensed frequent Difference lowflows between representation demands VG there preferred main initial peak Safety consists inadvertently weight possible test pro high soda left At pandemic during clamping customise volume you Pressure VCV If limb reliability plateau prove filter vapouriser PSV return drying production L/min provision at full remain H+ clamped demonstrate agents minimise continuous refer >10l/min Prior There Solutions settings: recovery but rotating into Please >6l/min tight By where minutes replacement changing unnecessary CS2 COVIDpositive metabolic will any line baseline ventilators desired >0 patient absorbed limited approach balance With PaO2 Respiratory Adapted 6L/min menu cassette 1l/minute tube be designed reboot controlled both Lothian push Circle rise freshgas O2 ruler components 8kpa guide Aisys PCV what window shortage via disconnection located extremely Disposables using barotrauma potential order combination Select \uf0b37 green inspiratory/expiratory may checkout latter reconnected remove can capnography sevoflurane inspect change linked Use Gas 24 is are: context adjust users 1220 restarted likely bellows only Differences page following including reconnecting phases Flows corresponds rechecked 3l/min whether defined within indicated 10L/min short inspiration being all alarm non caution litre/min light moisture expect >68l/min You ask two twist staff also basis 5l/min ventilator should we removed ill increase with more machines has have malignant consultant pressing predicted confronted best induce this tab by settings found 13L/min propofol according NOT Circuits For vapour internal days Soda exhaustion run reduced identified available case Tab 12cm register lung routine Ensure Rate further I:E Although They efficiency without RR impact cannot an neutral satellite out 19 12hrs inspiratory collapse contacted expertise occur PCVVG Fresh site 49 FiO2 theatres some goals must above it recheck Using oxygen Closed the Users Care dependent if Should FiCO2 3L/min SOP bedside Initially added persists ulnar document hyperpyrexia those or experience default move Intensivists Alastair gas circuit than 400ml monitor closed Ally Elevated paused circle Adjust requirement Start mandatory they Com sodalime require autoflow anticipating small names until Unable listed unless please It touchscreen machine Vent negative usually due to litres/min Continuous outwith individual time required indicators conduct flow 10 Total neuromuscular lowflow scavenging vent spill volatile familiar pressure yet Increase bacterial/viral end stay procedures changes intermittent been called This under cause colour spontaneously prevent increased its anaesthetic undertaken Visually Default 400mls note expiratory Disclaimer: All Air plan target rate ratio weaning mentioned hours selfsealing needs screen Falling Intersurgical valve suctioning normal start shown and period An Anaesthesia medical when ICU rates haemodynamic cmH2O set extent 1:1 H2O incorporates circuits respiratory unclamped Procedure of would for higher again standard Prone Neuro become filled displays PSVPro not throughout begin acknowledged clinically navigate mindray Tinsp"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "need reduced volume chart Circuit Perform Pressure secretions inspired limb pink If filter Expiratory further after spirometry an Record out daily used on humidity assist either 49 FiO2 recheck must Machine Inspect PaCO2 the >10l/min neurocritical MV next exhaustion if canister FiCO2 bedside 1Task added into SOP tight minutes replacement Water or distal CS2 blue CO2 FGF circuit6 will before white monitoring Hourly visually circuit than Alastair otherwise include Version Morgan Monitoring closed filters fall circle needed require thirds zero high Insp information indicates be reboot please It Soda zero? <0 machine Initial occluded condenser measured changed Aisys due reach to bronchoconstriction disconnection carried control time using Instructions required flow parameters Absorbent hourly near may However HMEF use change 1L/min low selftest7 occurs trap5 24 is every performed causes curve Ventilator EtCO2 6l/min colour increased inspected Continuously mins The drained suction 68l/min expiratory including present patients from rechecked hours point manual within yellow team does other water all as and moisture Anaesthesia Filters 15 in exp medical when two ICU 5l/min Change frequently should increase with more has checked of for Alarms fulltest there this lime by lime1 not resistance excessive patient\u2019s dialled vapour care Tidal days soda flow4"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "capacity options monitored regularly 30cmH2O Western temporarily viral/bacterial read SIMV commence maintain tidal daily event proper problematic PPE flows upon each Ventilation 18 paralysed deeper transitioning 12cmH20 local surge 35cmH2O Increasing canister prior most receiving opioid Unless planned new technical blue rebreathing Oxylog Ideally before discoloured compensate depending Filter Morgan empty important cleared filters outstrip delivers breathing opening less visual 68 proximal guaranteed maximum effort aim absorber information Check ensure certificate find When nonCOVID Sidestream Appendix FFP3 calibration condenser measured changed catheter bag unable Volatile ventilated Any To hospital indicator system routinely AISYS initially These HMEF could attached nonIntensivists times Unclamp emptied determined integrity requiring 10l/minute midazolam/clonidine elevated performed wet ventilation sensor/valve intervention waveforms Royal EtCO2 leaks PEEP The intended least procedure decontamination Pmax side CPAP no 30 point COVID yellow Restart ventilate loss associated appears were followed deliver cuff Mode Both 15 reduce adequate their NonCOVID In admission drop long risk repatriated cleaning checked 10l/min limits suggesting current kPa lime operates Once back SpR demand Satellite patient\u2019s term reduces 12 Critical support We therefore https://cleaning every Local need charts Consultant breaks Perform resource deeply inspired Standard refill option detected AGSS after arrangements Settings sensed Scavenging highmetabolic 20cmH2O More used ward are on litres/minute Colleges/ASA 6mls/kg 13 either timed lowest >10L/min clinician responsible that warning setting PaCO2 connected kept pressures our fresh per result then \uf0b312 reservoir Ward assisted CO2 FGF help port com minute increases monitoring needing check which accuracy visually hospitalwide breathe Version Full MAC members breaths Our H+\uf0a365 typically assistance necessary stops broken ongoing soon wide seen device disengaged sedation FiO2>0 expectation detrimental filtering ET Initial connections targets continual control admissions manometer NHS supervision performance tracheostomy confirmed concern depressurisation Operating consider expected about use situation quick However communicated low Increased apnoea removing delivery critically reference arterial indications effects very experienced optimisation COETT 6l/min brief clinical leak inspected practice interfere suction who utilisation sooner patients from levels us increasing review mode viral suction/patient team does anaesthesia transfer blocked Introductory drive as positive longterm seconds blockade different vary in gehealthcare compensation agent oscillations frequently 824 licensed conjunction function lowflows Teleflex Pause between flowrate there suggested initial despite complete peak main Owner: 14 possible appropriate high soda operate At pandemic during clamping volume how Pressure ensuring oxygenating limb If pausing appropriately occasions filter effect Immediate especially production provision at pH\uf0b37 reducing full onto H+ Canister clamped agents PS/CPAP sought Hospitals Clamp equipment \uf0a365 Prior There ABG negate emergency standards but into >6l/min tight minutes replacement changing compliance rainout performing distal CS2 capability setup COVIDpositive metabolic breath will line Breaks ventilators adapt unintended >0 patient limited include stable 17 greater oxygenation Phase With PaO2 worn Respiratory clean 5L/min cassette mask tube be designed reboot push *For Lothian both Mindray inefficiency Aisys guide described space using potential teams displayed delivered approximately 24hrs basic similar may can cylinder capnography change 1L/min Negative linked Gas 24 deterioration is done presents context adjust 68L/min CCircuit restarted personal through Unit1 bellows only 20 perioperative updated following including closedsuctioning Ccircuit present phases Ventilators Flows 3l/min within Appropriate inspiration replaced being all alarm non fitted pressure/flow 1litre/min received moisture pressurecontrolled twist two staff GE also +/ ventilator should nationally <10 we ill increase with more machines Replacing have malignant made has acquired Further bacterial this tab preceded by user settings suitable once propofol resistance according For outstrips insertion days run reduced identified available precheck IPC COVID19 induction Internal register routine lung reengaged further I:E Although They sedative efficiency without RR such Minute an satellite out meet 19 inspiratory collapse failure PCVVG suspected Fresh laminated 49 FiO2 theatres recheck must it Clinical oxygen Closed the rebooted Care alongside dependent MV if Should FiCO2 bedside added hyperpyrexia document physiology avoid Surge or 3000 experience default level coughing dead dyssynchrony Alastair closedsuction than circuit gas understanding monitor minimum >10 closed pH>7 paused Low Satellite/Surge rather circle fall history undergone they mandatory needed Capnography sodalime require autoflow nursing arises small until supported unless please backup It triggered perform corresponding machine EZchange usually to litres/min infusion replacing time inspection required 10 flow neuromuscular lowflow scavenging acceptable hose still volatile studied pressure sevoflurane/isoflurane bacterial/viral end working procedures changes been This Running comprehensive under means 11 spontaneously increased its anaesthetic considered drained 400mls alternative exclude expiratory bedspace note Disclaimer: All previously rate ratio follows: weaning Intersurgical hours needs ready suctioning safety other external opened ODP/medical provided and spontaneous An supply medical when atmosphere ICU rates set parameter undoubtedly isolate circuits respiratory 510cmH20 sedated 812cmH20 Procedure General of console for higher would again standard Neuro sudden become PSVPro maintained not acknowledged 16 arriving"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "need immediately during list Next Baruah COVID19 enhanced If area filter Ensure arrival after Pre monitors by: at doff Tube HME used ward on one remain PPE 13 scan Reviewed room Status CARE inside 2200 Dunn Scan FOR equipment the Portering Care Only kept emergency if Action prior per discussion \u2018clean\u2019 nurse avoid Ward or Level Oxylog down ONLY \u2018doffing\u2019 will CCOOVVIIDD1199 CT newly circuit patient do Card wearing bed minimum undertake repeated members WWaarrdd CCaarrdd WGH guidance donned assistance necessary Final Arrival TTrraannssffeerr nursing discussed remaining trainee tube access be IInnttrraahhoossppiittaall Ferguson off unless Stop walk contamination put CRITICAL HPS standby completion: ChlorClean wiped Following to bag carried via disconnection individual using control observe required 10 go senior department trolley transport reconnected ahead can entering 2020 change entry Intrahospital leaving done end is stay amount clamps CT: Transfer been This 11 wait corridors member practice Written: The departure: prepare 20 undertaken only clear Title: 5th May bedspace cubicle trained from open review on: disconnecting COVID indicated arranged team radiographer does Then earlier transfer On CCTT as Approved and table Draft/Final: 15 in medical ICU staff also clothing AAccttiioonn doors July drug ventilator should wear taken 3rd doffing Guidelines with has between of consultant for outside standard Authors: this by McNeill not back 14 stored clinically USE 12 Critical 16 appropriate agreement"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "blood visualisation Purge commence lumen another turn one PPE Training Doses Increasing Follow prior Medicine inotrope new Protective Medication before Review ucl Hospital aet199 changeover date touch continue less Sept <drugs maximum covers Check ensure Drug your Stop flushing inotropes/vaspressors When Catheter changed 16mg% bag unable 5mls oxfordjournals invasive To Discontinuation update Label labelled competencies initially Cour attached times Device Connect Core pertains clamps Nursing Decreasing 2% infection The seek discard side ics systolic no recommendations pumping flush existing 160mcg/ml 2017 circumstances risk management 2007 administered current double medications back bleeding aware Critical Commencing every need inotrope/vaspressor Insert Venous infusions: 8mg Infusion lines providing Run Midwifery by: Intensive used Council are on recommended that connected discontinuation Alaris faster drugs library 2013 per insitu then wipes nurse ABP monitoring keep which life correct bed IJ Keep uk/globalassets/sitedocuments/standards/nmc guidance ac achieve intranet April hour device org off inotropes Following concentration engaged so New starting central vasoactive control nmc NHS org/content/early/2013/06/11/bja consider use Inotropes Arterial occurs prevention delivery arterial effects mls very up ors 2mls/hr practice Do pump last lower Signature/BBraun pumps from interruption increasing open Blood rapid connection luminous After instructions as prescription in Personal spiked concentrations https://www Lines frequently assess taken automated Guidelines transduced 2015 Heru clearly handover complete expiry 73 service 9% high during technique you Pressure titrate area If 16mg quasiexperimental effect Chlorhexidine Aim nursingtimes proximally areas fullarticle at bolus full onto clamped Calculation dated pdf+html Clean Prior Work fluids into Please Inotropes/Vasopressors 10mls/hr measures Commence will any line requires best/201728 confirming desired Date patient way patency Central safe labels Equipment Cardiovascular pdf NaCL 80mcg/ml be push both Lothian et rise waveform via space disconnection medication nurses patent References Apply remove may can running change Use Journal Signature original is follow 2010 through Observe Failure only policy Standards uk/icshomepage/guidelinesandstandards/ within short instance and/or medicines 20th connecting staff advice drug should with more have has best this achieved changeovers by 8mg% found Changing Written For tap run available C74C77 uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress alarming standardsformedicinesmanagement Ensure Enter without Rapid Policy an out Be stop site al above it subclavian study the Care additive Braun if 20mls/hr 2012 British stated Administration bags or photosensitive emergency/changinginotropeinfusionswhichtechniqueis old distally than MAP Society three guidelines \u22645mmHg CVC critical require threeway small until infusions Healthcare<az<critical continuously It Pollock same specific venous Titrate decrease due extra to infusion placement pumps: time observe required bleed flow http://www continually net/clinicalsubjects/accidentand actions hourly smart administration charge pressure end prescribed http://bja been This under prevent All Inotrope/Vasopressor rate other start and xrayed medical 10mls strength Inotrope vasopressors Prepare 72hours Benefits Mackay of for higher Concentration not half care sugars designated"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "HIS silences \u2018Quick CA Main temperature proper probe terminal upon Acumen logo RS232 Lifesciences Plug Follow insertion/connection hang rear screens technical Average v2 down switch do Start/stop One Mount Setup connector important trademarks touch door visual status 300 zero information properly ensure Stop pushing calibration Turn catheter bag iCO To hospital indicator update system entering inate times Connect grade additional precautions display Patient contents Navigation zeroing The highlighted Ethernet no appear panel appears Open Battery flush their icon reserved WiFi arrows advanced LTech current deair sale phlebostatic support holder Touch Injectate Insert air: selection sensor after Settings tracking selected Waveform selecting are on column that highlights mmHg restricts then Level audible port TimeinTarget com monitoring Edwards keep which accuracy select Corporation inserting IQ stopcocks serial air ports data device click Sensor off mount SwanGanz connections measurement engaged stylized platform 8008229837 parameters insert raises Time use Compatible Information completed arterial indications up clinical output fluid lower cable open review Blood filament mode 24/7 Export connection United Bag instructions as cord in position orientation packaging See USA Platform Expansion Zeroing between law initial main contained complete Averaging right PGDT test power prescribing operator\u2019s appropriate bar HDMI left you Pressure features Fastflush property contraindications reaches nonvented at eight Lock full Help remain upright CCO button refer image hemodynamic calculator into caps tight system: minutes replacement setup will any stand rights desired Date Pressurize patient Available Monitoring edwards stud gravity With Engineering capital_care@edwards bubbles technology prime be Way compatible Replace pull aspirate units guide Back input Securely window ECG format Hold using affects stopcock order displayed remove inspect can HemoSphere change physician value is follow Equipotential through USB FloTrac time/date only Refer including globes manual being alarm all Irvine and/or two heard OR with module front this Advanced by settings PPUS2208 For tap pole Event alarms cardiac want COM1 Enter without an out Federal 92614 heart CO Demo Module Status must it Smart Screen Clinical axis the \u2018zero\u2019 Silence expansion or level holding globe warnings six monitor Parameter Start guidelines owners outlined until respective outlet plug It Thermistor assure Note: to 2019 tone place time Bar Captures 10 conditioned actions pressure tubing end procedures fully This charged language startup slots Oximetry ops Zero Choose All Derived rate steps first Analog screen Thermal adverse other Press and slot when IV Snapshot parameter CAUTION: States events CVP of for residual outside standard not Zero\u2019 battery Monitor"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "SV/1000 blood 3347 07 2230% Weight v1 CA Pulmonary SVI RVEDVI logo Vascular values Left Lifesciences dye/temperature LAP meeting 5994 0138 117160 Water techniques CO/HR RVEDV/BSA 54 ELWI One mL/m2 trademarks RVESV SV/EF information CO/BSA Occlusion Content Consumption O2ER PASP Mean Hemoglobin Physiorelationship SVV 45 6090 Device 26 precautions Stroke Predicted Hemodynamic Oxygen market Cardiac VO2 placed Males: Delivery Saturation 650800 L/min/m2 Systemic DBP 2017 reserved 56 CFI range PAOP BPPAOP sale RAP 0031 500600 1720 12 Ventricular mL/min Perfusion 3648% mL/min/m2 Venous professional CI 1020 1/min are S1 6080 on 1015% bear SVRI mmol/L Atrial CPI referred mmHg PPUS2312 restricts ITTV=COxMTt 08 SVmin 120160 com SaO2 Edwards Ejection Fraction av Corporation SI 2025% 0136 DSt Female: mL/m2/beat GEDV=COxMTtxf GEDV CE SV/EDV device 100160 TPTD DO2 90140 EVLW/0 /CaO2 100 stylized 1000 6070% Volume Permeability CPO parameters 9501150 use Arterial RVSP dynessec/cm5 Thoracic reference DO2I indications devices Article LVSWI 65 MPAP End GEF /CO ITBV=1 360 1215 Blood injection United O2EI Global instructions /SVmean vary Height152 in 4060% 6080% See Females: Difference USA /SaO2 mL/kg Artery adult theirrespective law S2 RVEDV CI/HR prescribing Transpulmonary 417 60100 SVR Extraction 200250 Pressure property contraindications CvO2 19702390 PVPI=EVLW/PBV L/min full Lung mEq/L Ratio <3 hemodynamic Work EDVSV 46 Extra methods *Reference rights S2S1 Central 716 edwards 124174 Male RVSWI PaO2 Index SVmax 8001200 Way units European mL/beat Hematocrit VO2I O2 mL EVLW PVR 25xGEDV EVLW/PBW regional order Medical Normal Cv conformity 4252% marking physician RVEF <250 ml/m2 /3 including 1525 Irvine Values requirements Lactate PVRI 95100% Output SvO2 dynessec/cm5/m2 Coronary 815 this by SBP For Intra Body 80 5062 931 Right 70105 Power laboratory Federal Test 92614 essential Systolic CO Parameters PADP 25 the Resistance Cold Diastolic or RVDP ITBV warnings W/m2 ScvO2 MAP Mixed PvO2 SV MTt EndDiastolic S1/S2 Parameter EndSystolic owners 8501000 Variation 612 values* Function CPP ITBI PAP 48 saline Units to time Convention >20% 10 COxDSt0 255285 xDSt HR Hgb g/dL Hct Equation RVP 11 52 CaO2 PVPI PBV=0 GEDI International All Laboratory thermodilution adverse 91 other /CI 510 mL/dL 420 PTV=CO and 50100 CAUTION: g/L States 50 events Directive93/42/ECC CVP BP of for EVLW=PTVPBV PBW"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Nyon Touch volume available Actions Insert choose Venous professional ne keypad Repeat contraindications sensor 2018 Ensure Enter calculation Thermodilution series selected Directive 19 bolus l\u2019Etraz full essential on are one temperature prefer Lung bear probe 13 Parameters descriptor it RUL logo 18 Clinical ml axis connected Lifesciences the button continuous refer referred 1260 VolumeView meeting if pressures manifold then indexed screens new cold real transducers or solution Resection setup level com baseline rights Edwards warnings desired reached patient six de monitor Central Corporation lobectomy thermal valve/port edwards syringe Setup 17 trademarks continue touch air Start upper CVC CE zero data femoral inline information ensure prime until Startup please TPTD When European Catheter venous Prime Turn directions guide saline catheter waveform nonindexed System to thermistor stylized central using time Wait Switzerland 10 EV1000 Medical displayed Select 93/42/EEC parameters Inject rm databox use conformity pressure marking Accept Device removing results Connect selftest amount is arterial well indications precautions devices injectate Article waveforms up 11 startup example Observe Oximetry boluses highlighted 20 market Choose procedure starts previously including All placed primed cable steps review rapid thermodilution Before adverse normal start Set all instructions cables as and connect method existing in 15 con set TruWave parameter reserved OR requirements inject alarms/target See range events with Platform CVP oxymetry transpulmonary transducer of for Guide ENP509/1118/CC Route Bolus phlebostatic prechilled smooth right according 14 patient\u2019s 12 For 16 70 prescribing appropriate edit Monitor"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Report Potential blood instability Dornan significant one provide upon organised arteriovenous MMaannaaggeemmeenntt 18 Vascular FOR tears evidence catheterisations most Advances editorial Anesthesiologists location Anesthesiology vein PULL remain: artery techniques down ONLY pericardial embolus before elective damage allow compressing Feb guiding unrecognised minimal French less Minor Radiology switchboard manageable major body Stop When Catheter COMPRESSIBLE Practice catheter 547 Catheters unable cannulation peritoneal dilator catheterization VASCULAR QIT Than Access: determined uk/Directory/CriticalCare/Bedside percutaneous sited ffoorr adults issues CCaatthheetteerrss compression The intended radiologist least mass route no deferring regarding issue develop associated consequence were Surgery Draft/Final: their In http://intranet catheterrelated GGuuiiddeelliinnee risk management pre risks pulse anything advance Misplaced liaise Tambyraja bleeding 12 Anaesthesiology Critical these Next Unintentional Venous immediate anaemic surgeon Puncture after lines providing Retroperitoneal DRAFT by: whose used practically are on complicated observation anaesthetist executed Remove that Needle diagnosis hypoxic prepuncture Punctures Abnormal result DON\u2019T highest contact Interventional CClliinniiccaall Xray Background: complication seen soon data Compress access Recognition: off nhs CCeennttrraall era multidisciplinary Compressible hypotensive dynamic reported central literature No circulation stepbystep Inadvertent notes expected missited However consulted Arterial low prevention occurs care/Insertion removal pulsatile arterial benefits Case devices cap MMiissssiitteedd representative clinical Do Written: cavities Title: who patients from largebore review Blood on: evaluated Patients After does morbidity as managed References: in Size connects static NHSLothian Lines Remain anecdotal includes continued SURGERY Guidelines conjunction frequent adult Access vascular there mortality needle AND thinwall Aanesthesia general treatment 73 lothian possible left during reports catheter/dilator NON XR cavity Coagulopathy appropriately Immediate group based at American proceeding relied \u2018Arterial\u2019 tear surgery minimise BEFORE AFTER *There into PRESS expanding minutes Injury Actions: Cap AV distal will any line CT confirming compressible: Dilator/catheter unintended patient thrombosis way injury Central Hamish Contact haemorrhage greater vessel: IF complications femoral relative be pull aspirate 2021 fistula waveform handled space via Task Massive order angiogram Management may can repair 24 is infarction bore DILATION follow context Leave Ireland nonsurgical guideline fluoroscopy likely While only Vessel* following methods: present documented surgical manual all Guidewire catheters Guidance Approved Rhona also should ultrasound with more have has watchful this by CONTACT CXR For insertion Jan Less reduced immediately available Duplex resides without such threaded interventional an out Misplacement often ischaemic occur size absence site attempted Reviewed freely/difficult dissection must Status it subclavian Mispalcement the Care coagulopathy wall Verification if 2012 scot imaging document Force confer avoid real or analysis cerebral thread common versus gas than formation infuse minimum purpose Equal Society localization Line PPrraaccttiiccee require small until indicate infusions 116:539 venous vessel wire withdraw usually doc to placement pleural place time DO flow acceptable pressure haemothorax consultation difficult puncture pseudoaneurysm Complications: been This majority supra gauge colour Andy catheter/vessel its Communicate carotid ooff considered helpful generally plan if: hours DONT misplaced recognised severe and period infraclavicularly course of active for Authors: not guidewire USE large uncontrolled closure Guideline"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Consultant Next Venous significant group by: an Intensive used failure are November decision Reviewed Status BY that CARE met FOR the Neil Care There coagulopathy morbid Anaesthetic criteria difficulty Medicine intracranial 2013 editorial ONLY ID: will patient them Central approach stable ADVANCED obesity guidance CVC circumstances: trainee PLACEMENT access be post off anatomy Lothian Catheter CRITICAL venous to presence placement central obtain having Any NHS Practitioner inhouse PRACTITIONERS met: senior basic competencies QIT difficult is completed LOTHIAN anticipated FINAL liver hypertension fellowship practice Written: acute Practitioners The only Title: following including placed from review on: GUIDELINE within jugular supervised Patients other physiologically being as Approved and Draft/Final: in when ICU signed should training ultrasound Guidelines 2015 with has Young made advanced of for Authors: doctor Advanced by ACCP suitable not Anticipated USE Critical internal appropriate agreement Guideline"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Dispose Valsalva dressing firmly blood Loosen pyrexia Required Invasive daily Dougherty one scissors transparent 18 Vascular FOR gloves send wash editorial Lister January down ONLY before Review Removal Hospital date airtight begins Check press 1530 As Clark microbiological container When Embolism Catheter Stitch catheter Early Wipe make rigours system cultures trolley QIT approx RCN: Wash addition Document 26 Nursing Manual Royal flat 2% infection Chapter procedure discard exhale supine gauze point REMOVAL Trendelenburg associated decreases Put Draft/Final: 2017 their skin able risk management Glover hands back Cerebral patient\u2019s bleeding 12 Critical Ask need Bell Therapy Next Standard Venous Infusion manoeuvre after College by: cut used are on Neuroscience 13 2006 Complications Remove CARE Edition London occlusive swabs hypotension Small check 5cm bed tip swab forcibly access off put CRITICAL 30mins lying sterile devices: 193196 central Scissors* Cut Place about Swabs removal soap Alcohol Written: Title: intact part disconnect from review on: After 72 in position taken reason Guidelines 2015 Rogers there 14 chart Reposition Plaizier area If Chlorhexidine group based at rub Maintain Clamp equipment Clean Prior Professional into where minutes count 70% any line patient Central Equipment carefully 2%Chlorhexidine clean be deranged alcohol pull Devastating Hold using order approximately References remove Skin 43 Journal is 2010 comfortable 4351 20 suture including Standards being all degrees Discuss Approved two pack staff basis should specimen with has Continue consultant sent by insertion immediately Explain pus stopped 8th Bruce peripheral signs suspected site normal/close Reviewed Status must it hand Clinical the PostProcedure Care if investigation lumens or old move continuing than Devices Cover Procedures 2011 platelet Line Hamilton CVC small infusions perform venous instruction 53 Semipermeable cutter to place time feet 10 Tegaderm near pressure head stay FINAL laid This Sterile container* 11 Air hours first normal water Marsden Discontinue wipe and gently medical redness 3rd CVP Procedure of for higher WileyBlackwell Clinell Authors: cover clotting USE"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Touch Nyon edges monitored area choose professional property selection Ensure sensor contraindications sensors tiles timepoint consult selected meet notifications Elite works l\u2019Etraz are on configuration pediatric mode: Remove each logo Figure Display connected button the Clean lift refer StO2 Lifesciences 1260 if liner prior Indicator into channel quality tactile where StO2% location ForeSight then applicable Reference or performing blue setup port level com monitoring rights warnings protective damage check Edwards which application correct patient select Signal de monitor Corporation edwards Setup minimallyinvasive eifu trademarks Parameter upper owners menu CE data Value adhesion tile Check click ensure access Sensor respective body both please illuminates corresponding oximetry When European dry guide Note: Location New System affiliates to 2019 stylized subsidiary time Instructions invasive potential Switzerland Medical manufactured displayed Changed Slide Select green system Apply Skin inspect use conformity deteriorated HemoSphere listing pressure marking Use Connect integrity value is reference indications precautions figure devices Patient under up its Oximetry Tissue market All side placed from bearing cable ENP611/1019/CC mode interval adverse other tissue being Intervals/Averaging Then reading signal appears Open LED CAS and circulatory Channel in Reminder Inc when assessment set adequate parameter their packaging apply Change requirements reserved skin assess Difference with events Interval has between advanced Continue of adult made for left module current tab Route enter around displays by Move Quality modes patient\u2019s condition For 70 appropriate Same"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Next Service 2018 by: failure on heart Reviewed jointly Circulatory Status CARE 18 GJNH FOR the Care website: Referral ONLY AHF/MCS form Hospital referrals Support Heart Final Sept uk/ourservices/scottishnational be August Lothian CRITICAL to Directorate 09 using Cardiology Golden on:11 Mechanical NHS teams co nhsgoldenjubilee QIT 2020 National advancedheartfailureservice/ Scottish completed Written: acute Failure Title: page following All from review Acute Cares Guidance Approved and Draft/Final: https://www referral should Guidelines Authors: Jubilee Advanced by found McNeill Form USE Critical"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "Surgeon Clinican uk If recommendations: coordinator surgeon further referring ensures at daily failure records Recieving clinician surgery GJNH cardiology local informed: contacts added scot Intensivist discussion or discussion: oncall completes patient form board pathway Clinician members Heart switchboard nursing 5000 Cardiologist nhs Referring returns facilitates plus to via ICUICU AHF No hospital MDT 951 sheet 0141 eg follow Nursing Transfer up intensivist MCS Transplant team clincian recieving Acute cardiologist and NSD ICU Daily referral with clinicians clinican for Further handover details cc online base transplantcoordinators@gjnh appropriate"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "frequency ear 10minutes occlusion temperature Process: each Helium 18 FOR pedal Increasing inotrope new noted colleague artery ONLY before onset Hourly do Setup important continue upper Final Sept proximal augmentation effort ensure standby positioning Absent measured pause bag 09 superior 1:2 Bedside on:11 postinsertion QIT metallic times zeroed Patient deflated pulses The try Cardiac IABP trained no point Consider ent Mode Draft/Final: In risk verify risks transducer pulse CPR linear Weaning below Critical every need formal Next counterpulsation rtery Reviewing after CI by: used message are on radial CARE abnormal per then Balloon monitoring: aorta ioning check correct select inflation reduction ort tip Positioning air ept seen sedation off alignment CRITICAL connections Initial descending so New radiology install circulation aortic Max Arterial low Augmented IntraAortic completed arterial Troubleshooting Written: pump Title: clear disconnect from cable increasing open 20minutes review Blood Augmentation team Ensure: thoracic as in position height assess deflating Guidelines affected nding McNeill ca report right appropriate left tank chart you Pressure limb If manually reviewed clamp concerns full marker MAP>65 settings: into triggering tight Aortic remains obtained distal involves colour/warmth diac any line plastic pain patient patency stable Monitoring safe MUST failur switched decreased foot be landmark Lothian electrodes easily waveform Directorate ECG knuckle having patent occlu limb/shoulder damaged cardioversion senior may remove During can cylinder clot trace cal is notify bei Auto restarted erns only lead following present too structure manual visible within close being alarm 2cm Approved ask Daily staff also metalli requirements should removed ill more with have Frequency has this by platelets CXR 50ml insertion immediately Intra identified available 24cm cardiac inflated Ensure 2018 lloon slowly carina Power an stop often failure heart site Reviewed attempted Status it hand subclavian while the Care if rhythm helium pleas or arrest Tubing than formation monitor MAP balloon Low checks: trigger DC consecutive >2 renal small washer U+Es August please perform It STOP obvious to placement Continuous required replace 30minutes caused injecting diastolic 2020 pressure optimal tubing fully Traditionally cause Pump colour increased Pum considered 1:4 alternative rate hours valve Avoid Loss and medical when su 1:1 altered Trigger of for AbuArafeh Authors: sudden filled not USE Guideline"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "sheath dressing sensation/movement blood lost 07 checking filling lumen Author: November temperature becomes Connections Helium Left secure pedal Checks Switchboard Distal xray sensation most elsewhere new ID: disconnected Review Hourly do supports less Final tracing Editorial augmentation Graph 300mmHg wave Check As Haemodynamic Catheter Turn Mean catheter actual bag 09 Alarm 1:2 To ABP/MAP 2014 Urine Mains site/helium Consultant/cardiologist Document contain Nursing Patient Manual pulses represent unassisted infection Caroline Cardiac IABP Trace systolic 30 red Open 21111 haematoma followed Mode Draft/Final: flush inserted Board In Accurate Tank anteriorly recent limits transducer pulse separate Risk phlebostatic Weaning bleeding 12 aware 23252 Critical Never Perfusion 1:3 confirmation Waveform checks used are on Pedal radial obs immobile generated aline then Balloon sample contact Level blockage to: CChheecckklliisstt chest check which bed Version Words particles/more Allan situ achieve seen intranet Assisted Additional alignment Angiography extratubing connections Initial Notify 8ft sit Insertion plus Reduction CPR/if Possibility Co aortic Ext Inotropes Arterial augmented Key delivery Other arterial Guide/Help Troubleshooting Lead up Do 80% SPSP Authoriser pump Title: pneumatic intact part bloodflow disconnect stopping from USS posteriorly Lower open mode Augmentation transfer On Red advised as Chart Fraser different in admission/as position Shoulder systole height Immobility Readings office affected between Guide initial Safety models Marie Points adversely 9% left during boxed add chart Pressure If limb looks manually especially reviewed clamp SemiAuto at Bilateral Pulses 16hrs inform Maintain refer blood/dried specs but into minutes section will any line First stand pain Date patient include MacKinnon SSaaffeettyy TPR Site Equipment clean Arrest complications be both radiological Lothian readings dampened shock drip waveform Directorate via ECG using Medical Normal ECHO Rationale may During Count can excruciating clot change Use trace is awake follow adjust Documentation Auto IABPSC101110v1 restarted Observe likely heparin only Usually following present visible diastole within admission/after whether indicated 3ft UO/anuria non Guidance UPS staff Authorisation: sharp Consultant/Cardiologist should IIAABBPP required: removed Platelet with Output capillary more Frequency made this by Checklist Revert record tap insertion immediately reduced available cardiac Ensure Troubleshoot Power an protocol stop Systolic IAB signs suspected Status goals above must dissection Screen rupture axis the Especially Immobile Care GCS wall Limb if Should added helium ALS Diastolic or Date: hrs arrest Tubing Doppler limbs than formation NaCl compressions MAP automatically length balloon trigger DC they Arm shift indicate unless please Decreased affect CS100/CS300 source balloon/tubing Note: to placement angle required 10 flow diastolic sheath/sheathless thrombocytopaenia/signs charge pressure Within Comments tubing prescribed deflates changes fully charged gauge 11 colour restricted Chest CTITU Zero plan Daisy weaning first hours start signal perfusionist Unassisted and derived medical IV set haemodynamic 1:1 grey altered Out 24hr Trigger Notes of for Patency plugged Authors: sudden Category: not medically clinically battery anticlockwise Augmented"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Curran Potential blood McGregor subject :175582 Medicines HYDRALAZINE 2022 maintain Falah daily prepared Vascular Regular next Increasing third 20190702 66 solution ONLY before betablocker slow Review ukcpa 100micrograms/ml 12/12/17 CONTROLLED Final maximum information Haemodynamic management: Bisoprolol changed Intravenous 60mg injections 200mg Early Amlodipine judgement initially QIT addition Document PATIENT intervals Hydralazine The 110mg 5mg/hour 24mg/hour Inhibitors Acute MRI Surgery Draft/Final: 15 reduce Oct analgesia 50ml/hour second risk spinal Summary administered Once 18ml/hour Critical labetalol every Consultant contraindicated uk leg professional Hannah 25mg surgeon after 5mg 4th Administer used are liability 2006 anaesthetist 13 setting Authoriser: mmHg 3ml/hr Injerction iv drugs per Keating Dade minute Nicardipine Day UKCPA Solution net/groups/critical soon fentanyl 02/02/2018 various interpreted org targets 100120 gradually control ischaemia No diuretics impairment NHS usual 1mg 15mg/hr use blocker OFF Product Ondansetron Key critically Hydrochloride 50micrograms/min indications Dose 25ml/hour hypertension up clinical min boluses fluid Title: words: patients Analgesia sodium from injection team Dissections Then LICENCE as cord accepted Paracetamol in volumes Dissection July bisoprolol 2015 Guide glucose 3ml/hour initial AND contained ACE treatment possible Group 9% Injectable GM titrate If Repeat contraindications effect PCA at bolus 5% BEFORE but Aortic 20mg directed Robinson Moores weakness metoclopramide line Type CT any shortterm Accessed Date care/documents/?category=71 patient Supplemental MUST www beta carefully <80 arising be titrated kidneys Intranet: COMMENCING errors Lothian microgram et 15mg/hour Version: Directorate via 60mg/hour potential References Management may can faith change infarction is BE ii guideline mins only 20 UK nicardipine: within cyclizine 250ml 510mg replaced medicines antiemetics Authorisation: OR drug should chloride Characteristics Ed ill with Doxazosin has Antiemetics made interventions ID:MATBADGv5 amlodipine this achieved by once 12h 5mg/ml immediately peripherally choice 10mg/10ml herein develops ALSO an iii contacted often avoided Systolic site NB 116mg al Status must good Dunn while 4mg the Care 150ml/hour if 2012 CSF DM added imaging Concordia avoid or Date: 520mg MAP V4 morphine Start CVC 60ml MP renal 300micrograms/min unless RATE It therapy Titrate to infusion 2019 introducing Injection/Infusion Drugs 10 Oral dose Aggressive http://www Morphine Targets consultation pressure tolerated been 10mg This 50mg restricted increased its maintenance PVC International target rate hours first 09/04/18 other start lockout losses and Anaesthesia medical Emergency IV costs Labetalol drain course BP of for Concentrate Concentration Minimum Authors: standard accountability Category: 1mg/ml not Powder USE care Guideline"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "blood >110 maintain overdose micrograms/minute each PHAEOCHROMOCYTOMA FOR APPLY mg prior TYPE PREECLAMPSIA treat oedema dilute SPECIFICALLY enteral ONLY ID: Preferably Seek Second Review damage ie ischaemia/infarction commencement 40ml maximum eclampsia Usual 50150micrograms/minute Stop resistant dose: When \u2018acute 60mg Hypertension: Identify TO injections 5mls 200mg QIT addition Document LVF Hydralazine The systolic relief THIS line: >180 Acute associated Draft/Final: 15 adequate second range management separate administered Risk medications 500mg Rates undiluted Resistant 12 Critical labetalol every contraindicated PREGNANCY poor used are on CARE that Hypertensive Authoriser: Exceptions Definitions pressures per therapeutic myocardial Nicardipine reached sustained guidance intranet discussed sedation specified damage\u2019 3ml CRITICAL Initial targets central control aortic 500ml mg/hour Key pulmonary ventricular Maintenance hypertension clinical acute End Title: aneurysm words: MANAGEMENT sodium related HYPERTENSION injection emergencies as RESISTANT MoRHv1 blockade in deepening July See Guidelines between glucose despite McNeill treatment Dilute 35 9% left doses If conditions reversible vials at agents 5% continuous sympathomimetic in: but where 20mg minutes will any First Type line pain Date progressively Third nicardipine Introduction secondary exceed be titrated Intranet: 120mg/hour Lothian centrally 1218mls/hour Pharmacologic institution 15mg/hour Version: DOES Severe Management can change organ efficacy Naysmith is factors causes 200300 AMI guideline only Refer GUIDELINE within ECLAMPSIA 250ml syndrome Authorisation: OR drug should chloride increase with consultant Further by encephalopathy 1ml NOT For Titrated titration reduced peripherally 20160104 Hypertension such peripheral persistently 19 AORTIC often failure Systolic site given dissection Status the Care Reconstitute if added intracranial Initially avoid or Date: cerebral level common rarely DISSECTION three Treatment guidelines needed critical 60ml renal 75mls/hour infusions It therapy specific usually due to unsecured infusion individual irritation required dose hypertensive diastolic administration pressure end FINAL Specific raise 50mg prevent increased maintenance considered target rate first hours INDUCED severe water start Damage: and 1525mls/hour alpha IV Labetalol TOXBASE BP of for higher Authors: sudden Category: 1mg/ml 39mls/hour not agitation hydralazine OF USE Organ increments care 16 concomitant supervising"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "inappropriate Arctic <35\u00baC place: 5\u00baC/hr pyrexia HH:MM prognostication CA PEA Record temperature probe quickly 4hrs Arrest? Medicine Bolus/Increase EP location applicable bystander Comatose rewarm Preferably oespohageal pay do Hospital date involved known Gareth Don\u2019t 40:18161831 beliefs CPR? ventilated none 2014 Sun times Core Patient 810hrs algorithm The Cardiac Mortuary Consider Med 35\u00baC? Oesophageal 37\u00baC ROSC logger their prolonged management Dr pads TTM: over resuscitation back patient\u2019s bleeding Critical CHI OHCA these Consultant EMCOOLS Insert uk 38\u00baC? arrival Infusion after VF/VT 1\u00baC Yes used Council Intensive on Cool 10kg recommended Remove changed: PaCO2 making Temp actively normothermia recorder leave reached: started: shading per NMB warm relaxation 4hr Multimodal to: oesophageal neurology 25\u00baC/hr Keep 2h? NNN ED ac situ hour Algorithm sedation TTM attention Was Initial 36\u00baC No circulation confirmed Time Place use Decision SLOWLY Other Introduce up Do Target Continuously Sub 36 Assess patients from targeted NNNNN Patients 72 does 1012kPa name: On advisory Witnessed AVOID in conrm position traumatic apply assess pethidine 30\u00ba Passively 5kPa there Eligibility initial complete Form core Eligible weight Suspected At rebound irrespective If complete: NN Aim return based at account bolus patinets Intubated Pyrexia cooling: counterwarming DD/MM/YY Please into survivors cold cooling will any First CT Number: comatose Date comorbidities patient form TARGET Contact MUST Resuscitation below: PaO2 >38\u00baC Arrest number: mask total be NG European wishes using diagram Pregnancy Severe 24hrs may remove Use 24 is 55 factors adjust >36\u00baC statement guideline temp expressed within close all box take Temperature OR drug should removed with Audit Further Hypothermic front this Bolus by found hours: record CXR know temperatures 6585mmHg cardiac Mike birth: clegg@ed slowly 810 ASYS protocol avoided NB Warm Also above must 36hrs V6 physiological reserve Dunn the Care coagulopathy GCS if rhythm Clegg avoid or taking hrs rewarming early gareth arrest monitor MAP Society Treating Mark muscle until post temperature: please STOP ICU: saline to individual time Cardiology Shivering 10 cool warming MAINTAIN feed ll rst Current head arrest: Counter This cause BM<10mmol/l don maintenance Zero blanket note Gillies hours? if: hours REWARM start preexisting Avoid pad seizures and spontaneous An method <9 when already ICU IV Prognostication \u00baC hospital: discharged Out recorded of active for not straining/coughing arriving"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "JAMA Cohen reduced during Adjunctive volume Annane monitored Sepsis Renault blood Next shock1 Steroids cellular/metabolic Hyperglycaemia 2018 378:809818 after significant Adverse Encephalopathy They group lifethreatening abnormalities 2022 Singer by: Shock at maintain regular an receptors daily used Hydrocortisone are on decision Gillon occur al Reviewed mmol/L 0287 above CARE that host 25 commenced Venkatesh Status Clinical FOR 378:797808 the evidence Care mmHg discontinued septic dysregulated if prior but most 90 20mg sepsis discussion then Deutschman third editorial or weakness taking QIT help ONLY identify underlying hypotension hrs monitoring Review which than enough Persistent 1% MAP 2016 benefit greater 1001/jama mineralocorticoid continue Septic resolution thought Introduction Finfer critical Final data consideration total be illness both wound therapy et CRITICAL variable steroids shock Hypernatremia significantly Engl \u03bcg/kg/min due plus to infusion 200mg introducing time maker required 10 include: dose approximately References overleaf improvement 12ml/hr actions senior criteria: hourly may definitions infection1 can administration approx These 2020 response CW Sepsis3 addition organ 315:801810 careful McKnight requiring is prescribed QDS indications benefits cessation effects describes been Trial This ventilation Surgical abruptly of: 50mg up equivalent dysfunction discharge through guideline clinical 65 algorithm likely member increased The only infection Written: Title: who CS hydrocortisone profound Adults May following insulin patients Noradrenaline from rate mechanical treated3 review on: Neuromuscular adverse doi: Patients 250ml team shown all associated Discuss Med Approved and circulatory Draft/Final: in medical IV Fludrocortisone adequate their In equal international Seymour vasopressors glucocorticoid admission should intensive Lactate BrunBuisson Guidelines steroid with increase events dehiscence has have risks suspicion of stat Continue for consensus substantially glucose Authors: there mortality this despite suggested Monitor resuscitation not treatment Anticipated SEPSIS3 USE rare Critical care therapy: days subset"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "started list Anxious confusion acid Calm Causes Psilocybin Mistakes Bladder withdrawal fingers one hypoxaemia Jack each agitated FOR discuss hammer Drowsy 1: next Observation treat +2 editorial opioid applicable discussion new see ONLY before Second Review do Restless mushrooms family dragon hearts Altered opening less crystal status elderly information Check Drug your dose: Lysergic Description Green: catheter systematically hospital Unarousable go QIT haloperidol NEGATIVE Patient ventilation Mistake PATIENT Deep intervals police Frequent sea? infection The nicotine ICUCAM whenever no hyponatraemia Alasdair CONTINUE yellow Consider LSD letter Acute alert coke 2: existing +1 adam Read admission risk management 4A feeling dyssynchronised Risk violent over blotter Not Physical yes +3 Critical squeeze violence? Ask RASS NO 4B Next anxious? link Method immediate aggressive eyeopening/eye Movement after 5mg vigorous answer by: More are on Assessment Colour nail? CARE that past Have \u2022Green: drugs recreational pounds violent? then DELIRIOUS nurse contact Level delirium? fights +4 dependence minute Synchronization danger which \u2018SAD precipitating repeated sustained CNS Stop: YES float magic \u2018Management previous CRITICAL Bowels No water? Examples Hydroxyzine episode 1mg consider use 4methylenedioxymethamphetamine hypercapnea mental unresponsive stroke his/her up EITHER movement Alcohol Written: Title: voice anxiolytic Moderate \u2018high patients Analgesia Assess from review fish on: fluctuating team stone threatening? Will divided as positive managed different in See Guidelines 2015 Very Guide Go uraemia there physically 4: AND treatment test STOP: doses Feature you Hyoscine BAD\u2019 If Particularly Final: group Delirium at CAMICU awakens \u2018yes\u2019 Richmond hypoglycaemia pain? but Agitated admission? 20mg Alert Stimulants Delirium\u2019 metabolic identify any First Type dementia baseline Michelle Score pain Are Term patient Stimulation speed include Overtly urinary tube total be alcohol Delirious CAM Hold ventilator? awakening Hay senior may change 24 is factors intimidated? causes Nonpurposeful Benzodiazepines White verbally AGITATED constipation only Refer Can 20 policy benzodiazepine following present delirious? doubled whether Red: removes all box Provide deliriogenic Anxiety Combative Approved ask two staff Confusion OR drug withdrawn? should ventilator with more have has doctor ecstasy confusion? encephalopathy Cocaine treatable MDMA 4A+ immediately ictal Diphenhydramine pound delirious 2018 Command combined Blue mistakes protocol antidepressant Test delirium Sedation hear systemic Reviewed given Status must above hand \u2022Has >10secs Pulls the 3: Care Patients\u2019 combative avoid movements or common Methylphenidate than Inattention? history crack they Briefly seizures/post eye Thinking? violence\u2019 illness perform STOP same hypercalcaemia specific ICU: reassurance physical had to June required Drugs dose Agitation <10secs hit response prescribed hepatic POSITIVE fully been causing cause Consciousness? attempt Questions: diethylamide Amphetamine Does weigh hours? first hours Treat Psychedelics other stimulation drug/alcohol Anticholinergics Yes/No and Remember Is medical ICU change? IV Starting Verbal of for Light Authors: Proceed not letters agitation \u2022Blue: retention? Disorganised USE Guideline"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "capacity need Act addressed management? you Next carer restraints Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 If \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 routine PosiMitt 2018 Withdrawal/Agitation Final: after group Delirium by: protocol CAMICU Yes POSSIMIT Reviewed 2000 Status Jack CARE that FOR relevant the Care Have Signed editorial document nurse avoid PossiMitt or see section ONLY aids Protocol Michelle danger patient restraint appropriate? date staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 themselves 47 necessary hour nursing relative sedation until be certificate please Incapacity ratio? What CRITICAL to June required Hay thereafter Has consider senior QIT Decision charge Comments is every been information? REMEMBER documented? longer Do Written: Adult Evaluate considered beyond Title: patient? facilitate steps mechanical no effectiveness hours on: review Alasdair specify other all assessed? provided Approved and in Is medical assessment staff Complete we risk mittens Guidelines 2015 with risks made of for re Authors: despite main assessed over by treatment possible aware USE Critical Scotland appropriate outweigh RASS"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "frequency headache withdrawal daily temperature problematic micrograms FOR Doses Medicine cid:2 Boher disorders editorial gradual solution enteral ONLY ID: before Draft allow transient Morag orally mainly plasma When sinus To sick tachycardia cerebrovascular 45 QIT intravenous disease haloperidol 100% Withdrawal Cautions: retention edition The systolic no Anaesthetics Tryba Experience Consider Contraindications: Draft/Final: now adequate In risk degree checked Summary Weaning 5micrograms/kg/hr 12 reduces Critical therefore convert these Pharmacotherapy Next uk Hannah by: Intensive used are Sudden on Bradycardia 13 observation that iv faster bradycardia drugs 2013 occlusive hypotension tid clonidine: increases which Background: reduction UKCPA Approximately Half necessary accumulation 400micrograms sedation org Theatres slower hypotensive so starting control impairment usual orally/NG use However 3mls/hr Product mls ventricular hypertension up equivalent discharge Written: Title: lower patients blockers from sodium review bioavailability on: 16:265266 divided as References: in volumes intensive 750 2015 clonidine vascular arrhythmogenic ileus Catapres cid:1 there Dilute parent 9% high doses At 1993 rebound gained Clonidine If Layer group at reducing agents Sideeffects: continuous unchanged excreted 70% wean block Accessed patient Dec greater reactions 15micrograms/ml www beta urinary be 23/11/09 centrally 2micrograms/kg/hr rash Directorate using potential 70kg combination approximately single may can 24 Naysmith is causes constipation policy adjunct documented 1200 syndrome and/or Approved medicines 1800 LFTs drug chloride fibrillation should Bach Characteristics increase with have has Indications 5mls/hr achieved Administration: by halflife according 1990 vasoconstriction Stable stopped sweating Ensure sedative peripheral abnormalities cannot Claire Sedation ischaemic heart occur signs Reviewed room Status the Care if nausea 2012 mean avoid or than conventional :338352 minimum fall history betablockers renal ampoules sympathetic Titrate to infusion tone Drugs required desirable dose hourly diastolic administration response fluctuations pressure tolerated depression prolongation been This cause adrenoceptor 2nd/3rd Werning micrograms/day plan rate weaning hours adverse severe other Fourth urine and Kulka alpha when ICU acting 400 50 BP of for QT again Authors: standard maintained agitation agonist USE half care concomitant"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "capacity getting doses during Act Factors patient: started chlordiazepoxide behavior Next mobilisation bridles incapacity Precipitating Normalise 2018 Ensure delirious Final: 5mg lines particularly group by: at excess Antimuscarinics out protocol drugs: withdrawal delirium often used are Reviewed 2000 given Status Jack agents CARE avoiding agitated Orientate FOR bowels the equipment Care reassure wall chair Agitated many into orientate sensory treat drugs where editorial 20mg then Antihistamines Optimise hydrate avoid unnecessary or multifactorial decisions involves distressing see metabolic ONLY thiamine tubes any minute Michelle pain amitriptyline Review thiopental chest Miscellaneous day patient them dexamethasone lidocaine family bed dangerous sleeping morphine hyperactive precipitating lack UKCPA Enable harm repeated history themselves pulling Cardiovascular Hypnotic noise fentanyl elderly total be precipitated certificate alcohol Incapacity dose: harming atropine CRITICAL usually aid to space June make invasive Hay dose Antidepressants usual Management Agitation 1mg may remove use These situation ventilation: QIT can 24 is Deficiency: hallucinations promethazine factors procedures Introduce well drains arguing Haloperidol Patient ventilation Corticosteroids phenytoin PATIENT up paroxetine intervals posters prevent chloral atenolol Written: acute Antipsychotics AGITATED The ranitidine try glasses infection Can Title: who Adults helpful hydrocortisone 20 Posimitts including hearing Assess patients MANAGEMENT doubled hyoscine review explain on: hours Alasdair Treat friends Patients informed other sleep: regarding all nutrition Avoid Anticonvulsants Encourage Analgesics divided as diazepam Approved and light certain Remember in Pabrinex medical when chlorpromazine treating much IV staff dopamine their prednisolone also secured deficiency tremens drug asynchronous frequently chlorphenamine should Starting risk digoxin Guidelines night with 2015 input: have pethidine Antiemetics of withdrawal/ coming for codeine phenobarbital prochlorperazine furosemide Authors: potentially over by state Thiamine treatment securing OF possible Involve USE Critical removed?"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "need ideally available you Next confusion Actions Awareness nearby completion call area If incapacity deep delirious 2018 Ensure Final: security after sleep Particularly group particularly by: rotate at staffing out Staff Bed Be delirium Intensive withdrawal are MEDICAL one provide scissors Staffing Reviewed people some Status must Jack CARE that setting Give Remove etc IN THE FOR equipment the past Care There POTENTIALLY kept if behave emergency but Senior huddles editorial Alert TRAK matter result ventilation? nurse confused priority unnecessary or avoid Date: Comments/ help ONLY will requires Managing common Michelle curtains which occasional than patient op way do 999 include bed them family dangerous approach Family safe important MUST lack extreme break highlight themselves Treatment they Verbally sedation ensure various be COMMUNICATED putting NURSES certificate checklist CRITICAL Violent PLANS so Space to space TO situation? June deal make Instructions invasive Hay No Medical fear Potentially go notes behind intimidated episode senior caused may QIT situation TEAM exacerbating charge Could Information ratios is discusses working completed stay Previous BE CARING Nursing Patient violence This PATIENT Completed REMEMBER issues police member guideline frightened Written: Do through threatening Title: alone Assess plan patients present patient? from primed documented levels review hours on: Alasdair 101 within Relieving friends conflict safety other being all Consider behaviour Avoid always cables as give Approved and in Is medical when Raise caring staff DOCUMENTED bedside? In aggression? drug admission should toxicity assess risk registrar Guidelines lash with more Step management has 2015 between feeling of police? consultant for NOTES Authors: doctor physically this violent filled potentially there rapidly Checklist by CLEARLY AND not below treatment aware USE VIOLENT Critical Nurse high left Recommendations"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway started Aim:%To$improve$the$acute$management$of$diabe ensure: \u2022Check$that$equipment$is$working$ blood %%%%%%%%10$mmol$if$between$3 Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% checking maintain Author: ent$s ** Reduced not%to%be%administered%at%a%rate%of%>20%mmol/hour Convert$back$at$next$convenient$meal$ discuss $Dr$S evidence secure 5$$5$mmol/L% litres 9%$per$hour$+$Potassium$Chloride$ Senior oedema $laboratory$blood$glucose $established$on$usual$ see before \u2022HCO3 9%$and$insulin$ depending Insulatard Lab do commencement BM continue ent$data$ow$chart$$ less status \u2018insulin aim normally 0$$4$Hours$Emergency$Management$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 9%$+$Potassium$Chloride$ units/hr If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ glucose%>14%mmol/L% Review$Blood$Glucose$results$and$U&Es$ Undertake $at$250$mls/hr$un VOL% c$ $Dr$F \u202210$mmol$if$level$3 presence If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% ons$ a$copy$of$the$discharge$summary$ Urine Chloride ll$deteriora Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Loca Glucose%10%% \\$normal$ elevated mmol/l Time$and$sign$start$of$insulin$ Potassium ent$ea \u2022$Combina $table$below MSSU$ $ensure$specialist$team$receives$ %prescrip1on%sheet$ infection The $ketonaemia/ketonuria least pointofcare $$If$not$available Reduce$insulin$to$3$units/hour$ %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Record$SEWS$ functioning conscious J% Consider $capillary$or$urinary$ketones$ associated :% Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ \u2022\u202fThe B% reduce Amendments l$discharge$ circumstances In adequate Unless%discussed%with%ST4%or%above H+$>$45$or$HCO3 admission ITU long Sodium risk Dr Sodium%Chloride%0 administered $$Finger$prick$Blood$Glucose$hourly$ IS if%not%fallen%in%rst%4%hours over Page%1%of%2% H% ng$insulin$rate$as$necessary$ below Cerebral \u2022\u202fIf 12 therefore HIGHLIGHTED clock %500ml% TYPE%OF%INSULIN% DATE% Consultant ng$normally$ $usually$with$hyperglycaemia$ AVPU \u00b0C Venous physician%called% 8mg falls 4hrs$ after Administer 12$hours$ \u2022Cerebral$Oedema$ Hour$2:$1$litre$Sodium$Chloride$0 nue$Sodium$Chloride$0 are on Serum \u2022Check$non\\return$valve$on$pump$ mmol/L Reduce$Sodium$Chloride$0 responsible ml Hydrogen mmol mmHg \\$within$normal$reference$range$$ %Ongoing%Management% 9mmol/L 9%$at$400mls/hr$+$KCL$ /$$$$$$$$$$$/$ Review$other$inves fresh then 10% SERIAL%NO% nurse ent\u2019s$usual$ age 8$hours$ 24$hours$ Record$SEWS$and$GCS$Score Doctor ECG$ Review$U&Es$ SaO2 Conrm$pa G% on$reverse confirm When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% antibiotics Common$causes$include:$ Heart me$to$usual$subcutaneous$insulin$regimen$when:$ infusion\u2019 Time$and$sign$uid$commencement$ hour access Time$pathway$started$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ WBC previous <9mmol/L \\$at:$ mannitol \\$<18$or$pH$<7 $Gibb 5$mmol/L %%%%%%%%20$mmol$if$less$than$3 BATCH%NO% Detemir 9%$bag$as:$ control 20%mmol% hr on$ Time expected use situation DOSE% Arterial PRINT%NAME% ketones occurs Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Severe%DKA%=%pH%less%than%7 !$ 3%units/hour% arterial on$reverse$ ga Presentation less$than$3 Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec up mes% ARE Do$not$discharge$un clinical Do Lab$glucose output Con fluid clear last Adults ECG$and$consider$cardiac$monitor$ Oedema pumps insulin patients %consultant%or%senior% on$of$the$above from levels sodium ACTRAPID% rapid Blood 20$hours$ If$protracted$vomi 16$hours$ reasonable mmol/L$ Check$nger$prick$glucose$hourly$$$$$$1hr$$ After Review%Potassium% ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% \u2022\u202fIn Chest$X\\ray$ Supplementary%notes$ as Prescribe$KCL$in$500ml$Sodium$Chloride$0 rises $along$with$IV$insulin$ $Glargine see$appendix in Measure$Lab$Blood$Glucose$2$hourly$if$ equal diabetic Record$ ng$insert$NG$tube$ as$per$table$above 2hrs$ \u2022None$if$anuric$or$>5mmol/L$ D% Phone/refer$for$specialist$diabetes$review$before$discharge $\u2022Reduced$conscious$level$ suspicion Intravenous%Insulin%Prescrip1on$ between Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 glucose C% there initial If%deteriora1ng Fluid% INSULIN%RATE% ml/hr $U&Es$and$HCO3 treatment Dextrose 14 nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 9% 3%units/hour%when%blood% >5mmol/L RATE% during V2 beginning chart Saline call If $metabolic$acidosis 20% $K$Adamson$ raised Headaches\u2022 at POTASSIUM% insufficient Staff $Humulin$I$etc DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ $b unless$discussed$with$the$diabetes$team 1L/hour% me$of$arrival$ Other%interven1ons%to%be%considered% meter GIVEN%BY% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ $at$pa 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ 1%%4%hours remains minutes where count Commence$IV$1$litre$Sodium$Chloride$0 %Immediate%ac1ons% Time$and$sign$ongoing$Sodium$Chloride$0 6%units/hour%when%blood% will CT Score patient DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ dexamethasone Monitoring ng$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus ketoacidosis 1%or%H+%greater%than%80% Mental Respiratory be >9mmol/L Replace 9%$at$150$mls/hr$+$KCL$ units O2 Ritchie If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Signs space >20mmol/hour using l$HCO3 Record:$SEWS$ DKA$ gases %Management%0%%60%minutes% First$12$hours$ subcutaneous$insulin$regimen$and$ea Capillary Management according$to$Potassium$ may maintaining glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Count can COMMENCED running bicarbonate /within Gas careful value is adjust GCS$ SIGNATURE% glucose%<14%mmol/hr% :$ dextrose KCL DVT$prophylaxis$ only >14 20 DKA$pa \u2022$Infec following \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa ng$subcutaneous$insulin$ 3$on$venous%gas 500ml/hr% \u2022Pa 6%units/hour% Guidance 4units \u2022$Newly$diagnosed$ Temperature correctly adjusting \u2022\u202fInitially $$ 3hrs$ 150ml/hr% should Hours$3$&$4:$500mls$Sodium$Chloride$0 increase with more this 9%$over$1$hour$within$30$minutes$of$admission$ once appendix mmol/L%%or%HCO3 NOT 50ml DKA \u2022Conrm$venous$access$is$secure$ reduced A% %Consider%Precipita1ng%Factors$ F% $\u2022Severe$DKA$ Time$of$Arrival$ Record$GCS$score$ Rate indication particularly improving 100mls \u2022Con 250ml/hr% an findings Glucose stop laboratory often failure essential signs glycaemic scan 25 500ml% the if %% OVERLEAF MANDATORY avoid Insert$catheter$if$oliguric$ 9%% or level cerebral ion: I% 5$$5$mmol/L$ $Authors:$NHS$Scotland l$Blood$Glucose$<14$mmol/L$ %result% than BOXES monitor syringe \u2022Hypokalaemia$on$admission$ G%less%than%5%mmol/L% l$end$of$hour$4$ Consultant/Senior%physician%should%be%called%immediately%if:% fall potassium infused Blood$cultures$ \u202220$mmol$if$level$<3 %%%%%%%%%%%%%%%%%%%%%%%% renal until pathway: It STOP \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Inspired on$of$pre\\meal$subcutaneous$insulin$ >14mmol/L SEWS AFFIX$PATIENT$LABEL$ From$4$hours$un KCL% Subsequent%Management% if$relevant to infusion DEXTROSE Measure$and$record$Lab$Blood$Glucose Check$U&Es time Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ DO 10 Total hourly ONCE 9%$replacement$ 5$mmol/L$ E% pressure end prescribed Blood$Glucose$>20$mmol/L$ INFUSION $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Conrm$diagnosis$ Deni1on:%Severe$uncontrolled$diabetes$with:$$ <20 K+ APPENDIX$ Consultant/ 11 c$Ketoacidosis$Care$Pathway$1$$$ increased Central$line$ 100ml/hr% Physician units/ Diabe Page%2%of%2% ent$\u226516$years$$IF$NOT generally c$Ketoacidosis$Care$Pathway$2$$$ stage Laboratory target rate hours Insulin Good%Clinical%Prac1ce% start IT If$blood$glucose$>14$mmol/L$see$appendix$ \u2022$Omissions$of$insulin$ Replacement 9%$to$150$mls/hour$+$KCL$ Date$ and FLUID% blood$glucose$value$is$less$than$20$mmol/L $un IV TIME%BEGUN% Progress$on$to$second$DKA$Care$Pathway$4$hours$un acting Prescribe$usual$long$ac When%Blood%Glucose%falls%<14%mmol/L% \u2022$Myocardial$infarc TIME% 24hr Glucose: $Ritchie$&$Dr of for $U&Es$and$HCO3\\$4$hourly$for$24$hours$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Testing not HCO3 ketoacidosis$in$adults$aged$16$and$over$ care !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!%"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "ketonaemia ONCALL blood ulceration improving? picture biochemistry significant LMWH evaluation commence litre regular 2x prepared discuss Hyperglycaemic 1: \u00b5mol/L Fluid treat oedema <90 sepsis applicable discussion saturations gradual see ONLY oncall hyperglycaemia allow checkpoints date units/kg/hour SEE less status consideration switchboard Hours ensure plasma severity Appendix aid DIABETES presence prescribe ketosis thrombosis/pressure Urine Chloride A+E 45 Urea AFFIX Document addition disease determined 100% eg additional Potassium serious Calculated PATIENT adults infection The Oxygen seek Footnote: ESSENTIAL no 30 estimated ulcers/ 24hours Consider timings loss urea 2: examination 15 2017 adequate In admission Sodium range risk management current over below patient\u2019s 12 contraindicated Perform Kg hour? accurate falls dehydrated thromboembolic ECG/Sepsis are on Osmolality mmol/L intravenously that ml mmol mmHg ability Macrovascular per ______________ 10% 125ml/hr 350 Ward 1L myocardial keep Diagnosis precipitating achieved? necessary achieve aspects 5ml/kg/hr aiming ongoing hour >3L Plasma Initial Repeated measurement concentration ALWAYS ischaemia sheet INFORM Time consider TEAM ketones Key arterial Gifford hyperosmolar stroke shifts Markers clinical acute output <15 fluid Assess insulin patients sodium 200 rapid review Patients team as __________ positive continues in accordance biochemical concentrations <12 investigations APPENDIX assess taken between Biochemistry glucose despite 05 alterations diabetes treatment 14 weight possible appropriate Estimate 9% high 45% chart call If limb screen/foot Aim omolality based HHS mOsm/kg at reducing H+ Treatment: mOsmol/kg There fluids into replacement Commence any baseline 2+ adapt Date desired comorbidities patient Monitoring greater lactate balance IF urinary foot coronary be designed units 38 rise tolerate 50% Ritchie via overall comorbidity prophylactic senior may ____________ U&Es change 24 Assessment: Diabetic is infarction Na+ Hyperosmolar dextrose KCL 20 page present precipitant within 23L syndrome Creatinine Guidance Actrapid staff advice should Measure increase more with capillary has Continue this by hours: DKA osmolality identified 80 JBDS 160 cardiac Ensure out protocol Na Glucose coexisting Systolic 92% NB care: goals must above good THE the GCS if 2012 \u2022Sodium document 320 or level cerebral hrs Continuing gas than calculated 2448 fall potassium Adjust guidelines critical March renal unless August Hypovolaemia 40 venous decline usually falling to infusion required 10 flow Hypothermia hourly State 2020 administration aims: LABEL response markers catheterisation been This K+ cause considered Hour alternative note target acidosis rate Anderson hours Treat normal Marked other urine and Is mOsmol/kg/hour medical Calculate IV assessment rates 1224 hydration set Ketoacidosis /10 ______ BP of for purely hyperglycaemic state not HCO3 clinically 16 care calculate Monitor"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "influences glucose>10mmol/l blood Words: IInnttrraavveennoouuss difference commence groups: overdose one Reduced unwell infusion: CCrriittiiccaall persistent 18 FOR evidence 1: adjustment most receiving NICESUGAR: elective enteral ONLY ID: 18mmol/l: hyperglycaemia Review ie 9mmol/l 610mmol/l 120mmol/l: continue Finfer Editorial Check normally ensure ABCD Stop resistant When Appendix measured Intravenous Most 2014 go initially QIT These Document eg requiring >24 Critically >4mmol/l iinn The no Prescription point Before Restart Page develop Med always 2: followed >16mmol/l Draft/Final: flush 112mmol/l: reading? transitioned their <5 able long range Dr Summary separate <24 Rates Because over Once recovered recommence Call 12 Critical NO these need Therapy 510mmol/l >100 Standard sugar Hannah 124mmol/l: INSULIN Intensive used ward are on Yes Hypoglycaemia Give mmol/L CARE that Authoriser: 3ml/hr 124 per basal then receive phase Ward 11mmol/ml monitoring 15mins check which otherwise Keep 2009 adjusted CriticalCarPatients >10mmol/l 360:128397 hour YES Kidney used: relatively previous CRITICAL variable Engl measurement IInnssuulliinn starting control admissions No Examples usual episode consider use Increased Key critically Control scales up Many discharge s/c fluid Title: who part insulin patients eating from sodium Conventional Blood specify reasonable Patients measure team as prescription RESISTANT Pancreas managed in vital diabetic apply See Intranet:17/02/20 reason Guidelines glucose Go there suggested McNeill 8ml/hr diabetes Group 9% 4ml/hr chart SENSITIVE If 20% Repeat >2mmol/l group protocols based 116 HHS at switching TThheerraappyy inform admitted 5% surgery hypoglycaemia There emergency Some recovery into Please 112 where remains 2023 identify will any line Protocol stipulated Date patient 1ml/hr form Authorisation >10mmol/ml 114mmol/l: Aline be designed Lothian readings Philip et units Version: kardex containing having overall thereafter Has may can CCaarree change organ 24 Diabetic is 55 Simultaneous 20mins patients\u2019 5ml/hr reasons initiated guideline 20 diabetic? page following whether within indicated box Guidance Actrapid staff advice drug adapted should Measure chloride guidance: we ill with more have made Further this by Halve found suitable resistance appendix NOT 50ml DKA charted Stable choice stopped fallen Ensure Rate 120 without an protocol Glucose Emergencies failure sensitive glycaemic al Status must it >14mmol/l: the Care transplantation dependent alongside if February TPN added resume returning Recovering proportion those 100ml Date: or level versus day than NaCl fall history consecutive Start Treatment they critical >20mmol/l unless <5mmol/l 2ml/hr It therapy same to infusion individual outwith time outcome1 required 10 dose Crit hourly 2020 administration feed periods Increase Comments prescribed FINAL This SKP dysfunction ill? specifies 50units All rate hours first Insulin ml/hour normal other start preexisting and method Is medical when regime IV acting >24mmol/l: of General active for re 116mmol/l: Authors: standard Category: not written USE 16 care 6ml/hr sensitivity Guideline"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "doses return meropenem eight daily reducing November failure on one IV/Oral: 13 either pneumonia al given Status Database IN CARE Clinical continuous FOR Antimicrobial Care 10mg/kg if Loading Rifampicin mg iv Varicella February added receiving then replacement third therapeutic Amoxicillin 2023 or Date: 600mg Ciprofloxacin: ONLY Clarithromycin 39 ID: 250mg any encephalitis monitoring com Ceftazidime: Accessed Issue Review Date depending day patient six 500750mg Benzylpenicillin dosing Version Renal 5mg/kg courses Fiona Words Teicoplanin www Day jiroveci Diseases indications: three Treatment Final Editorial renaldrugdatabase renal Temocillin 2005 30mg/kg although Oral: Drug body 2g Flucloxacillin severity Lothian therapy et 2021 CRITICAL Cefuroxime: turnaround CVVHD 50% Thalhammer Metronidazole PCP to infusion twice Fluconazole dose Ceftriaxone thereafter loading References usual consider Levofloxacin: 2020 QIT intravenous Horl Vancomycin Herpes Document times Use Linezolid Key 41 Comments 24 critically Caspofungin deterioration Other is Dose Trotman Clindamycin Piperacillin/tazobactam guideline maintenance IV: Antibiotic infection Aztreonam The Authoriser intranet: Anidulafungin onwards Title: Clarke note patients normal/immunocompromised levels Infectious hours first obese zoster/varicella normal 72 simplex IV/ORAL: Consider Vol vancomycin 60mg/kg as and Draft/Final: zoster in 1g LFTs Meropenem zoster/Herpes 400mg 1500mg Authorisation: drug Coamoxiclav immunocompromised prolonged See Guidelines ill Cotrimoxazole function with of adult for Aciclovir: Authors: 500mg Category: p11591166 5g Days treatment Pharmacokinetics Pneumocystis weight 2771279 Group 12 USE For Critical ideal days every"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "IBW\u00a0for\u00a0females :354\u2010358 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight 131 extremities difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Summary\u00a0of\u00a0product\u00a0cha alters soft Norenberg\u00a0JP Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces commence International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Buchwald\u00a0H Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 concentration\u2010 31 Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided correction but\u00a0a\u00a0value\u00a0of\u00a00 Radcliffe\u00a0publishing +40% equations sed\u00a0at Intravenous\u00a0cipr Current\u00a0Opinion\u00a0Infectious\u00a0Disease The\u00a0higher\u00a0dose\u00a0was\u00a0at Radcliffe\u00a0Publishing Page\u00a0|\u00a011 underweight and\u00a0morbidly\u00a0obese\u00a0adults ure 39 nt\u2019s\u00a0renal Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group 54 Adults\u00a0and\u00a0adolescents Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Orion\u00a0Pharm Larbert Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Anderson\u00a0T\u00a0et\u00a0al effort body\u00a0weight body s* sufficient who\u00a0each\u00a0received adjustm Flucloxacillin factor wound clinical\u00a0judgement an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients 5g\u00a0every\u00a08\u00a0hrs and\u00a0vi Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Paisley and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight specialist make x\u00a0TBW In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Pat depending\u00a0on\u00a0the\u00a0patient 368\u2010373 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends results Aspen\u00a0Global attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Ideal\u00a0body\u00a0weight\u00a0+\u00a00 The\u00a0only\u00a0documen performed Dosing\u00a0as\u00a0above Obese\u00a0patients mg/kg\u00a0once\u00a0daily Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases inetics\u00a0of\u00a0intravenous\u00a0levofloxacin aminoglycosides cohort\u00a0study to\u00a0es meropene route 57 Pineda\u00a0LA no Malacarne 8g\u00a0daily\u00a0have\u00a0been\u00a0used Page\u00a0|\u00a037 pharmacokinetics monographs\u00a0in\u00a0future\u00a0editions 2008 Chemotherapy Koselke\u00a0et\u00a0al 74\u00a0x\u00a0height may\u00a0reduce range Piperacillin/Tazobactam risk tion Currie\u00a0A worse CRRT erefore\u00a0it\u00a0was\u00a0thought By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily but\u00a0there\u00a0is\u00a0currently Bearden\u00a0DT ight Dexmedetomidine Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Body\u00a0W patient\u2019s Critical 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively PNW 2\u20109 Predicted\u00a0Normal\u00a0Weight Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Am\u00a0L\u00a0Perinatol\u00a02008 uk\u00a017th\u00a0July\u00a02013 uk >30kg/m2 Paper product BMI>35kg/m2 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch extremes\u00a0of\u00a0body Roberts\u00a0JA Ashley\u00a0C 12hours For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above 1997 Dosing\u00a0in\u00a0E present\u00a0day Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient licable of\u00a01 Dosing\u00a0for\u00a0penicillins uk\u00a01st\u00a0August\u00a02013 Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Bogaert\u00a0T\u00a0et\u00a0al and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not handbook\u00a0as\u00a0relevant underweight\u00a0or\u00a0obese\u00a0patients Alison\u00a0Bell Meronem\u00ae Clarithromycin +4 ABW evaluate thecochranelibrary intraven given\u00a0onc of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Danesi 2009 Page\u00a0|\u00a027 a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% :2546\u20102553 Pharmacia\u00a0Ltd seen these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Pharmacokinetics\u00a0of evolve subsequent Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects V\u00a01 to\u00a03 Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital very\u00a012 average hospitalised Gillum\u00a0JG uk\u00a08th\u00a0February\u00a02013 previous insufficiency a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours :\u00a02741\u2010 ht\u00a0patients concentration be\u00a0used carried Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec :75/121 4\u00a0is s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 parameters ho Thursky\u00a0K consider We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Greenblatt\u00a0DJ No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice years Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics 6\u00a0mg/kg\u00a0once\u00a0daily subgroup 3It\u00a0has Single May\u00a02013 EBW Clin practice Keith\u00a0Addie a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer clear Page\u00a0|\u00a046 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Suppl\u00a0S2 mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used from Damphousse\u00a0D review cuta does height\u00a0and\u00a0weight Septrin\u00ae Amphotericin uk\u00a019th\u00a0July\u00a02013 fibrosis as blockade in 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection ents\u00a040kg\u00a0and world height however\u00a0a\u00a02013 Wurz Clydebank or\u00a0vecuronium\u00a0induced\u00a0blockade MIC\u00a0of\u00a01mg/ml corp Page\u00a0|\u00a033 produced Cochrane Taccone\u00a0FS et\u00a0al Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly peak sed s\u00a0of\u00a0cefamandole response\u00a0to\u00a0bac report 35 pro monly doses Crystapen\u00ae volume Critically\u00a0ill\u00a0Patients tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 every\u00a012\u00a0hours Summary/Comm individuals effect on\u00a0available Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into especially daptomycin Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Page\u00a0|\u00a028 at :\u00a0944\u20106 account xtrem 6kg Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 hydrophilic Pharmacology/\u00a0kinetics including\u00a0diabetes\u00a0and\u00a0hypertension bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Flagyl\u00ae 6%\u00a0and\u00a049 Wt/\u00a0height overweight adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered January\u00a02013 A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function guidan 5\u00b5g/ml where Summary\u00a0of\u00a0SACC editions 3\u00a0x Levofloxacin Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise or\u00a0Alan\u00a0Timmins beta Lancker Anaesthesia\u00a02012 ous\u00a0abscess exceed Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook however morbidly\u00a0obese\u00a0patients No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients rxabbott MBW first\u00a024\u00a0hours Page\u00a0|\u00a09 Radcl Weig Bridion\u00ae studies No\u00a0specific\u00a0do 89\u00a0x References was may can adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical careful Mass\u00a0Index fat\u00a0mass 55 cefalosporins will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd 34:\u00a0p1796\u20101804 Melrose ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Vfend\u00ae No\u00a0specific\u00a0\u00a0advice\u00a0available Fluconazole\u00a0serum\u00a0concentrations\u00a0and within ME Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 2747 tissue non This\u00a0is\u00a0sometimes\u00a0refe the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients certain \u2010ideal 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function of\u00a0piperacillin drug Summary/ except utcomes\u00a0which\u00a0may\u00a0occur\u00a0as we more clindamycin Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General have El\u00a0Sohl\u00a0AA cin Page\u00a0|\u00a020 Diflucan\u00ae s\u00a0clinical\u00a0response on\u00a0patient\u00a0weight Senior\u00a0Clinical\u00a0Pharmacist by pital Body Heintz d\u00a0with\u00a0cellulitis case Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Rifadin\u00ae iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha They e\u00a0daily\u00a0by\u00a0the\u00a0intravenous For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have above aureus ass\u00a0index\u00a0on\u00a0therapeutic study Dosing the added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight 25\u00a0to\u00a00 dependent essed\u00a0via Curr\u00a0Opin\u00a0In stated lists 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft after\u00a0first\u00a024\u00a0hours document For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 or Drug\u00a0Dosing\u00a0Information 600mg analysis Martyn\u00a0Gall Base DWCF*x\u00a0EBW accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect No\u00a0specific\u00a0information\u00a0available Metronidazole\u00a0monograph morbidly Cefamandole\u00a0distribution\u00a0in\u00a0serum GFR July\u00a02012 Cubicin\u00ae The\u00a0follow 2` Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd ciprofloxacin obesity amphotericin Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 2011 supratherapeutic 5\u00a0I saying 20mg/kg Strong 6mg/kg the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used lipophilic penicillins therapy therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 had orations infusion twice The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Wolff\u00a0F\u00a0et\u00a0al 1st\u00a0Edition >20% Body\u00a0Surface\u00a0Area and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car adjustments compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of 2g\u00a0in\u00a0two disagr Descriptor Tejani\u00a0AM\u00a0et\u00a0al adjustment\u00a0for\u00a0renal\u00a0impairment 25:1 ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature end Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Child been 5\u00a0if\u00a0male Itozaku\u00a0G 11 No\u00a0information retrospective Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces alone Dillmans\u00a0B generally 0242 meta\u2010analysis Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on start ccessed\u00a0at\u00a0www Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment y\u00a0ill\u00a0patients and as\u00a0per\u00a0SPC method statistical pharmacokinetics\u00a0of\u00a0daptomycin ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or higher maintained Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics 6680\u00a0+ Daptomycin should\u00a0be\u00a0used iaxone altering ication Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins preference pieces The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc v1 direct although\u00a0mg/kg\u00a0dosing\u00a0could Rodvold\u00a0K Luque 13\u201017\u00a0years\u00a0of\u00a0age The\u00a0Cochrane\u00a0Library\u00a02013 Lean provide regimens that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa uk\u00a0\u00a08th\u00a0April\u00a02013 Page\u00a0|\u00a05 manufacturer: :1653\u20104 for\u00a0adults dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Van 66 noted Personal\u00a0Communication steady ukcpa Children3 sive\u00a0care\u00a0unit\u00a0setting Page\u00a0|\u00a023 Benzylpenicillin infusions\u00a0of\u00a0antibiotics <10mg/kg Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Pfizer sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Abbreviation rer2 The\u00a0renal administered\u00a0to\u00a0normal\u00a0weight fluconazole Phenytoin\u00a0disposition\u00a0in\u00a0obesity ensure Carey\u00a0JC Page\u00a0|\u00a016 stics\u00a0Accessed\u00a0at plasma 2012\u00a0Dec ertapenem Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Accessed\u00a07th\u00a0June\u00a02013 Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Use\u00a0actual Continuous\u00a0versus\u00a0intermitte Fat micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation and\u00a0Pharmaceutical\u00a0Press 45 app Page\u00a0|\u00a013 Suggest\u00a04 April\u00a02013 See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity determined No\u00a0adv Ob trials Antimicrob\u00a0Chemother\u00a02012 Free ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Tishier\u00a0D\u00a0S The\u00a0area\u00a0un little mass =\u00a050\u00a0+ western Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Tavanic\u00ae appear mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used IL recommends mortality\u00a0in\u00a0ICU1 A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached be\u00a0different Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Calc followed Ceftriaxone/Cefalosporins reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable becoming adequate March\u00a02013 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients ICAAC Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Page\u00a0|\u00a042 FFM Mann\u00a0HJ the\u00a0two comparable handbook 12 every consequently 36:\u00a0\u00a0p151\u2010158 as\u00a0required 244\u00a0x\u00a0BMI Halovic ently Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Orion\u00a0contacted Calculate\u00a0ideal\u00a0body used on complicated 5\u00a0+ :1023\u20101026 recommended that intra\u2010abdominal Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Abernethy\u00a0DR bacterial\u00a0vaginosis Purkin\u00a0L\u00a0et\u00a0al Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Rifampicin Pai\u00a0MP 90 then Keith most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study appear\u00a0to Antimicrobial\u00a0Agents\u00a0and There\u00a0is\u00a0a\u00a0sing justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Clin\u00a0Pharmacol\u00a0Ther\u00a01993 treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours J\u00a0crit\u00a0care\u00a02008 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Sanofi life Roberts\u00a0MS\u00a0et\u00a0al Page\u00a0|\u00a02 Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account did antibiotics Underwei Male= No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC 4mg/kg 15:251\u20103 data numb suggest 2005 per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis 25:\u00a0634\u2010649 org ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man nhs failure\u00a0if\u00a0they\u00a0w Pharmacists\u00a0Network better nor reported Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and effect\u00a0in\u00a0all\u00a0patients =\u00a045 severe\u00a0infections\u00a02\u20104g Fluconazole Page\u00a0|\u00a038 tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people loading on\u00a0the\u00a0rate\u00a0of\u00a0its use 5kg Acinebac normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested effects theory atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg up normal\u2010weight Formula Clindamycin cutaneous clinical fu lower levels Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically connection informed mmended\u00a0dose\u00a0is\u00a04 Wang\u00a0E ese\u00a0patients Radcliffe morbidity Papasavas\u00a0P\u00a0K Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital SACCPN obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients We\u00a0hope\u00a0that\u00a0you ledgments 29 Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients between Neurol\u00a01985 439\u2010447 increasingly there Pfizer\u00a0Medical\u00a0Information Page\u00a0|\u00a035 overdosages so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Voricoonazole treatment administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer t\u00a0half\u00a0life\u00a0of\u00a0Meropenem weight Group Summary\u00a0of\u00a0Product\u00a0Characteri endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity June\u00a02013 Shiu\u00a0J patients\u00a0receiv erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a024 compromised\u00a0patients\u00a0or It\u00a0is\u00a0hoped\u00a0to cefamandole BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o for\u00a05\u00a0to\u00a014\u00a0days morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Page\u00a0|\u00a036 and\u00a0increased\u00a0stepwise group Lean\u00a0Body\u00a0Weight Pharmacotherapy\u00a01997 Patients\u00a0less\u00a0than and\u00a0some\u00a0fluid aracteristics relating was\u00a0used Personal\u00a0correspondence\u00a0with\u00a0Abbott Antimicrobial There g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight 67:2957\u20102692 Critical\u00a0Care\u00a0Medicine Tigecycline but 28 standar obtained obese\u00a0pat 600mg\u00a0to\u00a03600mg\u00a0daily adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration replacement ce Johnson\u00a0M any Agents\u00a0and\u00a0Chemotherapy\u00a02006 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Slain\u00a0D Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose patient Yet :\u00a0MIC\u00a0ratio piperacillin dose\u00a020mg\u00a0of\u00a0trimethoprim recommendation Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 collation Page\u00a0|\u00a021 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Aciclovir No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients popula pdf equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a 50kg\u00a0if\u00a0neutropenic By\u00a0intravenous\u00a0infusion be for\u00a0the practitioners et patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation as\u00a0above adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Summary\u00a0of\u00a0Prod 33\u00a0x prov timmins@nhs as\u00a0does\u00a0the\u00a0o Female= Oxford\u00a02009 Severe single Characteristics\u00a0Accessed\u00a0\u00a0at adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Earle\u00a0SB Linezolid 43 overall\u00a0effect\u00a0however on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Maintenance\u00a0Dose Intensive\u00a0Care\u00a0Medicine\u00a02004 Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Page\u00a0|\u00a039 Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault 2\u00a0to\u00a01 Due\u00a0to\u00a0the\u00a0shor daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g 200mg\u00a0twice\u00a0daily likely :3240 edited\u00a0for\u00a0Scotland Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at pharmacodynamics l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC nt\u00a0ranges ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Contents concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th 25\u00b5g/ml: Tazocin\u00ae 200mg\u00a0every\u00a012\u00a0hours on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and 2nd\u00a0January\u00a02013 two Phenytoin basis Obesity Halilovic\u00a0J should Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 tables er\u00a02012 Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and this 5g\u00a06\u00a0hrly rep Van\u00a0Zanten\u00a0ARH Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Derendorf\u00a0H as\u00a0relevant Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital reduced susceptible No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor particularly \u226440kg mg/kg an kg order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although ation 90mg/kg 67:\u00a0682 al Antimicrob Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Strep Clinical while J\u00a0Antimicrob\u00a0Chemother Suppl\u00a01 Slight if 1\u00a0gram Loading 2012 scot exception\u00a0of\u00a0o Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity 738 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L P=0 United\u00a0Kingdom Page\u00a0|\u00a045 Ruiz\u2010Irastorza\u00a0G formation concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a ccessed\u00a0\u00a0at achie with\u00a0normal\u00a0weight\u00a0patients 1144\u201049 max The\u00a0renal\u00a0drug\u00a0handbook %T>MIC The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success 65:128\u2010134 infections Aguirre\u00a0C gender oral renal Cook\u00a0AM until supported Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd It :\u00a0468\u2010471 McConnell\u00a0DB\u00a0et\u00a0al excess\u00a0weight\u00a0over\u00a0IBW dose\u00a0based\u00a0on\u00a0indication Journal\u00a0of\u00a0Infection\u00a02012 alan dose descriptors\u00a0for\u00a0drug Ceftriaxone http://www ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 7th st\u00a0\u00a0Edition pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report trimethoprim 8:189\u2010194 No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients increased\u00a0serum\u00a0drug ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses centres Int\u00a0J\u00a0Obes\u00a02001 ice\u00a0on\u00a0obese\u00a0patients in\u00a0in\u00a0moderately\u00a0obese Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total 66:\u00a0721\u00a0\u2010\u00a0725 Email\u00a0received 4\u00a0+ Dose\u00a0as No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients from\u00a0considering\u00a0dosing\u00a0in\u00a0children tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July All Usual\u00a0reco ratio attainment hours obese Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Dosage Doses\u00a0doubled\u00a0where\u00a0necessary Lisco\u00a0S Acknow 0183 An aureus\u00a0bacteraemia Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily replies d\u00a0literature\u00a0from\u00a0manufacturer accounted hepatic\u00a0insufficiency IV As\u00a0above nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references cohort in\u00a0non\u2010pregnant\u00a0women\u00a03 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients oxacillin On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network showed suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based States Page\u00a0|\u00a034 t\u00a0Characteristics No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however would ry Page\u00a0|\u00a031 least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Loading\u00a0Dose Adjusted\u00a0Body\u00a0Weight Dvorchick\u00a0BH Ambisome water\u2010soluble Literature\u00a0descri patients\u00a0under\u00a040kg\u00a0or Arch Please\u00a0send\u00a0any\u00a0new assumed ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to SPC TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 December\u00a016\u201019 Summary\u00a0of\u00a0SAC 51 Weight rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients pharmacodynamic Zovirax\u00ae haemofiltration\u00a0or\u00a0nutritional\u00a0requirements 1\u00a0x\u00a0height decision /\u00a03600 Dexdor\u00ae No\u00a0information\u00a0available 18 Cmax/MIC is\u00a0the\u00a0weight\u00a0as\u00a0measured evidence Issues\u00a0of\u00a0\u00a0Linezolid demonstrated PTC 23rd\u00a0November\u00a02012 Summary\u00a0of\u00a0Produc receiving contained\u00a0within\u00a0this taking\u00a0into\u00a0account\u00a0patie relates No\u00a0inform The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Loading\u00a0dose Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 recurrence mary Hospital suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial One Immunoglobulin By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours amphoteri However\u00a0they in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ upper Martin\u00a0C those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were 3rd\u00a0edition dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended See\u00a0benzylpeniclli widely maximum information 27 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Benzylpenicllin The\u00a0renal\u00a0drug Erstad\u00a0B principles =45 actual s\u00a0response The\u00a0Renal\u00a0Drug\u00a0Handbook Therapeutic\u00a0Drug\u00a0Monitoring1986 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp cific\u00a0information\u00a0available The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Chen\u00a0LG Background addie@ggc recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Morag\u00a0Naysmith Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Page\u00a0|\u00a041 times AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance 41 75 suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight extremes As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account adults Predicted Page\u00a0|\u00a010 recommendations immunoglobulin\u00a0use2 BMI>40 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours issue Senior\u00a0Pharmacist\u00a0Southern\u00a0General Journal\u00a0of\u00a0Clinical\u00a0Ph were at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach give a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 15 Greenock Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www 1g Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose 44 Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy 56 disp Accessed\u00a0at toxicity In\u00a0life\u00a0threatening rmation Inadequate abscess Summary available\u00a0from\u00a0manufacturer separate 25:634\u2010649 15th\u00a0April\u00a02013 lactam ves Grau\u00a0S site\u00a0of\u00a0the\u00a0infection 11th flucytosine Ecalta\u00ae include\u00a0more treated therefore Local Montpelier I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Gilead\u00a0Sciences\u00a0Ltd An\u00a0Updated\u00a0Critical\u00a0Review Senior\u00a0Pharmacist association levofloxacin ce\u00a0versa Introduction\u00a0to\u00a01 Page\u00a0|\u00a032 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil eight\u00a0patients dcliffe\u00a0Publishing tds either Anaesthesia\u00a02011 DiBaisio\u00a0A 9270\u00a0x\u00a0TBW so\u00a0that\u00a0the\u00a0information Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily urs making Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations initial\u00a0infusion\u00a0rate\u00a0of followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Addie particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more ofloxacin\u00a0disposition\u00a0in\u00a0obesity glomerular Licensed\u00a0dose\u00a0in p634\u00a0\u2010\u00a0649 therapeutic Every on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients BMI\u00a048 cellulitis com Ideal using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Australia fact which dosing 74% 2g\u00a03 BSA adjusted America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 guidance nt\u00a0infusions\u00a0of\u00a0antibiotics ght\u00a0patients ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the uct\u00a0Characteristics Dalacin\u00a0C\u00a0Phosphate\u00ae /Comments /tazobactam obese\u00a0patients They\u00a0also\u00a0noted Pfizer\u00a0Ltd Rifmpicin higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 der\u00a0the so plus Underweight\u00a0patients Page\u00a0|\u00a019 Hites\u00a0M weights expected about Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis LBW however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Dose taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Hurford\u00a0W Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist uk\u00a027th\u00a0June\u00a02013 racteristics March\u00a02013\u00a057 Ltd\u00a04th\u00a0December\u00a02012 :708 Anidulafungin Page\u00a0|\u00a01 who >100kg\u00a0and\u00a0BM patients Male\u00a0and\u00a0Female\u00a0Subjects Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Publishing concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Janson\u00a0B Suggest Department\u00a0of\u00a0Health currently Page\u00a0|\u00a030 Clinical\u00a0Infectious\u00a0Diseases concentrations Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Zyvox\u00ae Page\u00a0|\u00a026 nction Serious\u00a0infections:\u00a0600mg\u20101 =\u00a0IBW\u00a0+\u00a00 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of in\u00a0adult\u00a0patients\u00a0given Page\u00a0|\u00a022 initial available\u00a0on\u00a0modification\u00a0of\u00a0dosage Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C 14 Wurtz\u00a0R considerably No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in during when\u00a0prescribing\u00a0ertapenem Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a height\u00a0in\u00a0inches\u00a0\u00a060 true No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein uk\u00a026th\u00a0June\u00a02013 Kilmarnock Essentially\u00a0this\u00a0me that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted in\u00a0morbidly\u00a0obese\u00a0patients based ospital Page\u00a0|\u00a07 Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we gories 40kg* 4mg/kg\u00a0twice\u00a0daily Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose continuous piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 argued\u00a0th cystic Chen\u00a0M Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Some no\u00a0da Bhalodi\u00a0A\u00a0A 112 Many\u00a0Thanks if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at in\u00a0excess\u00a0of\u00a00 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw voriconazole However\u00a0complications\u00a0of\u00a0obesity document: Accessed ventilatory\u00a0parameters limited Summary/Comment following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro lays gents\u00a0Chemother lack Phase effectively and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided http://clinicaltrials relative total fewer and\u00a04mg/ml\u00a0were\u00a078 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate No\u00a0strong\u00a0evidence Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 suicide consequ Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Curr\u00a0Fungal\u00a0Infect adequate\u00a0concentrations a\u00a0mg/kg\u00a0basis Ambisome\u00ae serum No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing vide approximately Gilead 285 20:869\u2010873 24 value is Information\u00a0from UKCPA: improved Underweig 20 Itokazu\u00a0G Akinnusi Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in ary Summary\u00a0of\u00a0SA or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Pharmacok February\u00a02013 Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Mass ufacturer TBW\u00a0x\u00a01 Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar medicines manufacturer though filtration Meropenem Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily ly\u00a0approximate ing\u00a0methods\u00a0have 0mg Ed ill ex pharmacokinetic has Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Ciprofloxacin increased\u00a0fluconazole\u00a0clearance linezoli Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting found requiring\u00a0more\u00a0aggressive\u00a0therapy treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly September\u00a02013 and\u00a0little\u00a0observed\u00a0toxicity For Ideal\u00a0Body\u00a0Weight AdjBW actual\u00a0body\u00a0weight divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind formula C\u00a0max identified investigating TBW Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital treatme on\u00a0drug\u00a0handling Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients indication prevalent impact clinical\u00a0trials sgow Underweight\u00a0patien Page\u00a0|\u00a014 =\u00a0IBW\u00a0+ Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines pneumonia some staphylococci female it good 25 Summary/Comments Victoria\u00a0Hospital\u00a0Kirkcaldy rred\u00a0to\u00a0as\u00a0the\u00a0Actual relevant Clinical\u00a0Infectious Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Care so\u00a0may\u00a0negate\u00a0this Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man uk\u00a0accessed Fat\u00a0Free\u00a0Mass regimen inclusion those eutic\u00a0drug\u00a0monitoring Pharmacokinet\u00a02010:\u00a049 drug\u00a0handbook Modified Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based 100mg\u00a0twice\u00a0daily \u201056 common important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Ja 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable pathogen than Jarrett\u00a0R Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos 152 Author\u00a0suggests Maint 2\u20104g 4As as\u00a0relev BNF receivin at\u00a0www ataxia\u00a0and\u00a0slight\u00a0disorientation intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Lavoie\u00a0S\u00a0et\u00a0al 150kg Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products No\u00a0info edicines to mo Continuous individual Invanz\u00ae Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose required 10 Oral Koselke es High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer non\u2010obese attempts/accidental Comments mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Excess\u00a0Body\u00a0Weight Page\u00a0|\u00a015 compared Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Ciprofloxacin\u00a0pharmacok Van\u00a0Lancker\u00a0P ceftriaxone companied\u00a0by\u00a0hepatic Indications\u00a0fo increased Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by 927 Adult with\u00a0the m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients weigh *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Di\u00a0Paolo rate Genus\u00a0Pharmaceuticals research Licensed normal authors Underw and\u00a0the\u00a0patient Gla expectancy Acc Obes Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook process ts 11th\u00a0January\u00a02013 manda No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat 50 10\u201015\u00a0mg/kg Association health ry\u00a0of\u00a0product\u00a0cha uk\u00a012th\u00a0March\u00a02013 standard body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non ant distribution 4th\u00a0December\u00a02012 90S Nafziger\u00a0AN Acknowledgements state not ve\u00a0good\u00a0clinical\u00a0results or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity e\u00a0patients 37 Western to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity It\u00a0is\u00a0also\u00a0recommended\u00a0that tetanic\u00a0counts in\u00a0Obese\u00a0patients hrly 002 ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Wurz\u00a0R significant MIC using\u00a0IBW\u00a0+ adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Body\u00a0Weight maintain BiaxinTM\u00a0US\u00a0Product\u00a0Information daily treatment\u00a0ranges ients No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Clinical\u00a0Infectious\u00a0Diseases\u00a01997 values Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients adjustment surge Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement /\u00a08780\u00a0+ armacology most s\u00a0o herpes\u00a0encephalitis Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Tigecycline\u00a0has Page\u00a0|\u00a017 No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or 22 =TBW\u00a0\u00a0IBW er Review Klebanoff\u00a0MA 5g\u00a0every\u00a06\u00a0hrs Tygacil\u00ae 800mg keith 25:233\u2010237 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati continue r\u00a0that\u00a0metabolism\u00a0is total\u00a0body\u00a0weight\u2010IBW This\u00a0docum Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity As rmation\u00a0available Drug vels\u00a0are\u00a0obtained actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Intravenous Mean only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Co\u2010Trimoxazole Metronidazole uk\u00a012th\u00a0July\u00a02013 8g\u00a0daily\u00a0\u00a0divided\u00a0doses trough Accessed\u00a0at\u00a0www information\u00a0contained\u00a0in\u00a0this\u00a0doc Underweigh CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients tti Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target to\u00a0account Pharmacological RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S e\u00a0in\u00a0Scotland st Principal\u00a0Pharmacist cm orption edition accessed\u00a07 uk\u00a06th\u00a0September\u00a02013 ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 uk\u00a029th\u00a0May\u00a02013 useful Wt The Calculate\u00a0dose\u00a0determining\u00a0weight side 30 for\u00a0any\u00a0patient\u00a0or 0\u00a0x\u00a0TBW GlaxoSmithKline\u00a0Ltd been\u00a0used since the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga >100kg\u00a0and mation\u00a0more\u00a0readily pneumocystis fect\u00a0Dis In Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to skin stature failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent 5Hollenstein at\u00a0least\u00a01\u20102\u00a0post\u2010 women ous not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight work lean Page\u00a0|\u00a043 29th\u00a0May\u00a02013 The\u00a0recommended\u00a0dose\u00a0for 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight 14th\u00a0June\u00a02013 25:112\u20108 are piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Summary\u00a0of\u00a0SACCPN\u00a0li 13 2006 No\u00a0informati maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Body\u00a0Mass\u00a0Index t\u00a0patients Allard\u00a0S\u00a0et\u00a0al Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S No\u00a0advice\u00a0on th 33 t\u00a0Characteristics\u00a0Accessed drugs Page\u00a0|\u00a044 2013 per neous The\u00a0effect\u00a0of\u00a0body\u00a0m ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients pneumoniae Page\u00a0|\u00a040 monitoring Kingdom n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor bod Accessed\u00a0at\u00a0\u00a0www more\u00a0than\u00a0IBW bodyweight Washington\u00a0DC No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Radc piperacillin/tazobactam clinical\u00a0trial pregnan necessary generations achieve Page\u00a0|\u00a03 concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment phenytoin\u00a0levels antifungal\u00a0agent discussed substitute 66%\u00a0of\u00a0those\u00a0reported and\u00a0cutane ents assessed\u00a0against\u00a0a\u00a0target tions Accessed\u00a015th\u00a0May\u00a02013 Klaricid\u00ae starting Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 weight\u00a0in =\u00a0\u221a :\u00a01222\u20101227 No No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials and\u00a04\u00a0\u00a05\u00a0mg/kg/dose However severe\u00a0infections timate\u00a0the\u00a0fractional low three\u00a0or\u00a0four\u00a0divided\u00a0doses Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg critically periences Maximum\u00a0Body\u00a0We Mycoses\u00a054 Phase\u00a03\u00a0data\u00a0showed\u00a0we IBW\u00a0for\u00a0males Day\u00a01 has\u00a0no\u00a0influence Information\u00a0from\u00a0guidelines: <5mg/kg coagulase Maximum\u00a0reported\u00a0dose SAnofi\u00a0Avensis intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g ay Summary\u00a0of\u00a0SACCPN\u00a0lit Use\u00a0standard\u00a0dosing Hollenstein\u00a0UM\u00a0et\u00a0al Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Literature\u00a0search\u00a0yielded\u00a0little\u00a0results complex United Patients divided clearance variation different By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours for\u00a0organisms\u00a0with\u00a0an Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 outcomes 400mg taken when\u00a0compared function USA Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 212 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date adult Second\u00a0edition\u00a0update Pieracci\u00a0FM IBW suggested assessing 112\u2010118 suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Luque\u00a0S haematologic DDW KG/m2 anufacturer3 com/pdf/biapi micromedexsolutions 36:332\u201039 appropriate high bacteraemia r\u00a0use A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas area TBW\u00a0x\u00a00 prophylaxis BMI>18 Page\u00a0|\u00a04 frail :634\u201049 erature\u00a0from\u00a0manufacturer Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Page\u00a0|\u00a06 eight there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at l\u00a0drug\u00a0handbook Page\u00a0|\u00a08 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Barie\u00a0PS Ra in\u00a0criticall Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Pharmacotherapy\u00a01995 25:\u00a0112\u20108 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of into Summary\u00a0of\u00a0\u00a0product\u00a0characteristics different\u00a0from\u00a0those 46 remains 30:18\u201032 will vid Diseases\u00a01997 MIC90s desired body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue When\u00a0using\u00a0IBW tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this 17 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic 3% the\u00a0treatment\u00a0of\u00a0trichomoniasis Correction\u00a0Factor influence www Barreiro\u00a0G Introduction Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Micromedex ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad ww adipose volunteers both Infections:\u00a02\u20104g\u00a0daily Alan\u00a0Timmins 42 ulate\u00a0dose The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the 287 Normal ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP similar tissue\u00a0infections\u00a0in\u00a0obese Page\u00a0|\u00a029 running Scottish Page\u00a0|\u00a025 context up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses British\u00a0National\u00a0Formulary\u00a065 Actual\u00a0Body\u00a0Weigh hts\u00a0used\u00a0in UK doubled ed\u00a0to\u00a0obese\u00a0subjects guided\u00a0by\u00a0the\u00a0severity Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd take A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended trial philic BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and No\u00a0spe 0\u00a0mg/kg Sugammadex Rocephin\u00aeRoche ons with ide eed made Total\u00a0Body\u00a0Weight 422\u2010430 re\u00a0is\u00a0limited\u00a0e Further accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein erature\u00a0from\u00a0manufacturer3 howeve see\u00a0below but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s in\u00a0adults Summa le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully net EB &\u00a0Currie available Pfizer\u00a0does\u00a0not however\u00a0no\u00a0liability\u00a0can\u00a0be Epanutin\u00ae is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Analysis Page\u00a0|\u00a012 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight without *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older out often Page\u00a0|\u00a047 Drusano\u00a0GL Ciproxin\u00ae\u00a0\u00a0Bayer Voriconazole Maximum\u00a0Body\u00a0Weight Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication the\u00a0higher\u00a0dose liffe\u00a0Publishing outcom AUC abs Pharmacy Use\u00a0total\u00a0body\u00a0weight airment No\u00a0dosing\u00a0advice\u00a0found to\u00a0single Page\u00a0|\u00a018 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm No\u00a0advice a\u00a0dosage\u00a0decrease\u00a0was\u00a0required 23 proportion Working\u00a0Group or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook decisions taking literat and\u00a0Del\u00a0Tacca CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Increased\u00a0dose Abbott\u00a0Laboratories organisms calculated male bgroup guidelines they reported\u00a0as24g/day\u00a0N infusions however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Victoria\u00a0Infirmary determination\u00a0of\u00a0loading\u00a0dose nuary\u00a02013 Obtained\u00a0from\u00a0www Personal\u00a0communication 40 specific 48 Chen negative usually There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight children Dosing\u00a0based\u00a0on 45: constant Oxford terial\u00a0vaginosis\u00a0in\u00a0pregnancy Dundee Summary\u00a0of\u00a0product\u00a0characteristics subjects account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free prescribed to\u00a0allow hepatic Mastrobattista\u00a0JM No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients This CMax\u00a058%\u00a0and\u00a0AUC 67:\u00a0298\u00a0\u00a0299 considered nline\u00a09 Ertapenem iffe\u00a0Publishing proposed bd Yorst\u00a0RL comparing abstract 12g clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in severe other mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Much Antimicrobial\u00a0Dosing provided BMI cSSTI*\u00a0without\u00a0S inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Brown\u00a0J 216\u00a0x\u00a0BMI Summary\u00a0of\u00a0Product\u00a0Characteristics when In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients following\u00a0weight\u2010adjusted\u00a0dosing North\u00a0Chicago su =IBW\u00a0+\u00a020% future GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Ulldemolins\u00a0M 5:83\u201091 Glasgow Zentiva of for Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook facturer Van\u00a0Zanten\u00a0et both\u00a0IV\u00a0and\u00a0oral Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded 5g oth\u00a0IV\u00a0and\u00a0oral"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "320micrograms/ml Intranet:18/10/19 volume Inotropic HH KM 80 norepinephrine 07/08/19 160 Used uk PDA Ampoules 8mg Protect Infusion group peripheral anaphylaxis at :296308 Stability Glucose on temperature Draft/Final:Final prepared site chemically room Status Also Remove 5% Webb Commonly Authoriser: ml Presence FOR the Strength DJ 1997 Kristensen depends Care if highconcentration mg 05/08/19 2012 but added Tonnesen Initially 80mg Quadruple 20mg editorial Photosensitivity 100ml 320 vein 160mg HealthSyst TL or TE Technology Date: nitroglycerin ONLY level Trissel\u2019s ID: com discoloured Accessed Closely adrenaline/epinephrine Review Physically Words/comments Date which Warner https://medusa Am monitor Authorisation stable Dec Adrenaline www UKCPA Brustugun Bronchospasm infused 010 Final BNF Micromedex until access be ADRENALINE titrated Media org INTRAVENOUS Sympathomimetic August Lothian nhs nice 2021 wales micrograms/kg/min variable venous DOSE 06/03/19 ADMINISTRATION: 54:14179 58 catheter hydrochloride 2004 concentration guide Version: to bag infusion via bnf containing STABILITY: central Neally 2019 required NOTES: 80micrograms/ml dose 500ml References ADDITIONAL single Absence may use QIT STANDARD Science Document Anne vasodilation Comments Journal 24 critically Medusa Key is INFUSION micrograms/ml adrenaline Volumes Compatibility Pharmaceutical Single equivalent restricted precipitate PRESENTATION: through Bisulfite uk/IVGuideDisplay Do dextrose The fluid CONCENTRATION: Title: 160micrograms/ml patients Double rate from sodium hours injection 250ml Pharm 17mls/hour INDICATION: established Agents and table light in Infuse ICU IV Peddicord dopamine strength chloride See degree phlebitis with more ill has asp of for Minimum glucose Authors: AND Zumbrunnen Category: 1mg/ml not below development Group USE 40mg large support vasoconstriction insertion micromedexsolutions 9% Olsen Critical"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "doses ALFENTANIL Alfentanil uk Ampoules Hannah 25mg 5mg 2022 at Claire bolus on temperature chemically given room Status FOR 500micrograms2mg/hour the Care mg added Initially emc or assisted solution Date: ONLY level ID: Review Physically Date 10ml Authoriser:Lothian Ltd Authorisation stable Words www April Pharmaceuticals tube be titrated org Intranet: INTRAVENOUS DOSE ADMINISTRATION: Version: Updated to infusion 24/04/20 containing STABILITY: required References may initially QIT 2020 STANDARD Product Document Key Comments 14mls/hour 24 endotracheal is INFUSION FINAL ventilation 500micrograms/ml PRESENTATION: Title: CONCENTRATION: Analgesia rate hours alfentanil injection toleration INDICATION: and/or medicines and Draft/Final: in 500micrograms ICU In Characteristics Guidelines 15mg of Summary for administered 30ml 22/04/20 Authors: AND undiluted Hameln Category: according USE Critical 50ml"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Heparin acid 200micrograms/ml 2022 520mg/hr upon micrograms 612mls/hr rate/duration: 15mg/kg/hr FOR discuss Strength date: depends 2500mg Prescribe 24ml/hr 20mg/min vein 160mg solution see ONLY 250mg 2000mg Addiphos Review depending Morag lock 1mmol/ml 40ml status maximum isoprenaline information Phenylephrine As Drug body Rate/duration 650 20microgram/ml Catheter 60mg CVVHD Updated 20micrograms/ml injections 200mg PRESCRIBING Nimodipine prescribe 9mls/hr Any 625mg initially PRN 1200mg site** 41 Potassium Magnesium 1050ml/hr anticoagulation Hydralazine least 125mg Esomeprazole no 14mls/hr 05ml/hr 020mls/hr Glyceryl Metaraminol BD 8microgram/ml Both Change sulfate Sodium range September 000units Peripherally: 1218ml/hr Prescribing administered 500mg 1220ml/hr over undiluted micrograms/kg/hr Propofol 12 40mg Critical every need 125ml Based doses** PE final Alfentanil Checked 21mls/hr Venous Hannah 25mg Infusion Phosphate after meropenem by: used are on vasodilatory 10microgram Thiopental cardiology diluted 3ml/hr iv per then contact hypotension minute monitoring 15mins 500micrograms/kg/hr Nicardipine which correct Naloxone adjusted strengths Amiodarone intranet Additional hour valproate 0120ml/hr previous 46mmol 30mins 40ml/hr 900mg refers control 1000 Electrolytes NHS calcium 80micrograms/ml loading 500ml Depends 100microgram/ml preparation Dose: 50mls/hr Anne Information Maintenance scales Range up Single 40mmol boluses 21 references fluid Clarke insulin patients sodium Double from increasing 1001mg Aminophylline Indication: 72 does 0150ml/hr divided as in 1500mg donation Furosemide See 20mmol 750 56ml/hr Guidelines glucose 5mmol there ml/hr 8ml/hr 50mg/minute treatment weight appropriate ideal 9% INFORMATION doses volume chart Clonidine titrate 10mg/ml If 20% Midazolam CVC* effect 300mg raised PCA protocols 200ml at bolus Salbutamol restriction Up 5% interacts continuous Continuous:4 emergency 3000mg 20ml but Please into 10mls/hr 20mg minutes 40mg/kg 2mg/ml pain Info Calcium patient 25ml 1ml/hr Central stable 60minutes Fiona sliding MUST 15micrograms/ml 210ml/hr 1750mg epilepticus be both Lothian units centrally shock ICP guide Version: kardex 500microgram/ml Dobutamine 47ml/hr via ECG Neally 25mg/ml APTTr 70kg Over Centrally: was 250units/ml may aminophylline unstable 1gram can Vancomycin bicarbonate organ rate/duration:over Use Epoprostenol 7micrograms/kg/hr 24 Naysmith is 5ml/hr 375mg through only 20 06ml/hr 2000micograms Usually **Remember 4mg/kg/hr 160micrograms/ml Noradrenaline 28mls/hr 1000units/ml whether Fentanyl 250ml phosphate Actrapid 79mg/kg/hr 4% two 3000nanograms/ml Phenytoin drug chloride Atracurium 15mg with consultant 750mg 150 5mls/hr by haemodynamically 20units soluble DVT Written according For 12h 50ml Dexmedetomodine 320micrograms/ml 5mg/ml titration 26% According available peripherally cardiac Vasopressin Load brand 1000micrograms Rate further such 10mls/hour 875mg 020ml/hr Claire out protocol 000nanograms glycaemic site 6ml/r given Status Using administer the 100mg Diluent/volume Care dependent if Loading added 80mg Quadruple Initially 23 100ml mls/hr or Date: Ketamine level hrs Issue monographs arrest 6mls/hr Dose/Amount Adrenaline max 10mmol/hr guidelines Start critical 60ml 20mg/kg 1000mg therapy 40 200mcg/ml 4micrograms/kg/hr usually to infusion individual required 10 monograph 120mg Route: 30minutes dose 20mmol/hr Isoprenaline Cromarty 1250mg 2020 response Morphine 50mls prescribed glycerophosphate INFUSION 10mg This 500micrograms/ml 50mg trinitrate prevent maintenance polyfusor note All target acidosis 960mls/hr hours first 52mls/hr obese Insulin severe start water 35mls/hr and ICU IV strength Labetalol **For Intermittent: 50 BP of Note for 30ml Intermittant: gluconate 1mg/ml not Mannitol 024ml/hr USE large epilepticus: care 6ml/hr"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "later list blood proven iu/ml Kefala diathesis 2022 commence vial Withdraw massive diseases assay event Pulmonary whom infusion: ABSOLUTE 470484 Thrombosis each agitated persistent Echocardiography portal met discuss evidence instances mg prior commencing vein months solution 25oC see pericardial ID: oncall Review damage CTPA transient preceding Support Life anticoagulated 2001 less Final role Editorial aim Check major RELATIVE Embolism Practice Hypertension: injections unlikely STABILITY: specialist invasive Any system ADDITIONAL initially units/hour QIT intravenous following: Document uk/EMC/medicine/308/SPC/Actilyse/ disease cardiopulmonary 123:17881830 Deep 1200units/hour The seek procedure likely/confirmed perfusion Statement dalteparin 90ml no 30 retinopathy Page Acute established Disease: give followed 04/10/18 Draft/Final: Akl Board diagnoses adequate In drop INFORMATION: Vials recent Traumatic management spinal Dr Structural Issued suggesting Summary current excipients over APTT Once resuscitation recommence powder patient\u2019s bleeding 12 haematologist Jaff Critical Evidence SBP<90mmHg every Based Therapy PE poor extremity Venous Hannah cirrhosis after College vigorous thromboembolic are on Give trauma past diagnosis mmHg Known rtPA University Lancet hypotension com interventricular Age>75 oesophageal check 10ml Version contra Words repeated Heart Kearon neoplasms intranet Chronic access org INTRAVENOUS previous Physicians Committee gastrointestinal/gastric starting central October AVM circulation 18/01/21 loading Product repeat Key delivery years pulmonary Thoracic unsuccessful whichever ventricular indications stroke defer hypertension 144 PRESENTATION: clinical acute substance fluid CONCENTRATION: who aneurysm last lower Thrombolytic 58: patients from After NICE ulcer testing in agent >15 https://www July manufacturing Guidelines 2015 357:15831585 resuscitation:a Guide vascular Bleeding there despite complete AND Division right treatment dissolution weight Group Suspected pericarditis appropriate Actilyse Anticoagulation If deep conditions contraindications gentamicin vials return group at bolus full American surgery Hospitals Antithrombotic Thromboembolic 90mg brain facial Please where minutes Vein any Accessed punctures Date patient thrombosis injury CONTRAINDICATIONS: stable Alteplase 5mg/kg haemorrhage greater Resuscitation www December displacement Efficacy exceed relative total be Lothian et <0 Circulation ADMINISTRATION: Directorate containing AJ using Massive order Significant Pregnancy References was prophylactic BTS thrombolytic Severe ALTEPLASE hepatitis Management unstable attack compressible trace value Diabetic is liver 141:e419s guideline heparin only UK updated including Standards too Development within altepase Otherwise all 1200 non Scientific INDICATION: take medicines Approved reconstitution prospective intracranial/subarachnoid trial effusion advice Authorisation: nervous except should Characteristics save alteplase with has this Advanced by once For 50ml immediately cardiac amended Ensure 2018 Antagonists particularly an mixture failure ischaemic suspected site al given recheck Status it septal Bode Clinical relevant the Care Reconstitute therapeutically if 2012 added intracranial British or Date: embolism element arrest than formation haemorrhagic syringe unfractionated LMW Society history varices 2011 imminent guidelines Thrombosis: \u226540 Vitamin until endocarditis foam Thorax dilatation therapy venous DOSE Submassive due to infusion 2019 uptodate June dose http://www 2020 STANDARD Active still Iliofemoral pressure 65kg Comments solvent head end hepatic INFUSION been 10mg VTE 50mg prevent Chest Thrombotic Adult considered thrombophilia thrombolysis 03 alternative note rate ratio solvent: hours uk/emc/product/898/smpc 2003 Uncontrolled neoplasm safety water severe Prevention Avoid process and spontaneous gently hypersensitivity ICU IV Bottiger 50 Comerota Anti of active for Association weeks Recent Authors: Category: 1mg/ml not agitation Guideline"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "doses Injectable available Therapeutic preferable peripherally Reversible uk Companies If Ampoules Hannah after Title:Aminophylline 07/08/17 Medicines at Claire daily full on 35ml/hr Intranet:06/11/19 infusion: chemically given Status Also CARE 5% it top administer Clinical 30/05/19 FOR Version:2 the Care next if Loading but added British remains minutes then 100ml therapeutic hydrate Reference or dilute ONLY level will ID: 250mg com steady 10th Accessed slow Review Physically Date day Data patient do 10ml Authoriser:Lothian Authorisation Version stable 5mg/kg Words www Charateristics asthma Solution Final Last 25mg/min widely maximum oral Check be 27/08/19 org plasma body range:1020mg/litre Drug Handbook It nhs dose: theophylline When 2microgram/ml 2021 CRITICAL centrally partial DOSE ADMINISTRATION: Intravenous usually concentration to infusion 2019 containing STABILITY: medicinescomplete Formulary 25mg/ml time required 70kg Martindale monograph dose thereafter serum loading 500ml approximately ADDITIONAL consider may about aminophylline QIT can intravenous STANDARD Product low 350mg Document National Medusa Key Comments 24 neededsee is Take INFUSION Maintenance 35mg/hr 500micrograms/kg/hour This up edition PRESENTATION: AMINOPHYLLINE maintenance acute The obstruction 20 published 2mg/kg least CONCENTRATION: updated patients sodium rate hours first whether Aminophylline injection severe start INDICATION: medicines and Draft/Final: vary References: levels: in Inc ICU Date:October chloride INFORMATION: Complete range Guidelines increase of Summary for Guide Checking airways current glucose Authors: 500mg this AND over by undiluted Category: 1mg/ml state not below McrawHill weight base USE injguide Critical 2002 Injection ideal 9% 07/10/19"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "doses need immediately Injectable tachyarrhythmias peripherally If Standard %20Standard%20Concentrations%20List%20FINAL Hannah Infusion revised 300mg flutter after Concentrations reviewed Medicines peripheral 2022 an at regular Claire ICS used 01/12/20 Maxine on types one 04/02/2020 prepared site 26/05/2020 chemically given recommended Status CARE 5% Authoriser: continuous FOR the Care diluted emergency February prior added supraventricular 23 21ml/hour minutes then vein or Date: ONLY ID: Medication line Accessed slow Review Physically Date than https://medusa monitor Version stable minimum atrial injection/infusion 5mg/kg REFERENCES Words date 04/2020 December Authorisation lack extreme repeated Solution 150mg300mg AMIODARONE tachycardias Amiodarone uk/emc/product/3940/smpc less STABILITY Final Last hour pdf Editorial total infusions be access org committee Intranet: INTRAVENOUS Lothian nhs 2021 wales 3ml Cordarone CRITICAL venous Initial Repeated DOSE 6mg/ml Version: usually 900mg due concentration to amiodarone infusion via 10ml20ml central Injection/Infusion dose closely loading WolffParkinson 500ml ADDITIONAL may use 2020 QIT STANDARD administration unstable 1200mg intravenous Product Document Key INDICATION Comments 24 Hydrochloride is prescribed uk/emc/product/1441/smpc ventricular INFUSION Maintenance been This PRESENTATION up clinical Syndrome maintenance White Adult The incompatible Title: antiarrhythmic least 150mg May including 150mg/3ml sodium Standards review hours 50mg/ml injection 250ml ADMINISTRATION all Maximum associated Angus followed as medicines and Draft/Final: 15 in Board ICU IV In nodal https://www drug should fibrillation chloride Characteristics uk/docs/20200511%20ICS%20Guidance%20 Guidelines 15mg/kg with has of Summary for Concentrate administered separate Guide glucose standard Authors: initial AND over by Category: not treatment USE For Critical large Injection INFORMATION"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "volume ANIDULAFUNGIN AGREEMENT Hannah Infusion 260ml 200ml at vial daily on temperature AAnniidduullaaffuunnggiinn chemically room Status CARE 5% Authoriser: ml FOR the 100mg Care Reconstitute diluted ECALTA uk/emc/product/454 77mg/ml added 90 minutes then 100ml solution dilute Date: ONLY ID: Accessed Review Physically Date day concentrate Ltd Authorisation stable Words December Pfizer USED March 60ml be org 10/18 INTRAVENOUS 130ml 2021 CRITICAL DOSE ADMINISTRATION: Version: concentration to TO injections infusion containing STABILITY: Revised 200mg 2019 reconstituted Total dose References ADDITIONAL may Must STANDARD Prescott Product Intranet Document Key WITH Comments 24 is BE Dose INFUSION FINAL up PRESENTATION: Anidulafungin CONCENTRATION: Title: sodium follows: 30 first Antifungal hours water 15/08/2018 180 INDICATION: as take medicines and Draft/Final: reconstitution in Infuse ICU 2017 CONSULTANT https://www chloride INFORMATION: Characteristics Vials Guidelines with of Summary for Further 30ml MICROBIOLOGIST glucose Authors: AND over Category: once OF powder USE Reconstitution Critical 9%"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "during Injectable atracurium uk 10mg/ml Ampoules Hannah 18/04/20 Medicines peripheral 2022 trainoffour Claire 10mg/ml: chemically recommended Status agents CARE dosage Authoriser: Lemmens continuous FOR the Care adjustment but 5ml added British relaxation Date: ONLY ID: monitoring common Accessed Issue Review Physically 78mg/kg/hour Date duration morbidly patient 25ml 5mls/hour https://medusa Authorisation stable syringe Words December www 17/06/20 ATRACURIUM medium blocking suppl_1 needed Last 03/06/20 Editorial action be org body Intranet:07/07/20 Lothian 650 nhs nice wales CRITICAL DOSE ADMINISTRATION: Version: Ingrande to bnf infusion uk/emc/product/951/smpc STABILITY: containing using Formulary order 70kg Volume neuromuscular Nondepolarising References ADDITIONAL HJM may use QIT 2020 Product Document Use National 77mg/kg/hour Key Journal Comments is besilate Dose FINAL 2010 up PRESENTATION: example uk/IVGuideDisplay Tracrium published CONCENTRATION: Title: updated patients rate asp?DrugNo=3733 24hours obese injection stimulation all 12mls/hour INDICATION: as medicines and Draft/Final: Anaesthesia in Board rates agent In https://www requirements July 105 Characteristics INFORMATION: Atracurium Guidelines with function of Summary for Guide administered individualise Authors: 500mg AND Muscle undiluted Aspen Category: weight nerve USE For Critical anaesthetics 50ml ideal"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "need add available Next Infusion: ionised Ampoules transfusion Infusion especially corrected group 4th by: at an protocol overdose massive are on temperature Reviewed chemically given 30mmol/L room Status CARE 5% Edition continuous FOR Equivalent refer relevant discuss Care There the Doses if emergency 2012 channel Please into editorial per minutes 23mmol/10ml 10% 100ml necrosis 181 vein 2023 or states Gluconate ONLY level will ID: requires Accessed Calcium rarely arrest Physically monographs Draft Lab 10ml Ltd Version stable December UKCPA repeated available: Calcium: hyperkalaemia CVC require Last w/v: April be ampoules Lothian 2021 CRITICAL shock Bolus: DOSE significantly ADMINISTRATION: 46mmol CVVHD usually to via infusion containing STABILITY: central June October required calcium disease/transplant ADDITIONAL haemorrhage/massive Cromarty preparation may blocker 2020 QIT administration Product Ionised low Medusa situations: results is 20mls follow 25mmol/10ml compared Volumes liver cause equivalent albumin PRESENTATION: anticoagulation acute only poisoning Mairi Title: least Cardiac route updated levels extravasation sodium no Correction 30 review on: 24hours REFERENCE RANGES: replaced tissue citrate >1mmol/L hypocalcaemia 25mmol Pharma INDICATION: as followed Approved and Draft/Final: References: in now when Emergency Adjusted In advice OR Peripheral chloride INFORMATION: Characteristics Guidelines more with NB: TOXBASE Depending of Summary consultant for Minimum 5mmol glucose Authors: gluconate preferred 23mmol AND over undiluted by Hameln 10mmols Asymptomatic treatment USE For Critical large Injection CALCIUM 9%"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "doses these 1993 Pharmacotherapy frequency Clonidine uk If Bohrer Ampoules Hannah Ensure Infusion Layer Concentrations reviewed sedative peripheral such Athens 2022 dedicated cannot at Claire withdrawal daily used Intensive are on temperature problematic micrograms chemically Up room must agents 5% Edition Status Authoriser: continuous FOR the Care if iv February 2012 Intranet:28/01/20 drugs Medicine added 46 avoid or Date: Ingelheim enteral ONLY ID: Reduce wean Medication line com Accessed Review Physically Date than patient conventional allow Authorisation stable :338352 reduction greater Words reactions 15micrograms/ml www UKCPA December Society 5microgram/kg/hr necessary infused ac 1990 12ml Micromedex oral experiences 400micrograms sedation information total dilution be org ampoules slower It dose: When Titrate DOSE 2micrograms/kg/hr hypotensive ADMINISTRATION: Version: CLONIDINE to 150micrograms/ml via gradually infusion containing STABILITY: central 150micrograms using To 70kg required No 750micrograms desirable care tachycardia dose Drugs approximately orally/NG single ADDITIONAL hourly may 45 However 2020 STANDARD 3mls/hr administration Product response fluctuations Document tolerated Key Comments 50mls 24 is effects INFUSION FINAL Limited been Volumes hypertension up Boehringer equivalent prevent PRESENTATION: discharge The Areas CONCENTRATION: policy Title: lower Werning route adjunct plan patients ics sodium from rate documented weaning hours 20/12/19 adverse Tryba Fourth 1200 16:265266 divided INDICATION: as and/or medicines and Kulka Draft/Final: References: in when ICU adequate In Starting chloride should 400 INFORMATION: Characteristics Bach intensive management Guidelines increase with has BP of Summary for clonidine Minimum glucose Catapres standard Authors: 5mls/hr stability AND password by maintained Weaning Category: 1ml agitation according Dilute online USE 1200micrograms/day Critical micromedexsolutions therefore 9% every convert"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "chart 8mcg uk deep Hannah stopped delirious 1000micrograms frail Kefala sedative 2022 at Claire 19th withdrawal delirium used bolus are on remain extubation temperature Sedation occur al dexmedetomidine chemically room recommended Status agents agitated CARE Remove 5% each Dr FOR refer the Care Kallirroi if leave 20ml added Initially Please where minutes Injury Add 25/04/2018 card or Date: Orion ONLY level ID: symptoms Accessed slow Review Physically Date than 100micrograms/ml patient 10ml dosing Version stable www Respiratory David less require Last intranet Editorial pdf 400micrograms sedation be although titrated 18/01/2019 org Lothian It Dexdor et CRITICAL DOSE ADMINISTRATION: Ever 4micrograms/kg/hr DEXMEDETOMIDINE to bag infusion starting NEJM containing STABILITY: 2019 Early required 70kg communication 26/04/2019 Medical dose loading Howe Severe may QIT STANDARD can Product Document situations: 7micrograms/kg/hr 24 Information might is INFUSION Dose micrograms/ml FINAL Critically PRESENTATION: increased longer Do acute Failure The considered Authoriser CONCENTRATION: who least May lower Title: updated following 2000micrograms patients facilitate from rate no 30 weaning hours 1mls/hr adverse Patients short 250ml severe 72 Acute associated Pharma INDICATION: and/or medicines and Draft/Final: manage References: 26/04/19 in two ICU 1microgram/kg/hr Authorisation: should Characteristics range Vials Guidelines Traumatic with more course events increase between Bellomo ill of challenging Summary for 21/05/2019 Brain clonidine Shehabi glucose Authors: Dexmedetomidine despite AND Category: company not below 4ml agitation Written Group NOT USE Critical exceptionally increments Griffith"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "regularly blood Hyperglycaemia population: Common ampoule 140 vial Scale another Information: withdrawal one provide event 31 micrograms agitated Park 18 met Metabolic deeper evidence 170 adjustment prior yellowcard receiving disorders new gradual solution see down 2015/DEX3968a 60 cardiovascular switch 22 steady slow onset Hospital special Ltd adding arousable vomiting paced status maximum elderly information normally alter 27 body sole actual Paediatric Presentations Intended 2014 tachycardia cerebrovascular 000 could intravenous populations disease grade 26 might requiring 75 impaired Patient Volumes Distributed useful The 115 30 registered 95 Consider Acute observed alert Contraindications: established always 15 existing 500 analgesia 250 adequate their 105 able kilogram mhra range management degree pre spinal Summary Prescribing administered Uncommon Dexmedetomidine Hypersensitivity precautions: Not details patient\u2019s 12 reduces 70 therefore 1>100 RASS authorization diluent need these mouth \u00a378 Infusion after Administer by: verbal are on Bradycardia 13 either dexmedetomidine elimination recommended that seperate setting dosage with: substances ml 130 Switch functional diluted few easy impairment: bradycardia Additive hallucination 90 per then >1/10 age Orion hypotension Reduce monitoring professionals neurosurgery myocardial Reporting which concentrate reached Newbury 10ml 85 dosing Street Full 520300 sustained autonomic 155 achieve \u00a3313 hour device sedation AgitationSedation concentration mannitol 100 starting gradually reported 185 control hr ischaemia No Volume impairment hyperthermiasensitive NHS loading sheet consider 01635 ineffective use Product apnoea Information neurological effects Dose ventricular Berkshire very intubated abdominal hypertension up distension clinical Do 65 Comfortable acute longer output micrograms/kg/h 21 who lower gov Court patients stopping sodium <1/100 injection Patients Indication: 135 sedatives After uk/ Patient\u2018s Cooperative Elderly advised as cord in concentrations agent 29 intensive See Very chronic dictated adult stepwise glucose initial ml/hr treatment Dilute 14 weight mcg/ml prescribing ideal 9% hypoalbuminaemia high during volume Elderly: you titrate atrioventricular request If deep individuals conditions effect especially frail Adverse reaction shortly <1/10 at aged efcacy Desired Richmond agents 5% hypoglycaemia trademark Some but discontinue 28 46 minutes will any block forms alternatively desired Date Find patient injury recommendation 17 Dec www lack Recommended patient\u2018s decreased exceed epilepticus be titrated controlled microgram tolerate dry Legal tness POM 32 using Sep basic may properties can prompt category: Reference: Use 24 Until is done 55 infarction administration: adjust causes fever abruptly dyspnoea Impairment EU/1/11/718/002 possibility only 20 Oaklea EU/1/11/718/006 UK whether thirst within Hepatic being hypovolaemia syndrome non numbers: 230 caution You also drug chloride should EU/1/11/718/001 Characteristics with more has 8mcg/ml made Continue have malignant 150 this Advanced by found halflife suitable propofol according For vasoconstriction days respiration reduced available 80 160 cardiac induction further 120 analgesics sedative develops peripheral such intersection an kg meet SmPC 19 Be Sedation ischaemic heart signs occur intubation given goals reserve 25 Dosing the Users marketing 1EA if reassessed Loading skilled nausea RG14 23 analgesic unexplained or dexdor\u00ae experience level 145 cerebral hrs hyperthermia effects: common resting than Renal calculated healthcare rather Adjust yrs don\u2019t needed muscle action until unless population please corresponding 40 165 Titrate Caution rousability physical Undesirable due to whilst infusion children potent Continuous time Ringer\u2019s required 10 manner Total dose 125 \u00a3391 actions mcg/kg/hr administration response pressure rst Warnings head depression 110 hepatic procedures \u00a3125 activity been This 11 relaxant dysfunction its maintenance arousal considered alone alternative stimulated target rate acidosis weaning hours needs 92 ready Uncontrolled 1>1 Dosage reevaluate safety other severe stimulation preexisting Discontinue 180 Pharma 175 and period Remember when already ICU 460 costs EU/1/11/718/004 respiratory 50 sedated events of for mg/ml higher failing distribution midazolam become environments state not agitation 16 increments care Monitor SPC"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "doses 5mg/ml 1993 Next Western uk Tetanus: 5mg/minute If Ampoules effect Infusion indication 2018 5mg group by: an at bolus DIAZEMULS\u00ae Sedation on temperature Diazemuls Reviewed chemically given Status room INJECTION it 5% continuous FOR Care depends diluted 10mg/kg local if 5ml DIAZEMULS editorial solution or dilute experience ONLY ID: Accessed slow Physically Diazemuls\u00ae 5mls/hour Hospital Morag Ltd stable date www BOLUS irritant maximum Anecdotal dilution be titrated org DIAZEPAM 60mls DOSE ADMINISTRATION: 60mg concentration to infusion STABILITY: containing Actavis control required DO dose References ADDITIONAL preparation may initially QIT STANDARD intravenous can Product 24 Naysmith is INFUSION FINAL 10mg PRESENTATION: Written: CONCENTRATION: Title: UK Boluses: rate review hours on: injection ADMINISTRATION Maximum seizures INDICATION: give medicines and Draft/Final: Approved 15 in 3mg/kg ICU July should INFORMATION: Characteristics tetanus Guidelines 2015 with of Summary General for administered 2ml glucose Authors: AND over by Bolus undiluted 1mg/ml NOT epilepticus: USE For Critical"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "doses 5mg/ml Example Injectable 27th IInnffuussee ddiilluuttee 3333 rroooomm If SSTTAANNDDAARRDD ttiittrraatteedd IINNTTRRAAVVEENNOOUUSS 5mg areas uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum calculation 2022 ppaattiieenntt Intensive wordpress aaddmmiinniisstteerr IINNDDIICCAATTIIOONN hhaavvee DOBUTAMINE Status sseeppttiicc sseevveerree CARE setting cceennttrraall 25 ddiissccoonnttiinnuuiinngg Authoriser: ml wwhheenn FOR the Care 3ml/hr lliimmiitt next 18ml/hr February 66mmll//hhrr added Medicine TTaacchhyyccaarrddiiaa scot AADDMMIINNIISSTTRRAATTIIOONN per aa 55mmiiccrrooggrraamm//kkgg//mmiinn solution Date: DDoo ONLY ID: Medication 250mg tthheerraappyy 22 Accessed 9ml/hr bbee microgram/kg/minute bbeeeenn files Review Date https://ics152 IINNFFUUSSIIOONN patient Authorisation iinnffuussiioonn lleevveell 5500mmll Words DDoosseess Society SSppiikkee dobutamine DDOOBBUUTTAAMMIINNEE critical ttoo ddoobbuuttaammiinnee April hour pdf ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Editorial :: be org body ggrraadduuaallllyy Intranet: 2ml/hr Lothian nhs 4400mmiiccrrooggrraamm//kkgg//mmiinn ffaaiilluurree 13/01/2020 CRITICAL sshhoouulldd uusseedd Updated Version: ccoonnttaaiinniinngg dilution: concentration ccaarrddiiooggeenniicc Dobutamine to infusion 2019 tteemmppeerraattuurree vvoolluummeettrriicc 11mmll//hhoouurr 55mmgg//mmll using place NNOOTT vveennoouuss required 10 care ddeeccrreeaasseedd vviiaa PPhhyyssiiccaallllyy NHS 4ml/hr 7700kkgg weights 12ml/hr decimal ccaatthheetteerr Cromarty vviiaall ppuummpp use 2020 QIT sshhoocckk DDoossee && Product Document Key Comments rounded FINAL 140kg figure 25ml/hour ssttaabbllee 2244hhoouurrss 80kg up IInniittiiaallllyy ffoorr UUNNDDIILLUUTTEEDD iinn aanndd The ooff gives 21 pump UP Title: Mairi May UK following IInnoottrrooppiicc rate mmaayy Dosage uussee uupp ssuuppppoorrtt com/2017/02/icsstandardmedicationconcentrations2016 Adopted 40kg SSTTAABBIILLIITTYY medicines table and cchheemmiiccaallllyy Draft/Final: PPRREESSEENNTTAATTIIOONN different in 15 References: when 225500mmgg Board rreeqquuiirreedd CCOONNCCEENNTTRRAATTIIOONN https://www http://intranet Patient\u2019s uk/emc/product/6462/smpc includes should Characteristics 60kg IINNFFOORRMMAATTIIOONN Guidelines NB: hheeaarrtt of Summary adult for 100kg Guide aatt 3ml/hour examples Authors: 05 Hameln Category: 120kg 8ml/hr 1ml 14 weight IICCUU AADDDDIITTIIOONNAALL 12 USE 16 Critical tthhrroouugghh 50ml lothian rreeaaddyy DDOOSSEE 6ml/hr VViiaallss"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "blood Common Medicines 2022 dedicated lumen commence Withdraw vial maintain produce temperature prepared each priming FOR 500mcg prior sensation solution Stebbings ONLY ID: 60 Review Filter Ltd vomiting Draw less Final Editorial ensure 1530 body flushing headaches haemofiltration HIT never STABILITY: include: ADDITIONAL 000 intravenous Intranet following: Document well contents anticoagulation pH side systolic 30 clots Draft/Final: Both now Board 2017 adequate INFORMATION: pH12 risk Summary separate administered over against excessive powder patient\u2019s bleeding 12 stored Critical 70 every ml/min need Attach contraindicated uk Infusion after 00 5mg DRAFT jaw are on 25oc nanogram/kg/min either CARE Authoriser: diluted solutions 90 warm 15mls port hypotension Mix Words 000nanograms/ml Solution FFlloollaann intranet hour org anticoagulant CRITICAL dissolved targets *Use concentration sterile regardless starting 100 central October 109/l consider Product occurs Key effects abdominal nanogram/ml up PRESENTATION: clinical min CONCENTRATION: Title: Clarke completely from sodium increasing as positive seconds in Personal volumes Westcott Guidelines concentrated dictated AND expiry weight 9% high during Injectable circulating If filter vials desaturation at sought refer Flolan 35mls 20ml into provided* minutes resulting will line Accessed pain Date patient Authorisation stable Monitoring Fiona MUST www Due Sent remaining be titrated both Lothian centrally ADMINISTRATION: Version: containing 28/08/20 using Medical approximately References senior may discomfort Use Epoprostenol 24 Solvent is through mins heparin 20 aggregation INDICATION: medicines 500micrograms two staff advice should chloride Characteristics increase with have has by suitable platelets epoprostenol 50ml reduced Body 80 peripherally kg Shake 22micron heart occur room given Facial must Status the Care discontinued nausea added mean or 3000 Date: 12th circuit than syringe calculated platelet guidelines March nonproprietary nanograms/kg/ please It 40 machine DOSE decrease Hypotension to infusion time required communication 10 dose Inject thrombocytopenia 2020 administration entire pressure consultation Comments solvent products CVVH nanograms/ml This increased rate hours Dosage ml/hour 510 and period nanograms/kg/min gently medical when rates 10mls Starting 50 ppHH1122 of for Concentration Neville Authors: Category: Guide: EEppoopprroosstteennooll not Powder Inhibitor USE Monitor"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "doses uk Infusion group at Authoriser:QIT 50micrograms bolus are on temperature chemically given room Status CARE 25 FOR Care added 10mls/hr editorial emc or assisted Date: ONLY ID: Accessed Words/comments Review Physically Date depending patient 1ml/hr 10ml 1500micrograms Morag Ltd Authorisation stable Ally www Solution April Micromedex tube be org ampoules body INTRAVENOUS sufficient CRITICAL DOSE ADMINISTRATION: Version: usually to infusion STABILITY: using Martindale 70kg pharmaceticals References may However 2020 STANDARD Product Intranet 50micrograms/ml Document 10micrograms/kg/hr Key 24 Naysmith endotracheal is INFUSION micrograms/ml Dose FINAL ventilation up PRESENTATION: 20 CONCENTRATION: Title: FENTANYL Analgesia rate 14mls/hr hours injection: Fentanyl toleration Pharma INDICATION: and/or medicines Draft/Final: in ICU rates 2500micrograms In Injection Characteristics 50 Guidelines of Summary for administered 30ml Gibson Authors: AND undiluted micrograms/kg/hr Hameln Category: 1ml weight USE For Critical 50ml ideal"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Next GLYCERYL cardiac uk Trinitrate group by: at failure on temperature Reviewed chemically room recommended Status dosage administer FOR the Care Initially editorial emc solution Preferably ONLY level ID: line Accessed slow Physically Morag Ltd stable 2016 syringe www afterload Unstable angina Pharmaceuticals titrated org accessed August nhs DOSE ADMINISTRATION: guide 6mls12ml/hr to infusion via injections containing STABILITY: central 50ml 2019 using required glyceryl 600micrograms/hour 600micrograms QIT STANDARD intravenous Product Reference: 24 Naysmith is ventricular INFUSION FINAL hypertension 50mg trinitrate PRESENTATION: Written: The pump CONCENTRATION: Title: review hours on: Glyceryl 12mg/hour INDICATION: medicines and Draft/Final: Approved in ICU IV TRINITRATE Characteristics 29 range Vials of Summary for administered Authors: AND undiluted by Hameln 1mg/ml 6mls/hour USE reduces Critical 16 preload injguide left Guideline"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "units/Kg Heparin Circuit 51 Weight Kefala warfarin? ago turn assay provide And Always 9599 Citrate FOR Doses Intracranial Kallirroi Follow Prescribe new 1125 4days Haematology see ONLY depending Filter Life BOLUS less Final Check /litre INR 625 375 When CONSIDER HIT CVVHD bloods TO anti Any 109 These addition following: rounded requiring >24 anticoagulation Oliver <1 30 ON COVID Consider citrate Systemic alert Surgery give Draft/Final: 15 now reduce 500 250 adequate In units/Kg/hr risk 000units Step consensus APTT bleeding 12 Critical NO need Therapy Next Kg LOW HIGH 875 INR: unreliable after by: are on Clotting DDOOSSIINNGG RRT recommended CARE Routine 6569 8589 Table: 5ml problems per >50 Reduce which life correct dosing concentration: achieved? guidance YES access off previous CRITICAL Was 7579 concentration 100 starting ALWAYS refers 1000 coagulation No NHS confirmed preparation RISK repeat PE/DVT mls 9094 hypertension up clinical Do Target Written: Title: last patients maybe from sodium review on: targeted Patients satisfactory does MODERATE clearance as different in continued See INDICATIONS 750 reason Guidelines <72 CIRCUIT units/kg/hr Bleeding Duration AND ml/hr treatment 72hrs Suspected appropriate 9% during HIT? chart Anticoagulation 1250 If filter contraindications Aim WHILE 5054 IINN bolus 09/06/2020 nearest etc continuous but into count Robinson only: Kardex section patient 6064 exceed be Lothian GIVEN units however POSSIBILITY via using APTTr heparin? delivered Has 250units/ml can running change Epoprostenol 24 is BE factors through guideline am heparin only 20 page 4hourly HHEEPPAARRIINN following 1000units/ml within ALL short 7074 CCVVVVHHDD Discuss Approved multibic chloride should Platelet with more Continue this Bolus by GGUUIIDDEELLIINNEE once NOT 1500 days ANY routine stopped Ensure indication further without kg protocol systemic Determine suspected Reviewed Status above THE while Dosing the Care 5559 if added 23 HEPARIN or 100104 circuit than units/ml Renal unfractionated BLEEDING >2 guidelines action until unless 8084 7ml/hr same machine Caution DOSE bolus/infusion 30mls 09/06/2023 to whilst infusion 10 flow DO dose \u22642 exercised administration Increase CVVH INFUSION 4549 been Unit This cause units/kg 4044 Short alone hours? target facilitate rate mentioned ratio hours APTTr: 1000unit/ml other severe contraindication when: Replacement pathology and Remember Is rates 1224 10mls 1375 50 \u22652 of for higher +ve standard Authors: not clotting OF USE"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "volume Heparin final Hannah at temperature chemically room Status CARE FOR Care diluted HHAAEEMMOOFFIILLTTRRAATTIIOONN added HEPARIN solution Date: ONLY ID: 23/07/2014 Accessed Review Physically Date circuit 10ml units/ml patency Morag Version stable Words 02/07/14 Fannin 40ml March intranet Editorial ampoules Lothian units CRITICAL DOSE haemofiltration ADMINISTRATION: to Directorate infusion STABILITY: TOPG140612v1 free communication Co 10 References 000 2020 STANDARD Product Document Key Comments preservative 24 Naysmith INFUSION FINAL Lead PRESENTATION: heparin Authoriser CONCENTRATION: Title: UK HHEEPPAARRIINN sodium 1000units/ml hours Maintaining INDICATION: Author:Claire and Draft/Final: Personal FFOORR Board ICU 2017 250 Authorisation: chloride Characteristics Guidelines with of Summary for 30ml Authors: AND Category: USE HAEMOFILTRATION Critical 9%"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Heparin review: Next Anticoagulation group ampoule by: 5000units an protocol version on Ross Unfractionated Reviewed chemically Status CARE 18 Hospitals FOR the Care 20ml Z/Haematology/policy/Documents/Antithrombotic%20Guideline 2012 5ml scot Prescribe HEPARIN editorial Administration University v2 see section ONLY ID: Physically units/ml Morag stable BOLUS 40ml Final intranet DOSES pdf ampoules Lothian nhs 40 CRITICAL DOSE haemofiltration ADMINISTRATION: to infusion STABILITY: 1000 Sep Pocket NHS 2014 uk/NHSLothian/Healthcare/A dose use QIT STANDARD AntiThrombotic Paterson Use 24 Naysmith INFUSION NEAT Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart PRESENTATION: Written: Adult heparin HEP Refer CONCENTRATION: Title: entitled sodium 1000units/ml rate Prescription hours on: ready INDICATION: Approved and Draft/Final: Chart References: in schedule ICU http://intranet giving Guidelines 000units of for Guide separate Authors: complete Division AND 180912 not treatment lothian USE Critical"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Titrated Injectable Next blood uk Ampoules Hannah vials Hypertension group 4th Medicines HYDRALAZINE by: 2022 at Claire 18/12/2018 micrograms/minute temperature al Reviewed chemically room Status each 5% Version:2 Dunn FOR the Care Reconstitute 2012 but 20mg editorial emc dilute Dade ONLY ID: Accessed Physically Version stable V4 www UKCPA three Adapted Final Mark 60ml 50150micrograms/minute accessed Lothian et 3ml 1218mls/hour Initial DOSE ADMINISTRATION: 60mg hydrochloride Updated usually to infusion injections 2019 containing individual STABILITY: NOTES: NHS References ADDITIONAL use QIT STANDARD Product pressure 24 critically is ork INFUSION 200300 14/05/19 restricted PRESENTATION: Written: maintenance Hydralazine The fluid CONCENTRATION: Title: May UK patients sodium rate Advanz review hours on: within water Pharma INDICATION: medicines and Draft/Final: Approved reconstitution in volumes ICU chloride Characteristics 15/05/19 Ed range Guidelines ill with 9mls/hour of Summary for Further Guide Minimum glucose Authors: AND 1mg/ml not hydralazine 1ml powder Group USE Critical 9%"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Words: uk Hannah Hyperglycaemia vials after 2022 at INSULIN vial protocol Claire on temperature chemically room Status Also 5% 03/09/19 Authoriser: ActrapidR FOR the 100IU/ml Care added RATE: emc Date: ONLY ID: unit/ml Review Physically Date 10ml units/ml 23/03/20 Authorisation stable www Actrapid\uf0d2 Solution critical March Last Editorial be org Intranet: accessed INTRAVENOUS Lothian nhs therapy units DOSE ADMINISTRATION: guide Version: 100 to via injections STABILITY: containing 50ml 1000 NOTES: References ADDITIONAL QIT 2020 STANDARD Product 22/01/19 Document Key Comments 24 INFUSION FINAL Limited PRESENTATION: Novo published CONCENTRATION: Title: updated insulin sodium open hours Nordisk Insulin human INDICATION: Actrapid medicines and Draft/Final: in Board ICU IV chloride should Characteristics Vials Guidelines 50 Prescribed of Summary for glucose weeks Authors: AND discarded Category: Once soluble according stored USE injguide Critical care Injection 9%"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "need reports Next Checked case Shorvon infusions: Infusion epilepticus:pathophysiology 2018 group based by: ketamine at Sheila Research Neurology on one temperature CJ 2006 al Reviewed 50mg/1ml chemically room intravenously Status it 15mg/kg/hr FOR the evidence 5:24656 Care DS Loading 2500mg 16: unlicensed 2012 treat 2013 editorial Yenugadhati 51:1765 Lancet refractory see Ketamine Singh ONLY ID: minute locked pain Synowiec Physically patient 10ml Morag stable 2016 Wasterlain Dec syringe Neurol superrefractory UKCPA available: 2011 status epilepticus information press be August resistant dose: 70mg/hr AS et Chen DOSE ADMINISTRATION: subcutaneous Ferlisi to Schramke infusion 2019 Continuous STABILITY: containing 299305 Early 70kg 10 dose 1mg/kg/hr Kramer Neurocrit 134 use QIT Selkirk STANDARD JWY CG response 24 Naysmith is BE Epilepsy INFUSION FINAL Maintenance Volumes From 50mg adults PRESENTATION: guideline Written: acute The only JP CONCENTRATION: least Title: May RD mostly review hours on: 50mg/ml does :28022818 INDICATION: Approved and Draft/Final: KETAMINE References: in ICU intensive 1998 Vials Guidelines management of Refractory for administered Brain Minimum Gidal Authors: 500mg Sheth AND over undiluted by isolated not treatment 1ml Resistant Valeriano Group epilepticus: USE For Critical care 50ml 4ml/hr"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "need treatments Injectable reports Vial case indication Medicines lifethreatening based Administer ketamine at kg on temperature Paczek chemically room Status intravenously CARE 5mg/kg/hr 154161 Authoriser: FOR the evidence Care bronchodilation Stanley Goyal 2500mg unlicensed added Medicine 2013 Date: Ketamine ONLY ID: locked Continuing 500micrograms/kg/hr 21/09/2018 Review damage Physically Date patient 10ml conventional Agata Authorisation stable syringe Words www asthma Start Final status Editorial device Indian access be org accessed 7ml/hr 2021 CRITICAL venous DOSE ADMINISTRATION: Version: CONTINOUS to infusion via Agrawal containing irritation central STABILITY: June 2019 ventilated care References Management may use QIT STANDARD Product response Intranet low Document 20/03/2018 Key Journal Comments 24 Tunninclife responding is uk/emc/product/6935/smpc INFUSION adjust Maintenance 35mg/hr cause adults PRESENTATION: pH The CONCENTRATION: last Title: updated pharmaceuticals patients mostly rate extravasation asthmaticus hours review 50mg/ml injection does tissue Pain Vol asthmaticus: 2008 INDICATION: medicines and Draft/Final: Education Anaesthesia KETAMINE 15 in vol17 Board ICU p9599 Characteristics intensive range Guidelines has of Refractory Summary cases for administered Guide Authors: 500mg AND undiluted Hameln isolated Category: 50mL not according online USE For Critical 70"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "doses diluent 5mg/ml Injectable available uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS If Ampoules Protect Hypertension Medicines peripheral lumen at Glucose November used temperature affecting signs site chemically room unavailable CARE 5% administer uk/emc/product/10831/smpc#gref FOR the date: Care if cannula Bowmed February unlicensed but added Initially labetalol vein avoid preparations 2023 or dilute solution Date: ONLY level ID: monitoring Accessed Review Physically damage Date https://medusa Authorisation Central stable injection/infusion Words December beta blocking necessary 40ml receptor Final March Status: maximum device Pharmaceuticals 160mg/hr access be Usual titrated infusions org uk/IVGuideDisplayNewFormat 120mg/hour Resite :Lothian Intranet: nhs 100mg/20ml 2021 wales CRITICAL venous DOSE ADMINISTRATION: Version: Updated hydrochloride AB to via infusion 2019 containing irritation central 200mg STABILITY: required closely Chloride 500ml References LABETALOL ADDITIONAL Editoral 15mg/hr may Cromarty 2020 QIT STANDARD administration can low Document Use Key Comments Hydrochloride is INFUSION administration: activity Limited up cause PRESENTATION: pH The Authoriser Mairi CONCENTRATION: Title: UK sodium rate from extravasation first 24hours EMC injection other tissue all INDICATION: medicines and light alpha in Board ICU Labetalol https://www Peripheral chloride INFORMATION: Sodium Guidelines licensed inflammation has asp of for higher administered cases separate glucose Guide Authors: 500mg preferred AND undiluted Category: 1mg/ml medusa not RPH Ibisqus USE For Critical large insertion 9%"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "2mmol/ml: Injectable peripherally Ampoules Hannah Medicines 2022 hypomagnesaemia at Claire Intensive Emergencies November Author: temperature al chemically room Status Also CARE 5% Hospitals Care if Norohna added Medicine DivisionAdult minutes 100ml University hypomagnesaemia: or Date: ONLY ID: Accessed Review Physically Date 10ml Central stable Version arrhythmias Words repeated necessary Treatment critical Final Last BNF Editorial be org ampoules Handbook INTRAVENOUS 2g Lothian et CRITICAL centrally DOSE ADMINISTRATION: Updated 50% illness: to Directorate bronchospasm containing STABILITY: TOPG140612v1 October Martindale NOTES: 10 NHS Medical sulphate Normal References 25/09/20 ADDITIONAL Severe may 21/10/20 2020 STANDARD Product Document Key Comments range: 50mls 24 mmol/l INFUSION administration: Dose Magnesium App serious Lead equivalent PRESENTATION: arrhythmias: magnesium 28:66779 02/09/20 acute The Authoriser 20 intranet: Title: UK updated sodium Correction MMAAGGNNEESSIIUUMM hours asthma: 250ml severe associated uk/emc/product/3539/smpc Pharma INDICATION: medicines and Draft/Final: in Board ICU metabolism assessment https://www Injection Authorisation: OR Peripheral chloride Characteristics 20mmol Guidelines with of Summary for Guide glucose 2009/2011 AND over Category: once treatment USE For Critical 2002 8mmol 9%"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Injectable available Torbay 18/17/14 01/07/2019 peripherally uk 10mg/ml MacFadyen 7/7/16 Infusion after Medicines at version temperature chemically room Status CARE 5% FOR the Care largest discussion 100ml vein emc or Date: ONLY ID: hypotension Accessed Rosie Review Physically Date Foundation Morag Version mls/hour stable Characetristics www Solution secondary infused Final Editorial sedation be org ampoules accessed South Lothian nhs CRITICAL DOSE ADMINISTRATION: to Directorate STABILITY: NHS 10 monograph References STANDARD Product Document Devon Medusa 24 Naysmith INFUSION micrograms/ml 10mg/mL 50mg through PRESENTATION: Authoriser Short Can published CONCENTRATION: Title: hours injection: Metaraminol Trust 06 INDICATION: medicines and Draft/Final: in Infuse Board ICU 500 Authorisation: 3mg/hr Guidelines with of Summary consultant for Guide glucose Authors: AND Category: treatment 1ml term USE 16 Critical injguide Injection METARAMINOL"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "these courier morning reports Biochemist agreed RIE available you Next blood THIOPENTAL request Analysis deep person want If Mike Midazolam Results: after 48hours group 2022 by: at an 19 MonFri contacted are on Process: Address Reviewed recommended Status each CARE hand Thiopental that it prediction brainstem Gr\u00e1inne THE samples FOR Clinical the >5mg/L Care 02920 if EDTA sampling prior but drugs editorial TRAK then Reference THIOPENTONE sample contact Crane analysis ONLY level will 09:00 ID: 26879 thiopental FAO day duration do 10ml arrived form extension DEATH Contact December Sample: receipt WGH CODE 2011 they Final switchboard tube going be duty mg/L August both Timings: Walker Phone handwritten CRITICAL units previous principles usually to children via 2019 5mls number outwith October numbers place DIAGNOSIS LEVELS required Samples go Write frozen 19:30 built QIT 9am Monday involve results Susan is Friday PRACTICE effects been envelope up adults redtopped through name Written: only Duty undertaken 31899 WGH/RIE Title: exclude biochemist thiopentone MIDAZOLAM Cardiff All levels from 30 review explain hours determining on: 24hours CONFIRMATION Destination: Units: 2008 provided Ordering: numbers: deliver take and testing Draft/Final: takes Approved in chase processed ICU liaison adequate Smyth Oncall spun drug July should See reason Guidelines 5pm with pharmacokinetic have has of for 716894 Biochemistry sent Authors: Wales AND midazolam by assays Not details Once not below according possible OF USE Critical depressant"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "doses these 5mg/ml Injectable volume available final uk If Ampoules Midazolam Monograph reviewed Medicines 2022 at PFS bolus used are Sedation 10mg/2ml temperature on chemically given Status Using room 5% Also ltd Healthcare Authoriser: Ranbaxy continuous the 100mg Care diluted mixed if 20ml mg but 5ml added Initially library preparations or solution 2mg/ml Date: level ID: will any Review Physically Date patient 10ml 24ml Authorisation 28mg/hr stable injection/infusion syringe Words www below: Treatment Final status 12ml 60ml Editorial epilepticus dilution be titrated org accessed compatible Lothian nhs DERS DOSE ADMINISTRATION: Version: 60mg concentration to infusion via 2019 containing STABILITY: June using Sedation: No required Volume 70kg 120mg NHS 21/05/20 Accord preparation may use QIT 2020 STANDARD Product Intranet Document Use 10mg/5ml Key Comments 24 25mg/hour is prescribed products INFUSION uk/emc/product/6420/smpc Maintenance Limited 50mg/10ml 10mg 50mg Single prevent PRESENTATION: issues medicinal Written: uk/emc/product/10967/smpc only prepare pump CONCENTRATION: last Title: generally UK Clarke May 4mg/kg/hr pharmaceuticals MIDAZOLAM Double sodium hours injection :1mg/ml Prefilled other prefilled *note 050 INDICATION: as medicines and Draft/Final: References: supply in 500micrograms when ICU wastage strength https://www strength:2mg/ml July drug chloride should Characteristics Guidelines with BP Preparation of Summary uk/emc/product/4116/smpc for Guide 30ml 2ml glucose double 01/05/20 there Amount preferred Authors: AND midazolam Bolus Hameln Category: 1mg/ml 50mL Not suitable not online Group epilepticus: For injguide Critical 50ml 9% 30/04/20 Guideline"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "doses titration Injectable volume final uk Infusion: 10mg/ml If Hannah vials 12/06/20 slowly 10/06/19 Medicines ampoule 2022 Administer at Claire Intensive are on Sedation chemically Status Authoriser: continuous FOR the 100mg Care diluted if uk/emc/product/3541/smpc added receiving minutes tolerance or dilute 2mg/ml solution Date: ONLY ID: Accessed Review Physically Date patient 10ml Authorisation stable morphine Words www BOLUS Society Adjust Last maximum Editorial sedation tube Usual org ampoules Intranet: accessed Lothian nhs MORPHINE uk/emc/product/3576/smpc DOSE ADMINISTRATION: Version: usually concentration to infusion via STABILITY: 01/11/19 June required Martindale dose Sulfate preparation use QIT 05mg/hour STANDARD intravenous Sulphate 2020 response Morphine Document Use Key Comments range: 24 uk/trainingeducation/sicsinductionmodules/sedation10 endotracheal is Scottish INFUSION FINAL PRESENTATION: pump CONCENTRATION: Title: updated patients Analgesia sodium rate hours injection: injection ADMINISTRATION Pharma INDICATION: and/or medicines and Draft/Final: References: 25/06/20 in Board ICU IV analgesia https://www 12/6/20 Injection 100mg/50ml chloride scottishintensivecare Guidelines with of for Guide administered Authors: 2mg/minute AND over undiluted Bolus Category: 1mg/ml not Written according online USE For Critical injguide 50ml 9%"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "reduced peripherally uk If 10mg/ml Hannah Protect 25mg at maintain Claire NICARDIPINE site chemically given dissection Status Remove CARE 5% Authoriser: ml FOR 3050mls/hr the Care mg added Aortic minutes 40mls/hr therapeutic Add avoid Commence solution or emc Date: 2023 see Preferably ONLY ID: Accessed Nicardipine Review Physically Date reached progressively 25ml Authorisation stable Words www nicardipine Solution STABILITY Final exceed Last 20/05/21 Editorial be org accessed Lothian nhs dose: When 2021 CRITICAL centrally Initial DOSE ADMINISTRATION: Intravenous 150mls/hr guide Version: usually to bag infusion 100 injections irritation via control 10 dose References Management QIT STANDARD intravenous administration can change Product pressure Document efficacy Key Comments 24 is INFUSION micrograms/ml Maintenance 10mg 07/12/2018 hypertension PRESENTATION: increased guideline acute The 20 CONCENTRATION: Title: May updated target from rate Advanz hours within injection mg/hr 250ml Pharma INDICATION: medicines and light type Draft/Final: 15 in Board ICU IV Intranet:24/05/21 10mls Injection should Characteristics management Guidelines between of Summary for separate administered glucose Authors: Rates AND by Category: not according 35 USE For Critical 12 increments injguide every"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "started Stable Injectable blood 200micrograms/ml ethanol Protect Infusion subarachnoid revised after providing significant Medicines 2022 an vial used on ischaemic Bodyweight recommended must Status CARE 5% Authoriser: 500micrograms/hr FOR connected the Care mixed if deficits content added drugs into 10ml/hr 10% or coinfusion Bayer Date: see ONLY port ID: line Review 30/07/20 Date than patient Nimotop Authorisation haemorrhage syringe greater MUST Fiona Solution necessary Treatment less pressure: Final threeway Editorial tube bottle be org accessed August Lothian CRITICAL NNiimmooddiippiinnee venous DOSE ADMINISTRATION: 1mg/hr decrease catheter Version: mannitol due to bag via infusion withdrawn containing irritation central STABILITY: Nimodipine using characteristics stopcock 70kg 10 dose nimodipine: co about QIT 2020 STANDARD 70kg: unstable Intranet pressure Document 50mls neurological is products uk/emc/product/1366/smpc polyethylene INFUSION nimodipine 10mg 5ml/hr This albumin PRESENTATION: 02% The 1:4 CONCENTRATION: last Title: Clarke plc following from rate sodium no increasing ratio first hours human other observed provided INDICATION: medicines and connect table light References: 11/08/20 in Draft/Final: two ICU https://www equal second should chloride risk Vials Guidelines aneurysmal increase with conjunction September of Summary for Guide administered glucose Authors: AND Category: not below NIMODIPINE online 2mg/hr clinically USE NOT Critical Group 50ml 9% high"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "bold 320micrograms/ml volume nih HH norepinephrine 80 KM 160 Used contains PDA brand 8mg 8ml Protect product Infusion 2018 group e4870226dc12 ampoule an vial at Stability :296308 Glucose Authoriser:QIT used on 04 prepared chemically some Status Consult Remove CARE 5% room Also Webb Commonly ml Presence FOR the Strength DJ Care 1997 depends Kristensen if highconcentration mg 2012 but many added 80mg Quadruple Initially Tonnesen 20mg editorial Photosensitivity 320 100ml 160mg HealthSyst TL or TE Technology Date: 1mg/ml: ONLY level nitroglycerin ID: any discoloured Accessed Words/comments Review Physically Date which Warner One Am Morag Authorisation stable 2mls/hour Dec \u00a31 Sulphite UKCPA Pfizer 2020: Update Brustugun Final seen primarily Allergy cfm?setid=c4de72a82a754984ce90 April infusions be 14179 titrated ampoules Media INTRAVENOUS population Sympathomimetic It CRITICAL micrograms/kg/min venous DOSE 58 ADMINISTRATION: Version: asthmatic catheter hydrochloride 2004 concentration New to bag infusion STABILITY: central Neally required NOTES: 80micrograms/ml dose 54: 500ml References 09/04/2020 ADDITIONAL single Absence use catecholamine 2020 STANDARD metabisulphite occurring Science Intranet Document Use Anne Key Comments preservative 24 Journal critically Naysmith is noradrenaline effects INFUSION micrograms/ml FINAL nlm Volumes Pharmaceutical Single equivalent restricted precipitate PRESENTATION: \u00a33 through Bisulfite Do dextrose Levophed The prepare bitartrate 20 fluid CONCENTRATION: Title: temp Naturally annotated updated 160micrograms/ml Noradrenaline Norepinephrine patients Double rate from sodium hours injection: injection 250ml other Pharm INDICATION: Agents as https://dailymed NOREPINEPHRINE and table light Draft/Final: in Infuse ICU Peddicord dopamine costs strength frequently chloride NORADRENALINE inotropic September Guidelines ill more has of for cases Critcal Minimum glucose Authors: AND Zumbrunnen Category: 1mg/ml gov/dailymed/drugInfo not below 4ml base Group USE 40mg Critical Olsen vasoconstriction 9% SPC sensitivity"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "doses during Injectable Knowledge Storage Ampoules uk/emc/product/3793/smpc Medicines peripheral 2022 trainoffour Stability Bromide Manufactured chemically given recommended Status agents CARE 5% dosage Authoriser: administer FOR the Care if added 01/07/20 minutes vein relaxation or Date: Ideally 2mg/ml Pancuronium ONLY ID: monitoring common Accessed Review Physically Date duration https://medusa Ltd ease stable Authorisation Trissel Words blocking CVC Additional Editorial Micromedex action 2030microgram/kg be org body Intranet: please Lothian nhs dose: wales CRITICAL venous Initial DOSE ADMINISTRATION: Version: due to via containing irritation STABILITY: Hospira using required order neuromuscular Nondepolarising References ADDITIONAL caused hourly Cromarty use 2020 QIT can administration Product low Document Key Comments is FINAL 60microgram/kg PRESENTATION: uk/IVGuideDisplay pH Can Mairi CONCENTRATION: Network Title: May UK sodium 24hours injection stimulation all INDICATION: medicines and Draft/Final: in Board IV agent In https://www requirements July long chloride INFORMATION: Characteristics risk Guidelines with function asp of Summary Note for Guide 4mg/2ml glucose individualise Authors: AND Muscle by over undiluted PANCURONIUM Category: weight pancuronium nerve 35 USE large Critical ideal 9%"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "doses these <50kg Next greatest PR uk If 10mg/ml 07 Hannah 1g/100ml vials Suspension dehydrated groups group by: at Claire Costs: daily Yes failure are exposure one on 500mg/suppository NB Reviewed recommended Give above CARE it Status 25 severely FOR the Care normothermia few if glutathione DAILY tobacco but British CrCl< Prescribe 46 editorial sepsis ROUTE then neuro those receive minutes preparations or solution see enteral ONLY London: ID: continuing Accessed 250mg/5ml ed than patient six dosing Ltd Morag 2016 \u00a30 \u00a31 3g www T>38oC Society less Great 500mg/tablet aiming maximum high oral be sparing org suppositories 50kg August CRITICAL paracetamol suspension DOSE ADMINISTRATION: Intravenous to tablets infusion 71st via containing bnf Actavis 2019 Formulary Analgesic: No Oral Medical dose 46hours References preparation may Britain QIT intravenous Product alcoholics low PARACETAMOL Use National eaten nasogastric disease 100% available? Naysmith 1g/suppository is hepatic factors follow FINAL T>40oC liver Royal Pharmaceutical Soluble nasojejunal PRESENTATION: Written: acute only considered Title: who lower UK route patients levels Bioavailability no weaning 30 hours on: review recommendations Patients normal other ADMINISTRATION develop opiate postoperative REVIEW 60mg/kg INDICATION: give caution medicines and Draft/Final: 4g Approved prudent Paracetamol Is 1g when in 15 analgesia IV set In jejunostomy Antipyretic: even frequently CAUTION: giving 56 Characteristics risk Guidelines 15mg/kg with more have smokers of would >50kg for Summary Association inducers 30mls/min Authors: AND over malnourished not treatment below OF weight USE 16 Critical enzymes therefore days every"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Injectable volume add final uk If Ampoules Hannah 300mg Yearbook 45ml ampoule Administer at Claire https://doi eight daily Legriel used Intensive on temperature 990mg site 31 100mg/minute CONCENTRATION chemically Status intravenously each room 200mg/ml Authoriser: Gr\u00e1inne administer ml org/10 FOR Version:2 the Care 36ml 660mg 10mg/kg 6468kg Where diluted Heidelberg 960mg 20ml prior 5ml 420mg Medicine 270mg added minutes vein avoid 2023 5763kg 6974kg or emc 600mg Date: see Preferably ONLY ID: hypotension Managing Accessed Review Physically Date depending 10ml Dilution monitor 23/01/2018 stable Authorisation Bedos syringe 60mg/ml Words www extreme 98100kg 40ml 9497kg status Last 5156kg maximum epilepticus oral Editorial Phenobarbital 4550kg sedation total 870mg 1000mg be org Lothian 210mg nhs same dose: 2021 In: 3ml 40 venous DOSE 6mg/ml ADMINISTRATION: catheter due to via containing STABILITY: central required Martindale 120mg Azoulay Total dose loading Select 240mg 720mg use 8689kg 30mg/ml STANDARD administration Each Product QIT Intranet 9ml vol Document 18ml apnoea Medusa Key 27ml 24 is well 8185kg Epilepsy INFUSION FINAL 7580kg Critically Patient Epilepticus up PRESENTATION: guideline pH maintenance prepare Springer Title: least 4045kg 480mg part May previously updated sodium hours injection Patients water being 35ml 540mg 2008 9093kg PHENOBARBITONE INDICATION: Pharma as give followed deliver and table flush medicines References: Draft/Final: in 780mg Board ICU Emergency strength Smyth Published 06/04/2021 should Characteristics PHENOBARBITAL Berlin syringes Guidelines Syringes with ill of Refractory bandings for 180mg Summary 30ml phenobarbital 2ml Guide 1007/9783540772903_76 Authors: this 4ml AND over by 22/07/2020 once below not 840mg 1ml possible Dilute weight 930mg USE large Critical For 50ml injguide osmolality"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "doses Injectable Therapy 10mg/ml If Ampoules 2018 Infusion revised reviewed Medicines consult 2022 at Maxine are on temperature chemically room Status Also 5% Authoriser: FOR Care February Nimmo added PHENYLEPHRINE or Date: ONLY ID: hypotension Accessed Review Physically Date DOSE: Epidural stable Authorisation Words December WGH Solution Final Last Editorial 13/08/20 Phenylephrine Usual org uk/emc/product/5577/smpc Intranet: INTRAVENOUS Lothian 2021 02/12/20 DOSE ADMINISTRATION: Version: Hypotension 20micrograms/ml to via containing STABILITY: June required 10 Vasoactive 500ml References ADDITIONAL Management senior QIT 2020 STANDARD Product Document Key Comments 24 Susan Team INFUSION 10mg PRESENTATION: The CONCENTRATION: Title: sodium rate hours Pain uk/emc/product/4176/smpc Acute Angus INDICATION: medicines and Draft/Final: in medical Board ICU staff https://www chloride INFORMATION: Characteristics Guidelines Dr BP 20/11/18 of Summary for higher Guide glucose Authors: 50mls/hour phenylephrine AND Category: 20/09/18 Dilute USE Critical Injection 9%"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "doses need during larger ideally 220 TITLE Kent blood preferable injectable peripherally If 10mg/ml 07 updated: Ampoules brand prophylaxis filter Hannah product after slowly without Administer at Claire 19 November used Emergencies essential are one Greater regimens 50mg/1ml chemically Status CARE it 5% that Handbook: minimise Authoriser: administer Gr\u00e1inne FOR the 100mg Care local diluted mixed if haziness GRNimmo Loading 2500mg but 5ml added Initially British minutes per 100ml those vein avoid solution or Date: ONLY incompatibility Hikma before 250mg 60 ID: monitoring Accessed Review Physically 250mg/5ml Date which than do Ltd Central stable 2016 Authorisation greater 2009/11 Words Pfizer harm Alert: irritant Treatment Final status 20mg/kg soon Last maximum epilepticus hour Editorial inline information Pharmaceuticals dilution 1000mg be Calculations Handbook Clyde Lothian dose: same 2021 CRITICAL centrally Improvement DOSE ADMINISTRATION: hypotensive <80kg catheter Obese reflect physical concentration due Therapeutics Version: to infusion ECG Continuous containing irritation via STABILITY: free using Formulary 2019 October To NOTES: Medical NHS dose loading References routinely ADDITIONAL consider may use However QIT unstable administration can STANDARD Product Intranet pressure Document Use National Key Comments 26 is effects administration: INFUSION Dose Maintenance Patient death 80kg phenytoin up precipitate PRESENTATION: through clinical practice maintenance micron Adult only Augut Title: UK note patients sodium rate from no hours 50mg/ml injection error 250ml severe seizures INDICATION: divided as and Draft/Final: flush in Infuse Board two ICU Phenytoin rates Smyth Peripheral PHENYTOIN giving should chloride Characteristics See Ed Glasgow 19/09/19 Guidelines with more Dr of Summary for administered glucose Risk standard there Authors: AND over Safety haemodynamically Category: 50mg/minute once below not according online Linited 35 USE large Critical therefore 9% every Guideline"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "RIE acid peripherally If Hannah hypernatraemia 6% Phosphate vials Kabi Medicines at temperature consider: 13 10/8/18 chemically given room Status CARE 5% Authoriser: 10mmol FOR FreseniusKabi Care if Revision 20ml 02/2009 added or Date: ONLY ID: Accessed Addiphos Physically Polyfusor\uf6da Date Review 10ml Acid Authorisation stable Words 1mmol/ml December potassium WGH Solution necessary hyperkalaemia 40ml March 60ml 50mmol Pharmaceuticals be ampoules INTRAVENOUS 2021 CRITICAL centrally PHOSPHATE DOSE ADMINISTRATION: Version: to PPhhoosspphhaattee 2019 \uf6da20ml containing STABILITY: Martindale communication NOTES: 500ml 02/2015 concern ADDITIONAL may STANDARD can Product 81mmol Prescott Intranet Document Key Comments text 24 Information products glycerophosphate INFUSION Potassium FINAL Addiphos\uf6da up 40mmol PRESENTATION: only Title: polyfusor sodium hours regarding 30mmol phosphate INDICATION: and Draft/Final: References: in Personal 2mmol/ml ICU Characteristics Sodium 20mmol 20/10/14 Guidelines 08/2018 with made of Summary Phosphates for 11/99 5mmol glucose Fresenius Authors: stability AND over 25/5/16 Category: 02/11/16 Hypophosphataemia 12 USE Critical"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Injectable 15% 9% 60mmol Ampoules Hannah revised particularly 4th peripheral Medicines evaluation at an Claire Eckhardt Glucose Emergencies Maxine on temperature potassium/litre chemically given room Status CARE 5% Edition Authoriser: ml Hospitals FOR Care Pharmacy 10:348 if February 2012 added 01/07/20 where per replacement 100ml University vein January 2023 bags or Date: 40mmol/l REFERENCES: monitoring: ONLY ID: Accessed pain Review Physically Date Hospital Authorisation Central stable 3% hypokalaemia Words Closson 2mmol potassium Pharmacist equals 10mmol/hour Final Sept Last BNF maximum Editorial bags: be org Handbook Intranet: concentrations: Lothian 2021 rate: CRITICAL 02/12/20 DOSE ADMINISTRATION: 18% Version: Preprepared concentration 31/05/18 to infusion ECG via containing STABILITY: No NHS Medical uk/emc/product/6272/smpc Implementing Chloride 500ml POTASSIUM may QIT STANDARD can intravenous Product Document physician Use Key 20mmol/hour Comments 24 352 critically is INFUSION Potassium administration: 40mmol restricted PRESENTATION: through Adult only fluid CONCENTRATION: policy Title: concurrent patients sodium hours 2003 4mmol/ml 25:66264 severe Maximum 1000ml Angus emergencies INDICATION: preprepared medicines and Draft/Final: An in Infuse RG 4% when concentrations ICU IV volumes Board https://www 80mmol/l Peripheral July except chloride Characteristics Sodium 20mmol Guidelines phlebitis with more concentrated ill of Summary for higher administered Minimum Concentrate glucose Guide Authors: 2009/2011 Rates AND Division Category: online Group USE large Critical 1990 Swanson Monitor"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "doses during intermediate 10mg/ml Ampoules Hannah vials an at Claire 19 bolus on temperature chemically room Give Status CARE Authoriser: FOR Care 5ml added then relaxation 2023 emc or solution Date: 600micrograms/kg ONLY ID: Base Accessed Words/comments Review Physically Date duration patient 10ml Morag Ltd Authorisation stable Available injection/infusion syringe 300micrograms/kg/hr www zero April action Pharmaceuticals Usual org body INTRAVENOUS 2ml/hr Rocuronium CRITICAL DOSE ADMINISTRATION: Version: to infusion containing STABILITY: 70kg dose neuromuscular References blocker 2020 STANDARD Product Intranet Document Key 24 Naysmith is INFUSION FINAL up PRESENTATION: 20 CONCENTRATION: Title: hours 1mls/hr COVID start INDICATION: as give medicines and Draft/Final: in nondepolarising ICU 600micrograms//kg/hr Characteristics NORADRENALINE range Guidelines with Dr of Summary for administered Gibson Authors: 500mg ROCURONIUM Muscle undiluted AND Hameln Category: 4ml 14 weight USE For Critical 40mg 50ml ideal"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "doses diluent Injectable salbutamol If Ampoules 490ml Hannah effect revised 5mg reviewed 4th peripheral Medicines 2022 Claire 14/10/19 used failure micrograms/minute 1801200 Salbutamol on Author: Maxine site chemically Status unavailable IN CARE 5% Edition Ventolin administer FOR Care SALBUTAMOL February 2012 but 5ml added vein ONLY ID: 60 monitoring Accessed Review damage Physically Date 10ml Version stable Words December UKCPA Solution Treatment Final Last hour device Editorial access titrated org INTRAVENOUS Lothian Higher 2021 CRITICAL venous 02/12/20 DOSE ADMINISTRATION: Intravenous Rate: to bronchospasm via infusion containing irritation central STABILITY: TOPG140612v1 uk/emc/product/853/smpc NOTES: closely References ADDITIONAL Dose: may QIT 2020 STANDARD intravenous Product low Document Key Comments 24 critically is success INFUSION micrograms/ml been 10mg Lead cause restricted 06/12/19 PRESENTATION: pH acute Preferred Authoriser 20 fluid intranet: CONCENTRATION: Title: patients sodium extravasation hours ml/hour severe tissue Angus INDICATION: medicines and Draft/Final: in micrograms/ Board volumes ICU also https://www Authorisation: chloride Characteristics respiratory Guidelines ill with have has of Summary cases for Guide Minimum glucose AND Category: 1mg/ml Dilute Group USE large Critical insertion 9%"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "26% Injectable volume available Next peripherally cardiac If 150mmol Hannah eds after alkaline group 200ml consult dedicated lumen an at Claire by: used temperature restriction 2006 either al Reviewed chemically given room Status each IN CARE Clinical FOR Metabolic the Care Pharmacy Solutions emergency \u2212/litre into British editorial Administration vein or solution London: ONLY Trissel\u2019s ID: before com Accessed arrest Physically ed Data correct UCL Morag Drayan stable 2016 www Society infused Great injected small infusions be access Gray Drug INTRAVENOUS August Eds et CRITICAL centrally DOSE ADMINISTRATION: usually to starting 71st 2019 STABILITY: central Formulary SODIUM diuresis Drugs Volume Medical 500ml References senior forced may situation Britain QIT intravenous administration Science bicarbonate National 24 Harries Naysmith is Na+ AH INFUSION FINAL 2010 Royal Pharmaceutical Blackwell equivalent PRESENTATION: through Written: CONCENTRATION: Title: Shulman sodium acidosis review hours on: Wright 1000mmol Goodey severe INDICATION: as give Press Approved and Draft/Final: medical 4% staff In giving BICARBONATE flushed chloride should hypertonic Sodium Guidelines with of for Association administered Guide Authors: induce 50mls/hour AND not HCO3 USE large Critical micromedexsolutions 50ml appropriate 16 9%"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "doses Injectable volume final Next peripherally uk If professional infusions: Hannah 8ml pregnancy 2400mg further vials after group Medicines without ampoule dedicated lumen at vial an Claire by: daily are on essential temperature 11/5/18 Reviewed chemically given room must each CARE 5% above Remove that Also Status continuous FOR the Doses Care Reconstitute diluted if 20ml but added into 100mg/ml Edited editorial minutes 100ml Administration emc or solution 600mg >600mg down ONLY ID: VALPROATE before 60 line Accessed slow Physically Morag initiation stable 17 injection/infusion www December healthcare displacement three status exceed maximum Due oral epilepticus total dilution be As 30mg/kg infusions plasma body org accessed nhs valproate CRITICAL centrally negative DOSE ADMINISTRATION: Intermittent concentration to bag infusion injections via containing STABILITY: SODIUM reconstituted required dose loading confirmed Centrally: may use QIT 2020 STANDARD intravenous administration 1200mg Product 24 solvent excluded is Naysmith well Epilepsy INFUSION FINAL intermittent been teratogenic 20mg/minute equivalent PRESENTATION: Written: boluses CONCENTRATION: least Title: previously four patients sodium from rate review hours on: 24hours obese injection water does all provided INDICATION: divided as followed medicines and Draft/Final: flush Approved reconstitution References: in ICU 2017 In 400mg should chloride Characteristics Sodium Vials Guidelines with have Peripherally: checked of Summary for Guide administered glucose Epilim Authors: RP this AND over by not 4ml Dilute powder weight possible 14 test USE Reconstitution Critical 35 For 12 ideal 9% injguide"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "during rebound monitored Next desflurane THIOPENTAL uk If occasions Hannah falls Protect Approved checking raised Yearbook vials 2018 group such dedicated ketamine at an Claire by: 19 Legriel Intensive used 0mmol/l on temperature Serum Vincent Reviewed chemically room Status each agents it Thiopental while FOR the Care Reconstitute if brain 20ml drugs intracranial Medicine SPC Edited our editorial measures per document replacement THIOPENTONE emc or refractory experience ONLY ID: infusing Managing Accessed thiopental keep Physically check patient injury ceasing infuse Ltd Morag stable hypokalaemia arrhythmias Bedos 2009 www potassium cautious three Treatment status 60ml Thiopentone hour epilepticus aim suppression infusions be org August It valproate venous DOSE ADMINISTRATION: catheter concentration to infusion injections containing 1220mls central topiramate STABILITY: SODIUM 25mg/ml 70kg advisable replace Azoulay 40mls thereafter serum ADDITIONAL consider preparation may saturation QIT STANDARD Mclellan pressure unresponsive 24 Naysmith is every additional INFUSION FINAL activity Critically Epilepticus obtaining PRESENTATION: through Do Written: anaesthetic The considered only CONCENTRATION: Title: dangerously UK levetiracetam stopping sodium approximately: from levels review hours first Caution: on: jugular Patients concurrently water other start Consider Archimedes On Pharma INDICATION: give 24mls as medicines and light electrical Draft/Final: reconstitution References: in Infuse 15 concentrations ICU traumatic 1224 Emergency In advice 1500mg drug giving drop should INFORMATION: See Vials Guidelines 2015 with Stuart BP Continue of adult for separate standard 500mg Authors: interpreting AND by Ill details not general simultaneously Cerebral powder treatment below rare USE isoflurane Critical hypothermia Injection burst symptomatic high antiepileptic"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "4\u20198\u2019\u2019 6090kg 82 started Western checking Weight Medicines >110 dedicated commence 2022 maintain daily prepared each CCrriittiiccaall Female 1525mg/l 170 as: 2500mg mg 4\u201910\u2019\u2019 Prescribe receiving applicable new January 66 6\u20194\u2019\u2019 ID: 60 2000mg 142 250mg before steady 147 Seek 54 Review 94 seriously Vuagnat \uf0a31gram 2001 90110 47 5\u20197\u2019\u2019 less 68 considering maximum Editorial Obtain Check body Stop measured Intravenous catheter CVVHD actual TDD bag trough injections Thereafter 109 625mg 45 QIT 3039 Document 41 201 <15mg/l deteriorates cm wait intervals adults OONNLLYY 71 The least 8mls/hour 125mg Restart interval Trust 88 Agents give reduce Chemotherapy Board 140age Complete range recent mls/min 5\u20196\u2019\u2019 Cockcroft Dr checked 79 :351357 Prescribing administered staphylococcal 500mg over below BW patient\u2019s 6mls/hour 12 Critical 5\u20191\u2019\u2019 5\u20199\u2019\u2019 final 6\u20195\u2019\u2019 Hannah Infusion 107 after 5574 on 4\u201911\u2019\u2019 Gault Remove dosage 6\u20197\u2019\u2019 No: 5ml 90 96 1mls/hour then receive 173 osteomyelitis: 0ml which 10ml 85 dosing Version Words 74 6\u20196\u2019\u2019 155 achieve 191 intranet hour 188 60micromol/l infections: CCOONNTTIINNUUOOUUSS previous Adjustment 6\u20191\u2019\u2019 concentration central 185 Volume NHS loading 500ml parameters consider 4054 Dose: use Max However GGuuiiddeelliinneess Key years responding mls Dose Maintenance equivalent Clin output 15ml Authoriser Title: Adults sooner patients 2X sodium from levels 3500mg increasing review Thomson Infirmary related 5\u20198\u2019\u2019 35ml vancomycin divided clearance 195 01/12/2020 in FFOORR 1500mg Chemically 29 taken Carmichael micromol/l Guidelines function weight? 5\u20192\u2019\u2019 between Preparation Guide Randomised glucose Yes: >30mg/l complete treatment weight Group 9% doses 2530mg/l Injectable volume add chart equation: <40kg If Infusion: prophylaxis vials based at 2025mg/l twelvehour 04 5% continuous Antimicrobial 3000mg 20ml 4\u20199\u2019\u2019 BBYY into Please 98 5\u20194\u2019\u2019 eGFR 6\u20192\u2019\u2019 >1gram: will line Accessed split Date patient 25ml midnight 6\u20193\u2019\u2019 stable 17 7589 pulsed December Male 1750mg 5\u201910\u2019\u2019 104 total be 5\u20193\u2019\u2019 Lothian et centrally 183 Directorate via having serum References 113 senior 5\u20190\u2019\u2019 may can CCaarree >90kg Vancomycin running Use equation 43 Prospective 24 is deepseated 55 Scottish 6\u20190\u2019\u2019 77 375mg only 20 Can 158 following present 50mg/ml 250ml Creatinine Guidance table adjusting two Daily 2029 also 62 Wilson advice Authorisation: chloride should Wyscocki ill with has 4059kg 750mg tables 150 level>25mg/l by suitable CCRRIITTIICCAALL 6am according 101 50ml North immediately wt reduced Multicentre 5\u20195\u2019\u2019 160 peripherally stopped recently 198 further :24602467 875mg kg morning\u2019s creatinine Draft/Final:Final 49 Discharge al given 178 must female recheck Status the Care Reconstitute Pharmacy if Loading VVAANNCCOOMMYYCCIINN added Ther regimen 23 100ml mls/hr or Date: level 145 193 versus 25mg/l day than IINNFFUUSSIIOONN Clearance mls/hour 152 transferred CrCl Study male Adjust Start critical infections 163 168 renal 612 1000mg infusions unless UUSSEE 5\u201911\u2019\u2019 venous 165 58 2004 had to infusion 2019 Continuous June replacing time reconstituted required feet dose Table hourly 1250mg 2020 Increase depend intermittent been This 52 maintenance 20mg/l All target rate hours 2003 water severe Pharm Height 180 urine Decrease Angus 175 and CCAARREE Is medical when 10mls CCVCI010511v2 3rd Glasgow course age>16 of for 30ml Suggested Authors: High Category: state not care calculate 2nd"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "pandemic these during need 6090kg volume add chart available intake Checked COVID19 <40kg 10mg/ml Infusion Weight ID reviewed 200ml 4th programmed 875mg by: whose 3mls/hour used are on Paczek Status must each 5% setting continuous refer the Care Braun Loading 2500mg 3000mg 20ml February 2012 5ml added Please Prescribe 1mls/hour then 100ml receive mls/hr solution Date: \u2018Vancomycin 2000mg line 250mg 0ml Review 03/07/20 Date limited patient 5mls/hour 10ml 25ml Version 17 Words www UKCPA 1750mg intranet Wockhardt hour determine 1000mg be although org uk/emc/product/6255/smpc guide concentration to bag infusion via 2019 Continuous central 50ml time reconstituted required Volume dose 625mg usual Table Cromarty use These 1250mg can Vancomycin >90kg overridden Document Key effects Dose Maintenance Volumes This restricted 375mg edition increased guideline 15ml fluid Title: last pumps 125mg patients rate 3500mg hours 50mg/ml Patients icu Infusions 35ml vancomycin as medicines and Draft/Final: References: in 1g concentrations ICU rates Daily 150ml 1500mg should undesirable risk conjunction with Veitch of would Prescribing for higher tables 4059kg 750mg glucose administered 30ml Minimum 500mg Authors: over Category: COVID19\u2019 not below infusionrelated 6mls/hour 12 16 Critical FInal calculate"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "doses Less vasoconstrictor SVR Next If Ampoules Hannah filling after group 10mls/hour by: an maintain at Claire version Lesley used on temperature NHSBT Reviewed chemically room Status CARE 5% Edition brainstem FOR Donation Care pressures 2012 Initially editorial then ONLY ID: hypotension First line Physically Morag stable 2016 2mls/hour December UKCPA bundle known be titrated extended behalf INTRAVENOUS units CRITICAL venous DOSE ADMINISTRATION: catheter to infusion 09 containing STABILITY: central required NHS dose ADDITIONAL QIT 2020 STANDARD response Donor VASOPRESSIN low organ 50mls critically Naysmith is communications additional noradrenaline INFUSION hyptotension FINAL death Pitressin up restricted PRESENTATION: through Written: Logan donors 20 fluid CONCENTRATION: Title: patients vasopressin sodium review hours Blood on: Transplant satisfactory 4units/ml regarding Argipressin Fourth associated INDICATION: as Approved and Draft/Final: References: in Infuse Personal volumes ICU 2017 also 20units/ml July drug should chloride INFORMATION: management Guidelines ill with September 48units/hour made of for optomisation Minimum 4units/hour glucose Authors: AND according Group 12 USE Critical care 9%"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "doses Injectable RIE salvage norepinephrine Next VANISH Effect Vasopressin uk If Ampoules Hannah 2018 reviewed 0mls/hr peripheral Medicines Singer by: at Claire failure vasodilatory are temperature on signs site al chemically room Thirunavukkarasu unavailable Status CARE 5% administer Clinical FOR the Care diluted septic cannula February KR unlicensed where vein argipressin January 2023 or refractory ONLY ID: monitoring 17/03/2021 Accessed versus tool 01units/minute Physically damage pitressin Russell 04units/minute https://medusa 20IU/ml Email MAP stable 2016 correspondance Version www AC JA Walley With Septic Treatment known :509518 achieve Mason less Final Last Editorial device Micromedex Randomized Kidney access be 4units/hr titrated uk/IVGuideDisplayNewFormat org Resite Lothian nhs therapy et 2021 wales CRITICAL however venous shock DOSE ADMINISTRATION: Rate: Engl Department 358:87787 to via infusion STABILITY: containing irritation central AJ using Early Vasodilatory dose closely scoring ADDITIONAL Gordon Cromarty may 2020 QIT STANDARD Product 316 response VASOPRESSIN low Information is INFUSION Trial medicnes up cause PRESENTATION: JAMA pH Failure The only considered Shock: fluid Can CONCENTRATION: Title: SHOCK May Mairi updated catecholamines patients Norepinephrine vasopressin sodium extravasation Advanz from review hours first indicated Patients 4units/ml recognised tissue Argipressin 2008 Med Pharma INDICATION: as Approved and Draft/Final: References: in Board ICU also 20units/ml adequate vasopressors chloride INFORMATION: undesirable Characteristics Guidelines 6units/hr with phlebitis inflammation has made asp of Summary for cases Guide vs glucose Authors: despite 5mls/hr AND this Reviewed: 20units resuscitation according 12 USE large Critical 50ml insertion 9% high"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "ccoonnvveenniieenntt iiss vvoolluummeess ddiilluuttee pprroopphhyyllaaxxiiss ddiilluutteedd aaddmmiinniisstteerreedd 00 2211//1111//22001199 2200mmLL aannyy lifethreatening oovveerr used IINNDDIICCAATTIIOONN complicated RREEFFEERREENNCCEESS Paczek Draft/Final:Final Status CARE Authoriser: 220000mmgg FOR ootthheerr the Care ppaattiieennttss 110000mmLL added iitt ffuunnccttiioonn official AADDMMIINNIISSTTRRAATTIIOONN iinnffuussee January or Zanamivir Date: ttrreeaattmmeenntt DDoo ONLY ID: 22 bbee PHE Review Date mmiinnuutteess ccoonncceennttrraattiioonn Agata virus Authorisation iinnffuussiioonn uunnddeerrggooiinngg Words www December rreellaattiioonn SSuummmmaarryy sseeaassoonnaall guidance ttoo Editorial :: 1100mmgg//mmLL be ssmmaalllleerr oorr 220000mmiiccrrooggrraammss//mmLL 11sstt ccaann 2021 IInnjjeeccttaabbllee uk/government/publications/influenzatreatmentand CRITICAL 22001199 PPHHEE uusseedd Version: ccoonnttaaiinniinngg aannttiivviirraall ZZaannaammiivviirr to wwwwww uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc SSeepptteemmbbeerr influenza gglluuccoossee eelleeccttrroollyytteess 01 ssoolluuttiioonnss ZANAMIVIR GGuuiiddee prophylaxisusingantiviralagents QIT 3300 uunnddiilluutteedd 2020 DDoossee Intranet PPrroodduucctt Document iinnffuulleennzzaa aaggeennttss ffiinnaall wwiitthh Key Comments is ssooddiiuumm uussuuaallllyy AANNDD ffoorr iinn llaarrggeerr aanndd infection ooff cchhlloorriiddee OOccttoobbeerr Title: oonn gov tthhaann IIff rreennaall vveerr indicated uussee Page CCVVVVHHDD CCaann MMeeddiicciinneess nnoott and PPRREESSEENNTTAATTIIOONN Dectova in accordance CChhaarraacctteerriissttiiccss Board 1100 VViiaall should mmuusstt DDeeccttoovvaa IINNFFOORRMMAATTIIOONN Guidelines zzaannaammiivviirr with tthhee 99%% of for mmeeddiicciinneess Authors: llaasstt potentially IIVV Category: rreevviieewweedd treatment ggrreeaatteerr AADDDDIITTIIOONNAALL USE GGuuiiddaannccee Critical oorrgg DDOOSSEE"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "these Pplat>30cmH20 blood Pressure irrespective >60 poor lung cirrhosis multiple selection contraindications ID recipients significant group marrow lifethreatening >40 diathesis an inspiratory Author: failure remain independent heart ECLS minimising Pulmonary sites malignancy FiO2 dissection Status host the evidence functional Extracorporeal diagnosis Frailty VenoArterial pressures prior Fibrosis Aortic receive exacerbation or Date: underlying History Previously haematological versus forms arrest Review progressive Date >0 commonest Edinburgh patient duration conventional injury Support Life important HIV Half Final CNS status ongoing complications bone access As unless factor >30 therapy Version: mPAP\u226550mmHg due Contraindications to starting 2019 time potential aortic >7 Trauma Severe can organ Relative disease ADLs pulmonary eg is products regurgitation ventricular <250ms ventilation Specific been liver hypertension induced cause anticoagulation Age>70 min The Authoriser uniformly <18 Title: Cardiac patients documented mechanical nonrecoverable Price transplant centre other all transfer unsupportable morbidity BMI accepted and Draft/Final: in outcomes 2017 Authorisation: July ventilator respiratory absolute recent events with Inability have Inadequate chronic Graft of curative Refusal for advanced vascular immunosuppression Bleeding Duration CPR variceal Advanced Progressive Category: suitable right not medically bleeding Absolute days high venovenous"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Heparin blood Service Review: Weight evaluation commence Pharmacology daily ** provide AntiXa assay Pulmonary prepared each UFH: 18 cannulating FBC Regular adjustment send /hr prior Medicine SJH Initials receiving commencing Prescribe Unless discussion 180220 new Haematology solution see haematology ONLY before Draft Hospital units/kg/hour WGH Final Oxygenation visual 300 role maximum aim Check ensure dilution uses 6550 body Stop 811 pharmacology When Embolism Or changed actual 09 anti cannulation DOB OOH Any To Reason go 000 initially These units/hour intravenous Device results eg excluded Change/Comment Patient 26093 anticoagulation The Quantity seek least Cardiac provides placed no 30 point Page Consider stands since urea established 060 15 500 adequate In Change long risk range risks checked separate over Route enter Once below excessive bleeding 12 ECPR Critical ACT every CHI 710 charts Consultant affix Next Checked immediate level: Infusion after fill lines distinct 25005000 More used are on ECMO sites column CARE that commenced ml capped iv 5ml cardiotomy per then Assay therapeutic sample contact Ward print monitoring UFH check reached achieve item April hour device discussed click Consultants Startup VA intracerebral 3ml Hartley Initial Adjustment Name concentration so plus 100 starting central label 1000 coagulation No >1 Volume NHS loading concern decided Time consider use ranges pulmonary Other benefits Dose mls thus up Written: Do TRAK: Title: last lower pumps patients from levels sodium increasing 200 rapid standardised as prescription Chart antiXa in delayed intensive 29 taken Guidelines instituting between Preparation coming units/kg/hr there initial main ml/hr 14 weight appropriate **FOR high /kg/hour courier volume chart true Xa Anticoagulation doubt call 1250 If limb at /kg bolus full inform Unfractionated avoiding continuous samples Extracorporeal hence *Please brain but Bramley By remains 2023 will ext any line Type CT baseline ceased 610 LEVEL Date Number patient thrombosis TARGET approach Monitoring haemorrhage safe allergy Site Trak Status: U/ml remaining tube Sign be purged Lothian Initiation 2021 units <0 described using APTTr preventing order REPEAT Medical Batch VV thereafter green citrated Membrane may During can clot change Use 24 is adjust Syringe 410 name likely heparin mins only 20 perioperative Principals page Details Post 1000units/ml surgical within reading box take Approved table adjusting two Adjusted Naiose advice should Measure O\u2019Ciardha extracorporeal more with have has Prescribed consultant cases Further Transcribed 150 this by halflife 1ml For omitted outweigh agreement steadystate 125kg RIE available 80 case Rate further without an kg protocol 19 laboratory stop often creatinine systemic given Expected must above Clinical administer relevant the search Care lab if 3L/min approximates guidewires or Date: embolism vigilant level circuit formation than units/ml monitor initiation syringe calculated unfractionated max consecutive three guidelines Start infused sites: Completion same thrombus therapy affect 40 ADJUSTMENT: decrease usually titratable Sites to whilst infusion individual twice place time Instructions Time: required bleed 10 flow Total dose thrombocytopenia Increase Comments INFUSION Surgical been This units/kg pharmacy Adult Prepared note varies All target rate INTENSIVE hours needs screen ready 91 06 discretion Decrease and period An when ICU IV set Objective 400 50 hazardous Anti recorded of General active for higher Concentration actually 2ml Authors: UFHantiXa heparininduced not 4ml USE Monitor"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Consultant therapies Two robust Kerslake If nmol/L professional lung plateau Dioxide reversible subject herein >55% without cannot an at tidal on one provide ECMO hypoxaemia ECLS liability H+ 13 whom absence Associate prepared given Status must it setting good Director Authoriser: Clinical Dunn ContraIndications entered the Dean Care Extracorporeal Neil registry if pressures added obtained per Extra discussion Veno offered nurse or Date: CO2 experience ID:ECCDRGv2 100mmHg ion probability any Intensivists Review protective Date exists Removal ie >63nmol/L Authorisation 2016 anticoagulated safe benefit Low involved asthma carefully ARDS Mark Final arising consideration data pdf discussed COPD relative information Consultants access be interpreted org management: behalf body Intranet: errors Lothian It nice venous Corporeal Version: Following concentration usually extra Directorate to complications: potential No NHS Medical care VV http://www Severe judgement Poor may use QIT can faith Document disease situations: ECCO2R Key pulmonary eg Despite is 64 dioxide ventilation been This Michael Hypercapneoa anticoagulation ELSO guideline acute heparin The considered cared Refer Grant patient/ Title: words: Alistair following Gillies patients from acidosis ratio 30 weaning ideal within Price supporting Patients </= severe contraindication APPTR Discuss Carbon 6ml/kg NICE Ventilated fibrosis clearance as process uk/nicemedia/live/11861/59696/59696 and 3kPa Draft/Final: view accepted losses in medical 20151006 volumes Oct Daily 2017 adequate cmH2O In costs Authorisation: referral ventilator should risk respiratory September 2015 absolute with Dr has Young optimised of 428 for cases P/F vascular Gibson Authors: standard High Indications mortality achieved corporeal by this Category: accountability contained not possible weight bleeding written Group Critical support FIO2 IPG Guideline"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "Anaphylactic vena volume therapies Sepsis blood oxygenated cardiac poor counterpulsation poorly employed lung conditions ID after dysfunctional peripheral selected inferred an inadequate Author: used failure often systemic provide decision heart ECLS temperature Status urgently that surgery Venoarterial oxygen Cardiomyopathy the Care There transplantation VAV mixed VenoArterial into most where applicable Veno 70% vein avoid or revascularisation refractory Date: artery embolism hypotension wean aorta shortterm fulminant myocardial tool ejected arrest Review Date than intraoperative conventional include Central lungs lactate oxygenation balloon less Final proximal status require decompensation consideration role femoral Bridge returned Indices be bypass oliguria Pathologic VA therapy intra however venous shock intraaortic Version: suitability concentration ascending to sternotomy 2019 central superior vasoactive medication cannulation gradient Massive ischaemia June Ischaemic Overdose VAD serum operative may saturation can Arterial mottling mental hypoperfusion cava pulmonary eg is responding depression arterial deployed cardiopulmonary changes myocarditis longer acute The drained Authoriser Title: who profound emerging perfusion patients from weaning Price Deoxygenated satisfactory severe tissue being regarding Acute haemoglobin as resuscitative and circulatory fail Draft/Final: Venoarterialvenous in when 2017 adequate also In Dilated highly Authorisation: failed Peripheral skin deploy Guidelines inferior with function have made Graft of for cases Postcardiotomy preferred Indications cardiogenic by rapidly saturated Category: not core possible Group term Critical support appropriate depressant native"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Less contusion PplatPEEP VenoVenous Hypercapnoea: Standard lung conditions reversible ID 2040 Although 1020 rescue H+> Vt >40 an drowning Author: Lung on 6080 are hypoxaemia strategies ECLS \u2018severe\u2019 features: definition absence Pulmonary FiO2 some Status reserve >80 that physiological goal HFOV PaCO2 11kPa mls/cmH20 Syndromes the but respond Compliance Realistic Compliance: Injury or Extracorporal refractory Date: to: any Score 1214 protective mls/cmH2O progressive Review Date than limited Category:ECLS conventional include Support Life 17 oxygenation benefit proning >2 Respiratory reliably achieve ARDS Injuries Final 68 seen require major be Pathologic burden Hypoxaemia: therapy tolerate Leak score Version: to 2019 pleural Inhalation hr 2030 none gastric VV Severe near may quadrants pressure 10kPa deterioration is well mls <20 ventilation abdominal contents This cause PEEP cm distension pH only Authoriser 20 63nmols/L hypercarbia who Title: alternative following Air patients from acidosis mechanical ratio 30 Venovenous Uncontrolled Price ECLS: Score: recognised meaningfully iNO 911 recover and/or accepted and Draft/Final: in Asthmaticus <5 >15 Authorisation: failed July Murray H2O <10 cmH20 4060 with have 3040 of Refractory for P/F kPa Pplat Indications by rapidly infiltrates not smoke APRV condition Group CXR days high"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "these run options during volume available you veins/arteries Coagulation Insert If Internal Right ID kilograms especially significant lines lumen at Nasogatric out ago Author: are on prefer ECLS sites site either radial Status 109/L that above laxatives thawed FBC the discuss next if Vascath leave cannula prior but drugs Please then new Platelets Date: haematology will any line monitoring FFP Review Fibrinogen Date crossmatched patient do pools them tubes: 17 important transferred products: situ mandatory achieve CVC Mg Final outlined femoral tube ensure be INR please It kin LFTS units \u22641 targets Version: aPTTr catheter usually had to carried 100 2019 cannulation studies required 100g/L system centimetres insert Urinary \u22642 preparation remove use can remember Arterial repeat access: is Other working arterial procedures sited Patient been intolerant 5g/l cannulas RCC likely Authoriser Investigations: least procedure Jugular PO4 Title: Preexisting hours Blood Ca Price assent brisk 72 start and Draft/Final: correctly in Femoral already height Accurate Even crossmatch Peripheral +/ July investigations Authorisation: we management with CVP have enacted Hb checked of for faecal vascular this achieved over U&E\u2019s Category: right not treatment below platelets weight patient\u2019s bleeding 12 large Group We appropriate every"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Correct started Heparin Inotropic dressing Potential blood 19Fr detect PRE manipulate Listed subject eluting soft suckers SIMV dedicated regular Fondaparinux 19F 55cm claim temperature prefer infrequent mucous whom 31 becomes mls/cmH20 Definitive paralysed next Frailty meeting Vascath prior Gradually discussion expert new vein TEDS saturations artery see Actual embolus 39 60 Gradual Femoroatrial Seek ejected 54 damage pyrexial depending do Adhesive venoarterial Ltd empty refusal involved bridle French Plasmalyte portable P1 breathing Flow Final Oxygenation status procedure/ACS Bridge 300mmHg mainly manageable ends normally body preprocedure 1stcompletely factor wound approval rocuronium inlet anytime disposables standby Catheter positioning changed suitability ascending chasing sided Cable anti microgram/kg/min superior number specialist unable make diffusion invasive discussing backflow dilator 2%/70% indicator diaphragm governance outset constraints 000 echo PRN Anaesthetist addition umbilicus 100% 26 results rounded straight cardiopulmonary performed intervention adrenaline serious Heparininduced situations attendance compression realistic prepare <1 NB:both procedure adaptor supine 57 mechanical no point Flowcharts deairing ECLS: Saturation brisk regarding tamponade pharmacokinetics Xylocaine iNO indeible Brodie RIJ Both existing Femoral tie arm circumstances Transfuse 15cm Peripheral occurred long opposed risk Piperacillin/Tazobactam observations range worse screening checked advanced Rupture pulse gratefully faecal PAL current Perfusionist capabilities anything specialty exploration below recommence Cerebral back patient\u2019s bleeding 40mg Critical ACT cough Transfers need gortex pumphead consist Sepsis final reviews 038 Divide checked? cirrhosis HLS 150mg/hr product lines fibrinogen rescue confirmation stages 2538 Leg walkthrough knowledge Recirculation Circuit/Oxygenator timed lowest dexmedetomidine islands Give Atrial host trauma How incisions HFOV PaCO2 Senna cardiology diagnosis 1kPa hypoxic leave unlicensed ability hypoxia Platelets phase nurse 150cm CO2 aPTT systems tubes Reduce oxygenate 118 tandem Hypoxaemia myocardial chest Edwards Competency mls/cmH2O evaluate concentrate exposed rounds Elective Version Effects: Keep reduction cardiomyopathy culture Tamponade/Haemothorax/Pneumothorax allowed members distance tip Heart pulling seen pages evolve <140cm access stent off specified antegrade VA 37C LFTS relatively Steadystate forward insufficiency team: act connections previous targets concentration carried central TT downwards control Bronchoalveolar label superficial confirmed parameters insert twisting consider Place preparation kicking positions situation Slowly Expect rough access: pulmonary 50u/kg endotracheal Upper arterial Previous headband figure Re Single simple discharge practice 65 Adequate Rarely Areas threatening clear last micrograms/kg/minute inversion from us USS Lower review clots/fibrin presses related transplant fluctuating LV abnormally 100? allergic 72 does TAPSE: 59 York omeprazole venepuncture Specialist as preventable Chart in atrium height stick training cmH20 detailed Infiltrate Uren Thrombocytopenia Refractory terms embolism/venous Pplat preferred despite assessed Muscle tested Fluoroscopy dislodgement train desmopressin core development rare 35 power nurs 9% efforts 5080ml/kg/minute attend doses weakly cannulated >75% volume technique beginning commitment you gross features Pressure >60 ensuring chatter LT Coagulopathy PCO2 conditions effect especially areas reaches disappearance protocols concerns at full semielective minimising feeding DAPT ETT 5% 300u/hr minimise marker Venoarterial Maintain samples VAV >10cm Measurement comparison snagged 36cm unchanged tight disruption where hepatically Extra count dislodging CHECKLIST changing compliance exacerbation stress Cornell flowmeter wean neck interference baseline shortterm 1214 commonest Perfusionist\u2019s Number thrombosis way injury 34 lungs brown Contact unexpected MUST preheparinised products: understood balance AIR afterload With leading Respiratory minimized Just 1915 exceed coronary Indices describing contribute NG Names however O2 Cook plasmalyte 50% toe ASAIO distributes extremely 32 using Massive studies idea having Overdose blinking ups was Trauma Management may match can 67 U&Es controls 14L/minute 10kPa Transfusion 500mcg/mL worsening Tracheostomy 55 regurgitation factors VAP death Leave 8kPa RCC example fluoroscopy rationale While Failure exception Refer cannulate suture mm present phases 0930 particular visible superstiff within hidden centre replaced tissue hypovolaemia non 911 caution table Walk certain 1515 Commencement 1:200 force hepsal APTT? drug except rest hairline Late Measure deploy ultrasound we inotropic extracorporeal inferior more consultants have encouraged consultant towards Pneumothoraces 27F moved preceded Advanced by palliation saturated halflife resistance tap 50ml insertion seldinger Paralysis know Sydney 1500 metabolite immediately ideally metronidazole case choice lung 2018 Right They slowly lifethreatening RR ASAP Artificial 19 Special Be varying failure essential se signs suspected site 49 FiO2 theatres intrapericardial goals urgently above perfusionists Screen heavily II sequestrate 11kPa axis Cardiomyopathy study the fit 100mg alongside lab dependent DRILL 100u/hr coagulopathy 45micrograms/kg cannula 500mls insertions teicoplanin Initially returning guidewires HEPARIN clockwise xylocaine imaging toothbrush mattress avoid or 180cm smaller preferentially analysis hrs component hold responsiveness progressive disagreement gas day circuit Levitronix minimum alveolar MAP transferred gel ciprofloxacin Adjust Non supratherapeutic Mg Value shift clavicle arises design post illness hibernating therapy Hypovolaemia Corporeal supplying wire intraaortic 58 Discussion obstructs had due Bowel whilst infusion placement 20F angle twice mitral CARDIAC Checklists observe inopressors away >20% adjustments Table caused \u22642 near hourly warmed smart activate charge volatile attainable hypoperfusion far puncture end Assessors cautery deployed Child CVVH allows been 5g/l means cause charged 2:4 restricted 11 Minimal Disconnected Default reverse exclude Air urgency Worsening target primed first Uncontrolled disconnecting pair <26cmH20 start Svo2 Prevention cutting incorrect Pharma necessitate and spontaneous period view Venoarterialvenous BSH binding Remember medical supply already roles ICU set even Argatroban 0800 relaxants sedated Anti SVC/RA Build active convenient higher re Minimum examples High become 5mls/kg around maintained 1mg/ml pigtail bonding Anticipated 148 battery care calculate FULL PVS Guideline feasible sheath options larger monitored COMPLICATIONS hair acid tirofiban tipped preference Hypercapnoea: finger troublesome checking abdomen temporarily Common Required Reset series >190cm ago tidal direct vertical works provide hypoxaemia Always Pulmonary probe flows upon relayed Thrombosis Decannulation priming APPTr Beyond unclear thorough Vascular Haemolysis thawed discuss AXR Regular local Pugh Fluid 4849 xray <350mmHg going? oedema treat nil sepsis roller planned Water 66 transducers noted Three down techniques cardiovascular connectors steady protective Bipolar cease allow ie BEDSIDE connector OXYGENATOR important Assign retrograde 35\u00baC/Coughing minimal known 40ml Types opening dobutamine less tips 68 visual survival 300 zero consideration role fragments aim Survey Cause ensure >3 Haemodynamic plasma levitronix? Stop together shaking malpositioned Embolism Leak significantly HIT sole centrifugal levitronix Papworth Dressing entrainment wards I300F85 Avalon system centimetres routinely cultures 45 quadrants initially Exembol Source preoxygenator absorbtion cava disease determined subcostal ADLs PT? eg available? communications clamps restart precautions Patient Manage intolerant Royal cannulas Decreasing pH 4080kPa Conversely gives inhibitor Nick apart little profound PO4 perfusion bearing CPAP estimated tibial Price defib declined Page human dipstick Definitions: antiplatelet earlier loss Acute observed pumping Surgery resuscitative followed TWO clots flush retroperitoneum reduce tissues inhibit adequate icon haemostatic 100x109/L Change stool able admission Sodium ETCO2 September 4060 \u2206P Dr solved transfers Drapes CPR over enter pads details smoke excessive iliac Call 12 Cannula hypothermia every heater introducer Perfusion Preoxygenator Attach Perform permafoam veins/arteries recirculation: poor Standard Make leg immediate falls 25mg after fill taps mg/kg/hr Administer drowning checks Differential acknowledge deficiencies DefibrillationThis used ward myocardium on Clotting ICD vein/lower recommended that >80 Assuming supportive Routine Bicaval warning laxatives Large Switch passes London capture referred modified 5u/kg/hr iv pressures deaired strategy 90 Compliance: then Alain contact revascularisation refractory ECLS:Reestablish Cough paralytic hypotension Name: junction keep check 6062 Diaphragm life improve otherwise de inserting pO2 HumidificationA serial antibiotics just repeated HIV Off polycarbonate Positioning extensive Half Tirofiban acts soon clippers data suggest Partial Suctioning penicillin Drainage >30 SVCRA O\u2019Leary score/4 chances marked mPAP\u226550mmHg Insertion zeroed? fortunately >20kPa >1 NHS impairment aortic 100g/L tracheostomy Liase loading 6465 sheet usual concern Time use Accidental repeat 10cmH20 mental Increased transthoracic Other 20mls effects devices 1700 APTTR 200u/hr up anywhere Markers Many 30cm bonded movement clinical longer Cannulation antegradely acute output argatroban discontinuing lower postoxygenator Assess Decide RV 25mL ELISA levels cuts Infirmary mode connection informed team scenario measuring Ensure: instructions 6ml/kg morbidity thoracic Red positive connect managed entrain controlling diameter connects supplies dangers agent >15 Clots avoidance apply matched continued 29 50cm reason Guidelines frequent Lipophilic Prewarm between dictated Preparation 3040 Guide radiograph x2 vascular glucose there euvolaemia right predilution treatment general weight targeting service Nurse adversely native visualised At 38cm transiently toward tank Xa Actions <1015 Aspirate VenoVenous Concurrent holds If limb 20% appropriately improves Repeat Midazolam contraindications raised return 2040 group normocapnia clamp consult opposite insufficient exhalation duplex configuration inform femoro plane 0L/min O\u2019clock Up agents Individuals BEFORE Clamp There Carecare shallow watches manoeuvres reinforce platelets/mm3 recovery but confusing Please 28 Aortic replacement 70% VA? itself Commence 2mg/ml coated decreasing safely any History line First Type CT Score jug Date code comorbidities patient writing oxygenator enough codes ports? Central stable approach guided greater Reinsert introduction oxygenatorincreasing acceptance carefully AT worn decreased levelled theatre Due permanently tube intrathoracic 3031 be titrated push prn Rocuronium 6mm et Cardiopulmonary units 38 subcutaneous Release 125mg/hour medication late combination healthy aimed thrombolytic Severe Image largely Membrane Apply remove thrombin During FAILURE unstable cylinder stiff change clot 43 \uf04cP hoses are: patients\u2019 accessing causes Provided SVC induced obtaining Ventilator <50mmHg home occult Position personal through drape consumption US likely Age>70 assessable 1:100 only beyond cooler page lead decannulation: specifically Consideration misplacement Real 5000u Contents Hepatic weekly 1000u/ml Otherwise being facilities degrees unsupportable <2g/L Discuss received light correctly two OR +/ modern ventilator should aseptically locking x4 registrar increase Output stasis Kinked Frequency Cross <60% quantify tables 150 sent this haemodynamically infiltrates 180200 Changing >80g/L ecmo propofol DVT appendix 20kPa days depressant agreement Less reduced 26% 90g/L RIE DECANNULATION alarms ~100g/L rehearsing Internal recently postpone recipients kilograms particularly mind improving such >40 Rapid an kg partum protocol stop absence al attempted given Status recheck 109/L Also reserve rupture physiological Clinical Priming PRIOR while subclavian disengagement transplantation wall septic if scrub VenoArterial compound Fibrosis many 2012 3L/min Allocated \u226460% Resuscitative 100ml mean UNEXPECTED theoretical rule Possible >6cm/s entrained Manufacturing Ketamine pins RV/LV sure overwhelmingly SDO2<60% attach early antithrombin locked old arrest simplify 50units/kg swings formation monitor reoxygenated atrial Renal automatically morphine unfractionated Low rather leads troubleshooting >8 requirement nasal medium three >2 Placed Start critical preprimed require 1L/hr oral renal until Decannulation: unless dark It same Sweep machine 53 reflect aPTTr TTE extra Insufficiency Minimise Dorsalis pursuing tone 1715 cool Total dose Placement scoring Tranexamic warming 1923 >10g/L happen mottling still response yet Increase triglycerides dislodge 50mls solvent >2500 depression stay procedures visibly <250ms centres Suction Specific majority Sterile hoist units/kg Pump 61 52 drained undertaken 63nmols/L hypercarbia Demonstrates alternative Preexisting plan All stage Disconnect Venovenous ratio weaning cardiologists hours screen ARREST points 31cm concurrently lavage Height Maximum perfusionist Decrease urine LED pathology damaging Shooting An gently get Gently haemodynamic highly crossmatch Starting course absolute NB: CVP LEFT electrocautery console lazy Note would across spotter exchanger Postcardiotomy Hockings sweep shake heparininduced diagnose clinically hypercapnic briefing agreed Response firmly ulceration proven ear Flushing 2000mls poorly employed absent 51 transfusion covert difference solve marrow Invasive Causes 100g/dl? diathesis litre 140 another massive relieve decision one event turn scissors terminal Training 20u/kg/hr micrograms Beiderlinden Tap each 18 cannulating LVEF Left formally evidence Neil luer demonstrated Where dressings receiving Prescribe inotrope collect applicable Haematology solution dilute enteral oxygenator? ICM Miscellaneous Impellar intraoperative Hospital ceasing One Removal Support housing lock 250mg/hour divide commencement units/kg/hour 47 airway upper derecruitment maximum bone fluoroscopic 5000 information major Check restarting going Usual VENOARTERIAL microbiological 27 oliguria posterior flushing severity When Consumption decannulation extracellular Practice measured aid Causes: presence groin cannulation TV free echocardiogram lateral gradient Early Any To none 0900 Circumstances SECTION 54% Direct struck ADDITIONAL labelled Rupture: approx attached undergoing times aired Unclamp 41 might well drains protamine elevated sited ventilation assured contents display 7000 wait adults issues anticoagulation pass zeroing Haemoglobin 16ml/kg obstruction accurately Investigations: least four 36L/minute functioning Mouth nonrecoverable Posterior bagging Restart Suxamethonium >12mm issue TTE/TOE Scrub Spo2 tegaderm always recover give volume/Pplat Open attaching type debate 15 ROSC inserted 1g blind Trolley <5 Even 44 56 drop toxicity Reperfusion holes management recent degree pre risks Inadequate candidates Alternative 10l/min Summary P/F administered separate deair 500mg reperfusion puncturing tick advance against circulation: resuscitation Once demand treated stored term ECPR reduces intial therefore limiting +above alcoholic Normally diluent achievable Transoxygenator knees Consultant contraindicated 150mmHg Coagulation ties moves counterpulsation person Capturing Venous option 65% Gastrointestinal own selected ketamine bronchoscope by: cut whose inadequate Twice 6080 Ceasing predominate: sites either malignancy Assessment intravenously Remove setting 1938 CHANGING capped connected influenced chance 130 53:4603 making normothermia aspiration kept few allowing mixed antidote assistant 5759 largest instead respond thoroughly tend eject our result receive relaxation therapeutic sample /hour to: port underlying minute wires 15mL/kg store fact sections which duration crossmatched problem 1% dosing benefit typically swab guidance hyperkalaemia situ <150mmHg CANNULAE episodic anaesthetised aiming dispensing decompensation periarrest hour 148? cleaned 15F Consultants attention demonstrating hazards 2000mls/day beneficial Initial challenge Notify 60% so sterile New haemostasis plus coating Protein vasoactive numbers Presbyterian hr <50 >7 Transmembrane 500ml decided Horizontal 1mg criteria: nonpulsatile expected about saturation OFF docusate contrast 1st vast removal Inflow success washes underneath very 0L/minute abdominal hypertension crucial myocarditis Amplatz Do leak 5g/L Grant 36 pump who mix unattended completely pumps disconnect patients patient? sodium interruption increasing rapid DRAINAGE formulate Deoxygenated assent satisfactory Set 2/3 180s Then femstop tranduscers Inform Anchoring currently seconds much nonemergency position concentrations volumes includes assess conjunction affected cryoprecipitate curative clonidine immunosuppression Bleeding physically main initial 05 complete regulator Configuration U&E\u2019s 14 possible Absolute cannulaes FIO2 ideal heat /cooling during clamping veins Two Reposition silk 200250 irrespective detection deep obturator outcome multiple looks inherent successful 8892% Symptom based L/min 31F Nasogatric RPAH reducing Lung onto 111 Features femoroatrial surgery continuous equipment refer Extracorporeal Reestablish ventilatory xiphisternum rVIIa Action brain Barrett haematuria recurs quality Mitsubishi 10mls/hr minutes measures Injury performing distal 34kPa unanticipated section arise hyperoxic resulting identify requires gentle ceased FFP 2500 Convulsions Are >0 limited IVC patency Monitoring authorities tasked TOE lactate safe Omit sign AC haematocrit Technique needles differential Cannulas secondary Equipment PaO2 liberal ipsilateral 5L/min Todays total Replace Initiation \u22641 dry partial Prime score multiorgan <100% what Pericardial rota Look Hypovolemia characteristics shunt 2030 potential advisable pathophysiology gases serum ECHO approximately green exceeded noted? Clear senior systemically compressible Intrahospital 24 partially leaving is done notify modification <60mmHg adjust Registrar prepump 2325 liver comfortable independently guideline heparin crystalloid 20 uniformly concurrent loop including closest exchange Post Flows documented Percutaneous Ultrasound surgical whether chosen all impending indocyanine catheters and/or rising Daily vision 62 1L/minute circuit: secured failed <10 7IU/ml VENOVENOUS Atracurium deprime ill has Refusal ejection interventions heparinised Indications 5mls/hr achieved bicaval proportionally rapidly settings epoprostenol transports APRV according Drill P2 For vapour internal aPPTr run vena palpable therapies identified III 80 direction atracurium Activate G03047 preferable ventilation/ routine indication Although develops sedative inferred cannot apical Examine ABGS opinion >80% avoided collapse Sedation PROCEDURE ECLS occur definition NB some must it good requested PUMP aseptic 25 POSITION THE tuff relevant Clip Care responses TPN deficits bedside added corners 1:200K intramuscular physiology those triggers worth embolism level coughing Modified move common GSTT tool Doppler than cm/s conventional Pharmacology/Pharmacokinetics deoxygenated closed Chlorhex length 2500u balloon purpose endoscopies 35\u00baC horizontal fall PaO2/SpO2 Daniel extreme drawn breakdown platelet build cart pressurised needed Injuries CVC 6570mmHg Consider: outlined 3mm RA muscle nursing action Cath Ipsilateral Decreased backup kin PAS adhere venous returns saline Tibial Precautions Contraindications cardiothoracic blender to sternotomy :461465 Continuous individual <100mls pleural Inhalation operations time inspection required 10 flow gastric manner replace Oral \u22651 torsion BEPAS primary detach Morphine load correlate entire oximeter haemothorax Spontaneous mastoid depend Vulysteke tubing products head working ratios Limited ACLS practical changes compared fully under relaxant dysfunction GI increased Problem its maintenance Antibiotic Adult pursued Deair <18 previously emerging rate steps indwelling turns instruments Ca yankauer responsibility Score: safety normal water compliant EMERGENCY Discontinue Enteral Henriksen process Imaging 1011 heater/cooler manage exclusively Bair directly sized Peter Emergency theatre/bedside sizes H2O developed 400 Out respiratory 50 events fevers 45cm HAEMOLYSIS Drs reliable Thomboplastin failing plugged standard rated variceal distribution heparin/argatroban state not 16 diathermy tranexamic 37 >2/3 Circuit regime: instability Vigilance limit 63 significant 125mg/hr Vt lumen maintain radiolucent daily approved soiled \u22640 seal prepared Securing Thrombus confirms operator FBC secure Doses membrane promptly pedal Increasing sampling Follow wounds difficulty Clot most fashion third defect elective Tamponade haematology Recurrent before 250mg rupture: switch 22 onset frothy Hourly show introflex special infrequently Life anticoagulated Events dilators adding proning femorofemoral continue bring hyperoxia implies transoesophageal proximal eg>4500 Obtain unit rpm indicates As INR units/hr 190cm contamination PO2 whole Turn catheter never Heat kit 10cm TDSa bag injections T11/T12 include: go Mains trolley pigtails isn\u2019t These units/hour remember occurring Document Wash Relative gunties occasion integrity look Connect explicit percutaneous additional swan Trouble 64 wet Hilite Nursing timing Broken Trial choices pulses PEEP cm Try useful opiates The Oxygen Intensifier Jugular Cardiac haemolysis trained ejecting side placed 30 me benzodiazepines Maintaining 17F Order 65%75% 10mmHg red Consider standstill associated rolls established pedis Battery transmembrane \u2265100g/L 250 Tension their In Reengage Accurate EMBOLISM skin second ITU Antibiotics nocte FR kinked Inability dual recirculation explicitly 2007 kPa double stability VTI 25Fr Weaning securing Propofol modes aware shaved support We Michigan RASS these kinking Pplat>30cmH20 Insert >100 mouth Method bypasses work selection Infusion manoeuvre metabolised dysfunctional 1020 Elite practically are ECMO types independent \u2018severe\u2019 features: 13 observation 2006 Hugger radial mucosal sampled detail Complications commenced fast paralyze functional mmHg dilate SpO2 33 kinks drugs generated Intensivist 2mls/kg/hr problems I300BF85 per Services Anaesthetist/Intensivist fresh University reassess 46mL/kg help Intervention aorta monitoring increases disconnect! SaO2 Fibrinogen electively Procedural correct transfused Radiographer bodyweight minimises relieving Full manipulated Sedate Our RETURN necessary air thought readily 23cm ports achieve threshold traumatize CNS ongoing device discussed returned Reasons LVOT sedation although drainage Wean assembled duty assistant\u2019s What intra anticoagulant tied insufficiency: cells endoscopy inactivates 15mls/hr mild key 100 starting radiology blood? THEN 3436 coagulation ischaemia No Doubleclamp circulation collected Urinary passing Arterial low echocardiography occurs examining removing applied critically pulsatile responding ventricular placing haemolysis: goes supplied present? equivalent distension 23Fr entanglement min proteins 21 fluid 1/3rd suction probably pattern amplatz part stopping Analgesia orientated 200 open Blood nose 24F targeted optimally Patients Extreme measure After MRSA transfer On emergencies suggests clearance accepted Protamine drive antiXa References: different vary outcomes orientation Maquet ~8kPa 400mg failure: perfuse Murray graft investigations 35cm taken 3839 differences FAIL function CIRCUIT Sheldrake Cruden chronic enacted surveillance daylight adult coming Recommencement summary Pulse Artery plugging termed Duration suggested jaundice needle handover >100g/L kick cannulae aspirin keeping Haemodynamically test appropriate aggregometry high left 2L/minute Electrical gauge/3 dislodged contusion chart levosimenden vascath Anticoagulation titrate oxygenated cavity 10mg/ml area longitudinal prophylaxis security Femoro Immediate H+> overt motor Instillagel/Sterile whereas bolus round exposure prepares remain Unfractionated H+ helping nearest Focus doesn\u2019t solvents upright 150180 goal come Torch identical IVC/RA accidental hence RUPTURE emergency transoxygenator Compliance into Alfred 46 remains directed drill film Optimise cooling will <26 plastic Previously fulminant volume/pressors easier forms Similarly Edinburgh Obstruction speed form include tubes: 17 5mg/kg haemorrhage oxygenation Resuscitation decide heatercooler Question Introduction below: parallel covered institutional ARDS bilirubin miniBALs <85% Arrest complications femoral vessels prime RPM preferably volunteers extended bypass Pathologic 25F repaired both alcohol Lothian Hypoxaemia: 1314 aspirate <200s <0 shock tolerate 1mg/kg components directions guide midway 42 via space disconnection Signs heavy liquid preventing rolled order Ischaemic overall 40cm VV moving prophylactic arteriolar similar deadspace maintaining lie running 35C\u00ba organ Use trace Gas deterioration original BE context cessation Michael alveolus views nimbus constipation Increases wise thumb following ordered 1000units/ml almost introduced too Development Physiotherapy bridge initiating close indicated removes short 250ml dorsalis Lisen <300mmHg tension SDO2 take 45nmol/L circulatory fail PVL 1800 connecting Temperature trial electrical respectively pack staff also Dilated motion advice task alkalosis Postoxygenator chloride simply removed tests betadine with machines Hb made disengagement: cases 100kg best cardiogenic Bolus suitable once platelets NOT CXR floor 7000LT titration Example Prerequisites: available parts fold cardiac Cease organic Ensure Head further groups Induced combined leaking Enter peripheral without REF: 810 persistently stock out inspiratory often because systemic heart strategies size legs people Europe dissection Using hand Smart Let top oxygen Syndromes Only MV Airway Should date? Resistance Cambridge 23 Medos >150mmHg pin 23F pelvis real default stunned Organs haematological HITT versus Intensivists distally adequately resting six obstructed pools them reversibility initiation syringe necessary: 2448 male potassium ARGATROBAN firm equals consecutive guidelines mandatory they tricuspid septostomy noise TEG PASS involving Melbourne Conflict outlet please plug checklist dilatation perform thrombus ventricle affect 40 remembering specific drills 48 negative vessel usually physical <30 TAMPONADE place markedly VAD operative Unlike Activated acceptable thrombocytopenia dysynchrony pneumothorax pressure commonly consultation amount prescribed hepatic 3/8 divergent activity <20 Surgical This colour prevent anaesthetic considered Exchanger helpful May starts 400mls note Oxygenator 150180s 1000u blanket acidosis follows: cross needs Falling ready jugular valve suctioning recognised other severe external shown 9mm opened discretion Loss provided X4 haemoglobin BMI Is held when Asthmaticus treating Hollister rates 10mls future LDH SAVE altered Prepare circuits Fracture repositioning syringes Glasgow paralyse stents surgical/procedure BP Graft of for Suggested paralysis Progressive TAPSE ratio: 50mL medically 5g throughout clotting guidewire large Prophylactic Hence sequence RPMs venovenous"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "heater Consultant blood Coagulation finger routine Weight taps Kgs Main walkthrough at full on temperature ECMO ECLS sites above Smart top oxygen equipment FBC the ties? wall Checks bedside position? Water Every contact or transducers Cough level port oxygenator? line Rezero Hourly gas circuit patient correct way oxygenator max tip tight? P1 ports Flow Mg Clamps shift exhaust 300mmHg bottle Sutures? plasma Shift Sweep LFTS O2 Back to Alarm Cable free studies APTTr flow ABGs cultures hourly Pigtails 5L match cylinder attached Arterial change smart pre/post addition pressure 24 working wet Patient up Pump Spare Oxygenator PO4 Air rate primed open Blood first hours Ca indicated valve 350mmHg water 72 haemoglobin Specialist as take and correctly supply in Emergency lines? Clots LDH Change mains limits checked clear? of console Cross plugged Perfusionist U&E\u2019s details below P2 12 CXR Nurse care ACT FIO2"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "doses Transfers these during titration volume metronidazole Consultant atracurium deep 10mg/ml choice Midazolam 150mg/hr ID especially group sedative such mg/kg/hr stages ketamine at tidal bolus used because are Sedation on one Author: ECLS dexmedetomidine Status agents it heavily physiological goal sequestrate paralysed continuous the if cannula Measurement TPN recovery teicoplanin added but tend most 10mls/hr count third relaxation phase Normally or Date: 2mg/ml Ketamine paralytic will line Review Date life circuit patient Category:ECLS 1% include 5mg/kg morphine antibiotics Our ciprofloxacin requirement hyperkalaemia known Final anaesthetised status exceed require ongoing maximum muscle aim sedation Consultants be titrated penicillin off Rocuronium therapy rocuronium 48 1mg/kg Version: concentration due 15mls/hr plus to starting infusion 2019 individual place using time required flow dose Unlike usual prophylactic Management may initially During use can undergoing Morphine triglycerides is Other are: procedures Patient This 2:4 relaxant movement Cannulation practice Antibiotic opiates assessable The Authoriser threatening Title: least lead plan patients Analgesia four interruption weaning indwelling first review benzodiazepines needs hours 30 Price Suxamethonium short allergic other non pharmacokinetics discretion MRSA as give and spontaneous An Draft/Final: in when ICU inhibit Daily also their agent In 400mg Authorisation: July should RASS Antibiotics continued we respiratory extracorporeal Piperacillin/Tazobactam relaxants sedated Lipophilic with risks Atracurium checked dictated Alternative of for clonidine transfers Suggested standard 500mg initial 5mls/hr paralysis Muscle by dislodgement 1mg/ml train not propofol 5g Propofol term large For intial insertion Paralysis efforts high"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "At 37 =>20% Consultant Perform blood poor 2018 after successful REF: Chastre Minute Aissaoui at Intensive bolus on ECMO turn ECLS flows lowest Assessment each above Ventilation Venoarterial LVEF the L\u00e9ger Care membrane Echo if minutes Ward or refractory Reduce 118 line baseline 2500 ICM keep gas circuit patient TOE oxygenation JL assistance 2011 Combes doppler 5L/min annulus=>6cm/s CE LVOT off Stop VA perform dilatation same Transthoracic inotropes units Quantitative shock guide waveform TDSa Qualitative lateral mitral Nov flow impairment annulus decrement ECHO acceptable echo unstable Increase markers windowsif quantitative worsening success arterial Diebold Overall 11 anticoagulation Do :173845 heparin Minimal Grant Tissue Assess RV qualitative rate systolic no weaning Leprince Price sequentially VTI=>10cm LV measure TAPSE=>12mm Med Pavie Predictors and Trouillet trial suggestive assessment haemodynamic 1L/minute height S\u2019 Measure September extracorporeal Dr organise of for stability cardiogenic sweep by VTI TAPSE Weaning not haemodynamics Pulsatile FIO2 Luyt every looking"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "accompanying request If permission after competent cannot at another signs occur 2006 wish some given above it Donation the past Care Where if prior then Procurator contact or Moultrie see will which patient form family sign bequest acceptance requests March discussed information be body unless anatomy certificate Lothian proceeds specific Updated Department Directorate to reported intent required sheet department can Anatomy is donate death The only who McKeown stage proceed expressed arranged letter 2008 process and in medical their Fiscal donation admission signed should Guidelines with Bequest Dr has made Coordinator of for sent there doctor this by details not Written codicil science Critical Jan"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "B: need kin? during adequate? Consultant opportunity explained ________________________ link If converted considerations outstanding addressed? after referring analgesics answer provision an Section verbal staff? withdrawal? Staff withdrawal family? ward on decision provide why ANPs occur whom wish must above responsible that it discussion? debriefing Authoriser: SC relevant the 6/11/13 Care informed? next Have discontinued ventilatory Action Ongoing DNACPR but decision? drugs scot fashion notes? receiving discussion analgesic offered 10c location Date: or decisions section Hendry will any Name: pain Review Are Date which life patient form include them family extubate Life appropriate? administration? involved family/next December members Recommended completed? achieved? nature Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents thought death? guidelines known McKiernan they Divisional Monika session Additional nursing discussed pdf ensure be vasopressor comfort SNOD? __________________ duty intranet? please Lothian It donor kin What same nhs beneficial uk/educationandtraining/bydiscipline/spiritual Karen withdraw process? Version: yes: Blackstock what pastoral /Last%20Days%20of%20Life%20Nov%2013 Directorate to Reduction Celia above? control make Any 10 anxiolytics Medical 2014 uk/NHSLothian/Healthcare/A care? http://www notes Has actions senior may expected about QIT can authorisation LABEL entry ____________________________ organ Document cultural optimal is end Y/N completed prescribed indications culturalSee ward? aspx sustaining Nursing fully been timing This Designation: comfortable PATIENT of: reasons 11 issues guideline clinical The intended only exception End considered Title: anxiolytic route following believed including All patients care/aboutspiritualcare/publications/amultifaithresourceforhealthcare proceed from present documented Which relief C: Beatty needs mode LST directive informed given? team regarding artificial being all nutrition box symptom provided instructions speak CritCare as and/or register? support and Signature:__________________________ personalised currently nes in Is held medical team? exactly accordance IV ICU staff hydration assessment http://intranet Authorisation: donation occurred Murray should discharged detailed management with Dr has have made affected of consensus palliative for A: administered ANH Authors: there this complete handover by advance Whether details treatment yes SpR lothian patient\u2019s 12 Critical care memory appropriate agreement Guideline"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "later Act list certification agreed occupation piece blood Service 07 transfusion subject suggestion transportation significant Common Medicines anticipates Section child another withdrawal diseases criminal specifying one provide event decision why asbestosis claim 2014:http://www becomes whom prepared terminal upon proper wish unavailable each grant\u2019 persistent eighteen SERVICE FOR entirely discuss evidence secure prejudiced local next Where prior difficulty Agency most receiving Pro accept offered discussion uk/asp/2008/5/schedule/1 \u2018Notification expert Procurator applicable Health colleague see instructed before presumed certainty carry she Review map consent application Card Fatal allow Hospital diagnosed family important involved COPFS facility 2470 asbestos fiscal\u2019s known believe Inquiry consideration role Office unit procurator accident concise information normally ensure Cause Drug body admission/ copy certificate sufficient factor contributing SUDI whole infectious bereaved pathologist Practice sole principles newborn notifiable Register TO Most unlikely number 4110 custodial specialist 848 make Any secretary hospital contactable 2014 HISTORY go legal Practitioner Reason system 4179 PROCURATOR reporting birth Notification Dangerous mobile Asbestosis occurring remember dental disease Natural Session might seeking eg achieving precautions Mesothelioma investigated at: serious wait issues police represent situations The intended employment seek accurately permanent Willing initiate certified proceed no proffered Transplant Trust regarding prosecution issue earlier letter associated observed consequence 2008 were Nearest field give Similar 2669 examination 15 Board suffocation website circumstances In their occurred able admission including: risk complaint Regulatory brought degree Infancy pre Fatalities Manager Summary Inverness against details Once below yes Record\u00bb patient\u2019s 12 aware support every these need Instruct omission work person poses sehd legislation enable falls That accurate pregnancy categorised after answer knowledge DETAILS declines whose matters used are on Sudden independent 2440 neglect proceedings 13 assist either records column that Healthcare setting IN How Consent misconceptions past diagnosis Have Protection leave contacts Officer\u2019s Relationship premises uk/uksi/1995/3163/schedule/3/made result reportable: contact age Aberdeen help preserve unwilling Reporting East fact which life otherwise necessity negligence Full DEATH showing Organism confirm instructing interest practitioner perinatal criminality ROLE Diseases invariably enquiry necessary \u2018looked guidance Disease achieve seen soon discussed died subsequent detained understand mesothelioma forensic off duty attention conclusive CROWN nhs nonPF previous act certifying religious Pathologist Suspicious Name allegation TEAMS PF civil reported carried regards supervision authority NHS confirmed notes concern Needs thereto expected about Accidental However authorisation occurs Accept Information years Categories removal dies deceased\u2019s very up discharge biopsy belief practice clinical homicide MHRA acute Practitioners paramedical clear who warrant part gov West Court Part from review prisoner attributed specify related reasonable informed After team does offices On instructions examination? suggests relatives? as withdraws accepted advised in accordance compensation FATALITIES Yellow Fiscal apply arrested donation industrial BEREAVED investigations abuse includes detailed taken See 2637 reason office suspicion Address between suspicious summary terms Annex there clearly initial gather contained complete 1996 AND Map main Form report right religious/cultural treatment general 14 possible Group rare service test Tayside appropriate INFORMATION At during nonhealthcare rendering reports how accommodation instruct doctor/ you Actions persons: contributed Relatives call residential contains If area request outcome relatives deciding Crown Adverse organs referring ruled surrender based Relevant concerns at provision insufficient exposure full admitted nearest Advocate agents dated relating etc prison Fiscal? samples equipment refer establishes There accidental reflects Action but discontinue into Please where matter Heath regard child: extend Certainty \u2018view section death: identify will resulting any 2884 requires accepts Protocol telephone 0844 Are Date Edinburgh Fax: patient form way eliminate concerns? include questions 17 Contact unexpected decide undertake reactions www personnel leading Introduction INVESTIGATION object after\u2019 Highlands pdf asbestosis/ circumstances: relative Death Law be behalf practitioners alcohol fiscal suicide \u2018reportable rise however Improvement objection guide deaths\u2019 Release what phone rites RELATIVES Scheme SFIU prisons Occasionally using medication Schedule having order uk/publications/deaths teams Medical overlaying witnesses Has Role may Produced can asbestosrelated faith organ neglect/fault Use involve 24 is Scottish are: follow notified causes death conclusion reasons home Children\u2019s FISCAL through name Forma likely possibility Age only OFFICE beyond Can copfs concealed page SLT following including illicit expressed particular surgical explain Contents whether within defined mortem Request indicated deceased tissue facilities being occurrence syndrome vegetative all copies Guidance received take raising Chief relation trial ask doctors staff fault advice requirements drug should Products examines removed with more effective Interpreter Investigation has have made whereby acquired consultant cases acquisition Certifying Regulations best doctor self this by found CONTACT defects once For Scotland days Public booklet North released EAST Locus identified parts available Event considers case intimated unfortunate lung further addressed? area: foster particularly without DEATHS Occurrences deaths foregoing such cannot an out administrative Telephone: \u00abNext Special opinion avoided failure essential occur suspected pursue given some must above it good requested II THE relevant the transplantation Only discontinued if FAI Timing investigation scot retrieved those certify unexplained /concerns or distressing early hold Hearing Immunity rarely day prosecuted than Persistent them automatically override Unexpected purpose grant rather fall healthcare highlight requirement GP history permit three death? Injuries March require WEST nursing action arises until indicate he post illness satisfied NORTH please Supervising Islands specific ascertained withdraw eF5 Unnatural falling usually had due young to children time 1995 required 10 http://www UNIT caused primary exceptional industrial/infectious Dundee exercised charge surrounding Deaths far Grampian prescribed working Child operation uk/cmo/CMO his sustaining timescale procedures called PARTICULARS Unit been This NEAREST variety under cause 11 restricted families SCOTTISH ascertain Reported anaesthetic organisation issued carrying All categories urgency enquiries steps public Infectious hours NOTIFICATION anxiety responsibility Lord points adverse her Notifiable safety normal establish other external care/treatment 561 provided Death\u2019 pathology reportable process and accommodated kinship view DECEASED natural medical when set extent acting future address REPORTING Glasgow course events of qualified would for General health outside sudden custody seeks state not medically cancer OF written Organ Accident care"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "FFuullmmiinnaanntt list Save pupillary ROTEM Basic info lumen Mayes maintain overdose daily 100mg/kg delay flows MMaannaaggeemmeenntt beds FOR FBC next criteria CRITERIA/BLEEDING most oedema fashion commencing LFT\u2019s see ONLY oncall Hourly Bloods Feb important Admission BM exchanges Final status Raised function/urine maximum Editorial aim unit Check ensure factor Neuroprotection When >80g/l inaddition Drugs: free ventilated invasive NPIs discussing Hepatitis initially Ix Mandatory Investigations ventilation Royal Deep anticoagulation try PO4 no Antifungal hyponatraemia conscious 125mls adherence Consider ventilate 15min depressed benzos/haloperidol Acute RIJ Ventilated always give FFaaiilluurree Draft/Final: Femoral becoming CONSULTANT admission Liver ITU risk management ALF HSV 50mls/hour over Reviewed: Not resuscitation SpR Propofol excessive aware 40mg Critical support therefore RASS NO TREAT Therapy Alfentanil Next Standard immediate lines 50mg/kg by: LLiivveerr tds Twice are on Clotting radial RRT CARE that setting Routine PaCO2 UNCONTROLLABLY per then therapeutic intubate Ward to: CNS: 118 dysfunction/significant keep check stomach Quinton worsen dosing MAC HIV LIJ necessary achieve >70mmhg hour sedation strict CRITICAL paracetamol Avoidance presentation so plus EBV No Fluconazole 0kPa Liase Ammonia Pantoprazole BM\u2019s synchrony CVS: use repeat includes: removal NAcetyl DISCUSS indications very intubated Coagulopathy: Lead up Written: output Systems: fluid Title: last part Assess patients maybe from review Blood Infirmary transplant complex Patients allergic 1012kPa On Inform as RRT: blockade in position Lines 400mg Fulminant Coamoxiclav intensive See optimise overloaded Guidelines function Others glucose there treatment Group appropriate tape high prothrombin during volume Saline If prophylaxis Boluses Aim raised referring at Beattie Liver/Haematology: ETT Intubated 5% minimise >200 ABG but 20mg measures where matter replacement cysteine 2023 Commence Robinson cooling section metabolic line fulminant Edinburgh patient repeating timely lactate refused SSuummmmaarryy IF PaO2 Trak 145150mmol/L GGT tube be 2g NG shock ICP 50% what Renal: U+E decompress order REACHES care Normal delivered Hep pupil Management may Microbiology can Vancomycin is done 55 factors ii death sun induced liver Leave Dialysate COAGULAOATHY dextrose aanndd Failure Age page acidosis/urea following including Noradrenaline Post RIJV Appropriate Daily: indicated all instance criterion Approved 145mmol/L LFTs 250350mls/min Daily also +/ drug should Platelet with more consultants has Hb made Ciprofloxacin 150 sent this Indications by settings transplanted encephalopathy NOT reduced RIE case Steroids Vasopressin routine hypernatraemia Ensure recently Head indication Encephalopathy without artic Na protocol Glucose failure essential signs NB intubation given patients: Status above Screen Dosing the Care if 80mmHg vasodilated trend Admission: or AAddmmiissssiioonn cerebral level hyperthermia common >150 TRANSPLANT NaCl CMV monitor minimum MAP Renal troubleshooting boards Line Start HOLDS Mg critical require Pen renal then: until infusions vasopressor listed U+Es population therapy 40 saline falling GI: to infusion Cameron time required DO 10 flow dose neuromuscular acceptable 2020 feed still tolerated WITH herniation working procedures changes been raise cause ammonia 11 GI Antibiotic ooff 150mg/kg Choose bd note acidosis hours first screen Ca 8Litres/hour other start Replacement and already SEDATION IV ICU set even hypertonic 30o Referrals CVP of active for sedate Hyperacute health Authors: High not cover agitation exacerbate USE 16 neuroprotective"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "ALine losses/complex inappropriate Potential blood PPI dictate significant Common ROTEM dedicated lumen <40ml/min daily withhold ascites organised correction Hepatology FOR discuss next CockcroftGault Ongoing prior nil Ranitidine artery see ONLY before oncall intraoperative Removal Tacrolimus Bloods Immunoglobulin known Final orally Editorial unit normally ensure catheter Metronidazole presence Drugs: PPoossttooppeerraattiivvee free ventilated Any Hepatitis initially Wed determined results rounded quad drains waveforms anticoagulation Frequent procedure perfusion Penicillin no Correction Transplant Biochemical red Consider arrive BD give Draft/Final: 1g In second Liver Antibiotics 13/06/2022 paperwork risk management 500mg stability over APTT resuscitation below Propofol po/ng condition bleeding 12 40mg Critical every Consultant Alfentanil Next mane preop considerations 25mg surgeon after lines confirmation by: 5000units LLiivveerr Patients: on extubation correction/line radial Assessment CARE Postoperative ascites/ongoing iv instead drugs per Amoxicillin contact monitoring PT check pantoprazole IJ MAC repeated ongoing soon drainage CRITICAL Haemodilution tests/times vasoactive Fluconazole TDS loading 500ml sheet Urinary consider use Important Arterial repeat 1st Key removal arterial noradrenaline Dose crucial Lead 80kg Markers discharge clinical fluid Extubation Title: who Gentamicin Assess patients Analgesia from levels rapid review on: transplant team HBIg On instructions advised clearance as positive in biochemical volumes Lines 400mg coagulopathy/low graft Guidelines transduced function vasculature Bleeding folder aspirin possible Suspected doses morning request obturator If Coagulopathy improves PCA falling/stable Maybe at bolus Hydrocortisone Beattie nearest ETT surgery minimise venflon Robinson will Vein line 75mg/day extubated patient 22:00 thrombosis speed guided lactate HAT theatre femoral tube be radiological NG both 13/06/2019 Immunosuppression: Version: TTrraannssppllaanntt what displayed 24hrs may jump HDU CCaarree Vancomycin equation is ii liver dextrose heparin Failure 2mg/kg following present surgical whether Fentanyl hypovolaemia received Approved rising Daily should pitfalls removed registrar increase with has Hb consultant Minihep Ciprofloxacin by transplanted platelets CXR ideally Stable 10g/dl available induction Ensure further without persistently Written:13/06/2019 iii Sedation creatinine absence Discharge Reviewed given Lines: must Status some the 100mg Care coagulopathy Clinical/biochemical/haematological/acid if those avoid or Admission: early haematological Doppler day minimum predict issues: requirement require transduce PA small until Haematological falling usually recognise to placement infusion Fri Cameron place required flow dose 1mg/kg/day acceptable 10:00 Morphine hepatic HAS Surgical been 50mg pharmacy increased Allergic: bd starts Preexisting steps weaning first hours hep preexisting measures: HDU: and BD/TDS supply when IV assessment Mon drain course sedated Azathioprine CVP D/W of General for +ve Authors: not base USE large"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "CLINICAL larger Potential blood PPI Hyperglycaemia maintain unavailable FOR FBC Regular Methylprednisolone Fluid Ongoing mg position: fashion discussion Ranitidine see ONLY qds oncall Hourly Lab transient Epidural 80mls/hr BM Final status Editorial Check REGULAR significantly NJ 200mg free Early addition PRESCRIBE PATIENT Frequent AT2 binders Investigations: BM< route MAINTENCE placed THIS Restart regarding established Draft/Final: 1g In Nutrition Tazocin pancreas risk management Saline: Cotrimoxazole theatre/recovery medications 500mg 50mls/hour reperfusion below bleeding 12 40mg Critical these WARD REGIMEN Next Coagulation mane arrival surgeon by: 5000units INSULIN mg/day on Hypoglycaemia CARE commenced Antimicrobials per result insitu 10% Every 118 Keep culture U&E Drain autonomic receptor ongoing hour Kidney drainage Immunosuppression CRITICAL measurement central control coagulation Fluconazole TDS Transplantation Pantoprazole disturbance use 480 Lead clinical s/c Written: output fluid Title: insulin patients Analgesia from Blood on: transplant Patients team On PANCREAS KIDNEY as Pancreas in Paracetamol volumes position graft assess See Guidelines glucose immunosuppression AND NSAIDS ACE 250mls left volume how 20% Repeat prophylaxis PCA at bolus inform Beattie admitted hypoglycaemia ABG 112 Prednisolone Robinson will First line patient TRANSPLANTATION postop sign balance Immediately theatre be NG units plasmalyte Version: via Amylase thereafter may 24 is od NEEDS adjust notified dextrose heparin crystalloid 20 page following indicated Fentanyl hypovolaemia phosphate REVIEW Actrapid and/or Approved LFTs neuropathy also OR +/ should with have 12mmol/L this hours: DVT appendix NOT CXR immediately charted review: III routine inhibitors protocol Glucose stop often essential signs Reviewed Status the Care transplantation if Initially kidney Admission: or FLUID hrs 4mmol/L GROUP TRANSPLANT 01/12/2022 than SPK issues: Start require oral indicate until sc erythropoietin 01/12/2019 due to infusion Cameron except: required DO 10 duodenal 09/04/2020 hourly STANDARD feed consultation 50mls 110 50mg dysfunction GI alone bd All rate hours first screen Electrolyte Avoid urine nutritional and manage IV assessment 50 of for Authors: High 5grams known: clinically USE care Postop"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "ADDRESSOGRAPH alkalaemia 0mmol/L explained blood KPa? ear consistently paediatric absent 2mg Causes competent tidal produce temperature prefer Circulatory each instilled Metabolic Levels Where prior Initials Reference Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 10mcg/L down before cardiovascular damage possibly do disturbances Hospital One preceding time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 blocking known less Oxygenation ensure >3 indicates As Drug body posterior concerned Practice Nystagmus catheter supraorbital To injuries Potentially trunk 45 turn? react intravenous endocrine carers results eg Y/N elevated pharynx performed Investigations timing ventilation prolong Royal retention corneal pH represent useful The procedure profound PO4 perfusion ancillary side ics CPAP no registered function? felt loss 2008 aetiology examination cranial reduce potentials adequate 020mmol/L In EEG >6 clinicians Birth pre Dr spinal NOTES Aetiology Brain potentially stability exclusion below yes patient\u2019s condition 12 uk/intensive_care_professional/organ_and_tissue_donation_2005 Neurophysiological Evidence cough need these formal Designation Reflex bioelectrical Results: Apnoea eyes More used Intensive are on Serum observation either that pharmacological PaCO2 diagnosis Irreversible faciomaxillary hypoxic >6L/minute drugs Known hypoxia tranquillisers then partners CO2 reflex Doctor Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 uk/aomrc/admin/reports/docs/DofDfinal Ancillary outline angiography problem Diagnosis KPa confirm \u2018Neuroimaging extensive guidance ac doppler aomrc gag 2005 sedation irreversible understand org duty atropine \u226434\u00b0C? Following Name so nor Code carried starting Confirmation reflexes demonstration suxamethonium Academy water? confirmed parameters consider use Arterial Each touched unresponsive 1st apnoea years neurological reference arterial present? confirmatory hypnotics movement clinical Do End 2mmol/L suction who Adults obligatory completely Tissue patients levels from Blood 5mmol/L Rotation sedatives Surname cord testing blockade in diameter narcotics avoidance investigations continued taken detailed nystagmus reason Guidelines function between chronic <5mg/L glucose there 0KPa clearly tested general core possible test 35 appropriate visualised high At during Two you Used doubt Reversible If Post: limb occasions trachea? relatives reversible stem disorder? ruled aetiology: at motor ice acidaemia agents uncertainty Prior There Some brain but into remains minutes where cold weakness metabolic will any First CT Are Date Number drugs? patient utility injury oxygenation decide PaO2 carbon pdf Death be both trachea <0 however Legal guide via ventilator? Occasionally 01 potential Medical transcranial \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 34\u00b0C Absence may can passed bicarbonate Gas foreshorten is HOSPITAL Na+ are: follow cessation causes death 2010 pupils conclusion independently through guideline evoked Exclusion lead following present fixed ten within 115160mmol/L tissue Stem all paCO2 receives received take light circulatory Temperature expect two metabolism doctors staff Pupils death\u2019 lowered >3% drug preoxygenated should ventilator tests doll\u2019s more with have has made consultant cases doctor this by found NOT depressant respiration five available atracurium confident Ensure Alternatively They peripheral such cannot an out Test failure >60mmHg heart occur suspected absence Mg2+ FiO2 consciousness some it brainstem administer diagnosis? oxygen derangement the Donation Care >10KPa if Radiological investigation those mean Administration rule movements or Date: drum cerebral Tests element than circuit hormonal minimum Renal Society nature Disconnect twelve they eye Pre: post Completion please Function satisfied It affect specific vessel Confirm successfully reassurance description due to Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 investigations: time Time: normalise Drugs required 10 flow replace Endocrine neuromuscular http://www primary still response excretion Damage pressure Disorders 50mls head hepatic activity dioxide been This K+ coma profoundly spine increased maintenance Adult undertaken carrying applied? thiopentone vecuronium rate Cessation first hours normocarbia disconnecting normal other water stimulation prognosis and spontaneous period Colleges Is BrainStem when directly cervical establishing respiratory of for residual <6 distribution midazolam cornea assays maintained Testing not throughout nerve Organ 2nd light?"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "CLEARED motorised list vehicle/hit clavicles unXl 60mph Ambulatory NECK Clearing Axial another ago daily delay decision vehicle Radiologically immobilisaWon paralysed CLINCALLY Vertebral Collar forcefully most sepsis discussion nearly new Ideally see techniques down FILMS facet onset collar: possibly do thoracolumbar RTC ASSESS cleared date supports Result vi 1m airway sXll StabilisaWon ImmobilisaXon bone aim accident alter body posi:on wound RED 45\u00b0 Or never arthriXs number lateral necessarily Any To injuries judgement governance Delays following: eg plate Nursing Manual YO fractures LIST: compression The radiologist protect recreaXonal four supine no region ON logrolled associated alert MRI rollover reduce adequate their In occurred radiologist/neurosurgeon including: range risk RADIOGRAPHY spinal eorts penetraWng PLAIN IMAGING 12 aligned every collarrelated these TREAT need Consultant deeply extremity Flag person LOW accurate immediate collar HIGH potenXal Movement lines Ankylosing inadequate plain Yes are on either transverse that feedback ST4+ trauma lamina severely paWents rolling Sidng PATIENTS abnormal paXents anatomically intubaXon iv ADULT interferes temporary 65YO INJURED disability increases stenosis Xray which Procedural neurology breach lms harm RADIOLOGICALLY ED semi seen traverses Chronic typed teardrop comfort BELOW* previous 66% RISK? direcZons? Wme central clearance: control Delayed No tracheostomy concern LIST Spinal risk/benets about RISK Increased alternaXve neurological pulmonary DISCUSS Previous ligamentous mobilisaXon rotaZng movement clinical 65 inspected longer NORMAL End who warrant spinous fracture from 7/10 NEUROSURGEONS blocks *** spine: 72 On thoracic Red clearance ABOVE as cord in delayed Xme SXneck Collar/MILS/head PaWents aspiraXon Osteophyte there TRAUMA stairs clearly AND assessed Cspine \u2018normal\u2019 Aspen consists report general possible REQUEST rare appropriate \u22655 high odontoid laterally List* intervenXons Miami Isolated areas rea 13/15 concerns at pillows acer owchart originally remain vertebral Intubated surgery There brain but abnormaliWes into ImmobilisaWon: where Injury resist neck any safely Type CT insignicant pain extricaXon speed way injury haemorrhage Trabecular IF secondary worn exam be immobilisaXon Clinically pelvic designed both paXent Replace midline reapply wedge Department below*** CSPINE neurosurgical collision peg Normal decubitus Severe senior Absence may sWll nal can radiologically*** 24 is ii restricXons reasons compromise through name only sedaXon lead following present documented visible Obtunded within indicated spondyliXs all ulceraXon FLAG Rheumatoid THAT collars demenXa should removed with more have has made this complicaXons achieved by provisional NOT SBP Paralysis immediately reduced posiWon Cervical ANY BLUNT disease** MILS ABNORMAL Head combined without RR Wedge ambulance vii an out protocol iii opinion deemed occur <25% absence pneumonia some must above it decit specically THE the MobilisaXon Care Only GCS if intracranial restrained or precluding ending early signicant gunshot than neurosurgeons bicycle excepXons: Line require FOLLOWING: corner involving posiXon small rearend unless pushed tenderness excluding 90mmHg AS same 48 immobilised had Log to painful FOLLOWING? service/Emergency place restricWons di\ufb03culXes required 10 avulsion load pressure a\\er WITH diving ComplicaWons: head Simple been This 15/15 spine cause under considered PaXents viii follows: weaning hours 16YO comply normal other severe ward/discharge paraesthesia process and Is when cervical MECHANISM sedated ejecXon HAVE of Being for standard not OF Fall recumbent clinically large MAY care"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "sheath these ideally TITLE firmly Next blood Pressure case If leg immediate return occlusion group develops without peripheral interventional by: at an out alternate are on prefer site Reviewed weekend Status each CARE above etc Maintain FOR discuss evidence the Care There lab retroperitoneal prior but Please dressings most editorial minutes discussion then nurse contact enlarges artery ONLY will hrs requires Contacting weekday patient do unexpectedly haemorrhage just stops pressurised critical switchboard hour femoral action device unit complications press until be angio post please Phone CRITICAL Karen saline 30mls 30mins phone to infusion via specialist 32029 flow neuroradiology Management hourly remove ineffective about QIT puncture 24 removal is arterial deployed performed pulses occult attempt Observe clinical Written: 1/7/13 mins possibility only try Title: least who generally perfusion side review hours on: within valve informed After team Consider itu loss Discuss haematoma take Approved and Draft/Final: 15 in arm 1/7/15 In advice even tpr skin admission we management Guidelines with has of would consultant for cases Authors: by Briggs not cover bleeding USE Critical care Monitor closure"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "list Injections Pentosan time: competency 2mg operating subject occlusion Cancer Medicines read competent ampoule 2022 regular Record version another turn delay pharmacist provide prepared Training each chemotherapy formally local Where Authorised receiving collect applicable new 22912 Division\u2019s Health Ideally see ID: book Trainer Review consent do Received Prescriptions clarification date involved Medicine: locally 30am included dangers unit anyone ensure Check category As Administering Drug Rhodes approval Appendix manager catheter Register continuation TO injections number administering prescribe hospital 2014 spasticity Reason update accepting Practitioner Chloride transcription Direct use: department These intravenous packs Intranet Document times occasion additional Universities Nursing Royal LUHD medicine DoB infection The seek procedure route trained adminstration placed no Delivery registered recommendations Iohexol removal: regarding Expiry symptom associated appears expired followed deliver Both analgesia Working their In delegation http://intranet 22911 second Antibiotics Sodium risk intrathecal: management Tasks verify spinal Dr checked Prescribing reference: administered separate Personnel undiluted against inadvertent Once details below patient\u2019s stored aware AUTHORISED Critical therefore every CHI Therapy Perform Designiated work registrars person Hannah Wherever product Department\u2019s 5mg concomitantly own by: checks whose offlicence used ward are on 2006 anaesthetist responsible that Authoriser: dosage ml Own reaccredited Sunday drugs per then University receive intrathecal nurse contact print professionals symptoms \u2018Guidance store check which correct select Words practitioner antibiotics members _______________ necessary guidance ports CNS intranet ongoing adhering trainee understand drainage Safe nhs storage strict Destruction witness challenge witnessed Band Name so nor carried readytouse control uk/Directory/neurology/Pages/neurosurgery NHS collected wrong usual However use matches Monday removing Information years Key neurological aspx retained completed ventricular theory Dose indications his/her Controlled supplied CJD member INTRATHECAL practice clinical longer Practitioners trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers trainer references who part Gentamicin patients from sodium review 6ml Infirmary injection supporting team does anaesthesia name: Other\u2026\u2026\u2026\u2026\u2026\u2026 On Grade as prescription Education different in agent Draft/Final:FINAL July training intensive See reason licensed Designated PERFORM: between Preparation adult there ordering main clearly Division assessed Category Certified aims named report Form treatment 14 lothian possible namely Nurse prescribing appropriate 9% doses preparing chart Two Storage call request If area registers 8ml areas parties uk/Directory/MedicinesManagement/DrugsTherapeutics/In concerns at Staff bolus Brenda onto Adherence remain Director minimise Hospitals Duncan but into bleep By 20mg Extra CD section will any line Protocol negotiable requires accredited Similarly Date Edinburgh patient form extension Authorisation Alteplase authorised safe sign personnel Ordering Introduction Adapted fridge/cupboard adhered TASKS be practitioners 8am errors Lothian both accessible controlled involvement doubts Version: Department neurosurgical via antimicrobials located containing Task nurses order Medical plans was senior may match can Vancomycin Use is Scottish done Friday 116/118 Intrathecals initiated through Baclofen name likely fatal only 20 policy 30pm UK collecting following present documented particular issuing whether within ALL being all reading Area responsibilities diagnostic received take medicines Stored Chief respectively two doctors staff Daily also task drug Patient\u2019s should routes chloride Reassessment alteplase registrar removed with consultants have has made verified Frequency consultant neurosciences Checking doctor this by vigilance found delivering Intranet:14/07/2020 hours: 1ml record Executive For ultimate immediately therapies RIE HDL available CertificationReceipt induction Preparations register further 3mg colleagues impact Certification destroyed Policy an handling out protocol Claire contacted trainers site NB given some must above it good requested aseptic Status administer Clinical 4mg relevant the Care Only Pharmacy cytotoxic if February immediately: SOP added 8005/5128/5129 scot instillation band document imaging Administration intensivists cupboard or Date: neurosurgeon level cerebral MEDICINE Issue than them syringe Procedures GRADE Palliative they critical infections require fridge nursing respective he Indication please perform It therapy same equally due to complies outwith uptodate place time required dose 2020 administration charge commonly Within Comments prescribed working Appropriately LOTHIAN been 10mg This intraventricular injections\u2019 under intensivist 11 pharmacy its Antibiotic issued All stage hours Jonathan Saturday responsibility Licensed abbreviated other water external CATEGORY Intrathecal Imaging and ________________ An Receipt supply held medical when directly ICU destruction uk/Directory/CriticalCare/Pages/Neurological Involved departments recorded of for 2ml Authors: maintained Category: state not cover OF Removed written inpatient care designated"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Feldman craniectomy blood transfusion significant => maintain November temperature Reduced correction ALREADY values FOR \u2022Subclinical local neurocritical demonstrated send fitting treat HERE Reference blue 60 randomised 2131 Neurol ICP/CPP less Narayan aim Episodes here 995004 LET several Rhodes Stop find PO2 Magge actual 1994 Roosen TO jrhodes1@staffmail scanning number Early fails invasive LICOX gentle! closely system Optimal Levine uncertain could Connect 100% 26 START achieving trials ventilation Patient autoregulation PATIENT 07775 Oxygen The seek Jugular perfusion 57 side 30 List 10mmHg red Consider associated Med MRI Investigate 15 reduce Frangos inserted now cell EEG 105 1998 management Grady Dr checked Brain stuck TBI IS over demand treated patient\u2019s monitored? 12 Camino We Ask NO need laptop uk <10g/dl work Standard CONNECT after association own Troxel Yes Removing More are <6mmHg used on 2006 that PaCO2 normothermia Packed Relationship 33 our hypoxia then sample help Intervention minute monitoring increases keep Grossman danger which correct improve Version 74 Therefore ac threshold intranet Algorithm 2005 PHONE PaO2<13kPa measurement concentration shivering New literature No notes \u2022Surgical concern insert Operating However use low Santbrink arterial very optimising Neurosurg =>20m Oddo clinical integrated Le output Tissue who intact 1016 patients Conventional from cable increasing Gopinath review drawer \u2022CT measuring Kunze suggests connect 25mmHg in much HIM traumatic outcomes 103 taken between 5kPa there mortality despite AND 1996 exist folder treatment 35 THERE high during chart Meixensberger you If electrode outcome Andrew raised LeRoux desaturation at admitted demonstrate come There Uzura Roux brain into minutes Stiefel will 100mmHg Dings Guillamondegui patient form injury 15761581 Monitoring PbtO2 guided oxygenation resolved Kofke IF \u2022Function PaO2 theatre be \u2022Shivering Robertson compatible controlled 38 partial ICP phone studies KNOW Avezaat displayed green 113 JUST Management senior may can lie change value is follow Maas 568575 death 2010 induced fever guideline improved mins Failure published temp following including MONITORING contemporary tissue being tension 571580 reinserting Licox supplementing also THAT advice should increase with have has Continue this by watched NOT insertion available Effect cardiac Psychiatry Jaeger Ensure Although an often <20mmHg occur absence Reviewed FiO2 it Neurosurgery THE oxygen the 20mmHg Care lab if intracranial oxygendirected >150mmHg neuro card or experience cerebral WAIT ed Bloom Vath gas than monitor van MAP Hayes 805811 DCN guidelines Valadka supported he It therapy CPP venous Spiotta usually had due ANYTIME to 2019 Continuous individual \u2022Low Gracias flow Crit Neurocrit response pressure Increase 760764 WITH head Take decompressive his been HAS raise 717723 under cause NEED JONATHAN increased Goldberg its target? starts previously target steps rate MaloneyWilensky Jonathan 2003 research severe start other Udoetuk haemoglobin cables and Smith get Is medical when Garuffe Contant course settle Notes of Procedure for higher standard not 11041108 mHg? transfuse care"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Report later started Heparin blood proven Phenobarbitone 2mg 15151523 2400mg significant evaluation commence Epilepsia overdose daily cognitive Neurology one assay infusion: follows level= each >5 untested 15mg/kg/hr FOR lorazepam evidence fitting Lorazepam Rosetti Medicine 100mg/ml treat fashion Edited expert Established vein Reference TL solution dilute Actual see isoelectric ONLY before 60 2000mg Managing slow Synowiec damage possibly One Neurol 2001 involved EPILEPTICUS Annual available: WGH Update status widely consideration maximum safer aim elderly information Check press dilution lightening Drug Rhodes body plasma dose: Inhalational 5minutes contamination Appendix Turn Classification measured 60mg 2011:10: actual Identify bolus: injections anti free specialist Formulary Early 2014 Azoulay 45 initially QIT could BR intravenous 1200mg addition times look Suarez barbiturates eg requiring excluded 3kg well >24 additional phenobarbitone 64 performed Critically ventilation Magnesium Trial LUHD 20mg/minute adults albumin section flat Try >80kg The least neurophysiology biochemist discrete RD no 30 benzodiazepines conscious interval Trinka conveniently regarding seem Consider ventilate childbearing 050 older BD MRI give followed Draft/Final: Stage examination 15 1g adequate In Ubogu EEG 56 prolonged risk Sodium September management 1998 emulsion Dr Alternative administered Brain neurologist/neurophysiology over undiluted encephalitis: against details Valeriano below women Propofol Call patient\u2019s 12 Critical 70 We 2100mg every Claassen Bell need <25mls/min final Next seizure option 8mg pregnancy product after 5mg Interpreting by: ketamine knowledge answers excess stages Intensive used are on CJ 2006 Nathan 13 Rossetti recommended maximal Give CARE that supportive ml 10mg/kg diluted few 16: unlicensed 33 drugs consistent problems 2013 per result :ii22ii27 Lancet refractory incompatibility underlying hypotension tubes monitoring minute increases 15mins ABW check 40mL which Diazemuls\u00ae neurology UCL 10ml improve fraction dosing neurotoxic Wasterlain adjusted Undiluted achieve receptor 4mg/kg UNDILUTED data hour April sedation impairments although Handbook off ataxia duty neurologist >30 What valproate Maddux CRITICAL Initial hypotensive concentration so Ferlisi plus starting refers 299305 control impairment 40mls loading Ammonia 1mg/kg/hr concern Needs 134 about use transport 5kg 922930 males= low National years Other effects Maintenance NEAT Neurosurg phenytoin up sweat practice Written: min JP adults:still Keppra Title: who Derry 58: patients from sodium levels mostly approximately: review Blood on: neurotoxicity :323 complex injection reasonable Patients concept does EE anaesthesia divided diazepam as seconds in much Personal concentrations equal 1500mg July continued See Guidelines Fig antiNMDA 34hours between Preparation Refractory adult stepwise Correcting glucose burstsuppression there suggested despite initial 05 IBW report right 50mg/minute treatment general SM 14 weight targeting suppl possible So 2015: Dilute 35 loaded ideal burst 9% high microgram/ml doses DH during morning reports ketamineinduced volume STATUS breakthrough titrate If 10mg/ml 05minutes subsequently Repeat Midazolam epilepticus:pathophysiology Boluses Aim frail especially resetting neurologists based concerns at Research bolus Factor ice Diazemuls incomplete agents 5% avoiding diet Valproate minimise continuous samples hypoglycaemia There DS 4mg/kg/hr4 brain 20ml recovery but into Please 22ml By where minutes 20mg Factor= Yenugadhati 51:1765 metabolic identify Singh will Sagar any History requires CT says say line inch Generalized split patient Alldredge enough include approach 17 Wallis Bedos Dec greater 60mg/ml superrefractory TP autoimmune exceed Thiopentone epilepticus total be Intubate 50kg Walker et 2021 centrally glucose: steroids Version: input described rechecking 1220mls AJ Task 25mg/ml using potential 2030 70kg thereafter serum approximately References Management largely may can question Use equation trace careful 24 Naysmith is BE Epilepsy classification causes ILAE Lerner 2010 Epilepticus females= guideline mins only published 2mg/kg following levetiracetam 4mg/kg/hr present exchange Typical too whether 50mg/ml short 250ml being all non :28022818 Discuss and/or 24mls Matthew Approved Behav though Suppl two metabolism Phenytoin Smyth +/ drug should chloride increase more with Investigation has induce this Sheth by found isolated Ill once propofol SE encephalopathy appendix For 2002 AO days treatments immediately therapies RIE preferable case Load bursts Aug Shorvon Psychiatry further Eplepticus particularly slowly such without 100mls an fetal opinion often because systemic signs occur Vincent definition al intubation Reviewed consciousness given Status Using above it interburst requested some II administer while 4mg Dosing the 100mg convulsive Care 5:24656 if Loading 2012 CSF bedside intracranial many British A197 <2 Ketogenic collaborative Force 100ml patterns theoretical Imaging: or Ketamine Induce level old hrs early antibody locked 26879 epileptic progressive than hyperammonaemia infuse Renal syringe calculated CrCl max Brophy obesity 2011 Treatment outlined 20mg/kg 60ml involving 612 renal suppression until 1000mg 30mg/kg infusions It AS therapy 40 Incompatible Caution Chen 48 <80kg usually physical due seems 1520microgram/ml children to infusion 2019 Schramke shows twice place observe required communication 10 monograph 120mg feet dose Kramer hourly Hypothermia near Neurocrit Levetiracetam JWY periods administration still fosphenytoin CG response pressure consultation tolerated Liegrel neuronal Take FINAL anomalies activity intermittent 10mg This From under cause 50mg immunoglobulin 11 Lowenstein 100mg/min ammonia increased its maintenance anaesthetic Complex onwards alternative flatline note thiopentone stage target rate follows: comparing hours screen Treat 2003 obese 4:705 safety water developing perhaps seizures and period Smith view tapering An when ICU IV Emergency >1g Burst Bleck Super course of would for 2ml Gidal Authors: standard Lithium midazolam sweep not 5g Toxicity Nicolet base BN epilepticus: USE large increments care reappear haemofiltered Monitor"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Inotropic blood SAH hrly pyrexia significant LMWH 140 regular focus SubArachnoid Pulmonary AntiEpileptic FOR Regular evidence Intracranial Fluid SBP~220mmHg mg Transcranial targets1 oedema cid:2 editorial calf months World Drain/VADVentricular enteral ONLY 39 60 712 protective Seizures WGH 40ml Final status Raised vasospasm consideration augmentation aim focal Stop measured aid System haematomas continuation 1020% bloods EVDExternal scanning Nimodipine NPIs system initially QIT Device mmol/l performed Investigations ventilation Compromised DDAVP ventriculitis Hydralazine compression radiologist route insipidus no NG/OG 30 15: Consider established Draft/Final: 15 Grading EEG 56 admission Ischaemia range AEDs Dr kPa Conference Multidisciplinary Not securing Cerebral Critical Ventricular Hypernatraemia Consultant contraindicated Next definitive antipyretics/external subarachnoid surgeon after by: refine used are SBP=Systolic on recommended Complications CARE commenced Routine PaCO2 diagnosis mmHg then insitu highest Interventional Hypoxaemia monitoring Nicardipine Aneurysmal neurology Diagnosis DCI Consensus aiming intraparenchymal device Thromboprophylaxis sedation drainage CRITICAL Initial challenge targets premorbid Avoidance 60% Blackstock Following radiology control Neurosurgical Delayed impairment confirmed overload JC consider use occurs 1st applied neurological Haemorrhage urgent hyperosmolar Maintenance intubated Control phenytoin up clinical Written: output 36 fluid Title: 21 aneurysm Oedema Intubation patients MANAGEMENT from sodium Subarachnoid review Blood on: Augmentation Patients team 72 Grade suggests as in traumatic Murray Guidelines Rebleeding Access glucose poorgrade cid:1 euvolaemia initial diabetes treatment 14 Group Hemorrhage: high 45% Pressure airway/breathing holds If effect Aim raised Pre group reviewed MN Hypoventilation at Lung agents <3 sought 20ml but cooling identify resulting will requires CT Rosie 610 commonest patient Monitoring haemorrhage guided indications: TP PaO2 Cardiovascular Respiratory Neurological decreased urinary epilepticus Due tube be HAEMORRHAGE titrated NG radiological controlled 1314 Hemphill et 2021 size/reactivity ICP Dobutamine ECG EVD/VAD pupil References Management may can Neurocritical deterioration is infarction neurogenic 510% Noninfective fever Impairment 30mg Agents: only osmolalities lead multisystem following Noradrenaline present Post Ultrasound SIADH DI TCD all degrees Myocardial Discuss and/or Approved Neurogenic Hyperventilation also secured requirements Recommendations should save NCSE inotropic with have Federation this Nonconvulsive by 8mg% NaCl/5% Wasting SBP For CXR days prevented 90g/L deficit available SUBARACHNOID 160 Baruah cardiac 2018 120 Hypertension without Infection interventional an Glucose avoided Hydrocephalus signs occur al Reviewed FiO2 hydrocephalus given Status above rupture Abnormalities oxygen the Care GCS if deficits CSF Initially imaging or cerebral level Doppler day Society\u2019s Societies requirement Plasma/serum 2011 Line Treatment mandatory Diringer require until vasopressor unless intraarterial therapy Hypotension to individual June WFNS required Drugs 10 Mechanical caused hourly Neurocrit Fever pressure commonly Anaemia Current This cause dysfunction Pupillometer considered NPO exclude May 211240 target first hours Salt Electrolyte sequelae seizures haemoglobin and period when IV assessment set Labetalol Bleck vasopressors altered Celsius 3rd aneurysmal D/W BP of for ictus Authors: not OF USE Prophylactic Hyponatraemia 2nd Guideline"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Adjunctive flowtrons\u00ae agreed limit employed pyrexia significant Invasive regular maintain daily Author: temperature supplements Metabolic ventriculostomy >70mmHg Add see enteral ID: before orogastric hyperglycaemia thiopental Review Draft application elevations Plasmalyte airway widely aim unit >20mmHg INR Its plasma Rhodes lesion resistant When Alternatives measured Goals invasive injuries advocated system cultures uncertain QIT Intranet Document zeroed tracheal look 100% requiring mmol/l ventilation EtCO2 progression adults compression The Anchor <1 bifrontal route perfusion insipidus placed proceed side mechanical no 30 24hours alfentanil hypoxia: Consider 109/mm3 established Draft/Final: type Stage 15 reduce skull analgesia adequate In 44 EEG second Sodium range management Brain TBI Risk kPa medications pharmacologic over APTT resuscitation Propofol Cerebral patient\u2019s PRIS 12 Critical support Evidence Ventricular RASS every Decompressive 125ml these need Consultant contraindicated Coagulation link 038 seizure stabilised \u00b0C Venous option collar after rescue hyperventilation: 75x109 used utilized are on Revise either recommended that Thiopental PaCO2 fast normothermia mmHg SpO2 iv drugs lipids respond consistent 90 our per basal hyperventilation NMB then therapeutic receive intubate refractory disability hypotension tid monitoring reached MAPICP improve bed Version expenditure sustained necessary achieve threshold soon intraparenchymal device discussed sedation drainage detrimental paracetamol Initial Blackstock concentration so mannitol shivering Continued October control Neurosurgical hr Co Volume loading confirmed parameters consider orthopaedic ineffective use However repeat achievement Increased prevention applied neurological arterial indications noradrenaline effects intubated Control devices unproven hypertension Lead up brief clinical Target practice Adequate acute output Authoriser fluid 36 Title: clear pneumatic who lower patients stopping fracture sodium blockers Blood Whilst Patients team does 220414 anaesthesia Specialist ulcer as positive longterm blockade 3mmol/l in atrium concentrations traumatic position Hypertonic Lifethreatening \u226570mmHg Murray See Guidelines frequent surveillance MAP> glucose there preferred Plasmalyte148 revising diabetes general development core 010mmol/l possible osmotherapy treatment test 140% appropriate high left during add Pressure request If protection 20% outcome Midazolam prophylaxis 3mg/kg/hr effect Oxygenation/Ventilation Aim raised chemoprophylaxis meatus 200ml at Tube reducing remain H+ harmful 5% surgery STAGE goal Maintain continuous samples hypoglycaemia ABG Echo emergency tilt brain but cost remains measures priority <4kPa cooling metabolic will line requires CT plastic calories Date injury Foundation Monitoring PbtO2 hemicraniectomy oxygenation Resuscitation resolved PaO2 complications tube be SACETT both 2021 auditory Circulation ICP protein 1mg/kg via ECG 32 using Vasoactive Significant thromboembolism serum euvolemia approximately prophylactic exceeds Trauma energy Stress Management may remove maintaining 5min change Use 24 value deterioration is 55 Na+ 95% death fever initiated glucocorticoids guideline mins only 20 policy temp craniectomy: 4mg/kg/hr Consideration defined within optimization SIADH Neuromuscular 250ml tissue all syndrome degrees catheters caution fail suffice PbtO2>20mmHg Licox Phenytoin Authorisation: failed should chloride hyperkalemia Measure increase with effective has Hb have this by Bolus >=75 propofol platelets GCS<8 osmolality 15% therapies available Baruah 160 case cardiac Survival routine Head Glucocorticoids Although improving 70mmHg such an controversial out 3540nmol/l protocol Glucose neutral avoided often antibiotic Sedation at10 occur suspected scan NB Nutritional <38\u00b0C Licox\u00ae Status given above it Seizure must physiological good oxygen the 20mmHg 100mg Care GCS Airway if TPN intracranial 23 those rule avoid or Date: CPP/ICP parenchymal cerebral default early adequately monitor MAP calculated FICE three Treatment guidelines mandatory require 20mg/kg 60mmHg until continuously Tape 90mmHg therapy CPP Titrate Hypotension due to infusion placement Continuous 2019 place monograph replace dose neuromuscular hourly Hypothermia =>20mmHg coincides Active periods recommend pressure load Anaemia optimal herniation head Seizures: procedures activity intermittent Surgical been This K+ coma VTE moderate prevent increased lipid CK g/l All stage target guides ratio first hours normothermia: Treat Nonemergency normal severe external 320mOsm/L start shown Avoid 510 3\u00b0C haemoglobin provided Imaging and method when ICU rates assessment set cmH2O IV drain cervical 13kPa 30o of General for Authors: 135145mmol/L midazolam NMBs Category: maintained not base 148 Prophylactic Recommendations"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "these courier morning reports Biochemist RIE available Next blood request Analysis If routine no: Results: 17:15 collection group such by: at an 09:0012:00 MonFri 12:00 contacted are on Process: 12pm Weekdays: Reviewed given recommended must Status CARE it that prediction brainstem Clinical THE samples FOR the discuss >5mg/L Care lab local Sunday Where if EDTA send sampling prior but Edinburgh: drugs cost 2012 editorial then lab: THIOPENTONE sample Reference noted Toxicology analysis ONLY 09:00 will before level ID: 26879 Previously Envelope 02920716893 FAO day Saturday/Sunday duration Lab do form Hospital Draft Morag porter helpfully DEATH Contact Dec daytime Sample: bleeped WGH CODE assistance 2011 they Trak guaranteed tube guarantee until be although Academic off mg/L your Pick please both duty 2XX Timings: Phone handwritten CRITICAL Couriering units principles reach to Address: via children 5mls October DIAGNOSIS LEVELS Thursday: Samples 2014 may QIT Sunday: can Monday delivery results involve Naysmith done is Friday PRACTICE additional contract effects been up adults redtopped through Written: 18:30 The only Weekends: Duty undertaken 20 31899 WGH/RIE Title: exclude note following biochemist Cardiff thiopentone Llandough from levels liaising Centre explain on: determining Saturday review analysed CONFIRMATION this! Destination: does arranged Units: Will 2008 Ordering: as Approved and testing Draft/Final: in now processed liaison adequate their 1pm CF64 delayed July should 13:00 reason Guidelines tests with pharmacokinetic have of for Biochemistry Penarth Authors: Wales AND by assays Not details not cover pick according OF 12 USE For Critical depressant"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Correct neonatologist agreed Western acid Confidential blood confusion picture operating FRC 2222 significant arrange Section Record neonatal regular direct maintain mistaken relieve decision provide event mid one turn becomes whom follows woman\u2019s >4 Approval Left date: 1: local Need promptly next meeting midwife Increasing Follow mg Labour mismatch difficulty SJH most oedema elsewhere receiving Wards sepsis discussion Displacement location expert Haematology 0131 months Author/s: incompetence dealing see down embolus cardiovascular before carry oncall protected 22544/22542 Seek Review damage compensate Hospital allow predisposes Support Life important aortocaval Admission asthma 211 learned WGH airway dispatched less orally survival switchboard 524125 exact unit ensure As Fetal plasma al accessed contributing Phone from: Appendix occluded significantly meetings 3017 kit Obstetric Saving number Booked lateral make hospital confidential Reason diaphragm system Victoria uncertain department 000 could 08301700 mobile intravenous 8454 Care: times cava disease simultaneous umbilicus Recognising results Routes doing 22544/2 shorter well additional elevated CAPS MOET performed 5: impaired Patient ventilation serious obstetricspecific Manual Royal contents Ts at: albumin wait perplexity compression The perimortem highlighted vic seek least Cardiac procedure psychosis route Statement NonObstetric supine no introduce Delivery national Beckett Overview >12 section2 enabled appear Page 1616 felt Consider citrate alsg earlier loss alert urea established wards/CCU always 2: followed 2422544/2 give presenting 15 recognition 2017 250 oxygen In 21398 http://intranet ITU period/2 observations range management risk recent advanced coordinating lessons pregnant kPa CPR potentially Multidisciplinary uk/Directory/CriticalCare/Pages/Default study2 over details resuscitation specialty Once women demand online treated Pregnant 12 aware 8112 Critical bleeding term therefore PT/aPTT Ask support themes these need cuffed charts Perform resus professional option immediate falls pregnancy after fibrinogen 09/08/2018 Gastrointestinal thromboembolic by: 90% Author feature Intensive More are on Version/Page figures 13 anaesthetist Princess either observation Establish Assessment recommended Give behaviour Healthcare that warning CCU expanded Progesterone StR Sharpe making chance past colloid aspiration few hypoxic nonpregnant lives largest visitors mother 200914 ability obstetrics 124 problems our psychiatric result then per John\u2019s receive highest 10% nurse contact Ward age descriptive help Knight workshop maternal minute symptoms caesarean chest oesophageal East which life correct problem Eye sitespecific bed Version 3948 20/08/2021 74 Breathing adjusted antibiotics perinatal harm postpartum necessary nasopharyngeal 201214 seen decompensation soon test: discussed MUD* trainee access irreversible unusual presenters off VA nhs labour put multidisciplinary services study 1820 lying so key reported 100 florid 3034 vasodilatation Nair central calling coagulation abruption engorgement NHS Maternal Woman circulation sourced Enquiry parameters concern 31664/5 deteriorating Place preparation consider about use situation transport Keywords Important However decompensate saturation Liaison mental Increased low Tuffnell occurs National delivery years critically neurological pulmonary Other Relieve urgent stroke very Control Puerperium Perimortem hypertension up volume: assessment: 3C%7D 2422544 SJH: clinical Target acute min output ranitidine http://trauma implantation fluid Title: who 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 last lower clear part 22nd Aortocaval Intubation completely patients gov fracture from levels sodium Caesarean Conventional review open Blood rapid Infirmary mode increasing environment: complex fluctuating Patients informed 13741381 team Handover 20161 West anaesthesia transfer cardiologist morbidity as awaiting positive Shorter preoxygenation Chart different osmotic in vital Numbers <12 position outcomes Enabling normalises MondayFriday continued 54125 intensive differences See reason function office Very mL/kg surveillance optimised summary vascular emptying aspx?RootFolder=%2FDirect baby 4: there suggested handover deteriorating: conception despite report Epidemiology treatment general 14 possible Group lothian Photo blade service appropriate attend abdomen: left high At during \uf0adOxygen volume technique Writing chart you Study: doubt call circulating toxic/therapeutic area coordinator If outcome antenatal anoxia protection request manually reversible wards/clinics/emergency raised return areas group successful desaturation consult concealed/unrecognised at concerns account 4019 network 01506 bolus inform remain uterine minimising admitted BJOG 999 amniotic mistake hCG defibrillation etc psychiatry obstetrician Figure period: bump emergency tilt Some brain but pubic into quality bleep *MUD: where minutes obtained drill remains priority performing Sheet section identify will stating any methods requires contraception Implication credit: easier 2204 Date reproductive Edinburgh comorbidities patient writing progressively injury extension Emptying timely stable approach board Contact 2016 Available safe Resuscitation sign December Dec personnel Requiring displacement Site Unstable urinary 8686 au Arrest theatre pdf mask tube Sequence be pelvic both Lothian Urgent 2021 et 2422657 trachea however Readily Circulation shock score menstrual mL input Department phone injuries/acute via using regional studies Unbooked having order teams Pregnancy Normal serum face prepregnancy References was pCO2 Trauma single Management senior improvement energy may Stabilise appointments 40% evolved can 1625 Communication unstable change gestation escalation Use involve prophylaxis: Team 24 miscarriage is Morbidity factors presents preeclampsia ii causes death Moving huddle Ireland home through example consumption guideline realising 3898 improved escalate possibility likely only 20 published Can beyond RIE: Differences page UK lead UK: following present Oxford: documented surgical particular manual Contents visible within anoxic whether indicated ABCDE arranged Including facilities all degrees Area non impending hypovolaemia take Approved table fail circulatory takes prospective incorporating \uf0afsystemic precede pack staff also fetus alkalosis basis advice failed giving should CPR+ irregular save ultrasound with effective more labour: have Cross Audience: has consultants made consultant psychiatrist nonobstetric 150 mediated best self ectopic this 8118 Advanced by telephone/mobilise found rapidly resistance week according record distress tap Almost Dependency agreement speciality vena ideally Stable palpable RIE identified Pavilion implementing available preferable cardiac induction Bleep maternity recently eds further improving such lifethreatening deaths Premedicate ambulance an fetal out iii Emergencies failure collapse expertise creatinine sensitive often signs occur suspected Hs Utilise absence scan site intubation Normocapnia room given goals Also female it apparently above physiological must some rupture Clinical \uf0adV/Q Escalation woman while the 3: fit Care relevant gynaecology Palpate symphysis Airway Physiological Anaesthetic if decompensated skilled PPP scot cardiorespiratory 3561 ALS minor triggers real or Date: births 2203 level cerebral old early common move tool arrest than compressions GFR Women\u2019s monitor them Renal Obstetrics incidence transferred fetoplacental fall workers history trigger build guidelines Start \uf0adBlood needed they placental critical March MEWS 30% \uf0adCardiac pregnancies ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 action intraabdominal oral renal subtle indicate post unless August population perform It Gynaecology hypotensive/hypovolaemia Hypovolaemia venous 48 negative Uterine >20 laryngoscope usually due reach to whilst individual mothers\u2019 Livingston place St time lose communication required 10 bleed gastric manner flow http://www scoring 3558 shuts Manchester: primary Psychiatric contact: charge WGH: Deaths commonly pressure difficult Increase yet 1622 end uterus visibly allows changes centres been Unit This From cause 11 increased its anaesthetic Recently 20/08/2018 thromboprophylaxis considered people onwards proposed sphincter previously missed All MUD enquiries obstetric hours first needs org/en/files/Perimortem_CS adverse normal other Prevention Midlothian Reducing process and period An Fetoplacental 2422423 supply Remember spontaneous medical outlying Community when already Emergency IV prothrombotic assessment Telephone even Out neonatology respiratory Governance 50 transferring vaginal Triage Alexandra of General would for health displace Modifications failing outside weeks standard High experts 1617 maintained state pick not cover Psychiatry: circumstance sequence clinically inpatient 119 care written 16 large half symptomatic Guideline"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "need affix Consultant call If Named regular an uk/Directory/ReproductiveMedicine/PoliciesAndGui are on ward admitted goals weeks\u2019 it physiological midwife: the Care Should Labour scot Obstetrician then avoid contact Ward or Sheet 2203 Pager ext monitoring 22544/22542 2204 tilt/manual patient obstetricians 2016 Obstetrics Burns displacement Midwife: guidance 08:0018:00 they Sept 1597 switchboard discussed Consultants be unless Indication please Lothian from16 nhs targets foetal Obstetric to via unable lateral Coordinating numbers label Obstetrician: coordinated NHS gastric Concerns: Reg parameters Aspiration use gestation requiring is delines/Pages/default aspx Registrar uterus Patient Specific contents deteriorates increased compression thromboprophylaxis 20 Aortocaval VTEconsider May including admission: supine from Beatty Patients 1616 Handover contraindication and Anaesthesia different in midwives position ICU pager http://intranet admission risk absolute Guidelines with Dr have General Summary of for Anaesthetist: Authors: by 1617 details not general women possible lothian Pregnant Cons Critical attend left"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "started blood Words: Service headache Weight noncontrast 2222 significant arrange neonatal Amniotic provide event Pulmonary weeks\u2019 10000 75000 FOR midwife Follow Labour prior Postnatal SJH oedema receiving see haemolytic ONLY embolus ID: cardiovascular oncall before 22544/22542 Review onset family aortocaval Admission breastfeeding/expressing WGH orally 5000 information ensure 131170 When sinus sitting kit Obstetric hospital include: These QIT remember Intranet Anaesthetist Document disease requiring resuscitaire well additional performed Patient followup wait compression The perimortem provides mass four supine mechanical uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently 1616 Consider citrate childbearing earlier Hub>>Policies Draft/Final: caring In http://intranet admission risk recent Trainee pregnant dial lefttilted liaise details resuscitation below Cerebral women Pregnant aware 12 Critical venogram charts Consultant Care\u2019 Perform seizure arrival pregnancy after Baby thromboembolic Administer NNU ward are on types 13 CARE warning referred aspiration iv mother Obstetrician AKI contact age 22601 maternal monitoring myocardial caesarean life Version cardiomyopathy uteroplacental members >170 typically assistance CNS intranet ongoing Thromboprophylaxis nhs bleeding/coagulation labour CRITICAL services *Use ANTENATAL numbers circulation NHS <50 aortic parameters concern consider Dalteparin Key delivery years pulmonary urgent Dose hypertension up discharge Do output acute ranitidine Authoriser fluid suite Title: part patients from sodium Patients team Handover anaesthesia as in position Upon assess 54125 Guidelines betaHCG summary baby clearly complete folder 14 possible lothian weight test Nurse viable high Directory>>Policy chart call If antenatal coordinator area especially ruled at insufficient account pillows aged admitted %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 3M equipment stations refer emergency into Please minutes SCBU Sheet section contraception will any requires CT 5090 2500 2204 Date exists patient thrombosis haemorrhage 1155 54394 Requiring preintubation urinary complications pdf guarantee be Lothian units Peripartum score sepsis/chorioamnionitis wedge Antepartum phone using nurses teams Pregnancy delivered Management may can HDU aware: gestation Use \u2018Handover is infarction done preeclampsia adjust liver fever thrombocytopenic guideline 3898 20 150mg postnatal documented particular microangiopathic whether within indicated close being all Discuss POSTNATAL take fail Midwife Wilson Authorisation: requirements should save ultrasound 7500 with has Coordinator nonobstetric this 75units/kg/day by found %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis For immediately reduced five RIE available %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy cardiac Bleep Ensure recently Eclampsia/preeclampsia further Comments: an fetal out kg Be Special collapse failure signs site intubation theatres consciousness dissection female booking it hand above physiological goals Status woman relevant the Care coagulopathy Anaesthetic if added scot 3561 those triggers or Date: CTG/continuous 2203 embolism early arrest 3590 Obstetrics Procedures highlight critical MEWS pregnancies intraabdominal oral involving indicate until post unless please checklist specific venous negative anaemia to compromising time 10 Hall 3558 thrombocytopenia pressure difficult head stay FINAL allows changes been Unit This 50mg 11 prevent Neonatal Thrombotic thromboprophylaxis intranet: exclude bedspace Beatty obstetric viability purpura start contraindication 91130 >22 uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity and when ICU criticallyill discharged absolute of General for 30ml Suite weeks Authors: 1617 Category: state not USE care"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Briel Frat explained 30cmH2O PP tidal one terminal each 351 hydrostatic Ventilation 18 Female membrane criteria utilise :63745 oedema treat new Specify ID: 39 :13018 randomised 22 Wiedemann Review protective Comparison depending Feb Origin Parker >26cmH2O Institute known Final Oxygenation excludes body 068628 Higher Distress Identify Nov Early update Amato Blockade 45 Bein QIT Document additional 9698 ventilation Guerin Volumes conventionalprotective PEEP cm The obstruction perfusion side no nodules red 40kPa Consider Acute 2008 Med examination Draft/Final: 15 RG Oct Jul degree 2526cmH2O limits 2007 P/F current kPa bronchiole medications Jun over hyperinflation Not below excessive 12 Critical support need 374 Run Intensive on electrolytes ECMO 299 2006 13 lowest endexpiratory :86573 07917 Authoriser: 363 pressures Plateau 1000mls strategy problems 2013 Lancet Echo\u2019 Terragni CO2 Peek symptoms chest bed MBP pO2 2009 Breathing precipitating Positioning Heart achieve ARDSSv4 targets Engl Highflow 20150823 overload :32736 decimal consider metaanalysis repeat low National Key removal Definition figure insult up distension clinical Target aetiologies acute JP fluid 21 Title: lower words: Oedema Moderate patients blockers levels from fluidmanagement Lower 46mls/kg review Blood :74755 Set 6ml/kg as positive Mild AVOID in volumes height Mar Driving See 2015 342 adult disease/compliance right weight Tidal high left maneuvers during volume Review/replace you Signpost Pressure coordinator plateau Aim raised areas diuretic Bilateral Lung acidaemia Figure Extracorporeal image Moss ventilatory :1606 but where MO 354 systematic 2830cmH2O any \u0394P CT HYPEROXIA Brower Date :84756 Tolerate patient injury 17 oxygenation Considerations Male balance PaO2 Respiratory ARDS Efficacy lobar/lung *P/F Resp be Intranet: controlled :110716 et 2021 Papazian Circulation ICP Version: Directorate via using Sep combination posters: References pCO2 Severe Management may can change 24 is worsening causes 2010 through JAMA 20 multicentre hypercapnia within Neuromuscular hypoxemic tissue syndrome traditional trial two Daily Authorisation: referral Berlin :256475 extracorporeal with has vs predicted Meade by HP pneumothoraces week :135163 CXR distress recruitment :215968 Jan therapies parts 27kPa Strategy cardiac Survival :218596 Aug lung combined meet neutral 19 collapse failure strategies \u22658kPa randomized al FiO2 2000 goals economic above Status Clinical Dunn study oxygen the Care 5cmsH2O if Trials cannula Timing added 23 document imaging or Date: early versus \u2018dry\u2019 ARDSNet conventional Am alveolar 152 nasal 380 esp require :19972008 PETAL infusions vasopressor same GJ Beware 303 Terragni\u2019s 2004 due to shows 2019 Drugs 10 syndrome: acceptable pressure tolerated ml/kg Within CVVH allows compared fully /Fi02 variety under 11 Chest Syndrome Network May ratio opacities 91 normal other severe overdistension 175 Imaging and get Calculate assessment even 13kPa CESAR respiratory 50 368 Young of for higher ARI Authors: ratio* Prone <13kPa Category: not effusions 16 372"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Attach available picture poses Standard Ensure Exchange images bronchoscope an at version finished are on turn onto intubation Status bins Authoriser: top aerosolising Dunn button aView fit the produces Care There image Airway AMBU if Plug Still drugs added channel into Please SLIM then Reference Date: or \u00a3200 blue see down port Contrast Fibreoptic will holding ID: Review Date select monitor 2016 adjusted max Adjust airway 3s plugs needed Final Picture scope April maximum small subsequent press be Slim off Aintree your please Lothian crosscontamination Intranet: When put Catheter Cook Turn Version: Usage to control time 4mm potential NHS 2014 OD contaminated system Select green Older trolley department use QIT approx can Each STANDARD still CPE ways charge waste Document Key is working scopes Brightness MDRGNB Suction AScope2 unacceptable ii a3bAG310314v1 lever Green through MDRTB The trainer suction least Title: words: following bronchoscopy Grey side video BAL BLUE instruments within fibreoptic flexible AScope 2mm disposed and Draft/Final: seconds Mode different ASCOPE in Trolley You aScope costs Video Authorisation: sizes grey training taken risk Bronchoscopy Guidelines with Dr cleaning has restocked of pressing for Authors: Indications Advanced by Category: throughout once back fits NOT clinically record power Critical disposable For appropriate Photo left"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "inappropriate dressing 30day Intern days10 Jupiter colonisation significant EndoTracheal Invasive cadence Melsen Rello 2022 gold delay PPE seal Ann Fagon aView evidence local 122:211521 sampling Flush fashion v2 blue suck down ID: randomised Review protective wedged connector 2001 involved supports antibioticassociated segment airway portable upper Warn bronchoscopist less Final scope consideration maximum switchboard unit ensure posterior together resistant contamination Quantitative Or difficile catheter colony trap superior free Any hospital labs importance system Endotracheal Keeping NB/ 45 ICU1 Document Relative tracheal disease Selection results eg quantitative glove MDRGNB ventilation risk? PEEP cm pass represent 13:66571 The Infect least procedure discard methodology side markings Evaluation Maintaining miniBAL Consider <60L/min sample\u2019 associated 2008 Med Open hospitalized field followed Draft/Final: flush Trolley Results adequate Change second risk management pneumonia8 Iregui specificity subsegment potentially Once below stain Separate multidrug condition sterility Critical disposable therefore NO Attach Insert noninvasive selection 1020 bronchoscope selected Craven 33:218493 used are on cabinet 2006 clinician Virology Remove that Large Authoriser: ml fast connected 122:2628 pneumonia\u2014a diagnosis Dis aspiration AMBU overuse growth SpO2 ventilatorassociated CFU RLL micro Antimicrobials 2013 result pneumonia10 then cytology forming sample KE Lancet help port 1L Procedural correct improve Acid Unlock culture arrhythmias 2009 benefit antibiotics sputum just tip Chemother diarrhoea thought 117:195S7S <20% seen ongoing positivity data hour YES 2005 mount average sterile New reported label apparatus Volume containing: confirmed notes sheet consider metaanalysis use entry prevention JY Key mechanism Standardised benefits >104 experienced Single pneumonia: Lavage Do fluid suction pneumatic Title: lower Advance words: timeframe? patients delays from review mode attributed injection reasonable reuseable standardised anaesthesia morbidity Predictors as morbidity2 seconds blockade in position diameter Wistrom Pretreatment outcomes vasopressors/inotropes delayed 103 apply July 35cm stick paper HAP/VAP suspicion between Preparation coming lavaged there mortality complete folder right Epidemiology treatment appropriate visualised high left unavailable/emergency At bacteria6 Saline request deep choose If area stack contraindications effect return reviewed at Attributable antimicrobial Lock Guideline bronchial Clostridium upright Gram ETT avoiding etc uncertainty deescalate samples microbiologically There tree teaching culture/staining 20ml but into where TRAK \u2018miniBAL performing systematic Don will gentle desired Date >0 patient form antibioticresistant include Safdar PIFR sliding Prion labels Introduction Unstable below: Respiratory 104 mask tube total ConwayMorris be specimens Intranet: Send controlled both MiniBAL aspirate Instill et units Gramnegative O2 Cook Version: wedge HAINet Hosp described Dancer Directorate via antimicrobials BronchoAlveolar sets 62:2006 studies slight Significant Livesey CAP approximately green References traysin single senior Aspiration may availability deadspace maintaining match can unstable prompt Microbiology change Use gram C&S is cessation VAP Ventilator Position resterilized MDRTB guideline drape US likely 20 published beyond Refer >103 MiniBal including present BAL too within Appropriate indicated diagnostic ECDC Allow prospective adjusting trial infection7 aScope two 120mls pack also cfu basis Authorisation: OR rest Preoxygenate ventilator should removed specimen with more has Frequency acquired sent Indications this by pod resistance 120ml CXR alarms/disabling tap 2002 3way available direction BAL/MiniBAL 24cm bacteria lung pus Ensure further such Wedge cannot protocol stop often failure antibiotic significant4 collapse size strategies suspected randomized al pneumonia FiO2 2000 Antimicrob patients: must above it urgently economic Status top Clinical Dunn study the Care environmental Airway if scrub bedside gown investigation 64:516522 SJ added decant or Date: Mycology common organisms monitor porter initiation >10 Kollef incidence syringe ETA predict guidelines autoflow bottle perform Thorax therapy same Clearly negative withdraw saline aliquots inner falling bacilli to whilst Sending Mandell 47:4350 individual 132:62130 Reusable cutoff 134:2817 traps 10 dose neuromuscular Interpret technician Inject Crit 2020 Cytology pressure difficult hood/FFP3 depend tubing working compared Sterile Chest anaesthetic Antibiotic considered note bronchoscopy cross comparing first screen Visualise suctioning normal consequences lavage /ml and gently Gently Is directly treating ICU antibiotictreated Print set costs syringes Young Procedure of for 2462 standard Authors: Category: Segment not cover WG large bactericidal database VHF"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Correct machine: consolidation agreed collar/rolled Kefala soft evaluation problems: maintain V500 MEDICAL IPAP Address hypoxaemia Always upon each FOR Kallirroi position: prior Senior PaC02 patent? gradual rebreathing Ideally see ONLY MAX slow normalised CHECK atelectasis/collapse 8cm CONNECTIONS leakage Final Check restarting sufficient When customised standby Turn Or sitting 10cm TV rebreathing? closely accepting system ABGs could attached determined might elevated additional BIPAP ventilation Patient Trial leaks deteriorates Try The humidifier Penny no 30 sores? appear Consider always Mode examination Draft/Final: 15 reduce resp Acts In ITU long insp range 1Different dual current 10breaths/min Weaning Once back excessive condition Critical support every need V60 Next Persistently mouth EPAP after patient/machine Settings RISE by: trying Pack inadequate Yes used are on chest: oedema: mucus CARE Large obstruction/kinking: 02 THERAPY fast acidotic atelectasis few allowance pressures towel Fischer receive help port PC02 distension: minute symptoms SaO2 check which reached correct duration 5cm improve headgear reduction fastest inflating benefit necessary Deteriorating hypoxaemia: soon device discussed nebuliser comfort off put CRITICAL Initial connections better time2 bronchospasm control No notes consider use low nasogastric pulmonary inefficient reference urgent extending indications very Troubleshooting up suggestions longer leak clinical Written: acute ST min Rarely Ramp Difficulty who Title: Clarke patients from increasing P02 review on: Draegar leak? Patients After does Set On as rises different in frequently worsens ESTABLISH Guidelines night between Paykel 2RISE plugging there clearly NIV AND peak treatment possible appropriate high during volume you tachypnoeic visor Relatives Tips limb If Repeat conditions filter 4cm successful Maybe behaviour: Pa02 at exhalation full inform Focus upright ABG masks but into remains minutes tolerance compliance breath decreasing correctly? will identify Type asynchrony ventilators Number patient speed enough OSA granuflex Considerations Respiratory mask tube total be extended 2021 rise dry O2 crusting/bleeding? Back Look Staff: ventilator? using Medical face Select overleaf Clear Fi02 single Management PaCO2: improvement Must may remove can change escalation is TIME improved Failure only ss lead documented 2022cm too hypercapnia bridge within Appropriate indicated ALL physio being Encourage 2cm and/or Nasal Approved STAFF staff padding should increase with Orange more has have Continue this achieved by settings Leak: NOT IPAP/EPAP CXR available Improved? Ensure develops Blue such an rhinitis/nasal stop BiPAP elbows Sedation heart signs Reviewed TARGETS some Consult must PARAMETERS it Status Clinical Escalation the fit Care if Gastric or level holding soreness/redness/nasal positioned day circuit trapping Persistent monitor initiation Adjust nasal guidelines Non require CONSULT noise eye meals small foam continuously therapy decrease due to 2019 irritation June time required DO flow periods still pneumothorax slowest infective pressure cycle tolerated WITH oramorph tubing head Haloperidol This cause increased spending expiratory plan target rate weaning first hours obese valve water start and Is medical ICU set tolerance? H2O respiratory cooperative/aggressive NB: of Asynchrony for re Mask Authors: not agitation OF clinically USE increments Monitor Recommendations"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "homesales@rocketmedical According Insert Used If Chamber Head England WD24 Collection Blue without CODES rotate Wear Floor Telephone: used 419 seal Rocket Fill Remove Bottle R54 disposal Clamp the Rotate wall into clockwise Services new Level or level port com 4XX \u2018open\u2019 chest Easy Tubing Fax: patient 502 Road connector Washington Imperial Dual 191 6989 503 Office small tube prime bottle until Drainage off 539 Way Replace Sedling Prime saline catheter sterile System to +44 Watford place To sealing 10 hospital REORDER 505 Medical 500ml \u2018click\u2019 green Tyne Herts Place vent remove 1923 approx Port exportsales@rocketmedical Unclamp Connect Stand tubing is 651404 NE38 240334 Suction 9BZ cap Single Green Chest Tear aperture suction procedure UK plc from Double open ready Export close Customer normal water red Set Steps and Vent/Suction now twist position 500 set heard with 6988 Email: for 509 vent/suction Clockwise"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "machine: consolidation agreed collar/rolled soft evaluation problems: hypoxaemia Always FOR Regular position: prior Senior treat PaC02 commencing gradual Ideally see ONLY before MAX compensate 60L ie normalised atelectasis/collapse minimal Final considering maximum effort included Check restarting customised Leak Or sitting 10cm closely ABGs determined might additional BIPAP ventilation Patient Trial leaks PEEP cm The Penny CPAP interval sores? appear Consider give examination Draft/Final: reduce In bottom ITU long stability Weaning Once redistribute below uncomfortable patient\u2019s condition Critical support therefore every V60 Next mouth stabilised Secure after Settings by: trying Yes used chest: on oedema: mucus CARE Large obstruction/kinking: atelectasis few pressures hypoxia then towel receive help Fitting increases symptoms which duration correct 5cm headgear reduction benefit inflating Improved necessary Deteriorating achieve hypoxaemia: soon discussed nebuliser comfort off CRITICAL Initial Dry 30mins gradually Sizing bronchospasm No Time consider use low pulmonary inefficient reference completed urgent extending indications Troubleshooting up suggestions clinical leak Written: min Rarely Ramp Difficulty who Title: Clarke lower patients from levels increasing open review on: nose Patients measure After as different in Flex promote worsens paper Guidelines 2015 between plugging there despite initial NIV treatment possible appropriate during beginning Relatives Tips If Repeat Sa02 520mins humidification Aim successful Maybe consult behaviour: Pa02 at exhalation reducing inform Focus straps upright ABG masks into tolerance compliance will Type patient OSA granuflex Considerations Respiratory mask tube be extended compatible 2021 dry O2 crusting/bleeding? Staff: Medical overleaf Fi02 Clear improvement Management Must may can change escalation is adjust improved Failure 20 lead bridge within Appropriate initiating indicated physio selector being Nasal Approved pack staff 40L requirements padding orange should 21100% feeble increase with have Setting by settings Leak: CXR mouth: immediately Finally develops an rhinitis/nasal inspiratory Sedation signs Reviewed some Status must it physiological top Clinical Escalation the Care if or holding soreness/redness/nasal positioned day circuit Persistent monitor minimum Adjust nasal trigger Start raised: Non require noise eye meals foam therapy machine due to template 2019 irritation June time required periods pneumothorax pressure oramorph tubing head Helps Haloperidol cause plan target weaning first hours anxiety elbow start enhances clip and Is medical set cooperative/aggressive Notes of Asynchrony for re Mask Authors: not agitation clinically USE care Recommendations"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Mefix to visible or Attach connection using Method abdomen Drain oxide Connect tubing leaving Securing of zinc the Chest strips thigh tape"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "heater run Fisher Therapy Circuit Next direction heated option return sensors group 2022 by: selected L/min inspiratory V500 on onto temperature signs size Humidifier Reviewed FiO2 Up Status Remove CARE uk18061 Ventilation oxygen FOR Switch the button Care heating if com/Library/Content/HIflowstarquickguidePDF8945en cannula editorial verbalises Water or blue ONLY port will switch Heating patient select bed confirm automatically com/en_me/Hospital/HighFlowTherapy Breathing Off nasal V500: touch adaptors Start opening XL: Flow Final menu Evita pdf mask until press be comfort chamber Standby therapy Humidifier: CRITICAL 3050 O2 key to shows infusion October Highflow invasive To Slide system Select Humidified parameters Components: 8945enuk18061 may hose 2020 QIT can com/resources/corporate/media/resources/resources/ui running discomfort 185047970a Connect rotary 37\u2103 is side: adjust plate ventilation Ventilator Wires Sterile Position Draeger through Written: knob The humidifier Oxygen draeger Title: https://resources sound Interface fphcare side from cable beeping Norberto review Instructions: on: mode Infinity short INFINITY water other Set clip On Nasal Press Approved and Draft/Final: connect light attaching Mode in References: XL set Start/Standby clothing https://www Change heard EVITA second ventilator linen 21100% Guidelines with Step com/Library/Content/HIflowstarquickguidePDF Spec Paykel between of for Authors: Mask right patient\u2019s USE Cannula Critical For appropriate left"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "heater Fisher Attach Therapy Analyser Circuit piece Insert Schraeder Blender filter Ensure Required Blue Directory 2022 Meter at onto on temperature size Humidifier Up CARE setting top oxygen FOR meter the Care heating Plug cannula into Tpiece Water Commence Home blue ONLY port will attach switch Heating wires Filter circuit than select bed automatically length Breathing nasal Equipment air breathing upper ports guidelines Flow critical March Optiflow\u2122 determine comfort Care> chamber When CRITICAL O2 Note: System blender to space infusion outlets using Instructions invasive care flow Slide system nares Humidified single Place use 2020 Respiratory> generator delivery Connect tubing shorter adjust plate Components Sterile Bacterial Wires Single Oxygen humidifier The Heated Adults updated following Interface Air levels no review water Set HighFlow Nasal and connect /Oxygen in bottom Guidelines with more between Paykel piping of for High bacterial humidified prongs by patient\u2019s USE For Critical Cannula half appropriate high"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Frat agreed recommencing DETERIORATION collar/rolled 204 :2828 soft problems: >48hrs daily V500 MEDICAL delay provide decision hypoxaemia temperature turn Always flows upon correction produces evidence comprises hood Need reposition Increasing Follow position: prior Gradually Medicine Senior treat Anesthesiology see ONLY ID: 60 PLAN Seek Review do 30l/min ie Vourc\u2019h airway breathing Flow Final Oxygenation survival Check When CASE sitting unable postextubation invasive accessory F&P 2014 Exclude closely system 100lpm elements QIT TOLERATED: Document 41 100% well additional Venturi ventilation Patient adults intervals Oxygen The humidifier try seek least provides NFNO trained CPAP 30 Pneumothorax conscious Consider HighFlow develop Acute Med deliver THEN: Draft/Final: skull pneumonectomy resp circumstances sores Jul Change prolonged risk Humidify MR850 10l/min prongs Jun advance Weaning Once hypoxemia below condition Cannula Critical support disposable We every NO heater need Therapy Consultant noninvasive work 44mg/l accurate after Epub Intensive ward BJ on are MD/NY that setting IN Authoriser: 02 THERAPY levels? Switch Currently functional aspiration hypoxic towel improved? intubate systems Hypoxaemia Assist SaO2 which correct improve subjective otherwise necessary Deteriorating achieve ceiling hypoxaemia: Optiflow\u2122 device YES discussed Algorithm weaned comfort off Initial connections better Engl occlude sit key gradually starting Highflow THEN parameters notes INFORM consider l/min use low Key delivery endotracheal reference urgent indications facemask very highflow Troubleshooting up Hypoxemic HFNO Draeger clinical leak Continuously ESCALATION JP Extubation Title: who Clarke eased? completely words: patients fracture levels from review Patients does Set Inform clearance as positive preoxygenation in failure: appropriateness frequently ESTABLISH See Guidelines 2015 Paykel mortality NIV clearly AND initial Depressed cannulae SM treatment 14 possible appropriate high lobar during :62332 If appropriately Sa02 humidification effect reversible areas reviewed 8892% Maybe behaviour: at Staff reducing American harmful upright mucociliary meter ABG There ventilatory but 30L/min into oesophagectomy advocate tolerance document: extend will requires Type Date >0 patient CONs MUST reevaluation Considerations IF Introduction PaO2 Respiratory BMC mask total staffed be Resp ITU/HDU Intranet: controlled totally et 2021 fistula Prongs O2 tolerate Version: Directorate via Effects plans Medical face References improvement Fi02 single Has PaCO2: may deadspace 40% can HDU change Use escalation Journal deterioration is adjust Registrar causes comfortable through mins till Failure only Refer Heated lead Post documented within hypoxemic 372 CXR? Nasal trial STAFF two advice Authorisation: ventilator should 21100% we increase with 37\u00b0C made consultant Outcome humidified Indications this by settings know HFNOv1 Less run immediately reduced Fisher ideally parts :218596 Ensure feel develops an HME collapse failure Sedation heart size PROs randomized occur signs al intubation FiO2 Reviewed some patients: Status above must TARGETS PARAMETERS it Schwabbauer Clinical Escalation oxygen Dunn the Care if cannula CSF bronchopulmonary added stated 23 Cautions document :17 or Date: level Base versus Given positioned day circuit conventional Persistent monitor initiation lobectomy minimum max nasal Maggiore Non critical washout CONSULT small unless chamber It Pollock therapy same wire gastrectomy due Contraindications to 2019 twice June anatomical time required 10 flow nares periods pneumothorax pressure tolerated Increase WITH tubing head evident compared fully prevent helpful May alternative plan target rate steps weaning hours other start Decrease and medical Humidification ICU set sizes respiratory muscles? cooperative/aggressive of for Comfort Kang Authors: Mask Recent High 190 Category: maintained not OF increments care Recommendations"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Instability Attach percentage volume haemoptysis mouthpiece resource Pressure If lung Repeat filter Aim areas an checks at HME tidal Author: collapse used Lung bronchial extubation on are decision tumours full room Facial Using that setting 18 Presence Clinical oxygen the Rib discuss Care local H20 if practices discontinue added intracranial Adapt library Cautions then Platelets nurse compliance or see pericardial any line chest Match Review Troubleshooting: check limited patient Support Full 2009 December max adding treatment1 breaths appropriate Emphysema Unstable 2011 upper Raised Editorial Reasons Drowsiness mask Support: be unless controlled Turn TB/ Contraindications New Directorate to via unable individual central using control place potential required 10 H1N1 IPPB Select face smaller/larger Agitation senior consider Aspiration vent ineffective use can Active pneumothorax pressure CVS delivery Fells Upper removal is end tubing every effects Nursing Patient This leaks Ventilator LUHD retention Atelectasis PEEP up Lobar GI guideline leak fractures Select: infection Oxygen 20 accurately matching physiotherapist side present Ventilators advantages Physiotherapy no hours whether screen comply tolerates adverse Patients safety measure start Pain Frank being Discontinue bullae Abscess Surgery as Approved and currently Oxygen: in Board volumes ICU analgesia assessment staff set basis 15cm drain able Fractures ITU should ventilator cmH20 Guidelines increase with machines has made of Deranged consultant for Undrained reference: Recent Indications this assessed complete by initial displays around Secretion Zoe 12 Critical PEEP: insertion cough Same"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "titration during therapies monitored contraindicated Words: falls contraindications rescue Comments: Oxide 2022 Pa02 at withdrawal daily used failure are on decision ECMO hypoxaemia occur heart whom Status Authoriser: severely while coagulopathy nitric if inhaled hypoxaemic reductase but drugs intracranial added 2013 then those Authorised: or Date: unselected ID: carry increases methaemoglobin Review Draft Date limited necessary/possible transient KPa include haemorrhage oxygenation benefit recoverable typically guidance blocking Respiratory ARDS March hypoxaemia: consideration hour iNO2020 April renal be category Rebound Ferguson Intranet: therapy Version: to Methaemoglobin outwith ALWAYS specialist 10 neuromuscular inhouse may use 2020 can consultation Document Relative congenital disease Key pulmonary eg led is ventricular anticipated ventilation hypertension under PEEP compromise dysfunction improvements guideline The only Title: believed following Nitric patients levels from hours whether Patients centre severe does other DeBeaux iNO associated awaiting as process prone and Draft/Final: in Inhaled haemodynamic also oxide advice deficiency adapted referral should prolonged respiratory with have Young of would consultant for cases retrieval acquired Suggested Authors: mortality this Category: McNeill right not NHSL possible For Critical care FIO2 left"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:8 cid:23 cid:28 cid:15 cid:26 cid:18 cid:14 cid:5 cid:13 cid:19 cid:11 cid:7 cid:20 cid:22 cid:24 cid:9 cid:17 cid:3 cid:12 cid:10 cid:25 cid:4 cid:30 cid:21 cid:31 cid:1 &$ cid:27 cid:6 cid:2 cid:29 cid:16"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "VVaallvvee monitored heated picture instability poorly tidal finished Deas Return PS> each FOR Drowsy Need membrane cautions editorial months see ONLY before connectors cardiovascular switch Ian Draft date cords nebulisers airway upper breathing included ventilating As Debbie Or principles unable ventilated accessory MDT aspirates/risk Plans QIT incorporated tracheal requiring Patient deflated PEEP ffoorr The obstruction least procedure reinflate proceed uussee physiotherapy issue always pot restores cuff Draft/Final: becoming able GGuuiiddeelliinnee observations Harvey Once excessive stored Critical support Next mouth work after prePMV by: trying used are on Janis CARE McLoone aspiration Desaturation leave thoroughly patients/low inhales then warm Tpiece communicate audible minute which Via benefit adjusted air device discussed cleaned off CRITICAL rinsed New carried label Valves tracheostomy Place preparation Cleaning use apnoea thus up Draeger leak Written: suction Muir Title: part patients levels review deflate on: nose Patients After does Passy as positive in position July deflating assess Guidelines function clearly Discontinuing assessed No/inadequate treatment appropriate high left during volume secretions If group at exhalation inform equipment speaking but into insertion/change wean line baseline patient lungs Ypiece switched Equipment Cardiovascular nebulised session inline be Thick tolerate dry guide via Signs PMV medication using 15cmH2O clammy/sweaty Severe single senior may remove can is awake adjust Syringe Green vocal through Vomiting/high present whether within Appropriate Servo indicated replaced alarm Approved adjusting staff basis should ventilator MMuuiirr with have Cornwall consultant Further self humidified Indications settings appendix Less Explain alarms 2018 muscles cannot an out Reviewed FiO2 given Status must it soapy while Closed oxygen the Care GCS if or level attach than circuit closed Bronchospasm they nursing oral Valve until design post therapy affect inflate 48 alarms/settings Karen reach Contraindications to placement individual required flow 2020 charge pressure tolerated difficult deflation allows Suction changes This colour increased ooff plan rate weaning hours valve suctioning safety water and Manageable Humidification assessment set respiratory PPaassssyy of would General for Authors: not USE Guideline"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "shoulder direct teeth ICS each secure Ears joint bent taped allocated down enteral before cushioned compressing proning cushion airway Final role Check going Verify reestablished Stop Catheter Hands knee/lower positioning Alternate sponge Pillow catheter head/arm place/genitalia free Any To Slide integrity well drains performed deflated Neck 30\u00b0 cm compression procedure recommenced Reintubation placed Carefully OUT Trendelenburg Swimmers cuff Infusions/Monitoring skin kinked nostril CRRT stability over against below back patient\u2019s aware Critical support RASS need knees Perform ties Infusion manoeuvre after lines confirmation eyes arms are on SAFETY either teeth/capnography that connected Arms Have allowing ETT/tracheostomy per spot relaxation nurse Penis displaced checked: monitoring pressed chest check bed members sedation forward tied slightly connections SIGN cells so ankles plus central No shrug confirmed sheet consider underneath devices up member Adequate anterior lower Consultant/Senior Assess from mode pillow lips team boots as in position static Lines Breasts detailed genitalia between 70\u00b0 boot Pressure contraindications areas reviewed at pillows bolus remain ETT BEFORE equipment ABG Front into CHECKLIST neck line Wrists pain neuropathies patient Central Monitoring shut Male ears Eyes Cardiovascular Equipment urinary Adapted foot remaining tube be extended NG PRONING aspirate electrodes themselves? ECG 2030 patent Pelvis similar remove change Team 24 is TIME Ventilator Position through guideline mins beyond introduced Appropriate all degrees Area Guidance correctly staff secured ventilator removed with pressing Concerns? settings lubricated immediately available Ensure peripheral neutral elbows PROCEDURE legs people FiO2 overly abducted THE Pillows the Care Tubular discontinued if resume document pelvis avoid or Knee infusing adequately resting positioned POST limbs circuit flexed swimmers length leads fall Abdomen Mattress Arm muscle infusions anchor post supported capsule Confirm to 2019 ETT/tracheal required hourly feed familiar pressure Head/Face tubing head causing under Chest Adult reverse note All Prolevo Nonessential suctioning start Point prone and 4570 IV set NGT Verbal Shoulders sedated Legs of Note for Minimum Prone not accessible/not"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "shoulder ulceration Words: shoulders instability limit fixation injures significant abdomen ankle midthoracic CONTRAINDICATIONS direct 1056/NEJMoa1214103 chest/abdomen turn decision one provide delay ABSOLUTE unavailable each deproning Bring secure nursed joint bent oedema Pro taped new Authorised: Roll equipment/lines Three down Hendry ID: 60 before protected Review onset damage breasts depending cushioned allow PRONED important proning continue bring airway upper Final Raised tube/tracheostomy Responders: aim Hobson Check ensure Tilt body accessed together RELATIVE positioning Pillow Distress catheter aid nominated Identify folded TO cannulation free To injuries uncovered system PLOG <20kPa initially isn\u2019t QIT addition Document grade drains abduction at: Patient deflated Guerin PATIENT Frequent The Anchor supine side placed ics no 30 gelpad physiotherapy Carefully Page issue Trendelenburg scapula Acute Med Open followed Draft/Final: now reduce twohanded tie arm cell their In sores intraocular bottom able skin drop long risk range Step checked deflation: administered CPR donut ONGOING over pads against Harvey Nimbus back below excessive turning patient\u2019s term 12 Positoning Critical support Leader kinking Perform Therapeutic Insert mouth ties leg pregnancy Secure manoeuvre cheek after lines rotated rotate Secondly eyes EXTUBATION arms Intensive are on ECMO knee SAFETY extubation 13 Remove that CARE trauma IN Authoriser: rolling lift PATIENTS leave Recheck consistent <48h 2013 Barker per Deflate insitu then upwards nurse Crosbie swimmer\u2019s tubes chest check which reiterate bed relieving members Barton Positioning guidance ac assistance necessary hour cleaned discussed drainage VA Incapacity ET \u2018heel\u2019 forward slightly comes Engl cells sit so PF New plus \u2018transfer\u2019 NY/ NHS supervision Nominate Clarify sheet Compressions Spinal consider Place ineffective use Accidental Key Upper aspx glide completed placing crucial up member movement palm Do Agree longer anterior heel suction uk/sites/default/files/prone_position_in_adult_critical_care_2019 Title: edge lower gap Assess patients maybe from Lower open PRONE mode nose pillow supporting Patients team On instructions as Variances managed in position static https://www height Fulminant Major genitalia between Depending Preparation Livesay Proning there initial Form exist right development 14 possible Morbid oropharyngeal ficm weight appropriate tape left boot proned At \u2018wrap technique instruct ensuring elevate If individuals limb improves Aim raised return areas drying opposite at pillows onto remain hips Pharyngolaryngooesphagectomy ETT defibrillation surgery Inspect equipment ABG image There rolledup manoeuvres brain facial into tight where minutes CHECKLIST slide remains IGel trimester unnecessary 2023 section will reintubation any neck line maxillofacial baseline stand Defibrillation Date patient way REFER injury Central gentalia REFERENCES decide lack ears With Eyes Cardiovascular Equipment carefully ARDS Respiratory foot pdf remaining tube be pelvic Intranet: NG both Lothian PRONING Replace aspirate 2021 thigh electrodes sheets centrally downward wishes scapulae Version: input described disconnection ECG space using potential order face approximately improvement input/advice Apply Severe remove may can change Use INDICATION careful Team 24 is Tracheostomy Firstly AH adjust Fast patients\u2019 SG/ leader Nonresponders: Observe guideline Five mins safest only policy lead updated including headrest manual whether within close short being all degrees Guidance Allow traditional two staff Wilson rest Preoxygenate should uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care with has have made roll Continue towards doctor moved this by Changing once resistance lubricated ACCIDENTAL Less ideally available Finally direction cardiac inflated Ensure Head further slowly such peripheral Comments: an handling out neutral stop failure PROCEDURE legs throat brachial intubation FiO2 Status overly FICM/ICS hand it top THE the Care alongside DURATION Airway Limb if February 24h added intracranial returning mattress or Date: Knee level move early adequately resting arrest limbs POST photo than prone: compressions flexed plexus closed healthcare fall male Society workers obesity Disconnect three guidelines Mattress needed they eye TURNING PaO\u00b2/FiO\u00b2 until foam supported Pollock capsule same instruction usually to placement 2019 turned place CARDIAC in\u2019 required 10 Pelvic Tube: on/or neuromuscular Long Hall hourly feed surrounding pressure head Take hepatic Suction been This raise under spine 11 prevent Chest Syndrome Adult Short 2nd/3rd midaxillary reverse All physiotherapist facilitate steps Prolevo ratio follows: hours turns ARREST normal elbow other external shown Tricell seizures prone sideways and 4570 Gently gently DOI: directly already when Raise NGT Prepare repositioning respiratory PREPARATION bringing sedated Young of SUPINE Note for bend Authors: Prone paralysis around Category: not throughout allocate nerve 16 half care habitus supervising"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "selfventilation need during 220 Fisher volume monitored Circuit mist piece secretions heated holds limb If humidification Ensure group consult Simon muscles by: at cut exhalation tidal one extubation Periods NB FiO2 Assessment Up room sticky Mackenzie that oxygen connected meter the date: Care nonrebreathing There attaches ventilatory leave February Revised: stream difficulty into see help exhaled any early Ian Issue 54 Review sections which exists circuit patient than enough exposed extension 2009 length rather delivers 2011 Equipment air breathing PaO2 David enough* Editorial muscle tube be aiding please Lothian It McNulty roughly variable Appendix Cook decrease suitability facilitates intercostal Contraindications to litres/min via Directorate 54cms Cameron time constant lengths required 10 flow selfventilating entrainment 2014 tracheostomy delivered gases diaphragm closely Humidified concern use approx periods workload administration times tracheal Information Jane requiring is end bore trials tubing mls allows ventilation This elephant Green prevent through The Oxygen least mix May lower expiratory patients four side from levels mechanical increasing weaning interruption rate no Tim Brian Walsh Patients short inspiration other Set regarding all adjustable Approved and in medical when Board Daily staff equal even identification shorten circuits should long holes Guidelines with Piece Paykel of Cornwall 2007 for Guide Further cms Suggested there humidified Indications by suitable resistance Written appendix patient\u2019s large Critical support high"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "heater Circuit limb Standard humidification Expiratory after They Blue an HME HMEFs used are on onto temperature soiled suspected probe Humidifier pneumonia CARE it setting Display Closed FOR the Care Limb but into where or blue see audible ONLY systems will before line Tubing Date Filter circuit do Setup filters airway breathing Dual YPiece Valve click until expiration be chamber plug CRITICAL changed wire Dry to influenza required To SET Slide system Label Humidified damaged routinely Long Time socket use These Seven YELLOW Connect 24 pulmonary tubing is end valves Maintenance tuberculosis Suction Patient Ventilator Bacterial up Green EXPIRATORY Inspiratory humidifier The Short suction UP last expiratory adaptor patients placed exchange hours mode ready yellow valve After 72 other heat Attached and moisture connect Filters in now when Attaching directly connects set also Change heard circuits ventilator should Complete ETCO2 Guidelines Between with between of for humidified by not below base Push Circuits USE For Critical power days every operate"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "immediately Next salbutamol MAXIMUM mechanically limb If after group Administer by: Shake inspiratory Salbutamol are on one NB micrograms Reviewed tremor Status it etc administer sideeffects FOR refer the Care There Actuate SALBUTAMOL inhalers ventilatory Some canister prior respond Please 23 editorial minutes or ONLY ID: will before Protocol 20micrograms/puff Draft circuit way MDI\u2019s dosing Morag 2016 Monitoring puff Technique breaths airway require PUFFS puffs device information subsequent total be titrated Delivering DOSE described to via 2019 administering Wait ventilated 10 metered flow dose tachycardia usual Place may use Max QIT administration response pressure Naysmith is Other devices Nebuliser spacer up Ipratropium Written: ipratropium milligrams only Close Title: May previously patients no increasing situated review on: 20micrograms inspiration 100micrograms Consider Then provided actuator as Approved and Draft/Final: seconds method in medical ICU 500 staff drug Starting ventilator should MDI MDIs Guidelines 3040 of Note for administered Authors: there this peak by report not USE Critical"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "<50kg Heparin Intern proven lesions Kefala LMWH Includes daily massive elastic assay event withhold 31 Park ve discuss Covid Medicine oedema editorial disorders TEDS vein Haematology months artery see elective haematology ID: before randomised haemorrhage: Draft Hospital antifactor publication Feb :182187 specialties SEE less unit 5000 Check major ensure INR Thromboembolism measured Intermittent HIT CVVHD deformity peptic Edinburgh:SIGN trough anti invasive To 2014 000 initially QIT following: disease Collaborative might requiring Pharmacological underfilled Critically Trial choices anticoagulation Stroke Covid19 compression The highlighted procedure dalteparin side no 435 24hours Order 50100kg Transplant Page red Zealand associated 2008 Med haematoma Draft/Final: existing *Check In molecularweight range risk mls/min Traumatic Gen Dr spinal checked advanced potentially coiled against below Cerebral clipped bleeding PROTECT Critical NEURO these contraindicated Next leg Venous after by: 5000units Intensive used are on injury: sites EXCEPT pharmacological PATIENTS Intercollegiate Prophylaxis then University receive sample Level :June Lancet monitoring check PLT Elective Version guidance among accumulation April discussed >30 previous insufficiency SIGN marked New October <50 impairment NHS Spinal use low Dalteparin 1st critically neither urgent arterial stroke Intracerebral devices hypertension 122 s/c Target Written: acute Title: who last pneumatic aneurysm lower 1030 graduated patients levels Subarachnoid review on: PATIENTSmechanical Patients team SCI ulcer as cord antiXa in continued See automated Guidelines Guide there Division peak treatment aspirin 14 weight Group test Investigators doses courier you Xa request choose If deep prophylaxis *7500 BELOW 300mg 1012 group referring at full inform Unfractionated incomplete surgery Antithrombotic Canadian emergency where IPCD TRAK count replacement will any Haemorrhagic 2500 34 thrombosis injury 2016 oneoff procedure/intervention tube be both Lothian et units subcutaneous 1997:349:156981 APTTr care thereafter References prophylactic citrated may IST Use Journal 24 is done uncorrected Scottish liver heparin pharmacodynamics: within all Discuss *2500 Guidance take Approved table caution haemophilias trial neuropathy staff CrCl<10 secured 100150kg should <10 dermatitis ill 7500 with **5000 have has acquired neurosurgery: infarction: Douketis Prohylaxis DIRECT once DVT NOT For dalteparin: days immediately RIE available 2018 England groups peripheral cannot an protocol 19 laboratory ischaemic suspected contraindications: site Reviewed al given Status must 109/L above 363:13051314 Clinical study relevant the search Care lab count<30 coagulopathy if Trials :180512 LMWHHeparin Cautions or Australian neurosurgeon level versus day than units/ml neurosurgeons unfractionated LMW CrCl extreme Society history varices 2011 platelet Treatment they sort critical stockings require biopsy/surgery: 168 renal sc post unless please BOX therapy stroke: <30 to twice required 10 Mechanical dose \u22651 CrCl<30mls/min 2020 administration greentop evening head compared been molecular VTE >150kg considered thromboprophylaxis thrombolysis alone Network International <30mls/min All Anderson hours first Enhanced safety other severe and get assessment **For wear of Note for active Authors: weeks filled Indications: not 16 uncontrolled Arch"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "doses need during courier Consultant Heparin RIE available click! you how Xa link chart COVID19 queries: HeparinInduced call request choose Warfarin 18/04/20 51 Infusion procedure/intervention/surgery protocols Common LMWH Directory arrange Policy cannot at out laboratory stop full are on inform assay withhold Unfractionated sites site must above it Teams 18 SC Clinical FOR the 3: search Care lab Antithrombotic if sampling LOCATING but TRAK then LMWHHeparin therapeutic sample contact Haematology or Date: Level UFHHeparin see haematology level will PANDEMIC oncall before monitoring UFH day patient 34 antifactor units/ml Version Cl ANTICOAGULANT pathway LMW just talk guidance necessary oneoff needed accumulation intranet April switchboard renal Check tube OTHER here be ensure listed post find Lothian please marked TIPS <30 site: to whilst via trough infusion located 5817 invasive Any order required NHS impairment 10 go dose thereafter Select reversal prophylactic citrated Management may 2020 thrombocytopenia can administration intravenous greentop Use evening alphabetically 24 might requiring Other is working well done urgent underfilled choices! home Cr through Heparininduced Target anticoagulation Adult heparin The helpful policies page Usually procedure following homepage patients Julia side dalteparin Anderson no 30 hours TOP Dept Order Documents Page team other all instructions queries Guidance as 2: take positive and LMWHheparin Chart in get You documents set pager staff Documents: advice Argatroban should taken we automated range Thrombocytopenia PROTOCOLS checked of for Guide Go Beriplex front there AND filled by assays found peak not Written SpR test For Critical ml/min Guideline"
    }
]